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Objectives 
This report presents detailed 
information on the National Asthma 
Survey (NAS), a module of the State 
and Local Area Integrated Survey 
program conducted by the Centers for 
Disease Control and Prevention’s 
(CDC) National Center for Health 
Statistics. NAS, sponsored by the 
CDC’s National Center for 
Environmental Health, was designed to 
produce national prevalence estimates 
of adults and children with asthma; to 
describe the health, socioeconomic, 
behavioral, and environmental 
predictors that relate to controlling 
asthma better; and to characterize the 
content of care and limitations of 
persons with asthma. National 
prevalence estimates were constructed 
to be consistent with those produced 
from the CDC’s National Health 
Interview Survey (NHIS), although 
prevalence estimates for 
subpopulations may or may not be 
consistent with NHIS. 
Methods 
Two separate random-digit-dial 
telephone studies were fielded: a 
national study and a four-state study in 
Alabama, California, Illinois, and Texas. 
Children aged 0–17 years and adults 
aged 18 years and over were included 
in both studies. The screening 
procedure differed between the studies. 
Percentages can be generated for the 
four states combined or for each state 
separately. A substudy was conducted 
in the national study to examine the 
accuracy of proxy reports of asthma. 
Results 
Data were collected from February 
2003 to March 2004. A total of 955 
detailed asthma interviews were 
completed in the national study and 
5,741 in the four-state study. A data file 
has been released for each study that 
contains asthma, health, and 
demographic data, as well as sampling 
weights. The weighted overall response 
rates were 47.2% for the national sample 
and 48.5% for the four-state sample. 
Keywords: health surveys c needs 
assessment c State and Local Area 
Integrated Telephone Survey Design and Operation of the 
National Asthma Survey 
by Kathleen S. O’Connor, M.P.H., CDC; Larry Osborn, M.P.H.,† and 
Lorayn Olson, Ph.D.,† Abt Associates Inc.; Stephen J. Blumberg, 
Ph.D., CDC; Martin R. Frankel, Ph.D., Baruch College at the City 
University of New York and Abt Associates Inc.; and K. P. Srinath, 
Ph.D., and Pamela Giambo, M.S.,† Abt Associates Inc. Introduction
 
This document reports detailed 
procedural information on a unique 
source of asthma data, the National 
Asthma Survey (NAS). The 2003 NAS 
data were collected by the State and 
Local Area Integrated Telephone Survey 
(SLAITS) mechanism of the Centers for 
Disease Control and Prevention’s (CDC) 
National Center for Health Statistics 
(NCHS). The survey was sponsored by 
CDC’s National Center for 
Environmental Health (NCEH). Two 
separate studies were fielded for NAS: a 
national study and a four-state study in 
Alabama, California, Illinois, and Texas. 
Information is provided on asthma 
and its affect on the U.S. population. 
This report describes NAS and its 
unique characteristics and discusses in 
detail the methods used in NAS, 
including information on the 
development of the survey instrument 
and procedures; sample design, 
selection, and characteristics; the 
collection, storage, and cleaning of data; 
and the construction of public-use data 
files. To reduce confusion and enhance 
data use, especially for novice analysts, 
a short list of frequently asked questions 
is included at the end of the 
introduction. Asthma in the United 
States 
Asthma is a chronic disease that 
causes swelling in the inner lining of the 
airway leading to the lungs. Adults and 
children with asthma may experience 
wheezing, breathlessness, chest 
tightness, and coughing. A 
nonexhaustive list of common triggers 
that may cause bronchial constriction 
and asthma includes inhalant allergens 
such as pet dander, dust mites, 
cockroach allergens, and mold; outdoor 
allergens; environmental exposures such 
as tobacco smoke, fumes, air pollution, 
and chemicals; and occupational 
exposures (1,2). Stress and exercise may 
also contribute to asthma symptoms in 
persons who suffer from exercise-
induced asthma. 
Asthma is a costly and common 
chronic condition in the United States 
(3). In 1998, asthma cost $12.7 billion 
dollars in the United States alone (4). 
According to CDC’s National Health 
Interview Survey (NHIS), in 2002 just 
over 12% of all children under 18 years 
of age had ever been told they have 
asthma (resulting in almost 8.9 million 
asthmatic children) (5). Almost 6% of 
children had an asthma attack in the 12 
months prior to the interview (5). †Indicates authors who are no longer affiliated with Abt Associates Inc. at the time of publication. Page 1 
Page 2 [ Series 1, No. 46 According to the 2002 NHIS, 10.7% of 
adults in the United States were 
diagnosed with asthma and 6.8% still 
had asthma (which means almost 22 
million U.S. adults have ever been 
diagnosed and almost 14 million adults 
had asthma at the time of the interview) 
(6). Data from the 2002 Behavioral Risk 
Factor Surveillance System (BRFSS) 
show considerable state-to-state 
variation in asthma prevalence rates for 
adults, with lifetime asthma prevalence 
ranging from 8.6% (South Dakota) to 
14.5% (Montana), and current asthma 
prevalence ranging from 5.8% (South 
Carolina) to 10.0% (Maine) (7). 
Uncontrolled asthma can be fatal. 
The asthma death rate in the United 
States for children under 18 years of age 
increased from 1.8 deaths per million 
children in 1980 to 3.3 deaths per 
million children in 1998, representing an 
average increase of 3.4% per year (8). 
The total age-adjusted (to the 2000 U.S. 
population) annual death rate increased 
from 14.4 deaths per million children in 
1980 to 17.2 deaths per million children 
in 1999, although this rate has been 
decreasing since 1995 (9). 
The Role of the National 
Asthma Survey 
NAS complements and extends 
other surveys conducted at CDC and 
elsewhere. Within the CDC, data on 
asthma are collected through various 
mechanisms such as NHIS, the Youth 
Risk Behavior Surveillance System 
(YRBSS), the National Health Care 
Survey (NHCS), and BRFSS. NAS 
addresses several deficits in these data 
collection systems. For instance, 
although NHIS collects information on 
asthma for adults and children, estimates 
are only available at the national level. 
BRFSS collects asthma data at the state 
level and permits calculation of a 
national estimate; however, data were 
only collected for adults aged 18 years 
and over at the time of NAS data 
collection. However, by adding annual 
optional modules at the state and 
territory levels, BRFSS collects selected 
information on the nonadult population 
17 years of age and under. More 
information on asthma surveillance for children and adults using BRFSS is 
available at http://www.cdc.gov/asthma/ 
brfss/default.htm. Asthma prevalence 
data for children have been collected for 
a number of years in states that chose to 
ask the childhood asthma module 
questions, and participation varies each 
year. YRBSS collects self-reported 
behavioral and health risk data from 
9th- through 12th-grade students but 
collects minimal asthma data. 
NHCS is a family of establishment 
surveys that provide information on 
health care facilities, services, and 
patient characteristics. NHCS collects 
information on many subjects, including 
asthma; however, it can only provide 
data on asthma care provided in 
ambulatory care, ambulatory surgery, 
emergency room, long-term care, and 
inpatient settings, and it cannot provide 
data on asthma care provided by 
household members. NAS addressed 
these issues by expanding the range of 
information available. NAS collected 
detailed asthma data on the sampled 
respondents’ access and use of health 
care (primary care, emergency room); 
asthma knowledge and behavior; 
medication use; family history; and 
environmental exposures for adults and 
children who live in households. 
This survey adds depth to the 
existing body of asthma data and helps 
address critical questions about the 
health and experiences of people with 
asthma. A nonexhaustive list of potential 
research questions that may be answered 
using NAS data includes the following: 
+	 What are the demographic 
characteristics of persons with 
asthma? What is the asthma status 
of critical populations, such as 
children or the population over 50 
years of age? 
+	 How well are asthma attacks, 
episodes, and symptoms controlled 
through medication use and 
preventive measures? 
+	 What is the range of ages when first 
diagnosed? 
+	 Which systems of care are most 
often utilized by people with 
asthma: urgent, hospital, or primary 
care? 
+	 Do persons with asthma know the 
symptoms, and do they understand what to do when they have an 
asthma attack? 
+	 Have people with asthma received a 
written management plan from their 
health care provider? 
+	 What modifications have been made 
to home, school, or work 
environments because of the 
disease? 
+	 What treatment modalities are most 
often used by those with asthma? 
+	 Is the use of asthma medication 
consistent with guidelines? 
+	 What does family history of asthma 
suggest about predisposition for 
asthma? 
+	 To what extent have guidelines for 
the diagnosis and management of 
asthma been translated into practice? 
+	 To what extent does asthma cluster 
within households? 
NAS was designed to improve 
understanding of how demographic 
differences, patterns in health care 
utilization, medication use, and 
environmental modifications are related 
to treatment and symptom control for 
children and adults with asthma. The 
data can potentially identify subgroups 
that may benefit from behavioral 
interventions. 
The State and Local Area 
Integrated Telephone Survey 
program 
SLAITS modules use the large 
sampling frame of the CDC’s National 
Immunization Survey (NIS) to identify 
samples and cases. NIS is a large-scale 
random-digit-dial (RDD) telephone 
survey that screens for the presence of 
young children in sampled households 
and collects detailed vaccination history 
information for eligible children. The 
size of this sample provides a 
cost-effective opportunity for SLAITS 
projects to survey other populations, in 
addition to the rare population that 
eventually screens into NIS. NIS sample 
design is described in more detail in this 
report, at the NIS website located at 
http://www.cdc.gov/vaccines/stats-surv/ 
default.htm#nis, and in the Vital and 
Health Statistics series report by Smith 
et al. (10). 
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Questions 
To reduce confusion and enhance 
data use, especially for novice analysts, 
this short list of frequently asked 
questions is included. 
How is this report organized? 
The main body contains detailed 
information on the entire survey process. 
Appendices contain additional detail on 
selected topics such as pretests, 
instruments, and weighting. 
What are the names of the Primary 
Sampling Unit (PSU) and stratum 
variables for each file? 
For the national file, the PSU 
variable is IDNUMR and the stratum 
variable is STRATUM. For the 
four-state file, the PSU variable is 
IDNUMR and the stratum variable is 
STATE. See page 27 for more 
information. 
What are the names of the weights 
for each file? 
The weights in the national file are 
post_pr_int and post_sr_int. The weights 
in the four-state file are post_adult_int, 
post_child_int, and weight_int. See page 
28 for more information. 
In the national file, when was it 
acceptable to collect proxy-reported 
data on asthma status in adults? 
Proxy reports were acceptable if 1) 
the adult sampled respondent was too ill 
or infirm to answer but still wanted to 
participate or 2) the sampled adult was 
not available at the time of the 
screening contact. In this case, a very 
short proxy interview was conducted 
with the adult household member who 
answered the telephone. If the sampled 
adult was reported to be asthma-
positive, an appointment was scheduled 
to complete a detailed interview directly 
with the sampled person. Asthma status 
was confirmed with that person at 
callback. The initial design of the 
national study also called for a subset of 
500 sampled adults who were reported 
by a proxy respondent as asthma-
negative to be called back to confirm their asthma status and determine proxy 
reporting error. 
In the national data file, why is proxy 
information included that has been 
verified or changed by the adult 
sampled respondent? 
This information is provided for 
methodological purposes only. 
In the national file, which weight do I 
use to examine asthma in children? 
This depends. The national file does 
not include a single child-level weight. 
Instead, it includes two weights, both of 
which include all sampled children: 
post_sr_int and post_pr_int. Estimates 
for children can be produced using 
either weight, but one should remember 
that adults are included in both weights 
too (in case there is no interest in 
estimates for adults). The weight to use 
for children must still be decided, as 
these individual weights may vary 
slightly for any given child because of 
the difference in the number of sampled 
adult cases used to calculate the weight. 
Therefore, which adult cases should be 
included: those with self-reported data 
only or those that have self- and 
proxy-reported data? The preferred 
weight to use for child and adult-level 
estimates is post_sr_int because it only 
includes sampled adult self-report cases 
in addition to all children. The alternate 
weight is post_pr_int, which includes 
sampled adult self- and proxy reports, in 
addition to all children. The post_pr_int 
weight should be used for 
methodological research to examine 
differences between self- and proxy 
reporting in adults. 
In the national file, what is the 
relationship between the proxy and 
sampled respondents for the screener 
contact and main interview? 
In the national sample, proxy 
interviews were allowed in two 
situations: 1) if the adult sampled 
respondent was too ill or infirm to 
complete the interview over the 
telephone or 2) a subset of sampled 
adults was unavailable at the screener 
contact and reported by a proxy 
respondent to be asthma-negative. These latter cases were called back to confirm 
their asthma status. Based on the 
observed proxy-report error rate for this 
subset, a decision was made to expand 
confirmation calls to all adult sampled 
persons with proxy-reported asthma-
negative status. For a sampled child, all 
interviews were conducted with a 
knowledgeable adult household member. 
For the four-state file, are the weights 
for the total population the same as 
the separate weights for children and 
adults, and can weighted data be 
examined individually for each state, 
or only as the four-state block? 
Yes, the separate weights for the 
total population comprise the individual 
weights for children and adults. 
Weighted data can be examined for each 
state individually, as well as for the 
four-state block as a whole. 
Why can’t I use the four-state data 
file to calculate prevalence estimates? 
The four-state file cannot be used to 
calculate prevalence because crucial 
information needed to do so was 
purposely not collected because of the 
selected screening process. This decision 
was made after extensive tests were 
conducted. The four-state sample can be 
used to describe the characteristics of 
children or adults with asthma. 
What can I use the national data file 
for? 
The national file can be used to 
calculate prevalence estimates. 
In the national file, what is the 
relationship between the proxy and 
sampled respondents for the screener 
and main interviews? 
In the screener interview, proxy 
respondent reports were allowed if the 
sampled adult respondent was either too 
ill or infirm but wanted to participate or 
the respondent was unavailable at the 
screening contact (initially this 
unavailable status only applied to a 
subset of cases for the validation 
substudy). If the sampled respondent 
was available at the time of contact, he 
or she completed the screener interview 
directly. 
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scenarios were possible: 
+	 If the sampled adult respondent was 
too ill or infirm, the detailed 
interview was conducted or 
terminated depending on the 
respondent’s asthma status. 
+	 If the proxy-reported asthma-
negative sampled adult was finally 
reached (or called in), he or she  
was asked to confirm their 
proxy-reported asthma status; the 
data file contains the information 
from both calls. If the proxy-
negative report was wrong and the 
sampled adult did in fact have 
asthma, the interview continued with 
the asthmatic sampled respondent 
through self-report. If the sampled 
respondent was asthma-positive, he 
or she completed the detailed 
interview. If the respondent did not 
have asthma, the interview was 
terminated after a few demographic 
questions were asked. 
+	 If the proxy-reported asthma-
negative sampled adult was never 
reached, only the proxy-reported 
responses were included in the file. 
Please contact slaits@cdc.gov if you 
still need assistance after you read the 
appropriate sections in this report. 
Methods 
Sample Design 
SLAITS studies benefit from the 
large number of screening calls required 
for NIS. NIS was established in 1994 to 
monitor immunization levels of very 
young children in the United States. It 
screens well over one million 
households per year but conducts 
detailed interviews in only a small 
portion (those that contain at least one 
child aged 19 to 35 months, the primary 
target of immunization programs). 
Because this large screening sample has 
been contacted, SLAITS enjoys 
considerable cost savings by avoiding 
the expense of frame development, 
sample selection, and residential 
screening. The 2003 NAS consisted of two 
samples: a national sample and a 
four-state sample that includes Alabama, 
California, Illinois, and Texas. NAS 
used the NIS sample to assess asthma 
prevalence at the national level and 
characterize the content of care and 
limitations of people with asthma in the 
four states and at the national levels. 
Because the four-state file contains only 
respondents who screened in as 
asthma-positive, this sample can be used 
to examine detailed characteristics and 
behaviors of asthma-positive persons but 
cannot be used to determine prevalence. 
Information needed to calculate the 
prevalence rate was not obtained during 
screening for the four-state sample. 
Because of the weighting procedures 
used for the national sample (which are 
covered in ‘‘Weighting and Estimation 
Procedures’’ as well as in Appendix B), 
national prevalence estimates are 
consistent with those produced by 
NHIS. Prevalence estimates for 
subpopulations within the national 
sample may or may not be consistent 
with NHIS. The two NAS files should 
NOT be combined to produce more 
precise estimates. Weighted estimates 
can be calculated for each state in the 
four-state sample (using a ‘‘where’’ 
statement to select the appropriate cases) 
or for the four-state sample as a whole. 
Each state was weighted up to its 
appropriate population control totals. 
The goal was to complete screening 
interviews in 10,000 households in the 
national study and in 12,000 households 
in each of the states selected by NCEH 
that comprise the four-state study. To 
accomplish this, telephone numbers 
were randomly selected from the NIS 
sample. 
The National Immunization 
Survey sampling plan 
This section describes the basic NIS 
sample design and serves as a 
nontechnical description of the NAS 
sample design and allocation procedures. 
Appendix B of this report includes a 
more technical description of the NAS 
sample design and weighting 
procedures. Each quarter of the year, NIS 
screens telephone numbers to identify 
households that contain at least one 
child aged 19–35 months. Because less 
than 4% of households in the United 
States contain children in this age range, 
a large number of households must be 
contacted and screened to identify 
households with eligible children. 
Households are selected for screening 
through list-assisted RDD methods. 
In the United States, telephone 
numbers consist of an area code of three 
digits, a central-office code of three 
digits, and a suffix of four digits. 
Combined, an area code and central-
office code form a prefix area. For 
example, 617–492 is the prefix area 
corresponding to the 492 central office 
in the 617 area code. For NIS, prior to 
the selection of the sample of telephone 
numbers, banks of 100 consecutive 
numbers in the same area code and 
prefix combination that contain zero 
directory-listed residential telephone 
numbers—that is, banks of 100 numbers 
that have a low probability of containing 
working residential numbers—are 
deleted from the sampling frame. For 
this step, the GENESYS Sampling 
System (a proprietary product of 
Marketing Systems Group) uses a file of 
directory-listed residential numbers from 
Donnelley Marketing Information 
Services. The sampling frame of 
telephone numbers is updated each 
quarter to reflect new telephone 
exchanges and area codes. The NIS 
sampling frame excludes cellular 
telephone exchanges. A random sample 
of 10-digit telephone numbers is then 
drawn from the retained banks of 100 
numbers. A further step eliminates 
business and nonworking telephone 
numbers from the sample prior to 
dialing. 
Each remaining telephone number is 
then called by an interviewer. If it 
belongs to a household, the person 
answering the telephone is asked 
whether any children aged 19–35 
months are living or staying in the 
household. If the household contains an 
NIS-eligible child or children, NIS is 
conducted in its entirety. This is 
followed by a NAS screening and the 
full NAS interview (if eligible). In 
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Table A. Percentage of overall sample that is an augmentation sample: NAS, 2003 
Percent of sample called 
Sample only for NAS 
National . . . . . . . . . . . . . . . . . . . . . . .  75.0  
Four-state 
Total. . . . . . . . . . . . . . . . . . . . . . . . .  52.4  
Alabama . . . . . . . . . . . . . . . . . . . . . .  61.5  
California. . . . . . . . . . . . . . . . . . . . . .  36.9  
Illinois. . . . . . . . . . . . . . . . . . . . . . . .  61.9  
Texas . . . . . . . . . . . . . . . . . . . . . . . .  50.0  
NOTE: NAS is National Asthma Survey. households that do not contain a 19- to 
35-month-old child, the NAS interview 
immediately follows the NAS screener 
(if eligible). 
The National Asthma Survey 
sample design and allocation 
When the 2003 NAS was 
conducted, the NIS sample design 
consisted of 78 distinct geographical 
areas that comprised the United States. 
Of these 78 Immunization Action Plan 
(IAP) areas, 50 were states and 28 were 
urbanized areas. To achieve the target of 
10,000 completed household screeners 
for the national study and 12,000 in 
each of the four states, the sample was 
allocated in proportion to the total 
number of households in a specific 
geographic area. In the national NAS, 
the number of households required to be 
selected in each state was determined by 
allocating the desired number of 
screened households among states in 
proportion to the total number of 
households in each state. Then, the 
number of telephone numbers that 
needed to be called was computed using 
the expected working residential number 
rate in each geographic area. The 
number of telephone numbers drawn 
compensated for the fact that not all 
respondents would agree to participate. 
Because of the quarterly selection 
and release of the NIS sample in each 
IAP, some telephone numbers were 
selected more than once during the NAS 
data collection period. Such numbers 
were not contacted a second time for the 
study. Instead, these cases were 
automatically finalized and assigned the 
final disposition code from the original 
sample. Response rates reflect the final 
disposition of a telephone number from 
its original sampling. 
The national study screened a single 
randomly selected household member 
about his or her asthma status. 
Regardless of asthma status, the 
screening interview included a series of 
demographic questions concerning the 
sampled person and the household to 
allow for the production of asthma 
prevalence rates. If sampled respondents 
indicated that they had ever been told 
by a doctor or other health professional that they had asthma, a detailed 
interview on asthma management and 
treatment was completed. If a 
respondent was asthma-negative, a small 
subset of items from the detailed 
interview was administered. In contrast, 
the four-state study involved screening 
all household members for the presence 
of someone with asthma. If no one was 
reported to have asthma, the interview 
was terminated. In households where 
asthma was reported, up to one 
asthma-positive adult and one 
asthma-positive child were randomly 
selected per household for a detailed 
interview on asthma management and 
treatment. 
Augmentation sample 
Insufficient NIS sample was 
available to complete the desired 
number of interviews for both studies. 
Additional telephone numbers were 
drawn to add cases to (or ‘‘augment’’) 
the overall sample using the GENESYS 
Sampling System. The augmentation 
cases did not receive the NIS 
age-screening question or immunization 
questions. The augmentation cases only 
received the NAS screening interview 
(and if appropriate, the entire asthma 
interview). The NAS-only sample adds 
cases to the overall traditional sample 
and is called the ‘‘augmentation 
sample.’’ To protect confidentiality, the 
variable that indicates augmentation 
sample status has been suppressed. 
Table A shows, by sample, the 
proportion of the NAS sample that is 
from the augmentation sample. That is, 
for each sample and state listed in 
Table A, the proportion listed is the 
proportion of telephone numbers that 
were called specifically for NAS. Proxy Interviews 
As noted above, the national study 
selected a single household member at 
random for asthma screening. If the 
sampled household member was a child 
under the age of 18 years, screening 
questions were answered by an adult 
knowledgeable about the child’s health. 
If the sampled household member was 
aged 18 years or over, screening 
questions were asked of that sampled 
adult whenever possible. However, in 
the initial design, if the sampled adult 
was not available at the time of the 
screening contact, a proxy interview was 
conducted with the adult household 
member who answered the telephone. 
The proxy interview included, at a 
minimum, questions about the sampled 
adult’s asthma status, age, and sex. If 
the sampled adult was reported to be 
asthma-positive, an appointment was 
scheduled to complete a detailed 
interview directly with the sampled 
person, and asthma status was confirmed 
with that person upon callback. The 
initial design of the national study also 
called for a subset of 500 sampled 
adults who were reported by a proxy 
respondent to be asthma-negative to be 
called back to confirm their asthma 
status (to assess the extent of 
proxy-report error). 
Error rates in proxy reporting are 
shown in Table B and were calculated 
using weighted data; chi-square 
significance testing was performed using 
SUDAAN software (11). Proxies 
incorrectly reported 37.3% of lifetime 
asthma cases, but correctly identified 
99.3% of asthma-negative cases. The 
overall proxy reporting error rate was 
4.7%, computed by dividing the false 
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Table B. Weighted error rates in proxy reporting: NAS, 2003 
Self-reported lifetime asthma status 
Proxy-reported lifetime  asthma status1
Positive n Percent Negative n Percent 
Positive  . . . . . . . . . . . . . . . . . . .  
Negative. . . . . . . . . . . . . . . . . . .  
72  
7  
62.7  
0.7  
50  
955  
37.3  
99.3  
1Sample sizes are unweighted; error rates are weighted. 
NOTES: p < 0.001. NAS is National Asthma Survey. reports by all reports (12). The proxy 
error reporting rate of lifetime asthma 
status for current asthma cases is lower 
than the proxy error reporting rate of 
lifetime asthma status for former asthma 
cases (data now shown). Proxies 
correctly identified the lifetime asthma 
status of 71.5% of the current asthma 
cases but only correctly identified the 
lifetime status of 61.7% of the former 
asthma cases (data not shown). Although 
this difference is not statistically 
significant, it does suggest that proxies 
are more likely to identify lifetime 
status correctly if the asthma is currently 
active (12). The relationship of the 
proxy to the sampled person was also 
related to the accuracy of reporting, with 
mothers committing the fewest reporting 
errors (data not shown) (12). Based on 
these results, a decision was made to 
expand confirmation calls to all sampled 
persons with proxy-reported asthma-
negative status. 
These findings also greatly 
influenced the reporting of results 
through the creation of specific flag 
variables and two weights for the 
national sample. A flag variable was 
added to the national sample data file 
(FLG_ASTHMA) to indicate whether 
asthma status for the sampled 
respondent was obtained from the 
sampled or proxy respondent. Proxy 
respondents reported asthma status in 
12.8% of cases (n = 1,100) in the 
national sample. 
Two different weights were created 
for the national sample as a result of the 
verification substudy findings. Both 
weights include all sample child cases, 
but they differ on the inclusion of 
sample adult cases. For example, the 
weight post_pr_int includes all sample 
adult proxy and self-report cases, in 
contrast to the second weight (post_sr_int), which only includes 
sample adult self-report screener and 
interview cases. These weights are 
discussed in more detail in the 
weighting and estimation procedures 
chapter and Appendix B. 
Proxy responses due to illness or 
infirmity—Detailed asthma interviews 
were conducted for cases in both 
samples with proxy respondents if the 
sampled respondent was too ill or infirm 
to answer questions. In the national 
sample, 103 cases, or 1.2% of the 
sample, were completed by a proxy 
respondent because of a respondent’s 
illness. In the four-state sample, 68 
cases (1.2%) were completed by a proxy 
respondent because of a respondent’s 
illness or infirmity. 
Tracking proxy cases—For both 
studies, a variable called FLG_TYPE 
was created to facilitate data navigation 
and establish the questionnaire path per 
respondent. The FLG_TYPE variable 
has 11 values for the national sample to 
account for the verification substudy 
paths, in contrast to 4 values for the 
four-state file. For the national sample, 
proxy and sampled respondent 
information is available for some cases 
if the sampled respondent was able to 
be contacted and interviewed after 
researchers spoke with the proxy 
respondent. 
Questionnaire 
Questionnaire development 
The initial questionnaires were 
designed by NCEH and further refined 
based on cognitive testing and a series 
of four pretests that are described in 
more detail in Appendix E. Many 
questions included in the instruments 
were borrowed directly from other national surveys (such as NHIS, the 
National Health and Nutrition 
Examination Survey [NHANES], and 
BRFSS) to facilitate comparison and 
because many of these questions had 
already undergone extensive testing. 
Other questions were written for this 
survey to measure progress toward 
Healthy People 2010 goals and the 
translation of the National Asthma 
Education and Prevention Program 
guidelines into practice. 
Content 
The NAS questionnaires were 
designed to immediately follow a 
completed NIS interview in households 
with an NIS-eligible child or to follow 
the NIS screener in households without 
an NIS-eligible child. They were divided 
into eight sections: 
1.	 NAS eligibility screening, 
respondent selection, and initial 
demographics—For both studies, a 
person who answered the telephone 
in group quarters such as barracks, 
dormitories, hospitals, or schools 
was coded as ‘‘does not live in a 
household.’’ In the national study, 
one respondent was randomly 
selected out of all household 
members, and the asthma status of 
the selected respondent was 
determined. The sampled person’s 
age and sex were also obtained. In 
the four-state study, an entire 
household was screened for asthma. 
If no one was reported to have 
asthma, the interview was 
terminated. In households where 
asthma was reported, up to one 
asthma-positive adult and one 
asthma-positive child were 
randomly selected for a detailed 
interview, and the age and sex of 
the sampled respondents were 
collected. 
2.	 History of asthma (symptoms and 
episodes)—This section, the first in 
the detailed interview, assessed the 
length of time since the sampled 
respondents had experienced asthma 
symptoms, taken asthma medication, 
or seen a doctor for an asthma-
related reason. This section also 
addressed the frequency and severity 
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episodes. 
3.	 Health care utilization—These 
questions asked about the 
availability of asthma-related 
medical services and the degree to 
which these services were used. 
Respondents were asked whether 
they had visited a doctor, urgent care 
center, or emergency room for 
asthma treatment within the past 
year. Respondents were also asked 
questions about their current health 
insurance coverage. 
4.	 Knowledge of asthma management 
plan—This section asked respondents 
whether they had ever received specific 
types of asthma-related information or 
treatment from a health professional, 
including a written asthma management 
plan and a description of methods for 
recognizing asthma symptoms and 
episodes. 
5.	 Modifications to environment—The 
goal of this section was to determine 
whether respondents had made a 
series of modifications to their home 
environment to reduce exposure to 
indoor asthma triggers. Additional 
questions for adult respondents 
asked whether they had been 
exposed to asthma triggers at their 
place of employment. 
6.	 Medications—In this section, 
respondents were asked whether they 
took asthma medications in inhaler, 
pill, syrup, or nebulizer form. A list 
of the medications taken in each 
manner was obtained. For inhaler 
medications, additional questions 
asked about the frequency and 
pattern of medication use. 
7.	 Family history of asthma—This section 
included questions regarding the 
asthma history of the respondent’s 
siblings, parents, and grandparents. In 
the national study, respondents were 
also asked whether any household 
members other than the person sampled 
or family member of the sampled 
person had asthma. 
8.	 Demographic information—A series 
of demographic items such as race, 
ethnicity, highest level of education, 
and income were asked. Respondents 
were also asked about the number of 
landline telephone numbers in the 
household and whether interruptions in household telephone service 
occurred during the past year. 
Although height, weight, and 
birthweight are not usually 
considered demographic variables, 
they were deliberately placed in the 
last section of the instrument to 
reduce item and section nonresponse. 
The answers to these items may be 
considered to be very personal and 
sensitive for some respondents, and, 
as a result, these respondents may 
hang up the phone immediately 
when asked these questions. A 
respondent would probably not hang 
up the telephone at the final stage of 
an interview after investing a 
considerable amount of time to 
answer other questions. 
The two instruments are included in 
Appendixes III (national study) and IV 
(four-state study). In the national study, 
the questionnaire sections that were 
administered depended upon the type of 
respondent (proxy compared with 
sampled respondent) and the sampled 
person’s asthma status. Table C 
illustrates the various paths that the 
national study questionnaire could take 
and are classified from optimal to least 
optimal. The optimal situation was for 
the sampled adult respondent to provide 
screener and detailed interview 
information. If a proxy respondent 
provided screener information initially, 
the adult sampled respondent was 
recontacted directly, proxy-reported 
information was verified, and the 
detailed interview was completed with 
the adult sampled respondent. 
Proxy-reported information that was 
verified or changed by the sampled 
respondent is only provided for 
methodological purposes. The next best 
scenario was a proxy report for screener 
and selected interview items because the 
subject was not available or too ill to 
participate. The least favorable scenario 
was if the adult sampled respondent 
could not be located at all, and proxy 
responses provided the only information. 
For sampled children under the age of 
18 years in both samples, a 
knowledgeable respondent 18 years of 
age or over provided all screener and 
detailed interview information for the 
sampled child. All questionnaire sections were administered in the four-state study 
interviews. 
CATI programming 
NAS was conducted using a 
computer-assisted telephone 
interviewing (CATI) system. The CATI 
data collection software presents the 
questionnaire on computer screens to 
each interviewer. The program guides 
the interviewer through the 
questionnaire, automatically routing the 
interviewer to appropriate questions 
based on previous responses. 
Interviewers enter the responses to the 
questions directly into the computer; the 
CATI program determines whether the 
selected response is within an allowable 
range, checks it for consistency against 
other data collected during the interview, 
and saves the responses in a survey data 
file. This data collection technology 
reduces the time required for 
transferring, processing, and releasing 
data and also promotes data accuracy. 
The NAS questionnaire was 
programmed as a module of NIS, 
integrating the two surveys into a single 
interview. The instrument made full use 
of the CATI system’s ability to check 
whether a response was within a 
legitimate range, to follow skip patterns, 
and to employ ‘‘pick lists’’ for response 
categories. Certain household and 
demographic questions were identical in 
the NIS and NAS portions of the 
interview. If a respondent answered 
these questions during NIS 
administration, the system was 
programmed so that the questions were 
not repeated in NAS. Instead, the 
answers to the appropriate NIS 
questions were copied to the data file 
for NAS. Once initial programming was 
completed, the instrument underwent 
rigorous testing to ensure correct 
functioning of the CATI system. 
Development and 
Implementation of NAS 
Interviewer Training 
Outline and materials 
Training sessions lasted 
approximately 12 hours and were 
Table C. Questionnaire flow in the national study: NAS, 2003 
If  the  sampled  respondent  is  asthma-negative  
If  the  sampled  respondent  is  
asthma-positive  
Questionnaire  section  
Is  the  proxy  respondent  
asked  these  questions?  
Is  the  sampled  respondent  
asked  these  questions?  
Are  these  questions  asked  
in  the  callback  interview  for  
adults  with  proxy-reported  
asthma-negative  status?  
Is  the  proxy  respondent  
asked  these  questions?  
NAS  eligibility  screening,  respondent  
selection,  and  initial  demographics  .  .  Yes  Yes  Yes  Yes  
History  of  asthma  (symptoms  and  
episodes)  . . . . . . . . . . . . . . . . . .  No  No  No  No  
Health  care  utilization. . . . . . . . . . .  
Health  care  
coverage  
items  only  
Health  care  
coverage  
items  only  
Health  care  
coverage  
items  only  
Health  care  
coverage  
items  only  
Knowledge  of  asthma/management  
plan  . . . . . . . . . . . . . . . . . . . . .  No  No  No  No  
Modifications  to  environment  .  .  . . . .  
Subset  of  
household  
environment  items  
Subset  of  
household  
environment  items  
Subset  of  
household  
environment  items  
Subset  of  
household  
environment  items  
Medications. . . . . . . . . . . . . . . . .  No  No  No  No  
Family  history  of  asthma  . . . . . . . . .  
Single  question  on  
asthma  status  of  other  
household  members  Yes  Yes  
Single  question  on  
asthma  status  of  
other  household  members  
Demographic  information  . . . . . . . .  Yes  Yes  Yes  
Yes 
NOTE: NAS is National Asthma Survey. 
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Series 1, No. 46 [ Page 9 conducted over 2 consecutive days. The 
following topics were covered: 
1.	 Overview of the project— 
Background information and an 
introduction to the study and its 
sponsors. 
2.	 Purpose and importance of the 
study—An explanation of why the 
study was being conducted and 
what it was designed to accomplish. 
3.	 Goals and expectations of the 
study—A description of the target 
goals for the number of completed 
interviews and the expected time 
frame for data collection. 
4.	 Relationship to NIS—A discussion 
of how NAS was conducted in 
conjunction with NIS, including 
information about the eligibility 
criteria for the two studies, the 
length of time required to conduct 
both surveys, and the procedures to 
be followed for gaining cooperation 
for each study. 
5.	 Discussion of each questionnaire 
section and question-by-question 
specifications—An analysis of each 
questionnaire section and its 
purpose. Mock interviews were 
conducted to acquaint interviewers 
with the questionnaire and to 
provide them with the project 
knowledge and refusal aversion 
skills necessary to conduct an 
interview. Two types of mock 
interviews were performed: 
trainer-led interviews (in which the 
trainer played the role of the 
respondent and the interviewers 
conducted the interview using the 
CATI system) and dual-trainee 
interviews (in which one trainee 
performed the role of the 
interviewer and another acted as the 
respondent). 
6.	 Skills necessary to display project 
knowledge and gain cooperation— 
In-class practice of answers to 
questions frequently asked by 
respondents and refusal aversion 
techniques as well as role-playing 
exercises. A project-specific job aid 
facilitated mastery of these 
concepts. 
Because the NAS questionnaire 
required interviewers to be able to 
pronounce the names of a number of asthma medications, emphasis 
was placed on the correct 
pronunciation of those names. 
Interviewers were provided with 
audiotape pronunciations to allow 
them to practice outside of training 
sessions, and exercises within the 
sessions stressed correct 
pronunciation. 
7.	 Capacity to conduct the interview 
with the CATI program—Mock 
interviews were performed to 
accomplish this objective, including 
a final evaluation mock interview in 
which interviewers were required to 
demonstrate successfully their 
ability to administer the 
questionnaire. 
Interviewer training materials for 
NAS included the following: 
1.	 Interviewer manual—An 
interviewer training manual served 
as a reference guide during training 
and data collection. The manual 
included an agenda that listed the 
topics to be covered, an overview 
of the study, a description of each 
questionnaire section, techniques for 
gaining cooperation, and case 
management procedures. 
2.	 Slide-show presentation—A 
PowerPoint slide show was used as 
a training tool during trainer 
lectures to facilitate the learning 
process. 
3.	 Question-by-question 
specifications—This documentation 
provided further information on 
administering selected questions and 
included special instructions to the 
interviewers on how to probe for 
answers and code key data 
elements. 
4.	 Job aids on refusal aversion and 
frequently asked questions—Refusal 
aversion responses and questions 
frequently asked by respondents 
were discussed during the 
gaining-cooperation module of 
interviewer training. The discussion 
covered general interviewing and 
NAS project-specific issues. 
Final review exercises at the 
conclusion of each training session 
consisted of a question-and-answer 
discussion summarizing the topics taught during the course of the session 
and an interactive review modeled after 
a game-show format, in which 
interviewers split into two teams and 
competed for points based on project 
knowledge and refusal aversion 
techniques. 
A final test mock interview and 
written evaluation were administered at 
the end of each training session. This 
mock interview was standardized, 
allowing interviewers to be evaluated 
against the same standard on their 
ability to navigate through CATI, gain 
cooperation, and display project 
knowledge. The written evaluation 
aimed to reinforce what was learned 
during the course of training. Each 
trainer received a written evaluation 
answer guide to rate the proficiency 
level of the interviewer. Interviewers 
had to complete successfully both 
evaluations before they were permitted 
to collect data for NAS. 
Training 
The initial NAS data collection staff 
members were recruited during January 
2003. To offset interviewer attrition, 
recruitment and training continued to be 
offered throughout 2003 at centralized 
telephone call centers in Chicago, 
Illinois, and Las Vegas, Nevada. The use 
of two telephone centers facilitated 
sample dialing across multiple time 
zones. A total of 115 Chicago 
interviewers and 177 Las Vegas 
interviewers were trained for the study. 
Data Collection 
Telephone interviews were 
conducted from February 27, 2003, 
through February 20, 2004, for the 
national study, and March 1, 2003, 
through March 10, 2004, for the 
four-state study. A total of 10,054 
household screening interviews and 955 
detailed asthma interviews were 
completed in the national study. In the 
four-state study, 48,185 households were 
screened for the presence of someone 
with asthma, and 5,741 detailed asthma 
interviews were completed. The mean 
number of calls made to complete a 
national study interview was six, with a 
median of four calls. In the four-state 
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Table D. Completed screening and detailed interviews for national study: NAS, 2003 
Age 
Less than 18 years 
Total 18 years or over 
Screening interviews: household level . . . . . . . . . .  10,054  1,351  8,703 
  
Detailed interviews: person level . . . . . . . . . . . . .  955  164  791 
  
NOTE: NAS is National Asthma Survey. 
Table E. Completed screening and detailed interviews for four-state study: NAS, 2003 
Age State 
Less than 18 years 
Total 18 years and over Alabama Illinois California Texas 
Screening interviews: household 
level . . . . . . . . . . . . . . . . . . . .  48,185  . . .  . . .  12,160  11,898  11,998  12,129  
Detailed interviews: person level . . . .  5,741  2,005  3,736  1,488  1,313  1,433  1,507  
. . . Category not applicable.
 
NOTE: NAS is National Asthma Survey.
 
Table F. Number of interviews completed by month: NAS, 2003 
Month and year National study Four-state study 
Total  . . . . . . . . . . . . . . . . . . . . .  10,054  5,741 
  
2003
 
February . . . . . . . . . . . . . . . . . .  13  . . . 
  
March  . . . . . . . . . . . . . . . . . . . .  761  102 
  
April  . . . . . . . . . . . . . . . . . . . . .  870  850 
  
May  . . . . . . . . . . . . . . . . . . . . .  316  456 
  
June . . . . . . . . . . . . . . . . . . . . .  1,139  447 
  
July  . . . . . . . . . . . . . . . . . . . . .  460  377 
  
August . . . . . . . . . . . . . . . . . . .  878  411 
  
September  . . . . . . . . . . . . . . . . .  1,142  411 
  
October . . . . . . . . . . . . . . . . . . .  458  597 
  
November . . . . . . . . . . . . . . . . . .  1,076  187 
  
December . . . . . . . . . . . . . . . . . .  1,799  241 
  
2004 
January . . . . . . . . . . . . . . . . . . .  1,016  1,142  
February . . . . . . . . . . . . . . . . . .  126  464  
March  . . . . . . . . . . . . . . . . . . . .  . . .  56  
. . . Category not applicable. 
NOTE: NAS is National Asthma Survey. study, the mean number of calls to 
complete an interview was five, with a 
median of three calls. 
Table D details the total number of 
screening and detailed interviews 
completed in the national study overall 
and by age. 
Table E lists the number of 
households screened and detailed 
interviews completed in the four-state 
study overall, by age, and by state. Pending cases at the end of 
data collection 
For most cases pending at the end 
of the data collection period, the 
telephone number had not yet been 
resolved as residential or nonresidential 
(72.7% of pending cases and 21.0% of 
the initial sample for the national study; 
76.8% of pending cases and 19.4% of 
the initial sample for the four-state 
study). A smaller number of cases had been resolved as households without 
respondent eligibility being determined 
(1.4% of the initial sample for the 
national study and 4.2% of the initial 
sample for the four-state study). An 
even smaller number of households with 
an eligible respondent did not complete 
the interview (0.4% of the initial 
national study sample and 1.1% of the 
initial four-state study sample). 
Data collection by month 
Table F lists the number of 
interviews conducted per month by 
study from February 2003 through 
March 2004. 
Pretests 
A series of four pretests was fielded 
to determine the most effective data 
collection methodology for the main 
study—one that would obtain the 
highest possible response rates, produce 
asthma prevalence estimates, and gather 
high-quality analytic data for people 
with asthma. Appendix E provides 
details on each pretest, as well as the 
advance letters and introductory scripts. 
Address matching process 
To obtain addresses that 
corresponded to RDD-generated 
telephone numbers, generated telephone 
numbers (i.e., the initial sample) were 
first matched against a database that 
contained telephone numbers that are 
directory listed in a business yellow 
pages and are not directory listed in a 
residential white pages. Any business 
numbers so identified were removed 
from the sample. Numbers listed in the 
residential white pages were identified 
and temporarily set aside. A 
computerized system screened the 
remaining sample to remove 
nonworking numbers. The residential 
white pages directory-listed numbers 
were then combined with those not 
removed by the computerized system to 
produce the sample. To obtain addresses 
that corresponded to the RDD-generated 
telephone numbers in the sample, a file 
containing the RDD-generated telephone 
numbers was sent to a subcontractor to 
be processed through that company’s 
address-matching program. This 
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service uses a database of more than 
160 million residential and business 
telephone numbers, including 
unpublished telephone numbers. In some 
instances, by customer preference, a 
listing might not have contained a street 
address. The resulting file contained 
listed and unlisted numbers for the 
released sample. Matched listings 
contained a business or residential 
identifier. 
Advance letter 
An advance letter was mailed to 
presumed households where the address 
matching process identified a mailing 
address for sampled telephone 
numbers—41.9%(initial sample) and 
69.6% (released sample) for the national 
study, and 41.2% (initial sample) and 
67.3% (released sample) for the 
four-state study. Recipients were asked 
to participate in a voluntary study on the 
immunization of their children, and the 
letter also noted that some households 
might be asked questions about asthma 
and other health-related topics or 
services. The letter advised recipients 
that their telephone numbers had been 
chosen randomly and indicated that they 
might be called in the next few weeks. 
A toll-free telephone number was 
provided for those who wished to 
participate immediately or to learn more 
about the study. 
As described earlier, a NAS-only 
(or ‘‘augmentation’’) sample was 
fielded. Households in the NAS-only 
sample with an identified mailing 
address were mailed an advance letter 
different from that used for households 
in the NIS sample. This advance letter 
asked respondents to participate in a 
study specifically regarding asthma and 
provided asthma-related key health 
statistics. No mention was made of NIS 
or childhood immunization. The advance 
letters used for the main NAS studies 
are in Appendix VI. 
Toll-free telephone number 
A toll-free telephone number was 
provided in the advance letter, in answering-machine messages, and by 
interviewers at the request of 
respondents. Potential respondents could 
use this number to ask questions about 
the study or to complete an interview. In 
the national study, a total of 260 
screening interviews and 44 detailed 
interviews were completed with 
respondents who called the toll-free 
telephone number. In the four-state 
study, 912 households were screened 
and 208 detailed interviews were 
completed via the toll-free telephone 
line. 
Informed consent 
Consent for study participation was 
obtained from NAS respondents 
immediately upon determining that at 
least one person with asthma lived in 
the household. Respondents were 
informed about the voluntary nature of 
the survey, the authorizing legislation, 
and the confidentiality of data collected. 
In addition, the informed consent script 
provided information about the content 
of the survey and the expected duration. 
These procedures were approved by the 
Abt Associates Incorporated Institutional 
Review Board and the NCHS Research 
Ethics Review Board. 
Assurance of confidentiality 
Participation in surveys conducted 
by NCHS is voluntary, and information 
collected on persons is confidential. For 
NAS, assurance of confidentiality was 
provided to potential respondents as part 
of the informed consent procedures. In 
the CATI system, interviewers 
acknowledged that they had read the 
following script to potential respondents: 
Before we continue, I’d like you to 
know that this research is 
authorized by the U.S. Public 
Health Service Act so your answers 
will be kept strictly private. Your 
participation is voluntary. You may 
choose not to answer any question 
you don’t want to answer or stop at 
any time without penalty. 
If a respondent requested a description 
of the authorizing legislation, the interviewer read the following: 
The Public Health Service Act is 
Volume 42 of the US Code, Section 
242k. The collection of information 
in this survey is authorized by 
Section 306 of this Act. The 
confidentiality of your responses is 
assured by Section 308d of this Act. 
Section 308d of the Public Health 
Service Act (42 U.S.C. 242m) states the 
following: 
No information, if an establishment 
or person supplying the information 
or described in it is identifiable, 
obtained in the course of activities 
undertaken or supported under 
section . . . 306 . . . may be used for 
any purpose other than the purpose 
for which it was supplied unless 
such establishment or person has 
consented (as determined under 
regulations of the Secretary) to its 
use for such other purpose and in 
the case of information obtained in 
the course of health statistical or 
epidemiological activities under 
section . . . 306, such information 
may not be published or released in 
other form if the particular 
establishment or person supplying 
the information or described in it is 
identifiable unless such 
establishment or person has 
consented (as determined under 
regulations of the Secretary) to its 
publication or release in other form. 
Strict procedures are used to prevent 
disclosure of confidential data in survey 
operations and data dissemination. 
Respondent selection process: 
national sample 
As described earlier, the national 
study selected a single household 
member at random. First, a household 
member aged 18 years or over was 
asked the number of people of all ages 
living in the household, followed by the 
number of females living in the 
household. The CATI system created an 
internal household roster of oldest to 
youngest household members by sex 
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selected a household member from that 
roster (e.g., the oldest male or the 
second oldest female). Once a household 
member was sampled, the asthma status 
of that person was determined by asking 
‘‘[Have you/Has the (selected person) in 
your household] ever been told by a 
doctor or other health professional that 
[you have/(he or she has)] asthma?’’ 
Persons with a positive response to this 
question were classified as having a 
lifetime asthma-positive status. 
Regardless of the sampled person’s 
lifetime asthma status, the screening 
interview included a series of 
demographic questions about the 
sampled person and the household to 
allow for the production of asthma 
prevalence rates. If the sampled 
respondent was asthma-positive, a 
detailed interview regarding asthma 
management and treatment was also 
completed. If the sampled target of the 
interview was a child under 18 years of 
age, the entire interview was conducted 
with an adult household member (18 
years of age or over) knowledgeable 
about the child’s health, regardless of 
sample type. 
Based on asthma status and 
availability of the sampled person, six 
outcomes were possible for national 
sample respondents: 
+	 The sampled person had asthma and 
was immediately available for 
interview. In these cases, a detailed 
asthma interview, including all 
demographic and household 
information as well as asthma-
specific items, was completed. 
+	 The sampled person had asthma, 
was not immediately available for 
interview, but completed the detailed 
interview on a later calling attempt. 
In these cases, the person who was 
on the telephone at the initial call 
(i.e., a proxy) was asked a select 
group of household and 
demographic questions. On a later 
call with the sampled person, a 
detailed asthma interview including 
all demographic and household 
information as well as asthma-
specific items was completed. 
+	 The sampled person had asthma, 
was not immediately available for interview, and future attempts to 
complete a detailed interview with 
that person were not successful. In  
these cases, the person who was on 
the telephone at the initial call (i.e., 
a proxy) was asked a select group of 
household and demographic 
questions only. No further data were 
collected. 
+	 The sampled person did not have 
asthma and was immediately 
available for interview. In these 
cases, demographic and household 
information was gathered from the 
sampled person to allow for the 
production of national asthma 
prevalence rates. 
+	 The sampled person did not have 
asthma, was not immediately 
available for interview, but did 
complete a verification interview on 
a later calling attempt. In these 
cases, the person who was on the 
telephone at the initial call (i.e., a 
proxy) was asked a select group of 
household and demographic 
questions. On a later call with the 
sampled person, that person’s 
asthma status was verified. 
+	 The sampled person did not have 
asthma, was not immediately 
available for interview, and future 
attempts to complete a verification 
interview with that person were not 
successful. In these cases, 
demographic and household 
information was gathered from the 
person who was on the telephone at 
the initial call (i.e., a proxy) to 
allow for the production of national 
asthma prevalence rates. No further 
data were collected. 
In the national sample, proxy 
interviews were also conducted if the 
adult sampled respondent was ill or 
unable to complete the interview over 
the telephone. These interviews were 
conducted with another adult in the 
household. For a sampled child, all 
interviews were conducted with a 
knowledgeable adult household member. 
Respondent selection process: 
four-state sample 
The four-state survey immediately 
screened households for the presence of someone with asthma, using a single 
question: ‘‘Including yourself, has 
anyone living in your household ever 
been told by a doctor or other health 
professional that they have asthma?’’ 
(exercise-induced asthma was coded as 
a positive response to this question). If 
no one in the household was reported to 
have asthma, the interview was 
terminated. In households where asthma 
was reported, the number of asthma-
positive adults aged 18 years and over 
and asthma-positive children under 18 
years of age were obtained. The CATI 
system created internal rosters of 
asthma-positive adults and children 
based on this information and randomly 
selected a maximum of one asthma-
positive adult and one asthma-positive 
child for a detailed interview about 
asthma management and treatment. If a 
household had a sampled adult and a 
sampled child, two detailed interviews 
were administered in that household. 
Thus, for the four-state study in 
asthma-positive households, there were 
three possible sampling outcomes: 
+	 One adult sampled for a detailed 
interview, but no child sampled for a 
detailed interview. 
+	 One child sampled for a detailed 
interview, but no adult sampled for a 
detailed interview. 
+	 One adult and one child sampled for 
detailed interviews. 
Interview length 
Mean and median interview length 
varied by NIS eligibility because some 
demographic and household questions 
necessary for NIS and NAS were 
administered as part of the NIS 
interview and were not repeated during 
the NAS interview. In the four-state 
study, interview length also varied 
according to whether one or two 
household members were sampled. As 
noted earlier, four-state study interviews 
consisted of the full questionnaire. 
Mean and median interview lengths 
(excluding the NIS interview) are shown 
in Table G. 
Table H reports mean and median 
screening interview lengths by NIS 
eligibility for the national study. NIS 
eligibility refers to household eligibility 
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Table G. Mean and median interview length in minutes and seconds: NAS, 2003 
Study Mean Median 
National study 
Screening interview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  7:15  6:20  
Detailed  interview  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  9:27  8:59  
Four-state study 
Detailed interview: households in which only an adult was sampled . . 17:20 16:21 
Detailed interview: households in which only a child was sampled . . . 17:46 16:55 
Detailed interview: households in which both an adult and a child 
were  sampled  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  27:57  26:37  
NOTE: NAS is National Asthma Survey. 
Table H. Mean and median length of screening interview for national study in minutes and 
seconds, by respondent NIS eligibility: NAS, 2003 
NIS eligible NIS ineligible 
Section Mean Median Mean Median 
Overall length . . . . . . . . . . . . . . .  
Section 1: 
Detailed asthma screening . . . . . . .  
Section 8: 
Demographics . . . . . . . . . . . . . . .  
5:35  
3:47  
2:06  
5:13  
3:34  
1:52  
7:17  
3:35  
3:41  
6:21  
2:59  
3:06  
NOTES: NIS is National Immunization Survey. NAS is National Asthma Survey. 
Table J. Mean and median length in minutes and seconds for national study detailed 
interview, by NIS eligibility: NAS, 2003 
NIS eligible NIS ineligible 
Interview section Mean Median Mean Median 
Overall length . . . . . . . . . . . . . . .  9:04  9:05  9:28  8:59  
Section 2: 
History  of  asthma  . . . . . . . . . . . . .  1:10  0:59  1:06  1:01  
Section 3: 
Health  care  utilization. . . . . . . . . . .  1:10  1:08  1:20  1:10  
Section 4: 
Knowledge of asthma/management 
plan  . . . . . . . . . . . . . . . . . . . . .  1:00  0:58  0:47  0:50  
Section 5: 
Modification to environment . . . . . .  2:39  2:32  2:47  2:34  
Section 6: 
Medications. . . . . . . . . . . . . . . . .  2:10  2:16  2:39  2:10  
Section 7: 
Family  history  of  asthma  . . . . . . . . .  0:53  0:49  0:47  0:43  
NOTES: NIS is National Immunization Survey. NAS is National Asthma Survey. (i.e., at least one child in the household 
was 19–35 months of age at the time of 
the interview). The NIS-eligible child in 
the household may or may not have 
been the child sampled for the NAS 
interview. 
Table J reports mean and median 
interview lengths by section and NIS 
eligibility for the national study detailed 
interview. As described previously, the national sample data were only 
self-reported if the sampled adult was 
available at the time of the screening 
interview. If the sampled adult was not 
available, proxy responses from another 
adult in the household were accepted. 
Table K reports mean and median 
interview lengths by section and NIS 
eligibility for the four-state study. In this 
study, up to one asthmatic adult and one asthmatic child per household were 
eligible to be selected for inclusion. In 
households in which an adult and a 
child were sampled as targets of the 
interview, household-level questions 
were not repeated in both interviews. 
Thus, the mean and median lengths of 
an adult and child interview cannot be 
added together to calculate a combined 
total interview length. 
Refusals 
In cases where an interview was 
begun but not completed, specially-
trained interviewers attempted refusal 
conversion. By the end of data 
collection for the national study, these 
interviewers completed 2,384 screening 
interviews and 111 detailed interviews 
with households that had originally 
refused to participate, or 23.7% of all 
screening interviews and 11.6% of all 
detailed interviews. For the four-state 
study, these interviewers completed 615 
detailed interviews with households 
(including all person-level interviews 
necessary within the household) that had 
originally refused to participate (e.g., 
12.0% of all detailed interviews at the 
household level). 
Spanish-language interviewing 
NAS interviews were administered 
in Spanish as well as English. A 
professional translator, with extensive 
experience in the translation of surveys, 
produced a Spanish-language version of 
the NAS questionnaire. A team of 
experienced Spanish-language telephone 
interviewers and supervisors reviewed 
the translation, evaluating it for accuracy 
and cultural appropriateness. Issues 
raised during this review were resolved 
in consultation with the original 
translator, and a Spanish-language CATI 
instrument reflecting the final translation 
was produced. 
For data collection and sample 
management purposes, a calling queue 
was used for households thought by 
interviewers to be Spanish speaking. A 
CATI flag indicated such households. 
Cases with this flag were then delivered 
through the CATI system to bilingual 
interviewers who were specially trained 
to conduct interviews in Spanish and 
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Table K. Mean and median length of interview in minutes and seconds for four-state study 
detailed interview, by NIS eligibility: NAS, 2003 
NIS eligible NIS ineligible 
Interview section Mean Median Mean Median 
Overall length . . . . . . . . . . . . . . . . . . . . . . . . .  16:08  14:34  18:31  17:13  
Households in which only an adult was sampled . . . 13:56 13:14 17:23 16:23 
Households in which only a child was sampled . . . .  15:44  14:36  17:52  17:05  
Households in which both an adult and child were 
sampled. . . . . . . . . . . . . . . . . . . . . . . . . . . .  22:53  22:34  28:08  26:49  
Section 1: 
Detailed asthma screening . . . . . . . . . . . . . . . . .  4:04  3:29  4:07  3:22  
Section 2: 
History  of  asthma. . . . . . . . . . . . . . . . . . . . . . .  1:09  0:59  1:20  1:14  
Section 3: 
Health  care  utilization  . . . . . . . . . . . . . . . . . . . .  1:34  1:33  1:38  1:29  
Section 4: 
Knowledge of asthma/management Plan . . . . . . . .  0:59  0:55  1:00  0:55  
Section 5: 
Modification to environment . . . . . . . . . . . . . . . .  2:32  2:31  2:49  2:38  
Section 6: 
Medications  . . . . . . . . . . . . . . . . . . . . . . . . . .  2:32  2:10  3:16  2:58  
Section 7: 
Family  history  of  asthma  . . . . . . . . . . . . . . . . . .  0:49  0:42  0:48  0:41  
Section 8: 
Demographics . . . . . . . . . . . . . . . . . . . . . . . . .  2:27  2:08  3:34  3:11  
NOTE: NIS is National Immunization Survey. NAS is National Asthma Survey. English. In the national study, a total of 
570 households in the Spanish-language 
queue were screened, resulting in 28 
completed detailed interviews. These 
cases account for 5.7% of all screening 
interviews and 2.9% of all detailed 
interviews. In the four-state study, a 
total of 282 Spanish-queue detailed 
interviews were completed, accounting 
for 4.9% of all detailed interviews. 
Response rates 
Weighted response rates for NAS 
are shown in Table L (base sampling Table L. Weighted response rates: NAS, 2003 
Rates (expressed as percentage) 
Resolution rate . . . . . . . . . . . . . . . . . . . . . . . .  
Screener completion rate . . . . . . . . . . . . . . . . . .  
Interview  completion  rate  . . . . . . . . . . . . . . . . . .  
CASRO response rate. . . . . . . . . . . . . . . . . . . .  
. . . Category not applicable.
 
NOTES: NAS is National Asthma Survey. NIS is National Immunizatweights were used in the calculations). 
Rates were calculated separately for the 
national and four-state studies. Within 
each study, rates were calculated in total 
and by sample type (i.e., the NIS sample 
compared with the NAS-only sample). 
Response rates calculated include the 
interview completion rate (the 
percentage of completed interviews 
among eligible respondents), the 
screener completion rate (the proportion 
of known households screened for 
asthma status), and the resolution rate 
(the proportion of telephone numbers National study 
Screening interview Detailed in
Total 
sample 
NIS 
sample 
NAS-only 
sample 
Total 
sample 
NIS 
sampl
87.50  
66.60  
.  .  .  
58.30  
91.40  
64.60  
.  .  .  
59.00  
86.40  
67.30  
.  .  .  
58.10  
87.50  
66.60  
81.00  
47.20  
91.40
64.60
81.00
47.80
ion Survey. CASRO is the Council of American Survey Research Orgthat could be identified as nonworking, 
residential, or nonresidential). 
A standard approach for measuring 
response rates in telephone surveys, 
known as the ‘‘CASRO household 
response rate,’’ has been defined by the 
Council of American Survey Research 
Organizations (CASRO) (13). The 
CASRO response rate equals the 
product of these rates and provides an 
overall measure of response. CASRO 
response rates were calculated in 
accordance with the American 
Association for Public Opinion 
Research’s Standard Definitions: Final 
Dispositions of Case Codes and 
Outcome Rates for Surveys (14). 
For the calculation of NAS response 
rates, the assumptions for the American 
Association for Public Opinion Research 
(AAPOR) Response Rate 3 (RR3) were 
used with one exception. The 
denominator of RR3 includes a factor 
called e, which is an estimate of ‘‘the 
proportion of cases of unknown 
eligibility that are in fact eligible’’ (15). 
When calculating e, CASRO and 
AAPOR guidelines indicate that the 
survey researcher must estimate and 
assume identical eligibility rates for 
screened and unscreened households 
when using the ‘‘proportional 
allocation’’ or CASRO method (15,16). 
However, if these assumptions are 
incorrect (i.e., screened and unscreened 
households are not eligible at the same 
proportion), the RR3 formula will yield 
an incorrect and conservative response 
rate (15,16). 
To estimate more accurately these 
proportions and address the exception, 
the NAS response rate calculation 
incorporated research findings reported 
by Frankel et al. (17), which used an Four-state study 
terview Detailed interview 
e 
NAS-only 
sample 
Total 
sample 
NIS 
sample 
NAS-only 
sample 
 
 
 
 
86.40  
67.30  
80.90  
47.00  
90.10  
76.70  
70.20  
48.50  
91.30  
74.60  
70.10  
47.80  
88.50  
79.60  
70.40  
49.60  
anizations.
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Table M. Response rates for the detailed interview by sampled adult or child status: NAS, 
2003 
Rate (percentage) 
National study Four-state study
 
Sampled adults Sampled children Sampled adults Sampled children
 
Interview  completion  rate  . . . . . . . .  80.00  86.00  68.60  75.50 
  
CASRO response rate . . . . . . . . . .  46.60  50.10  47.40  52.20 
  
NOTES: NAS is National Asthma Survey. CASRO is the Council of American Survey Research Organizations. alternate method to calculate e. In this  
research, data were collected to estimate 
the percentage of residential telephone 
numbers among unresolved numbers 
that had been finalized as ‘‘ring-no­
answer at all attempts.’’ The presence of 
ring-no-answer numbers in a telephone 
sample makes calculating an accurate 
estimate of the response rate difficult 
because considerable uncertainty exists 
regarding the proportion of such 
numbers that are residential. In the 
fourth quarter of 2002, a national 
random subsample of telephone numbers 
that had ring-no-answer to all NIS call 
attempts was drawn (17). These 
numbers were called 42 additional times 
over an approximately 2-week period 
with three attempts per day—morning, 
afternoon, and evening. From this NIS 
subsample, 20.4% of ring-no-answer 
telephone numbers were estimated to be 
residential and 79.6% were estimated to 
be nonresidential, resulting in a 
2.4 percentage point increase in the 
CASRO rate over the standard CASRO 
formula. Based on these results, 
ring-no-answer cases in NAS were 
redistributed: 20.4% were categorized as 
known unscreened households and 
79.6% were categorized as out of scope. 
Response rates reflect this adjustment. 
National study: screening interview 
response rates—The overall CASRO 
response rate for the national study 
screening interview was 58.3%, 
calculated as the product of the 
resolution rate (87.5%) and the screener 
completion rate (66.6%). The CASRO 
response rate for cases in the NIS 
sample was 59.0%, and the rate for 
NAS-only cases was 58.1%. 
National study: detailed interview 
response rates—The overall CASRO 
response rate for the national study 
detailed interview was 47.2%, calculated 
as the product of the resolution rate 
(87.5%), the screener completion rate 
(66.6%), and the interview completion 
rate (81.0%). The CASRO response rate 
for cases in the NIS sample was 47.8%, 
and the rate for NAS-only cases was 
47.0%. 
Four-state study: detailed interview 
response rates—The overall CASRO 
response rate for the four-state study 
detailed interview was 48.5%, calculated 
as the product of the following: the resolution rate (90.1%), the screener 
completion rate (76.7%), and an 
interview completion rate at the person 
level (70.2%) based on the 5,741 
person-level interviews completed in 
5,125 households. Because the unit of 
analysis for the detailed interview in the 
four-state study was the sampled adult 
or child, a person-level interview 
completion rate is appropriate for this 
calculation. The CASRO response rate 
for cases in the NIS sample was 47.8% 
and the rate for NAS-only cases was 
49.6%. 
The interview completion and 
screener completion rates differed 
substantially between the two studies. 
One likely reason for the observed 
difference in screening rates had to do 
with the greater complexity of the 
screening process in the national study. 
A series of items had to be completed in 
the national study screener, whereas the 
screener for the four-state study 
consisted of a single item. Another 
possible reason for the difference might 
be related to differential use of the 
NAS-only sample. Though both surveys 
used the NAS-only sample in addition 
to the NIS sample, the NAS-only 
sample proportion was much higher in 
the national study. The NAS-only 
sample cases received an advance letter 
and interview introduction that made 
specific mention of asthma as the 
interview topic, whereas cases in the 
NIS sample received the usual NIS 
advance letter and interview 
introduction. 
Impact of adult or child status on 
interview completion rates 
The impact of child or adult status 
of the sampled household member on 
interview completion rates (and 
subsequent affect on CASRO response 
rates) is examined in Table M. The 
national study selected only one person per household, so its household 
interview completion rate was a 
weighted average of the rates for 
children and adults. In the four-state 
study, all interviews with selected 
asthmatic household members had to be 
completed before a household could be 
included in the calculation of the 
interview completion rate. 
In both studies, the interview 
completion rate for children was 
substantially higher than the rate for 
adults. This difference may have been 
related to flexibility in determining the 
respondent for a child—the only 
requirement was that he or she be a 
parent or guardian who was 
knowledgeable about the child’s health. 
Therefore, someone may have been 
more likely to be available to complete 
an interview for a child immediately, 
whereas repeated callbacks were 
sometimes required to complete 
interviews with adults. Another possible 
explanation for the observed difference 
might be that the study used the NIS 
sample, and thus potential respondents 
were more easily able to make a 
transition from the NIS screening or 
interview to NAS questions about a 
child than to questions about an adult. 
Finally, parents or guardians could 
simply be more invested in or more 
accustomed to providing information 
about their children’s health than they 
are about their own health. 
The final disposition of the NAS 
study samples is detailed in Table N. 
More detailed information on final 
sample disposition and unweighted 
response rate calculations is in Appendix 
VII. One should recall that study 
eligibility was based on asthma status. 
Ineligible households were those in 
which no household members were 
reported to have asthma in the four-state 
study. 
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Table N. Final sample disposition, national and four-state studies: NAS, 2003	 
Number of selected telephone lines 
National study Four-state study 
Final disposition 
Total 
sample 
NIS NAS-only Total NIS NAS-only 
sample sample sample sample sample 
Total  . . . . . . . . . . . . . . . . . . . . .  
Not resolved as residential or 
nonresidential. . . . . . . . . . . . . . .  
Out of scope (i.e., business or 
nonworking) . . . . . . . . . . . . . . . .  
Known household, study eligibility not 
determined  . . . . . . . . . . . . . . . .  
Screened ineligible household . . . . .  
Screened eligible household, 
language barrier . . . . . . . . . . . . .  
Screened eligible household, 
interview  not  completed  . . . . . . . .  
Screened eligible household, 
interview  completed  . . . . . . . . . . .  
55,204  
11,626  
29,369  
4,155  
8,852  
19  
228  
955  
12,779  
2,229  
6,795  
1,190  
2,321  
3  
46  
195  
42,425  
9,397  
22,574  
2,965  
6,531  
16  
182  
760  
210,109 
40,824  
110,956  
10,144  
40,852  
10  
2,198  
5,125  
109,401 
19,638  
58,003  
6,450  
21,794  
7  
1,052  
2,457  
100,708 
21,186  
52,953  
3,694  
19,058  
3  
1,146  
2,668  
NOTES: NAS is National Asthma Survey. NIS is National Immunization Survey. Efforts to maximize response rates 
A number of approaches were used 
to maximize NAS response rates, 
including the following: 
+	 Careful attention to the introductory 
questionnaire script to ensure it 
engaged the interest of potential 
respondents and provided clear 
information on the study sponsor. 
+	 Thorough pretesting of the 
instrument to ensure it was clear to 
respondents and not unduly 
burdensome. 
+	 An advance mailing to households 
that had directory-listed telephone 
numbers to establish study 
legitimacy and increase rapport prior 
to first contact, as well as convey 
information about strict 
confidentiality procedures in place. 
+	 A toll-free telephone number to 
allow respondents to directly contact 
interviewers and to encourage 
potential respondents to obtain study 
information, immediately establish 
study eligibility, or voice any 
concerns. 
+	 A Spanish-language version of the 
instrument to reduce nonresponse 
among Spanish-speaking households. 
+	 A sample management system that 
provided daily review of 
appointment and refusal case status 
to ensure timely recontact. +	 Flexible call schedules to permit 
respondents to complete the 
interview at their convenience. 
+	 An interviewer training program in 
refusal aversion to reduce the 
number of unresolved cases and 
refusals from eligible respondents. 
+	 The use of refusal conversion 
attempts by specially trained 
interviewers, who prepared 
case-specific strategies for each 
conversion call based on call history. 
Results 
Quality Control—Data 
Collection 
To ensure high quality data, project 
staff monitored the sample selection and 
case release processes, interview 
administration, data consistency, and the 
estimation process. Below is a brief 
overview of the NAS quality control 
measures. 
Sample monitoring 
The prepared sample of telephone 
numbers was checked to ensure that it 
met sample design specifications. The 
sample dynamics were monitored daily 
to ensure a consistent pace of data 
collection across the data collection period, prevent the release of excess 
cases to telephone centers, and assist in 
timely sample management decision 
making. 
Interviewing 
Telephone center supervisors were 
available to interviewing staff at all 
times to resolve any questions or 
concerns about a case. Supervisors 
regularly observed data collection to 
monitor interviewers informally. In 
addition, supervisory staff used remote 
telephone and computer monitoring 
technology to evaluate whether 
interviewers were performing according 
to project specifications. They evaluated 
whether introductory materials were 
properly read, item wording and 
sequence of the questionnaire were 
followed correctly, respondent questions 
were answered properly, and any vague 
responses were properly probed. 
Computer monitoring also allowed 
supervisors to ascertain whether answers 
were entered accurately into the CATI 
system. NCHS staff also periodically 
monitored interviews, especially at the 
start of data collection. 
Supervisory staff monitored 5% of 
all NAS calls made. The selection of 
which interviewers to monitor was 
automated using an algorithm that 
ensured newly trained interviewers were 
monitored more often than experienced 
interviewers. Experienced interviewers 
were prioritized for monitoring based 
upon the length of time since their last 
monitoring session and recent 
monitoring scores. Each interviewer was 
typically monitored at least once a 
week, but some interviewers were 
monitored more often. 
Data collection 
The CATI system was programmed 
to help ensure complete and accurate 
data collection and used automated data 
checking techniques during the 
interview (such as response-value range 
checks and consistency edits). These 
features enabled interviewers to obtain 
needed clarifications while still on the 
telephone with the respondent. Online 
help facilities were also available to aid 
interviewers. 
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period, modified versions of programs 
that were ultimately used to clean the 
final data produced weekly checks of 
interview data. These programs 
identified any out-of-range values, 
incorrect skip logic, missing data 
elements, and inconsistency between 
data fields. Any issues identified were 
resolved during the data collection 
process. 
Data file production 
Another set of programs, produced 
independently of the cleaning programs, 
performed three main quality control 
checks of the cleaned data. First, these 
programs identified any out-of-range 
values and incorrect skip logic. Second, 
derived variables were independently 
created and cross-checked against 
variables created during the initial 
cleaning process. Any discrepancies 
were flagged for resolution. Third, the 
programs checked for the correct 
assignment of special reserve codes 
designed to differentiate among types of 
missing data (e.g., data missing because 
of eligibility criteria or interview 
breakoff or data missing in error). 
Variable labels and statements were 
checked for consistency with the data 
documentation provided. 
The quality control programs were 
run iteratively on each new version of 
the data files until no problems were 
identified. The quality control reviewer 
then signed off on the data file. The 
final step of the quality control process 
involved review of the file by a senior 
project manager. Once this last step was 
completed, the data file was ready for 
production. 
Estimation 
Staff compared the formulas for the 
weights and adjustments developed by 
the sampling statistician with the actual 
weights and adjustments constructed by 
the statistical programmer. The variables 
delivered by the data collection staff to 
the statistical programmer were used in 
independent calculations of the weights 
to verify the programmer’s 
implementation of the statistician’s 
weighting specifications. In addition to this independent 
check, univariate statistics were 
produced and reviewed for the 
adjustments and weights. Reviewers 
used general knowledge about the size 
of the population and expectations to 
examine responses for geographic areas. 
The sums of various weights were also 
compared to ensure that differences 
were in the expected direction. 
Weighting and Estimation 
Procedures 
This section provides a nontechnical 
overview of NAS weighting procedures; 
for a more-detailed technical description, 
refer to Appendix B. 
To obtain population-based 
estimates, each sampled respondent for 
whom data were collected was assigned 
a final sampling weight. The national 
sample data file includes two final 
weights from which the analyst may 
choose depending on the population and 
analysis of interest, whereas the 
four-state sample data file includes three 
final weights from which the analyst 
may choose (again, depending on the 
population and analysis of interest). 
Each final sampling weight incorporates 
a base sampling weight, an adjustment 
for multiple telephone lines within a 
household, and various adjustments for 
nonresponse. Each adjusted weight is 
then poststratified so that the sum of the 
weights for each state equals selected 
population control totals from an outside 
source. For the national study, the 
outside source was the 2002 NHIS, and 
for the four-state study, the sources were 
the 2003 BRFSS for adults and the 2003 
National Survey of Children’s Health for 
children. The steps to produce the 
national and four-state sampling weights 
are described below. 
Sampling weights for the 
national study 
Questions were asked of an adult 
knowledgeable about that child’s health 
if the sampled household member was a 
child under 18 years of age. If the 
sampled household member was an 
adult aged 18 years or over, questions 
were asked of that sampled adult whenever possible. However, if the 
sampled adult was not available at the 
time of screening contact, a proxy 
interview was conducted with the adult 
household member who answered the 
telephone. 
Because of the observed error rate 
in proxy reporting of adult asthma 
status, two versions of the national study 
sampling weight were calculated to 
permit production of estimates that 
include or exclude proxy cases for 
adults. The first version includes all 
adult respondents with data regardless of 
whether the data were collected by 
self-report or a proxy respondent. The 
second includes only the adult 
respondents from whom data were 
collected personally. Sampled children 
are included in the calculation of both 
weights. The process for creating the 
two weights was identical; the 
difference is in the set of cases to which 
the weights are assigned. 
Base sampling weight 
The first step in the weighting 
process determines the base sampling 
weight for each selected household. The 
base sampling weight attached to a 
household is the reciprocal of the 
probability of selection of the household 
(e.g., equal to the probability of 
selecting the household’s telephone 
number). 
The telephone lines selected to be 
screened for NAS represent a random 
sample of all possible telephone lines in 
each geographic area. The probability 
that any given telephone line will be 
selected from the population of all 
possible telephone lines can be 
calculated. If 1,000 total telephone lines 
are in a given area and 100 of those 
lines were selected for the study, the 
probability that any single telephone line 
would be selected is 100/1000, or 0.10. 
Therefore, each telephone line selected 
represents some larger number of 
telephone lines in that geographic area 
(calculated as the reciprocal of the 
probability of selection for any single 
telephone line). If the probability of 
selection for any single telephone line is 
0.10, then each telephone line selected 
represents 1/0.10 (or 10) telephone lines 
in the geographic area. This number— 
the reciprocal of the probability of 
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line—is the base sampling weight for 
each completed interview in that 
geographic area. 
The base sampling weight varied by 
geographic area in NAS, but was the 
same for every completed interview 
within that geographic area. Because the 
population of telephone numbers did not 
change much by each quarter, the base 
sampling weight was calculated for the 
overall survey and not separately for 
each quarter. 
Adjustment for multiple-telephone 
households 
If a household has multiple 
voice-use telephone lines, it has a 
greater chance of being included in the 
survey than a household with only a 
single voice-use telephone line. If 
selecting a simple random sample of 
households were possible, each 
household would have equal probability 
of being included. To adjust for a 
multiple-telephone household’s increased 
probability of being included in the 
sample, the base sampling weight is 
divided by the number of voice-use 
telephone lines in the household, to a 
maximum of three lines. 
If a household has two voice-use 
telephone lines, it could be included in 
the sample two times. If it is included 
twice and its base sampling weight is 
10, the household would be allowed to 
represent 10 (base sampling weight) x 2 
(number of telephone lines) = 20 
households. To adjust the weight so that 
such a multiple-telephone household in 
the sample represents the same number 
of households in the geographic area as 
does a single-line household in the 
sample, the base sampling weight (10) is 
divided by the number of telephone 
lines (2). With an adjusted weight of 5, 
this household (had it been selected 
twice) would still represent only 10 
households (5 x 2 = 10).  
Unit nonresponse adjustment 1 
(residential status unknown) 
When selected telephone lines are 
called, three results are possible: 
1.	 The telephone line is determined to 
belong to a household. 
2.	 The telephone line is determined to not be a working residential 
number, but rather a business or 
nonworking number. 
3.	 The status remains unknown. 
This third category includes some 
household telephone lines, but the exact 
number is unknown. Still, the completed 
household interviews must represent the 
households in this ‘‘unknown’’ category. 
When the number of households in the 
unknown category is large, the weight 
for each completed household interview 
must be increased substantially. When 
the number of households in the 
unknown category is small, the weight 
for each completed household interview 
must be increased only slightly. This 
proportional adjustment is the first unit 
nonresponse adjustment. 
The size of the adjustment is based 
on the size of the unknown category and 
on previous research in which telephone 
company business offices reported on 
the number of households among the 
unknown numbers. This adjustment 
varies by geographic area, telephone 
area code, and whether the telephone 
line was directory listed. When many 
telephone numbers in a geographic area 
and area code go unanswered and most 
of these numbers are highly likely to be 
households, the weights for completed 
interviews in that geographic area and 
area code are increased greatly. When 
few telephone numbers in a geographic 
area and area code go unanswered, or 
few of these numbers are likely to be 
households, the weights for completed 
interviews in that geographic area and 
area code are increased only slightly. 
Thus, based on the level of nonresponse 
in a given area, the weights are 
proportionately increased for interviews 
that could be completed in that area to 
compensate for nonresponse. The 
completed interviews represent the 
households in the unknown category. 
Unit nonresponse adjustment 2 
(households of unknown eligibility) 
In the national study, a screening 
interview determines eligibility (i.e., 
whether the sampled person has 
asthma). When a household has been 
identified, two results are possible: 
1.	 A screening interview is completed. 2.	 A screening interview is not 
completed. 
The households with completed 
screening interviews must represent the 
households in which an interview is not 
completed. When the number of 
incomplete screening interviews is large, 
the weight for each completed interview 
must be increased substantially. When 
the number of incomplete interviews is 
small, the weight for each completed 
interview must be increased only 
slightly. The size of the adjustment is 
based on the size of the two categories 
and is calculated simply as the ratio of 
the weighted total number of identified 
households to the weighted number of 
completed interviews. 
The adjustment is done separately 
within three urban setting categories 
based on U.S. Census Bureau-defined 
Metropolitan Statistical Areas (MSA), 
which are geographic entities associated 
with at least one urbanized area that has 
a population of at least 50,000. The 
MSA comprises the central county or 
counties containing the core, plus 
adjacent outlying counties having a high 
degree of social and economic 
integration with the central county as 
measured through commuting (18). The 
three categories, from most urban to 
most rural, used for the adjustment are 
1) within a central city of an MSA, 2) 
outside of a central city but still within 
an MSA, and 3) not within an MSA. 
Subsampling adjustment 
One household member was 
randomly selected from among all 
household members. In households with 
more than one household member, the 
randomly selected person represented all 
of the nonselected people in the 
household. Therefore, the sampling 
weight must reflect the total number of 
household members. 
Unit nonresponse adjustment 3 
(sampled persons who do not 
complete the interview) 
When a person has been sampled 
for an interview, two results are 
possible: 
1.	 An interview is completed. 
2.	 An interview is not completed. 
Series 1, No. 46 [ Page 19 The completed interviews must 
represent the interviews that were not 
completed. The size of the adjustment is 
based on the size of the two categories 
and is calculated simply as the ratio of 
the weighted total number of sampled 
persons to the weighted number of 
completed interviews. This adjustment is 
made separately for each IAP. 
Poststratification 
Despite the weighting and the 
nonresponse adjustments, the estimated 
number of people is unlikely to match 
perfectly the number of people in the 
population sampled. Discrepancies are 
likely to be due to random sampling 
error and nonrandom response biases. 
These biases may vary by age, sex, and 
race. Poststratification of the weights to 
match population control totals for key 
demographic variables obtained from an 
independent source may reduce this 
bias. When several poststratification 
variables exist and control totals are 
available for the separate variables but 
not for their cross-classifications, this 
adjustment is carried out through a 
process known as raking, which 
involves creating a separate margin for 
each poststratification variable 
containing control totals for categories 
of the variable. 
For NAS, the independent source 
for population control totals was the 
2002 NHIS. The NAS weights were 
adjusted so that their sum equaled the 
2002 NHIS population counts for the 
following groups: 
+	 Number of males and number of 
females in nine age groups. 
+	 Household size. 
+	 Number of persons of various racial 
and ethnic backgrounds. 
+	 Asthma status. 
+	 Number of males and females by 
asthma status. 
Adjustment for noncoverage of 
households without landline 
telephones 
The poststratification process also 
included an adjustment for potential bias 
that might exist because NAS, as a 
telephone survey, could not select 
households that had no landline 
telephone service at the time of the survey. This adjustment incorporated 
information about household 
interruptions in telephone service from 
NAS. Evidence suggests that households 
that have telephone service at the time 
of the survey, but have had service 
interruptions of one week or more 
during the year, are more similar to 
households with no service at the time 
of the survey than are households with 
uninterrupted service during the year 
(17,19–21). Therefore, noncoverage of 
households without telephones can be 
somewhat offset by proportionately 
increasing the weights for those 
interviews that were completed in 
households with interrupted service. In 
this way, completed interviews in 
households with interrupted service 
represent the households without 
telephone service at the time of the 
survey. 
To make the adjustment for 
nontelephone households, the proportion 
of telephone and nontelephone 
households was determined from the 
2002 NHIS. These proportions were 
then applied to the control totals of the 
number of households to derive the 
estimated numbers of telephone and 
nontelephone households. Next, from 
NAS, the weighted proportion of 
telephone households having an 
interruption in telephone service for at 
least one week during the past 12 
months was computed. This proportion 
was then applied to the number of 
telephone households to estimate the 
number of telephone households with 
interruption. These calculations 
produced two control totals: one is for 
households with landline telephones and 
no interruption in telephone service, and 
the other is for those without landline 
telephones or with an interruption in 
landline telephone service. These control 
totals are mutually exclusive and 
exhaustive. 
No weighting or poststratification 
adjustments were made for households 
whose only telephone service was 
available through cellular telephones. 
Truncation of large weights 
Extremely large weights were 
truncated in order to prevent a small 
number of cases with large weights from having undue influence on the 
estimates. 
Sampling weights for the 
four-state study 
The process to produce four-state 
study sampling weights was identical to 
that used for the national study up to the 
point of the subsampling adjustment. 
For the four-state study, subsampling 
adjustments were made separately for 
adults with asthma and children with 
asthma, because each could be sampled 
within a single household. In households 
with multiple asthma-positive adults, the 
randomly selected adult represents all of 
the nonselected asthma-positive adults in 
the household. Therefore, the sampling 
weight for the completed adult interview 
must be increased proportionally. The 
adjustment simply multiplies the weight 
by the number of asthma-positive adults 
in the household. The same logic applies 
to sampled children. 
Similarly, the nonresponse 
adjustment to the four-state study 
detailed interview was completed 
separately for adults and children and 
for each geographic area within the 
adult and child categories. The four-state 
study used two independent sources for 
population control totals for 
poststratification: the 2003 BRFSS for 
adults and the 2003 NSCH for children. 
The NAS weights for sampled adults 
were adjusted so the sum of the weights 
equaled the 2003 BRFSS counts of 
asthma-positive adults in the following 
groups: 
+	 Six age groups. 
+	 Males and females. 
+	 Adults grouped by various racial 
and ethnic backgrounds. 
NAS weights for sampled children 
were adjusted so the sum of the weights 
equaled the 2003 NSCH counts of 
asthma-positive children in the 
following groups: 
+	 Three age groups. 
+	 Males and females. 
+	 Children grouped by various racial 
and ethnic backgrounds. 
Finally, the adjustment for 
nontelephone households was slightly 
different for the four-state study. The 
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children in telephone and nontelephone 
households were determined from the 
2004 Current Population Survey’s 
Annual Social and Economic 
Supplement conducted in March 2004. 
These proportions were then applied to 
the state control totals of the numbers of 
adults and children to derive the 
estimated numbers of adults and 
children in each state in telephone and 
nontelephone households. Next, from 
NAS, the weighted proportions of adults 
and children in telephone households 
having an interruption in telephone 
service for at least 1 week during the 
past 12 months were computed. These 
proportions were then applied to the 
numbers of adults and children in 
telephone households to estimate the 
number of adults and children in 
telephone households with interruption. 
These calculations produced two control 
totals for adults and two control totals 
for children: one for those in households 
with telephones and no interruption in 
service and the other for those in 
households without telephones or with 
an interruption in telephone service. 
These control totals are mutually 
exclusive and exhaustive. 
Weights 
For both samples, the weight 
specified will vary depending on the 
analytic plan. 
The national sample data file 
contains two weights from which to 
choose: 
+	 Post_pr_int—Includes all sample 
adult proxy and self-report cases and 
all sample children. 
+	 Post_sr_int—Includes only sample 
adult self-report cases and all 
sample children. 
The national file does not include a 
single child-level weight. Sampled 
children are included in the calculation 
of both weights, but the two weights for 
any given sample child will differ 
slightly because of the difference in the 
number of sample adult cases used to 
calculate post_pr_int compared with 
post_sr_int. 
Estimates for children can be 
produced using either weight, but adults are included in both weights as well 
(even if the analyst is not interested in 
asthma in adults). Therefore, analysts 
need to determine which adult cases to 
include: those that contain self-reported 
information only or adult cases that 
contain information from the sampled 
and proxy respondents. The preferred 
weight to use for child-level estimates is 
post_sr_int because it only includes 
sampled adult self-report information, in 
addition to all information for children. 
The alternate weight is post_pr_int, 
which includes sampled adult self- and 
proxy reports, in addition to all children. 
The post_pr_int weight should be used 
for methodological research to examine 
differences between self- and proxy 
reporting in adults. One should recall 
that because of proxy reporting error, all 
asthma negative proxy responses for 
adults were verified with the sampled 
adult if possible. 
The four-state sample data file 
contains three weights from which to 
choose: 
+	 Post_adult_int—A person-level 
interview weight that only includes 
sample adults 18 years of age and 
over; it should be used if the analyst 
is interested only in examining 
characteristics of asthmatic adults. 
+	 Post_child_int—A person-level 
interview weight that only includes 
sample children under 18 years of 
age; it should be used if the analyst 
is interested only in examining 
characteristics of asthmatic children. 
+	 Weight_int—This person-level 
interview weight includes all sample 
adults and sample children in the 
sample and reduces the analyst’s 
work by eliminating the need to 
aggregate the adult and child 
weights to examine the whole 
sample. It should be used if the 
analyst wishes to examine 
characteristics of people with asthma 
in the entire sample across all ages. 
Data Files 
From the various CATI production 
files, two data files were constructed for 
release to the general public. All data 
files are in SAS version 8 format (22). 
Formatted value labels are not permanently attached to the files; 
instead, executable SAS programs are 
included to enable users to create their 
own format libraries. 
The national sample data file 
contains screening data (age, sex, 
asthma status) for all cases as well as 
accompanying interview data for all 
cases in which a detailed interview was 
completed and for those who completed 
a partial interview (i.e., sampled-
respondent cases that are complete at 
least through the variable BATH_FAN 
[S7Q16] or proxy-respondent cases that 
are complete at least through the 
variable S_INSIDEP [S7Q10P]). There 
are 10,054 screening records in the 
national file. It contains asthma-specific 
interview data for 955 adults and 
children, as well as person-level 
demographic characteristics such as age, 
race, ethnicity, education level, and 
asthma status of each sampled 
respondent. The file also contains 
household-level variables. 
The four-state sample data file 
contains all screening and interview 
information for 5,227 households and 
5,741 persons. This file contains 
asthma-specific interview data for adults 
and children, as well as individual 
demographic characteristics such as age, 
race, ethnicity, and education level of 
each sampled respondent as well as 
household-level variables. 
Missing data 
The CATI system is designed to 
minimize missing data. However, there 
are several reasons why data may be 
missing. Most analysts ignore records 
with missing data regardless of why the 
data is missing. However, SAS provides 
a mechanism to differentiate between 
different types of missing values. The 
following key describes the various 
codes used to represent missing data in 
the data files. 
(.N) Not in universe (sample 
logic)—Respondents skipped entire 
sections of questions based on 
eligibility criteria (e.g., asthma 
status). 
(.L) Legitimate skip (question 
logic)—Respondents skipped one or 
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because of an answer provided to a 
root question. 
(.P) Partially completed case—The 
question was not answered because 
the respondent broke off the 
interview prior to completing this 
question. Partially completed 
interviews, or ‘‘partial completes,’’ 
are interviews that were completed 
though question S7Q16 in sampled 
respondent interviews or S7Q10P in 
proxy interviews. These cases have 
interview records and are treated as 
‘‘completes,’’ even though data are 
missing for questions that were 
asked late in the interview. 
(.M) Missing in error —A response 
should have been captured for this 
question but was not. Data may be 
missing in error if records were not 
properly written to a data file; an 
interviewer did not properly follow 
procedures to return to a previous 
question to edit a response, a CATI 
programming error, or a data 
transfer failure; or the recorded 
answer was determined to be 
invalid. 
SAS treats all of these codes 
similarly in statistical analyses (i.e., as 
missing data), so analysts who use SAS 
and are not interested in the reasons for 
missing data may continue to analyze 
the data as usual. 
One should note that derived 
variables (i.e., variables whose response 
was not directly provided by the 
respondent) do not include the detailed 
coding of missing data. All missing 
values for derived variables received an 
‘‘.M’’ code regardless of the reason for 
the missing data. Similarly, ‘‘.M’’ was 
used when derived variables were 
suppressed to protect the confidentiality 
of the survey participants. 
Data missing because the 
respondent did not know or refused to 
provide the answer have been treated 
differently. Rather than assigning a 
missing value to these records, a 
numeric code was used to identify these 
responses. Typically, unknown answers 
are coded as ‘‘6,’’ ‘‘96,’’ or ‘‘996.’’ 
Refused answers are coded as ‘‘7,’’ 
‘‘97,’’ or ‘‘997.’’ However, the codes may be different for specific variables; 
analysts are encouraged to consult the 
data documentation and frequency lists 
to identify the correct codes for each 
variable. Failure to do so may result in 
inappropriate calculations, especially for 
variables measured using ordinal, 
interval, or ratio scales. 
Edits to protect confidentiality 
NCHS takes extraordinary measures 
to ensure that the identity of survey 
respondents and subjects cannot be 
disclosed. The risk of inadvertent 
disclosure of confidential information 
about individual respondents is higher 
with a publicly released data set having 
detailed geography variables, a detailed 
and extensive set of survey observations, 
or a sizeable proportion of the total 
population of interest. Coarsening a data 
set by suppressing survey variables, 
collapsing multiple variables into one, 
collapsing response categories for other 
variables, or introducing noise in the 
data are common techniques to reduce 
the risk of inadvertent disclosure. 
Details on the various edits to protect 
confidentiality are listed below for both 
samples. 
Education—The education variable 
for the highest level of schooling 
completed by the sampled respondent 
was not asked if the sampled child was 
under 5 years of age. These data were 
suppressed for sampled children aged 
6–17 years because of the relationship 
between age and grade at school. 
Geography—Geographic 
information that would identify the 
specific IAP area was suppressed. 
Three versions of the ‘‘state of 
residence’’ identifiers are included in the 
four-state file. The STATE variable 
identifies the state with a numeric code; 
the STATES variable identifies the state 
with a two character abbreviation; and 
the STATEL variable identifies the full 
name of the state. 
In addition, a variable identifying 
whether the household resides inside or 
outside of a MSA was included in both 
files. It was suppressed whenever the 
total population for all MSA areas or all 
non-MSA areas in the state of residence 
was less than 500,000 persons. Race—Respondents were permitted 
to identify all possible categories that 
described the sampled person’s race. For 
the national file, responses for the race 
variable were collapsed to five 
categories: white only, black only, Asian 
only, multiple race, and other race. The 
‘‘other race’’ category included people 
for whom only one of the other two 
categories (American Indian or Alaska 
Native [AIAN] and Native Hawaiian or 
Other Pacific Islander [NHOPI]) was 
reported. People for whom more than 
one race was reported (e.g., Asian and 
NHOPI) were included in the ‘‘multiple 
race’’ category. 
For the four-state file, responses for 
the race variable were collapsed to four 
categories: white only, black only, 
multiple race, and other race. The 
‘‘other race’’ category included persons 
for whom only one of the other three 
categories (Asian, AIAN, and NHOPI) 
was reported. People for whom more 
than one race was reported (e.g., Asian 
and NHOPI) were included in the 
‘‘multiple race’’ category. 
Number of persons in the household 
(national sample)—Information on the 
total number of persons in each 
household significantly increases the 
risk of inadvertent disclosure of 
confidential information in households 
with large numbers of persons. 
Therefore, the number of persons of all 
ages that live in the household was top 
coded at ‘‘10+’’ (ROSTER10) to 
suppress the identity of large 
households. 
Number of children and adults in 
the household who are diagnosed with 
asthma (four-state sample)—Information 
on the total number of asthmatic adults 
and children in the household can 
increase the risk of inadvertent 
disclosure in households with large 
numbers of persons with asthma. 
Therefore, the number of children in the 
household diagnosed with asthma was 
top coded at four and above. The 
number of adults in the household 
diagnosed with asthma was top coded at 
three and above. 
Relationship of respondent to 
sample child or adult—If a child was 
randomly selected as the sampled person 
in the household, a parent or guardian 
knowledgeable about the health of the 
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 child answered the survey questions. 
Additionally, for adult sampled 
respondents who were too ill to 
participate, another adult in the 
household was allowed to answer as a 
proxy respondent for the sampled adult. 
As detailed earlier, a separate proxy 
substudy was conducted for sampled 
adult respondents in the national study 
who were unable to be reached at the 
time of the screening interview. 
The original response categories to 
assess the relationship of the 
knowledgeable adult respondent to the 
sampled person (question S3Q6, 
RELA_CHILD) listed in the 
questionnaire included the following: 
mother (birth, adoptive, step, or foster) 
or female guardian, father (birth, 
adoptive, step, or foster) or male 
guardian, sister or brother (step, foster, 
half, or adoptive), in-law of any type, 
aunt or uncle, grandparent, other family 
member, or friend. In the national 
sample public-use data file, all responses
above were included except for in-law 
of any type. To mask households that 
contain unique family characteristics, the
responses were collapsed into the 
following categories for the four-state 
sample: mother (birth, adoptive, step, or 
foster) or female guardian, father (birth, 
adoptive, step, or foster) or male 
guardian, and other. 
Other variables—Several other 
frequency variables were top or bottom 
coded to suppress outliers at low and 
high ends of the distribution of 
responses. Because of their unusual 
characteristics, records that included 
these outliers might have been more 
readily identifiable. For the remaining 
variables, the sample frequency 
distributions were examined and cut 
points were created at natural breaks. 
The following variables were top 
coded in both samples: 
+	 Age of the respondent or household 
member, top coded at ‘‘85+’’ 
(S2Q5R). 
+	 Age of respondent when he or she 
was first told by a health care 
professional that he or she had 
asthma, top coded at ‘‘85+’’ 
(S3Q8R). 
+	 Number of times in the past 12 
months the sampled person saw a doctor or other health professional 
for a routine checkup for asthma, 
top coded at ‘‘13+’’ (S5Q1R). 
+	 Number of times in the past 12 
months the sampled person visited 
an emergency room or urgent care 
center because of asthma, top coded 
at ‘‘13+’’ (S5Q3R). 
+	 Number of times in the past 12 
months the sampled person saw a 
doctor or other health professional 
for urgent treatment of worsening 
asthma symptoms or an asthma 
episode or attack, top coded at 
‘‘16+’’ (S5Q4R). 
+	 Number of times in the past 12 
months the sampled person stayed in 
any hospital overnight or longer 
because of asthma, top coded at 
‘‘6+’’ (S5Q6R). 
+	 Number of days in the past 12 
months the sampled person was 
unable to work or carry out usual 
activities because of asthma, top 
coded at ‘‘36+’’ (S5Q9R). 
+	 Number of days in the past 12 
months the sampled child missed 
daycare, preschool, or school 
because of asthma, top coded at 
‘‘32+’’ (S5Q11R). 
The following variables were top 
coded in the four-state sample: 
+	 Age of respondent or household 
member, top coded at ‘‘85+’’ 
(S2Q5R). 
+	 Age of respondent when he or she 
was first told by a health care 
professional that he or she had 
asthma, top coded at ‘‘85+’’ 
(S3Q8R). 
+	 Number of times in the past 12 
months the sampled person saw a 
doctor or other health professional 
for a routine checkup for asthma, 
top coded at ‘‘13+’’ (S5Q1R). 
+	 Number of times in the past 12 
months the sampled person visited 
an emergency room or urgent care 
center because of asthma, top coded 
at ‘‘13+’’ (S5Q3R). 
+	 Number of times in the past 12 
months the sampled person saw a 
doctor or other health professional 
for urgent treatment of worsening 
asthma symptoms or an asthma 
episode or attack, top coded at 
‘‘16+’’ (S5Q4R). +	 Number of times in the past 12 
months the sampled person stayed in 
any hospital overnight or longer 
because of asthma, top coded at 
‘‘6+’’ (S5Q6R). 
+	 Number of days in the past 12 
months the sampled person was 
unable to work or carry out usual 
activities because of asthma, top 
coded at ‘‘36+’’ (S5Q9R). 
+	 Number of days in the past 12 
months the sampled child missed 
daycare, preschool, or school 
because of asthma, top coded at 
‘‘32+’’ (S5Q11R). 
The following variables were top 
and bottom coded in the four-state and 
national samples: 
+	 Birthweight in grams 
(BRTHWHT5). 
+	 Respondent height in inches 
(HEIGHTR). 
+	 Respondent weight in pounds 
(WEIGHTR). 
The birthweight variable was asked 
of sampled children under the age of 18 
years. This question permitted 
respondents to report the sampled 
child’s birthweight in pounds and 
ounces or grams. For both samples, the 
reported birthweight was recoded into 
grams such that at least 5% of the 
sample was contained in either the top 
or bottom code after examining relevant 
NHANES data. The resulting bottom 
code was 1,814 grams (about 4 pounds) 
and a top code of 4,282 grams (about 
9.4 pounds). 
The height question permitted 
respondents to report the sampled 
person’s height in feet and inches or 
centimeters. The reported height was 
recoded into inches. The weight 
question permitted respondents to report 
the sampled person’s weight in either 
pounds or kilograms. This value was 
recoded into pounds. 
Because the single-age samples for 
children in the survey were so small, 
specifications developed for the SLAITS 
NSCH were used to create the top and 
bottom cut points for height and weight. 
These cut points were applied by age 
for children 0–17 years of age. To 
protect the confidentiality of individual 
children, very short or very tall heights 
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were suppressed. Extreme values were 
identified within each single-age group 
and recoded to less extreme values. For 
example, for 11-year-old children, all 
reported heights shorter than 43 inches 
were recoded to 43 inches, and all 
reported heights taller than 68 inches 
were recoded to 68 inches. 
The height and weight cut points 
for adults used the NHIS specifications 
because the single-age samples for 
adults were so small. For men, weights 
less than or equal to 125 pounds were 
recoded to 125, and weights greater than 
285 pounds were recoded to 285. For 
men, heights less than 63 inches were 
recoded to 63 inches, and heights 
greater than 76 inches were recoded to 
76 inches. For women, weights less than 
or equal to 98 pounds were recoded to 
98 pounds, and weights greater than 259 
pounds were recoded to 259 pounds. For 
women, heights less than or equal to 58 
inches were recoded to 58 inches, and 
heights greater than 70 inches were 
recoded to 70 inches. Two flag 
variables, HGHT_FLG and 
WGHT_FLG, were added to the dataset 
to enable analysts to determine whether 
the height and weight values for 
children and adults were reported or 
assigned. 
Body mass index (BMI)—BMI 
indicates total body fat based on the 
height and weight of adult men and 
women. Because suppression of height 
and weight variables may hinder 
calculations of BMI (calculated as body 
weight in kilograms [kg] divided by 
height in meters [m] squared), variables 
identifying BMI for children 
(BMICLASSC) and adults 
(BMICLASSA) have been added to the 
dataset. 
Children aged 2–17 years have been 
identified as either underweight 
(BMI-for-age is in the 5th percentile or 
lower), normal weight, at risk for 
overweight (BMI-for-age is in the 85th 
percentile or greater but lower than the 
95th percentile), or overweight 
(BMI-for-age is in the 95th percentile or 
greater). Percentiles are based on sex 
and age (see http://www.cdc.gov/ 
nccdphp/dnpa/growthcharts/resources/ 
sas.htm); however, this program relies 
on the child’s age in months. Because age was only reported in years for this 
survey, children were assumed to be at 
the midpoint of the age-year (i.e., a 
10-year-old was assumed to be 126 
months of age) to calculate BMI-for­
age. Children’s height and weight were 
reported by the parent or guardian and 
were not independently measured or 
verified. 
The following classifications were 
used for the adult BMI variable and 
correspond to those used by the 
National Institutes of Health: 
underweight is less than 18.5 kg/m2, 
normal weight is 18.5 to 24.9 kg/m2, 
overweight is 25 to 29.9 kg/m2, and 
obese is greater than or equal to 30 
kg/m2. 
Access to suppressed data 
Analysts interested in working with 
suppressed data may access unmodified 
data files through the NCHS Research 
Data Center (RDC). For information 
about charges and how to apply for 
access, visit the RDC website at 
www.cdc.gov/nchs/r&d/rdc.htm. 
Derived variables 
A number of derived variables 
created for estimation and analysis are 
included in the national and four-state 
data files. The derived variables in the 
national sample data file provide 
household information on lifetime and 
current asthma prevalence, height and 
weight of sampled respondents (as well 
as birthweight for sampled children), 
respondent race, and household income. 
The four-state data file also contains 
derived variables listed above, with the 
exception of prevalence data. 
An alphabetical list of derived 
variables created for the 2003 NAS 
four-state and national data files follows. 
Derived variables marked with a dagger 
(†) take advantage of the fact that some 
household and demographic information 
could have been obtained from sampled 
and proxy respondents. If data were 
supplied by a sampled respondent only 
or a sampled and a proxy respondent, 
data provided by the sampled 
respondent were used to calculate 
derived variables. If the only data 
available were supplied by a proxy respondent, then these data were used to 
calculate derived variables. 
ASTATUS1—The variable 
ASTATUS1 describes whether a 
respondent self-identifies as currently 
having asthma. It requires a positive 
lifetime asthma status (as described 
below in ASTHSTAT) and a positive 
response to S3Q2 (or S3Q9, if it has a 
value), which explicitly asks whether the 
respondent currently has asthma. 
ASTATUS2—A second measure of 
current asthma status, ASTATUS2, relies 
on behaviors, not self-identification, to 
indicate whether a respondent currently 
suffers from asthma. It requires a 
positive lifetime asthma status (as 
described in ASTHSTAT) and one of the 
following criteria: 
1.	 Respondent has spoken to a doctor 
or health professional about his or 
her asthma within the last 3 years. 
2.	 Respondent has taken asthma 
medication within the last 3 years. 
3.	 Respondent has had symptoms of 
asthma within the last 3 years. 
These behaviors are assessed in 
questions S3Q10, S3Q11, and S3Q12. 
ASTHMST—This variable computes 
asthma status according to programmatic 
rules developed for the BRFSS. It 
indicates whether the respondent has 
been told by a doctor or other health 
professional that he or she currently, 
formerly, or never has had asthma. It is 
calculated from the variables 
R_ASTHMX01 (or S3Q7, if it has a 
value) and S3Q2 (or S3Q9, if it has a 
value), which assess lifetime and current 
asthma status. 
ASTHSTAT—The variable 
ASTHSTAT, a measure of lifetime 
asthma status, is created for each 
sampled household member from the 
variable R_ASTHMX01 (or S3Q7, if it 
has a value), which asks whether the 
sampled person has been told by a 
doctor or other health professional that 
he or she has asthma. 
BESTINCOMEG1†—The 
BESTINCOMEG1 variable is derived 
from the best income variable 
(BESTINCOME) of the respondent, 
grouped into the following categories: 
$0 to $4,999; $5,000 to $9,999; $10,000 
to $14,999; $15,000 to $19,999; $20,000 
to $24,999; $25,000 to $34,999; $35,000 
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to $64,999; $65,000 to $74,999; and 
$75,000 and over. For respondents who 
reported an exact household income, the 
BESTINCOME field contains that actual 
dollar amount. When respondents did 
not supply a specific dollar amount for 
household income, a series or cascade of 
questions asking respondents whether 
the household income was below, 
exactly at, or above threshold amounts 
was necessary. A matrix was then 
created to categorize responses to these 
income cascade questions. Each cell in 
the matrix was assigned to one of the 
following income categories: less than 
$7,500; $7,500 to less than $10,000; 
$10,000 to less than $12,500; $12,500 
to less than $15,000; $15,000 to less 
than $17,500; $17,500 to less than 
$20,000; $20,000 to less than $25,000; 
$25,000 to less than $30,000; $30,000 
to less than $35,000; $35,000 to less 
than $40,000; $40,000 to less than 
$45,000; $45,000 to less than $50,000; 
$50,000 to less than $60,000; $60,000 
to less than $75,000; and $75,000 or 
higher. 
The BESTINCOME variable, for 
respondents who went through the 
cascade of income questions, was 
calculated as the midpoint of their 
income category as determined by their 
location in the matrix. Respondents with 
an income range of $75,000 or higher 
were assigned a BESTINCOME value 
of $100,000, based on the median 
income reported for NAS households 
that provided an exact income above 
$75,000. Respondents who did not 
complete the income cascade, either 
because they refused or did not know 
the answer to one of the cascade 
questions, have a missing value for 
BESTINCOME. 
BMICLASSA—This variable 
classifies the BMI value for age for 
adults. 
BMICLASSC—This variable 
classifies the BMI value for age for 
children. 
BRTHWHT5†—The variable 
BRTHWHT5 provides a standardized 
measure of birthweight in grams for 
sampled children. Birthweight values 
given by respondents in pounds and 
ounces were converted into grams by 
multiplying the amount given in pounds by 16, adding any additional weight 
given in ounces, and multiplying by a 
conversion factor of 28.350. 
CASTHMA—This variable indicates 
who is at risk for current asthma 
prevalence according to BRFSS 
programmatic rules. These respondents 
are at risk for having been told 
sometime in their lifetime by a doctor or 
other health professional that they had, 
and still have, asthma. It is calculated 
from the variables R_ASTHMX01 (or 
S3Q7, if it has a value) and S3Q2 (or 
S3Q9, if it has a value). 
COMPLETE_STATUS (national 
sample only)—This variable indicates 
whether a screener and interview were 
completed and who provided the data 
(i.e., the sampled person or a proxy 
respondent). Because respondents could 
break off the interview at any point, this 
flag was created to categorize cases by 
the number of valid responses given 
(number 1 was not assigned a code): 
2.	 Screener complete, sampled person 
interview complete through at least 
S7Q16. 
3.	 Screener complete, proxy 
respondent interview complete 
through at least S7Q10P. 
4.	 Screener complete, sampled person 
(through at least S7Q16) and proxy 
respondent interviews complete 
(through at least S7Q10P). 
FLG_ASTHMA (national sample 
only)—This variable indicates whether 
asthma status for the sampled 
respondent was obtained from the 
sampled respondent or from a proxy 
respondent. FLG_ASTHMA has the 
following values: 
1.	 Sampled person reported asthma 
status. 
2.	 Proxy reported asthma status. 
FLG_PROXY—In instances where a 
sampled adult respondent or the 
knowledgeable parent or guardian was 
unable to complete the interview 
because of an illness or disability, 
another household member was able to 
serve as a proxy respondent in his or 
her place. FLG_PROXY is a derived 
variable that notes whether an interview 
was or was not conducted by a proxy 
because of a respondent’s illness or 
disability. FLG_TYPE—This variable is 
included for both samples to facilitate 
data navigation. It establishes the 
respondent’s expected questionnaire path 
or interview type based on asthma and 
respondent status. Variables that affect 
the questionnaire path (asthma status, 
current asthma status, and identity of the 
respondent) are determined in the third 
section of the questionnaire. 
For the national file, the variable 
FLG_TYPE had the following values: 
1.	 Current asthma—Sampled person 
was interviewed: data in original 
fields. 
2.	 Asthma, not current—Sampled 
person was interviewed: data in 
original fields. 
3.	 No asthma—Sampled person was 
interviewed: data in original fields. 
4.	 Asthma—Proxy interviewed 
because sampled person was 
unavailable: data in proxy fields. 
5.	 No asthma—Proxy interviewed 
because sampled person was 
unavailable, and sampled person 
was never interviewed: data in 
proxy fields. 
6.	 No asthma—Proxy interviewed 
because sampled person was 
unavailable, and sampled person 
was interviewed at callback: data in 
both fields 
7.	 Current asthma—Sampled person 
and proxy were interviewed: data in 
both fields. 
8.	 Asthma, not current—Sampled 
person and proxy were interviewed: 
data in both fields 
9.	 Current asthma—Proxy interviewed 
because sampled person was ill: 
data in original fields. 
10.	 Asthma, not current—Proxy 
interviewed because sampled 
person was ill: data in original 
fields. 
11.	 No asthma—Proxy interviewed 
because sampled person was ill: 
data in original fields. 
For the four-state file, the variable 
FLG_TYPE had the following values: 
1.	 Sampled person was interviewed: 
asthma symptoms, medications, and 
doctor visits in past 3 years. 
2.	 Sampled person was interviewed: 
no asthma symptoms, medications, 
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3.	 Sampled person was ill, and proxy 
was interviewed: asthma symptoms, 
medications, and doctor visits in 
past 3 years. 
4.	 Sampled person was ill, and proxy 
was interviewed: no asthma 
symptoms, medications, and doctor 
visits in past 3 years 
HEIGHTR†—The variable 
HEIGHTR provides a standardized 
measure of height in inches. Height 
values given by a respondent in feet 
were multiplied by 12 and added to any 
inch values provided. If height was 
provided in centimeters, the values were 
multiplied by a constant, 0.3937, to 
produce the value for the derived 
HEIGHTR. This variable was top and 
bottom coded (as previously discussed) 
for each sample. 
HISPANIC_DERIVED†—This 
variable indicates whether or not the 
sampled household member is of 
Hispanic or Latino origin. 
LTASTHM—This variable indicates 
who is at risk for lifetime asthma 
prevalence according to BRFSS program 
rules. It indicates whether the 
respondent was told sometime in their 
lifetime by a doctor, nurse, or other 
health professional that they had asthma, 
and it is calculated from the variable 
R_ASTHMX01 (or S3Q7, if it has a 
value). 
RACE_MAIN†—Respondents were 
permitted to identify all possible 
categories that described the sampled 
person’s race. The RACE_MAIN 
variable was created using all of these 
pieces of information. If a respondent 
offered a verbatim ‘‘other’’ race 
response, these open-ended responses 
were entered into a text field by the 
interviewer and, wherever possible, back 
coded into existing categories of the 
RACE variable. If all race components 
had a value of ‘‘don’t know,’’ the race 
variable was assigned a value of ‘‘don’t 
know.’’ If all race components had a 
value of ‘‘refused,’’ the race variable 
was assigned a value of ‘‘refused.’’ If 
any race component had a nonvalid 
value (i.e., missing), the race variable 
was assigned a value of ‘‘.M.’’ Race 
categories were then collapsed as 
appropriate for the national and four-state public-use data files as 
previously described. 
WEIGHTR†—The variable 
WEIGHTR provides a standardized 
measure of weight in pounds. Weight 
values given by a respondent in 
kilograms were multiplied by a constant 
(2.205) to produce the value for the 
derived WEIGHTR. To protect the 
confidentiality of individual children and 
adults, very low and very high weights 
were suppressed. Extreme values were 
identified within each single-year age 
group and were recoded to less extreme 
values. The weight cut points were 
previously described in this report for 
children and adults. 
Flag variables 
The following flag variables were 
created for the four-state and national 
data files: 
+	 FLG_ASTHMA (national sample 
only). 
+	 FLG_PROXY. 
+	 FLG_TYPE. 
+	 HGHT_FLG and WGHT_FLG. 
+	 SPANISH—For sample management 
purposes, a calling queue was used 
for households thought by 
interviewers to be Spanish-speaking. 
The CATI flag, SPANISH, indicates 
such households. If on subsequent 
calls the screener or interview was 
not conducted in Spanish, this flag 
was not reset and retained a value of 
‘‘1.’’ However, in past research, this 
flag was shown to indicate reliably 
the language of interview 
administration in more than 97% of 
cases, which suggests it is a useful 
proxy for language of 
administration. 
Grouped variables 
Several variables such as age 
(S2Q5G1, S2Q5G2, and S2Q5G3), state 
(STATE, STATES, and STATEL), 
education level (EDUCATION and 
EDUCATION2), and age at first 
diagnosis (S3Q8G1, S3Q8G2, and 
S3Q8G3) have been included in the 
datasets with multiple grouped 
classifications to assist the analyst. 
These grouped categories match the 
response categories that other large surveys use (such as NHIS or BRFSS). 
The analyst is free to choose the 
variable grouping that would be most 
useful. For example, the first age 
grouping (S2Q5G1) is under 5 years, 
5–17 years, 18–24 years, 25–44 years, 
45–64 years, 65–69 years, 70–74 years, 
and 75 years and over. The second age 
grouping (S2Q5G2) is under 6 years, 
6–16 years, 17–24 years, 25–34 years, 
35–44 years, 45–54 years, 55–64 years, 
65–74 years, and 75 years and over. The 
third age grouping, S2Q5G3, is under 5 
years, 5–11 years, 12–17 years, 18–44 
years, 45–64 years, 65–74 years, and 75 
years and over. 
The following variables have 
different grouped responses for both 
samples: age (S2Q5G1, S2Q5G2, and 
S2Q5G3), education level 
(EDUCATION and EDUCATION2), and 
age at first diagnosis (S3Q8G1, 
S3Q8G2, and S3Q8G3). 
National sample proxy 
variables 
As previously described, the 
national sample included a proxy 
response verification substudy. A proxy 
response was accepted in this substudy 
if the sampled person was not home or 
unavailable. This is in contrast to the 
typical proxy rule, which is that proxy 
responses will only be accepted because 
of illness, disability, or infirmity of the 
sampled respondent. Proxy respondents 
in the national sample substudy 
answered the following detailed 
questions: S3Q6B, S5Q1_AP, S5Q1_BP, 
S7Q1P–S7Q10P, S7Q18P, S7Q19P, 
S7Q20P, S7Q22P (if applicable), 
OTHERASTHP, HISPANICP, 
R_RAC2P, S2Q18P, S2Q14_1P, 
S2Q14_2P, S2Q14_3P, S2Q15_1P, 
S2Q15_2P, S2Q16_1P, S2Q16_2P, 
S2Q16_3P, BIRTHRFP, INCTOTP, 
EDUCATIONP, and EDUCATION2P. 
Recoding of prescription 
medication data 
In the Medication section, 
respondents were asked whether they 
took asthma medications in inhaler, pill, 
syrup, or nebulizer form. A list of the 
medications taken in each manner was 
obtained. A probe that asked ‘‘any other 
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respondents answered for each drug 
type. If respondents replied yes to this 
probe, the verbatim response was 
cross-checked against the detailed 
medication lists for each drug type. If 
appropriate, the verbatim response was 
reclassified to the proper category. 
Recoding was not necessary for records 
with a valid ‘‘other medication’’ 
response. 
Examples of valid recoding of the 
verbatim response to the ‘‘other 
medication’’ questions include the 
following: 
+	 Respondents who offered a verbatim 
response of a generic medication 
name of a drug that was in the 
detailed list of brand names. This 
response was back coded to the 
appropriate category. 
+	 A number of respondents 
erroneously offered the name of an 
over-the-counter cold or allergy 
medication or an over-the-counter 
inhaler, pill, or syrup as a verbatim 
response for a prescription asthma 
medication. In these cases, the 
verbatim response was set to 
‘‘missing,’’ and any questions before 
or after the verbatim response were 
set to the appropriate response. 
+	 Some respondents offered a 
verbatim response with an 
unidentifiable word or a word that 
was not the name of a type of 
medication. In these cases, the 
verbatim response was set to 
‘‘missing,’’ and any questions before 
or after the verbatim response were 
set to the appropriate response. 
+	 Some respondents offered a 
verbatim response that was valid, 
but not for the type of medication in 
question. For example, if a 
respondent answered ‘‘Singulair’’ for 
the question concerning other 
inhalers, the text response for the 
other inhaler question was set to 
‘‘missing,’’ and the response was 
moved to the Singulair pill questions 
(if the respondent did not already 
give Singulair as one of the pill 
responses). Additional data notes 
The following systematic problems 
were identified for the national sample 
data file: 
+	 RELA_CHLD (S3Q6) was 
incorrectly skipped in 50 interviews 
regarding children without asthma. 
This CATI system error was 
corrected on March 20, 2003. 
+	 In 15 cases, a programming error 
caused items in Section 5 after INS2 
(S5Q1_B) and all items in Section 6 
to be incorrectly skipped. This CATI 
system error was corrected on June 
20, 2003. 
+	 Items in Section 5 after INS2 
(S5Q1_B) and all of the items in 
Section 6 were incorrectly skipped 
for nine illness-related proxy 
interviews. This CATI system error 
was corrected on October 20, 2003. 
+	 ILP04 (S8Q19) was to be skipped 
for sampled children under the age 
of 6 years. In three cases, the flag 
variable that indicated the sampled 
respondent’s age to trigger this skip 
was blank, causing the variable to 
be incorrectly skipped for 
respondents 6 years of age and over. 
This CATI system error was 
corrected on July 18, 2003. 
+	 In 13 asthma-negative cases, a 
programming error caused S11Q1 
through S11Q9 and HISPANIC to be 
incorrectly skipped. This CATI 
system error was corrected on May 
28, 2003. 
+	 A CATI problem caused data to be 
lost for variables S7Q1P through 
S7Q10P and S11Q1P through 
S11Q9P for two cases. This CATI 
system error was corrected on 
December 3, 2003. 
+	 S7Q21 was incorrectly skipped for 
eight cases where the sampled 
person had asthma. This CATI error 
was corrected on November 14, 
2003. 
The following systematic problems 
were identified for the four-state sample 
data file: 
+	 ILP04 (S8Q19) was to be skipped 
for sampled children under the age of 6 years. A flag variable that 
indicated the sampled respondent’s 
age to trigger this skip was 
inadvertently left blank, causing this 
variable to be incorrectly skipped 
for respondents 6 years of age and 
over early in the data collection 
period. This caused S8Q19_03 to be 
skipped for 100 cases and 
S8Q19_24 to be skipped for 19 
cases. This CATI system error was 
corrected on July 18, 2003. 
+	 Because of a CATI system error, 
OTC (S8Q1), INHALERE (S8Q2), 
and INHALERH (S8Q3) were 
incorrectly skipped for nine cases 
where the respondent did not have 
current asthma and had not gone to 
a doctor, taken medication, or had 
symptoms recently. 
Quality Control—Data 
Files 
Construction of the data files 
A lead programmer modified the 
cleaning programs used to monitor the 
interview data during each quarter of 
data collection and cleaned the data at 
the end of the data collection period. A 
second programmer was responsible for 
reviewing the work of the lead 
programmer and signing off on each 
completed task. The cleaned data file 
was also thoroughly checked by project 
staff. A brief summary follows of the 
steps involved to produce the final data 
file, including the data monitoring 
process, data cleaning, and quality 
control review of the final file. 
Data monitoring 
During each quarter of data 
collection, weekly monitoring of the 
interview data served as a quality 
control check prior to the data cleaning 
process. The programs for this task were 
designed to identify out-of-range values 
and incorrect skip logic and to report on 
any missing data elements or 
inconsistencies between data fields. The 
necessary edit rules were developed and 
documented. Inconsistencies identified 
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resolved, and any missing data elements 
were sent to the telephone center for 
hard-copy data recovery. Recovered data 
were entered manually into the CATI 
system with the data entry 
independently checked to ensure 
accuracy. Additionally, at the beginning 
of each quarter, data for a sample of 
cases were printed and reviewed for 
consistency to pick up possible 
discrepancies that had not been 
identified by the monitoring programs. 
Data cleaning 
Using the CATI questionnaire 
specifications as a base, the lead 
programmer followed detailed cleaning 
specifications and produced a series of 
cleaning programs. The programmer 
annotated each cleaning program so that 
results could be replicated and reviewed 
by others. These programs were created 
to do the following: 
1.	 Check for duplicate cases across 
NAS data collection quarters. 
2.	 Verify the valid number of 
completed and partially completed 
cases in the data file. 
3.	 Check that all data elements for a 
completed case were present. 
4.	 Apply any final data corrections 
based on data recovery. 
5.	 Verify that values were within 
specified ranges and that skip 
patterns were followed. 
6.	 Create derived variables from 
existing variables. 
7.	 Assign special SAS reserve codes, as 
appropriate, to reflect missing data 
of various kinds (e.g., sections or 
questions skipped based on 
eligibility criteria or answers to 
earlier questions with data missing 
in error). 
After all edits were made, a final 
frequency report was reviewed for 
completeness. Once the programmer 
produced a cleaned interview data file, a 
rigorous quality control process began. 
Estimation and hypothesis 
testing 
The NAS data were obtained 
through a complex sample design involving clustering of persons within 
households and stratification of 
households within IAP areas. To 
produce accurate estimates, sampling 
weights had to be used. The sampling 
weights accounted for the complex 
survey design and included adjustments 
for multiple-telephone households, unit 
nonresponse, noncoverage of 
nontelephone households, and 
adjustments to known population control 
estimates. 
Variables used for variance 
estimation 
The interview records have unequal 
weights because of the complex design 
of NAS. Therefore, statistical software 
programs that assume a simple random 
sampling design will most often 
compute standard errors that are too 
low. Tests of statistical hypotheses may 
then suggest statistically significant 
differences or associations that are 
misleading. However, computer 
programs are available that provide the 
capability of variance estimation for 
complex sample designs (e.g., 
SUDAAN, STATA, SPSS, and WesVar) 
(11,23,24). Stratum identifiers and 
primary sampling unit (PSU) codes were 
included on the data files to allow users 
to estimate complex sample variances. 
These variables and the sample weights 
are necessary for the calculation of 
variances. 
The stratum identifiers reported on 
the data set are not identical to the strata 
used for drawing the sample. In states 
with multiple IAP areas, independent 
samples were selected from each IAP 
area in proportion to the total number of 
households with children in each IAP 
area. Therefore, these IAP areas should 
be considered strata for variance 
estimation. However, disclosure of the 
specific IAP area for each child (even if 
the code was scrambled) could increase 
the risk of disclosure of a respondent’s 
identity. For example, the IAP area with 
the lowest frequency of responses in 
Texas would be readily identifiable as 
El Paso. 
In the absence of IAP-specific 
identifiers in the four-state sample, data 
users should use the state identifier 
(STATE) as the stratum identifier. By using the state identifier rather than the 
suppressed IAP identifier for the 
four-state sample, the standard errors for 
estimates of key variables are affected 
only slightly and not in a consistent 
direction. For the national sample, data 
users should use the stratum identifier 
(STRATUM). The PSU for the national 
and four-state files is the household, 
represented on the data sets by the 
unique household identifier IDNUMR. 
Analysts should review and be 
mindful of the sample sizes of the file 
with which they are working. Analysis 
of rare responses or subclasses can lead 
to estimators that are unreliable. Small 
sample sizes used in variance 
calculations may also produce unstable 
variance estimates. Consequently, the 
user must pay particular attention to the 
coefficient of variation for the estimates 
of means, proportions, and totals. 
Variance estimation on subsets 
of the data 
Some NAS analyses may focus on 
specific population subgroups, such as 
children living in poverty. Analysts may 
be tempted to delete all records outside 
of the domain of interest so they can 
work with smaller data files and run 
computer programs more quickly. This 
procedure of keeping only select records 
and deleting other records is called 
subsetting the data. Subsetted data that 
are appropriately weighted can be used 
to generate correct point estimates (e.g., 
estimates of population subgroup 
frequencies or means), but most 
software packages that analyze complex 
survey data will incorrectly compute 
standard errors for subsetted data. When 
complex survey data are subsetted, the 
sample design structure is often 
compromised because the complete 
design information is not available. 
Subsetting the data can delete important 
design information needed for variance 
estimation (e.g., deleting all records for 
certain subgroups will result in entire 
PSUs being removed from the design 
structure). SUDAAN has a SUBPOPN 
option that allows for specific 
subpopulations to be targeted in 
analyses while retaining the full data set 
and sample design information. To 
reiterate, analysts interested in specific 
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SUBPOPN statement in SUDAAN code 
(and the equivalent statement in other 
software programs) instead of subsetting 
the data sets. 
Weighted sample frequencies, 
prevalence estimates, and 
standard errors 
Weighted sample frequencies for 
selected variables appear in Appendix I 
to assist users in verifying the correct 
use of the weights. The two NAS files 
should not be combined to produce 
more precise estimates. 
National estimates generated from 
the national sample file should be 
described as being consistent with those 
produced by NHIS. Disaggregated 
prevalence estimates from the national 
sample file are NAS prevalence Table O. Description of the weights, national an
Variable name 
post_pr_int . . . . . . . . . .  Includes all sample adul
all sample children 
post_sr_int . . . . . . . . . .  Includes only sample ad
post_adult_int . . . . . . . .  Includes sample adults 1
post_child_int . . . . . . . .  Includes sample children
weight_int. . . . . . . . . . .  Includes all sample adul
. . . Category not applicable.
 
NOTE: NAS is National Asthma Survey.
 estimates that may or may not be 
consistent with NHIS. 
Weighted estimates can be 
calculated for each state in the four-state 
sample (using a ‘‘where’’ statement to 
select the appropriate cases) or for the 
four-state sample as a whole. The 
poststratified state weights were 
weighted up to appropriate population 
control totals. One should keep in mind 
that the four-state sample cannot be 
used to calculate prevalence estimates of 
current asthma, lifetime asthma, or any 
other variables of interest. The four-state 
file can be used to calculate weighted 
percentages, proportions, etc., but 
labeling these as prevalence estimates is 
inaccurate because crucial information 
needed to calculate prevalence was 
purposely not collected because of the 
screening process selected. This decision 
was made after extensive tests were 
conducted. d four-state samples: NAS, 2003 
Description 
National sample 
t proxy and self-report cases and The natio
weight. S
both weig
will differ 
sample ad
post_sr_in
Estimates
weight, bu
(even if th
Therefore
include: th
or adult c
and proxy
child-leve
sampled a
informatio
which inc
addition to
for metho
self- and 
because o
proxy res
adult if po
ult self-report cases and all sample children . . . 
Four-state sample 
8 years of age and over This is us
 ages 17 years of age and under This is us
ts and sample children This is us
asthmatic
the analys
and child Using the appropriate weight 
Table O summarizes the weights for 
both samples. The weight that is 
specified will vary depending on the 
analytic plan. 
Variance estimation using 
SUDAAN or STATA 
The sampling variance (e.g., 
standard errors) of estimates can be 
calculated for the United States (national 
sample) as well as Alabama, California, 
Illinois, and Texas (four-state sample) 
using the Taylor series approximation 
method in software such as SUDAAN, 
WesVar, STATA, SPSS, and the SAS 
SURVEY procedures (SURVEYFREQ, 
etc.). The simplifying assumption that 
PSUs have been sampled with 
replacement allows most complex 
survey sample design computer 
programs to calculate Comments 
nal file does not include a single child-level 
ampled children are included in the calculation of 
hts, but the two weights for any given sample child 
slightly because of the difference in the number of 
ult cases used to calculate post_pr_int compared with 
t. 
 for children can be produced using either 
t adults are included in both weights as well 
e analyst is not interested in asthma in adults). 
, analysts need to determine which adult cases to 
ose that contain self-reported information only, 
ases that contain information from both the sampled 
 respondents. The preferred weight to use for 
l estimates is post_sr_int because it only includes 
dult self-report information, in addition to all 
n for children. The alternate weight is post_pr_int, 
ludes sampled adult self- and proxy reports, in 
 all children. The post_pr_int weight should be used 
dological research to examine differences between 
proxy reporting in adults. One should recall that, 
f proxy reporting error, all asthma negative 
ponses for adults were verified with the sampled 
ssible. 
ed to examine characteristics of asthmatic adults. 
ed to examine characteristics of asthmatic children. 
ed to examine characteristics of the 
 population across all ages; it is provided to reduce 
t’s work by eliminating the need to aggregate the adult 
weights to examine the whole sample. 
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straightforward way. This method 
requires no recoding of design variables, 
but it is statistically less efficient and 
therefore more conservative than some 
other methods because the PSU is 
treated as being sampled with 
replacement within the stratum. The 
with-replacement option is used because 
the sampling fractions for households 
within a stratum are all very small. 
To summarize, analysts must ensure 
that the following key points are 
attended to before running any code: 
+	 The program must be able to 
accommodate a complex sample 
design and with-replacement 
sampling to estimate variance 
properly. 
+	 The data file must be sorted by 
stratum (variable name is STATE in 
the four-state file and STRATUM in 
the national file) and PSU (variable 
name for both files is IDNUMR) 
within stratum prior to invoking the 
code. 
+	 The correct weight must be used to 
calculate estimates properly. 
The syntax examples below offer 
simple guidance to an analyst; one 
should refer to the appropriate program 
manual for more in-depth details. The 
syntax listed below does not take 
advantage of the full range of options 
available in SUDAAN and STATA. 
SUDAAN 
SUDAAN code example, four-state 
sample 
Research question—What is the 
frequency, percentage, and standard 
error of current asthma (using the 
derived variable ASTATUS1) for all 
females by income group? 
One should assume the following: 
1) SAS-callable SUDAAN is being 
used, 2) the name of the four-state SAS 
data file is ‘‘fourstate,’’ 3) the variables 
have been recoded to exclude 
‘‘missing,’’ ‘‘don’t know,’’ and 
‘‘refused’’ answer categories in the 
analysis, 4) appropriate variables with 
answer categories of ‘‘0’’ (zero) have 
been recoded with a nonzero number 
category to run in SUDAAN, and 5) females of all ages should be included 
in the analysis. The variable ASTATUS1 
is a derived variable that denotes the 
current asthma status of the sampled 
household member based on self-
identification. The following is the code 
example: 
PROC SORT DATA = FOURSTATE; 
BY STATE IDNUMR; 
RUN; 
PROC CROSSTAB DATA = 
FOURSTATE DESIGN = WR; 
NEST STATE IDNUMR; 
WEIGHT WEIGHT_INT; 
SUBPOPN S2Q6 = 2; 
SUBGROUP ASTATUS1 
BESTINCOMEG1; 
LEVELS 2 11; 
TABLES ASTATUS1* 
BESTINCOMEG1; 
PRINT NSUM WSUM ROWPER 
SEROW / SYTLE = NCHS 
WSUMFMT = F7.0 SEROWFMT = 
F5.4; 
RTITLE1 ‘WEIGHTED FREQ, 
PERCENT & SE OF CURRENT 
ASTHMA: ASTATUS1’; 
RTITLE2 ‘IN FEMALES OF ALL 
AGES BY INCOME GROUPS’; 
RTITLE3 ‘FOUR-STATE 
SAMPLE’; 
RUN; 
SUDAAN code example, national 
sample 
Research question—What is the 
prevalence and standard error of current 
asthma (using the derived variable 
ASTATUS1) for all females by income 
group? 
One should assume the following: 
1) SAS-callable SUDAAN is being 
used, 2) the name of the national SAS 
data file is ‘‘nation,’’ 3) the variables 
have been recoded to exclude 
‘‘missing,’’ ‘‘don’t know,’’ and 
‘‘refused’’ answer categories in the 
analysis, 4) appropriate variables with 
answer categories of ‘‘0’’ (zero) have 
been recoded with a nonzero number 
answer category to run in SUDAAN, 
and 5) self-reported data for adult 
female respondents should be included 
(recall that children are included in both national sample weights, but the analyst 
must decide whether to include adults 
who self-report only or to include 
self-report and proxy responses for 
adults). The variable ASTATUS1 is a 
derived variable that denotes the current 
asthma status of the sampled household 
member based on self-identification. The 
following is the code example: 
PROC SORT DATA = NATION; 
BY STRATUM IDNUMR; 
RUN; 
PROC CROSSTAB DATA = 
NATION DESIGN = WR; 
NEST STRATUM IDNUMR; 
WEIGHT POST_SR_INT; 
SUBPOPN S2Q6 = 2; 
SUBGROUP ASTATUS1 
BESTINCOMEG1; 
LEVELS 2 11; 
TABLES ASTATUS1* 
BESTINCOMEG1; 
PRINT NSUM WSUM ROWPER 
SEROW / STYLE = NCHS 
WSUMFMT = F7.0 SEROWFMT = 
F5.4; 
RTITLE1 ‘WEIGHTED 
PREVALENCE & SE OF 
CURRENT ASTHMA: 
ASTATUS1’; 
RTITLE2 ‘IN FEMALES OF ALL 
AGES BY INCOME GROUPS’; 
RTITLE3 ‘SELF-REPORTED 
ADULT DATA, NATIONAL SAMPLE’; 
RUN; 
STATA 
STATA uses essentially the same 
variance estimation method as 
SUDAAN (e.g., assumes with-
replacement sampling). The SVY 
commands in STATA handle complex 
survey data. The relevant arguments 
should be structured as follows: 
+	 SVYSET STRATA (STATE or 
STRATUM as appropriate; do not 
include the parenthesis). 
+	 SVYSET PSU (IDNUMR). 
+	 SYVSET PWEIGHT (insert the 
appropriate weight variable name). 
For a more-detailed description of the 
SVY commands, review the STATA 
documentation for the appropriate 
version. 
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Information 
Any published material derived 
from NAS data should acknowledge 
CDC, NCHS, and SLAITS as the 
original source. The suggested citation, 
‘‘Data Source: Centers for Disease 
Control and Prevention, National Center 
for Health Statistics, State and Local 
Area Integrated Telephone Survey, 
National Asthma Survey, 2003,’’ should 
appear at the bottom of all tables. A 
disclaimer should be included that 
credits the authors (i.e., the recipient of 
the data file) with any analyses, 
interpretations, or conclusions reached. 
NCHS and SLAITS are only responsible 
for the initial data. In addition, the 
acronyms ‘‘NAS’’ and ‘‘SLAITS’’ 
should be placed in titles, keywords, and 
abstracts of journal articles and 
publications to facilitate retrieval in 
bibliographic searches. 
Data users can obtain the latest 
information about the SLAITS 
mechanism by periodically checking the 
website at http://www.cdc.gov/nchs/ 
slaits.htm. This site features 
downloadable public-use data files and 
documentation for SLAITS modules, 
important information about any 
modifications or updates to data and 
documentation, and current contact 
information. Questions should be sent 
by electronic mail to slaits@cdc.gov, 
and a staff member will respond as soon 
as possible. 
Researchers may also wish to join 
the SLAITS electronic mail listserv. To 
subscribe or unsubscribe, visit 
http://www.cdc.gov/nchs/about/major/ 
slaits/slaitslistserv.htm and follow the 
directions as listed. The listserv has 
approximately 1,000 subscribers around 
the world who use SLAITS data or are 
interested in the SLAITS mechanism. 
Subscribers periodically receive e-mail 
with news about SLAITS surveys, new 
releases of data or documentation, 
publications, or related conferences. 
Listserv membership is not shared. 
Although the SLAITS mechanism 
uses the NIS sampling frame, the 
websites listed below should be visited 
for further information on vaccines and immunization. For general information 
on child and adult vaccinations, please 
visit http://www.cdc.gov/vaccines. For 
more information on the NIS sampling 
frame, please visit http://www.cdc.gov/ 
vaccines/stats-surv/default.htm#nis. For 
more information on vaccine and 
immunization surveillance and statistics, 
please visit http://www.cdc.gov/vaccines/ 
stats-surv/default.htm. 
For more information on NCHS and 
its publications or data files, please 
contact the following: 
Data Dissemination Branch, NCHS 
3311 Toledo Road 
Hyattsville, MD 20782–2003 
Phone: 301–458–INFO (4636) or 
866–441–NCHS (6247) 
E-mail: nchsquery@cdc.gov 
Internet: http://www.cdc.gov/nchs/ 
For more information on CDC, 
contact CDC’s Information Contact 
Center (CDC-INFO) in English or 
Spanish by calling 800–CDC–INFO 
(800–232–4636), or email 
cdcinfo@cdc.gov. If you are hearing 
impaired, you may contact CDC-INFO 
with a TTY (text telephone) machine at 
888–232–6348. The CDC-INFO fax 
machine line is 770–488–4760. 
Guidelines for Data 
Use 
With the goal of mutual benefit, 
NCHS requests that recipients of data 
files cooperate in certain actions related 
to their use. 
Data users who wish to publish a 
technical description of the data should 
make a reasonable effort to ensure that 
the description is not inconsistent with 
that published by NCHS. 
The Public Health Service Act 
(Section 308d) provides that data 
collected by NCHS may be used only 
for the purpose of health statistical 
reporting and analysis. Any effort to 
determine the identity of any reported 
case is prohibited by this law. NCHS 
does everything possible to ensure that 
the identity of data subjects cannot be 
disclosed. All direct identifiers, as well 
as any characteristics that might lead to 
identification, are omitted from the data files. Any intentional identification or 
disclosure of a person or establishment 
violates the assurances of confidentiality 
given to the providers of the 
information. Therefore, users must 
adhere to the following: 
+	 Use the data in these files for 
statistical reporting and analysis 
only. 
+	 Make no use of the identity of any 
person discovered, inadvertently or 
otherwise, and immediately advise 
the Director of NCHS of any such 
discovery at 301–458–4500. 
+	 Not link these data files with 
individually identifiable data from 
any other NCHS or non-NCHS data 
files. 
By downloading and using these data, 
you signify your agreement to comply 
with the above-stated statutory-based 
requirements. 
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Specification of the 
National Asthma Education 
and Prevention Program 
Severity Indices Using the 
National Asthma Survey 
Data 
In 1989, the National Heart, Lung, 
and Blood Institute of the National 
Institutes of Health initiated the National 
Asthma Education and Prevention 
Program (NAEPP) to educate people 
with asthma, the general public, and 
health care providers about asthma and 
update clinical treatment guidelines. The 
NAEPP Expert Panel developed an 
asthma severity classification scheme to 
document medication adjustments that 
should be implemented to maintain 
long-term control of asthma adequately 
in children and adults. In 2002, this 
severity classification scheme was 
updated to reflect clinical practice more 
accurately. The prior iteration included 
three severity categories—mild, 
moderate, and severe—and a stepwise 
approach to treatment (i.e., the 
medications were adjusted as needed by 
reviewing the frequency of daytime and 
nighttime symptoms). The revised 
classification uses four descriptive 
severity categories to describe asthma 
before treatment or adequate control: 
mild intermittent, mild persistent, moderate persistent, and severe 
persistent (25). Under the revised 
classification, at any level of severity 
the patient can have ‘‘mild, moderate, or 
severe exacerbations’’ (25). The National 
Asthma Survey (NAS) data can be 
explored using these revised NAEPP 
classifications as specified below. 
Please note: all values of ‘‘don’t 
know’’ (coded as 96, 996) and 
‘‘refused’’ (coded as 97, 997) are treated 
as missing. 
30-day index 
Recoding before calculation: 
If S4Q1 equals .L or .N, recode S4Q1 
to 0. 
If S4Q3 equals .L or .N, recode S4Q3 
to 0. 
A) Question S4Q1 
1. Mild intermittent (0 to 8) 
2. Mild persistent (9 to 29) 
3. Moderate persistent (30 and S4Q2 
equals 0) 
4. Severe persistent (30 and S4Q2 
equals 1) 
B) Question S4Q3 
1. Mild intermittent (0, 1, 2) 
2. Mild persistent (3, 4) 
3. Moderate persistent (5 to 10) 
4. Severe persistent (more than 10) 
The severity rating is the higher of 
elements ‘‘A)’’ and ‘‘B)’’ above. If only 
one element is nonmissing, that element 
should be used to assign the index 
value. 12-month index 
Recoding before calculation: 
If S5Q2 equals 0, recode S5Q3 to 0. 
If S3Q10 equals 0, 2, 3, or 4 and 
S5Q3 equals .L and S5Q4 equals .L, 
recode S5Q3 and S5Q4 to 0. 
C) First, add responses from S5Q3 and 
S5Q4. If one of the two variables is 
missing, take the value of the 
nonmissing variable as the sum. Then 
code as follows: 
1. Mild intermittent (0) 
2. Mild persistent (1, 2) 
3. Moderate persistent (3 to 6) 
4. Severe persistent (7 and over) 
D) Question S5Q9 
1. Mild intermittent (0) 
2. Mild persistent (1 to 5) 
3. Moderate persistent (6 to 75) 
4. Severe persistent (more than 75) 
If age (S2Q5) is less than 18 years, 
the severity rating is the value of 
element ‘‘3).’’ 
If S2Q5 (age) is greater or equal to 
18 years, the severity rating is the 
higher of elements ‘‘C)’’ and ‘‘D)’’ 
above. If only one element is 
nonmissing, use that element to assign 
the index value. 
Combined index 
The severity rating is the higher of 
the 30-day or 12-month index above. If 
only one of the two indices above is 
nonmissing, set the value of the 
combined index to the nonmissing 
index. 
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Sampling and Weighting 
Technical Description 
Sample design 
The basic design objective of the 
State and Local Area Integrated 
Telephone Survey (SLAITS) 2003 NAS 
was to select a random sample of 
households for asthma-status screening. 
The target number of households was 
set at 10,000 for the national study and 
12,000 in each of the four states 
comprising the four-state study. The 
sample of households selected for 
screening for NAS was derived from the 
sampling frame for the National 
Immunization Survey (NIS), a 
continuous list-assisted random-digit­
dialing (RDD) survey administered in 
78 Immunization Action Plan (IAP) 
areas (consisting of the 50 states and 28 
metropolitan areas, including the District 
of Columbia). Therefore, the sampling 
design for the selection of households in 
NAS was essentially the same as in 
NIS. 
Drawing NIS sample 
The household selection procedure 
and NIS sample design is briefly 
described below. For additional 
information, please consult the Smith et 
al. (10) publication or the NIS website 
at http://www.cdc.gov/vaccines/stats­
surv/default.htm#nis. 
Associating telephone numbers with 
estimation (IAP) areas 
To draw a sample of telephone 
numbers in an IAP area, one must (in 
effect) compile a list of all telephone 
numbers that belong to that area. For 
some IAP areas, this step is 
straightforward. For example, when the 
IAP area is a state with a single area 
code, the list would consist of all 
telephone numbers within the 
central-office codes that are in service in 
that area code. Combined, an area code 
and a central-office code form a ‘‘prefix 
area.’’ For example, 617–492 is the 
prefix area corresponding to the 492 
central office in the 617 area code. For other IAP areas, however, this 
step is more complicated. When the IAP 
area is a city, county, or combination of 
counties, some prefix areas may cover 
part of the IAP area and part of an 
adjacent IAP area. In such situations, 
NIS applies a plurality rule: if at least 
50% of the directory-listed households 
in a prefix area fall inside an IAP area, 
the prefix area is assigned to that IAP 
area. 
Drawing the initial NIS sample 
The sampling frame for an IAP area 
consists of banks of 100 consecutive 
telephone numbers within the prefix 
areas assigned to the IAP area. For 
example, the numbers from 617–492– 
7100 to 617–492–7199 constitute a 
working bank in the 617–492 prefix 
area. Banks that contain zero 
directory-listed residential telephone 
numbers (‘‘zero banks’’) are excluded 
from the frame because they have very 
little chance of containing working 
residential numbers. For this preliminary 
step, the GENESYS Sampling System 
(a proprietary product of Marketing 
Systems Group [MSG]) uses a file of 
directory-listed residential numbers from 
Donnelley Marketing Information 
Services. The result is a file that lists 
the remaining banks (the ‘‘1+ working 
banks’’). From the 1+ working banks, a 
random sample of complete 10-digit 
telephone numbers is drawn for each 
quarter in such a way that each number 
has a known and equal probability of 
being selected. The sample is then 
segmented into replicates, or random 
subsamples, with each replicate 
containing sample telephone numbers 
from each of the 78 IAP areas. 
Segmenting the sample into replicates 
allows for the release of telephone 
numbers over time in a controlled 
manner. 
Updating the NIS sampling frame 
The set of telephone banks with at 
least one directory-listed residential 
telephone number changes over time. As 
a result, the sampling frame of 1+ 
working banks also needs to be updated. 
The phenomenon of frequent area-code 
splits has produced additional changes 
to the sampling frame. The GENESYS 
database reflects these changes in a quarterly update. MSG has developed a 
separate sampling frame for each IAP 
area. Quarterly, the database is 
examined to determine whether 
currently included banks should be 
assigned to different IAP areas and to 
assign newly included banks to IAP 
areas. The rules for assignment are the 
same as in the initial definitions of the 
IAP areas. Once all modifications have 
been made to the GENESYS database, a 
number of checks ensure that all 
changes have been applied correctly and 
that the new database produces samples 
that are consistent with those produced 
prior to the changes. These checks 
compare the number of active banks and 
RDD-selectable lines in each IAP area 
before and after the update. In parallel, 
the actual exchanges assigned to each 
IAP area before and after the update are 
compared. Small changes are 
expected—new banks are put into 
service as new numbers are assigned. In 
the event of a major discrepancy in any 
of these checks, MSG is notified of the 
difference and asked to provide 
documentation of the reasons for the 
change. 
Forming NIS sample replicates 
The total size of the initial sample 
for an IAP area is calculated according 
to the following formula: 
Total sample size = (1.5)T/(AC) 
Where T is the quarterly target 
number of completed interviews for the 
IAP area (this number ranged from 95 
to 126 in 2003), A is the proportion of 
telephone numbers that remain after 
identifiable business and nonworking 
numbers have been removed (as 
discussed below), and C is the 
proportion of telephone numbers sent to 
the telephone center that result in a 
completed interview. 
In the formula, A and C are specific 
to the IAP area and are adjusted each 
quarter, taking into account the results 
from prior quarters. The target, T, may 
also reflect results from previous 
quarters. If the three previous quarters 
have not produced their target total of 
completes, T is raised accordingly. 
Likewise, if the three previous quarters 
have exceeded their target total of 
completes, T is reduced accordingly. The 
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performance among IAP areas and 
among quarters. 
The total sample selected is then 
randomly divided into replicates. In the 
first quarter of 2003, the number of 
replicates was 36; the first 26 were 
equal in size and the last 10 were 
one-half that size. For the second, third, 
and fourth quarters, the number of 
replicates was 30: 24 full-size replicates 
and 6 half-size replicates. This 
procedure permits smoother release of 
the sample at the rate of one or two 
replicates per week for each IAP area 
separately (as needed). Toward the end 
of the quarter, the half-size replicates 
allow tighter control over the total 
amount of sample released. The aim is 
to produce an even distribution of work 
in the telephone center over the course 
of a quarter and to give all cases an 
equal probability of being completed. 
Removing business and nonworking 
numbers 
In a traditional RDD survey, all 
sampled telephone numbers are given to 
interviewers for dialing. Because more 
than one-half of all selected telephone 
numbers are businesses, modem lines, or 
unassigned, a large part of interviewers’ 
efforts may be directed simply to 
identify and remove these numbers from 
active sample. MSG has produced 
companion products to their GENESYS 
Sampling System that quickly and 
accurately reduce the size of this task. 
First, the selected sample is 
matched against a GENESYS data file 
that contains telephone numbers that are 
directory listed in business yellow pages 
and are not directory listed in residential 
white pages. These business numbers 
are removed from the sample. Second, 
numbers listed in residential white pages 
are identified and temporarily set aside. 
Third, a computer system 
(GENESYS-IDplus) screens the 
remaining sample to remove a portion 
of nonworking numbers. Using personal 
computers with special hardware and 
software, this system (called an 
‘‘auto-dialer’’) automatically dials the 
telephone numbers to detect nonworking 
and modem numbers. Nonworking 
numbers are usually indicated by the 
familiar tritone signal for out-of-service numbers, an extended period of silence, 
or continuous noise on the line. If the 
telephone number starts to ring, an 
attendant responds if the telephone is 
answered. Nationally, approximately 
15% to 20% of the numbers are 
answered. The GENESYS-IDplus 
equipment is operated only during 
daytime hours on weekdays in an 
attempt to reduce the number of 
answered calls. In addition, the white 
pages directory-listed numbers identified 
in the second step are not dialed. Rather, 
those numbers are combined with the 
numbers that were not removed by the 
auto-dialer to produce the sample for the 
telephone centers. These steps cull out 
approximately 40% of the sampled NIS 
lines. 
Obtaining addresses for advance 
letters 
To obtain addresses that correspond 
to sample telephone numbers, the 
numbers for each replicate are sent to a 
company that provides this 
computerized matching service. It uses a 
large database of residential and 
business telephone numbers including 
unpublished numbers. A listing may not 
contain a street address by customer 
request. The resulting file contains 
numbers with and without address 
matches. Matched listings contain a 
business or residential identifier. 
‘‘Do not call’’ requests 
NIS maintains a file containing 
telephone numbers of people who have 
requested that they not be called. Each 
quarter’s sample is compared with this 
file, and numbers in the contractor’s 
‘‘Do Not Call List’’ are excluded in the 
quarterly sample of numbers loaded into 
the CATI system. 
Duplicate telephone numbers 
Some telephone numbers may be 
selected more than once because of the 
repeated quarterly sample selection in 
each IAP area. To avoid respondent 
problems created by being recontacted 
for the same survey, a further processing 
step identifies duplicate numbers. Each 
complete replicate sample file is 
compared with all sample files released 
during the four prior quarters (taking 
into account area code splits). For NIS, identified duplicates are processed as 
follows. 
If GENESYS-IDplus removes an 
identified duplicate number, that result 
supersedes the disposition of that 
sampled number from the original 
quarter in which it was sampled. 
Otherwise, the processing depends on 
whether the number was sampled in the 
immediately preceding quarter. 
Duplicates from earlier quarters are 
mailed advance letters and released with 
their assigned replicate. Duplicates from 
the immediate preceding quarter are not 
mailed advance letters because they 
might have received such a letter 
recently. If the sample telephone 
numbers are released before the 
immediate preceding quarter has 
finished, they are put on hold until 
household data collection for that 
quarter has closed to ensure that they do 
not receive calls simultaneously for two 
quarters. Numbers that have certain 
types of refusals (e.g., ‘‘take me off the 
calling list’’) as their final disposition in 
the earlier quarter are counted as 
refusals in the current quarter. Certain 
final outcomes from the immediate 
preceding quarter are counted in the 
current quarter. For example, if the case 
is called for the preceding quarter in a 
month when data collection for the 
current quarter is also open, and the 
final outcome is ‘‘nonworking number,’’ 
‘‘no child in range,’’ or ‘‘complete,’’ the 
outcome is counted for both quarters 
and data are copied for the current 
quarter. 
Because of repeated quarterly 
selection of NIS sample in each IAP 
area, some telephone numbers were 
selected more than once over the course 
of the NAS data collection period. Such 
numbers were not contacted a second 
time for the NAS. Instead, these cases 
were automatically finalized. Response 
rates reflect the final disposition of a 
telephone line from its original 
sampling. 
Sampling design and allocation for 
NAS 
As noted earlier, the target number 
of households to be screened was set at 
10,000 for the national study and 12,000 
in each of the four states comprising the 
four-state study. The number of 
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each IAP area within a state was 
determined by allocating the desired 
number of screened households among 
the IAP areas within the state in 
proportion to the total number of 
households in each IAP area. In the 
national study, the number of 
households required to be selected in 
each state was determined similarly by 
allocating the desired number of 
screened households among states in 
proportion to the total number of 
households in each state. Estimates of 
the proportion of households were 
obtained from the March 2004 Current 
Population Survey’s Annual Social and 
Economic Supplement (ASEC). The 
number of telephone numbers that 
needed to be called was computed using 
the expected working residential number 
rate, and it was increased to compensate 
for refusals. 
A random subsample of the required 
number of NAS telephone numbers in 
each IAP area was selected from the 
NIS sample. These numbers were called 
to identify NIS- and NAS-eligible 
households. The sample selection was 
spread over four quarters of NIS data 
collection (quarters 1 through 4 of 
2003). The split of the total sample 
among quarters varied among IAP areas. 
A screening interview was 
conducted once a NAS-eligible 
household was identified. The national 
study selected a single household 
member at random and asked about the 
asthma status of that person. Regardless 
of asthma status, the screening interview 
included a series of demographic 
questions about the sampled person and 
household to produce asthma prevalence 
rates. If the sampled respondent was 
asthma-positive, a detailed interview 
about asthma management and treatment 
was also completed. In contrast, the 
four-state study immediately screened 
households for the presence of someone 
with asthma. If no one was reported to 
have asthma, the interview was 
terminated and no information was 
obtained on the household members. In 
households where asthma was reported, 
up to one asthma-positive adult and one 
asthma-positive child were randomly 
selected for a detailed interview about 
asthma management and treatment. A few questions in both studies asked 
about nonsampled persons, such as the 
asthma status of biological parents, 
grandparents, and siblings, total 
household income, and indoor air 
quality questions relevant to the entire 
household. In the national study only, 
the age of each person in the household 
and whether anyone else in the 
household had asthma were also asked. 
By design, the national and 
four-state studies also used some 
NAS-only sample, allowing an 
examination of response rates with and 
without the conduct of NIS. Sample 
design and allocation were identical 
regardless of whether the NIS was 
conducted, except that respondents in 
the NAS-only sample received an 
NAS-only version of the questionnaire 
and advance letter, and the NIS screener 
and interview were not administered. 
Sampling weights 
Overview 
Each sampled respondent for whom 
enough data were collected was 
assigned a sampling weight to obtain 
population-based estimates. This weight 
should be used for all analyses. The 
sampling weight is composed of a base 
sampling weight, an adjustment for 
multiple telephone lines within a 
household, and various adjustments for 
nonresponse. The final, adjusted weight 
is poststratified so that the sum of the 
weights at the national level or for each 
state (as applicable) equals selected 
population control totals from an outside 
source. For the NAS national study, the 
source was the 2002 NHIS. For the 
four-state study, the sources were the 
2003 BRFSS for adults and 2003 
SLAITS National Survey of Children’s 
Health for children. The steps to 
produce the national study sampling 
weights are described below, followed 
by a similar discussion for the four-state 
study weights. 
Production of sampling weights for 
the national study 
If a sampled household member 
was a child under the age of 18 years, 
questions were asked of an adult 
knowledgeable about that child’s health. If the sampled household member was 
an adult aged 18 years or over, 
questions were asked of that sampled 
adult whenever possible. However, if the 
sampled adult was not available at the 
time of the screening contact, a proxy 
interview was conducted with the adult 
household member who answered the 
telephone. Because of the observed error 
rate in proxy reporting of adult asthma 
status, two versions of the national study 
sampling weight were calculated to 
allow for production of estimates with 
and without proxy cases. The first 
version included all adult respondents 
with data regardless of whether the data 
were collected through a self-report or a 
proxy respondent. The second included 
only the adult respondents from whom 
data were collected personally. Sampled 
children were included in the calculation 
of both weights. The process to create 
the two weights was identical, and the 
difference is in the set of cases to which 
the weights were assigned. 
Base sampling weight—A sample of 
NAS telephone numbers was selected in 
each IAP area (as applicable) over four 
quarters of NIS data collection. In NIS, 
an independent sample of telephone 
numbers is selected each quarter. A 
telephone number could have been 
selected for NAS in any of the four 
quarters of the data collection period. 
Once a telephone number was selected, 
it was not selected again for data 
collection in subsequent quarters. To 
compute the base sampling weight, the 
overall probability of selection was 
determined considering the probabilities 
of selection over four quarters. 
The number of quarters over which 
the total sample is selected is q; pi 
denotes the probability of selecting a 
telephone number in the ith quarter, and 
p is the overall probability of selection 
of the telephone number of the 
household. Therefore, 
q 
p = ∑pi . 
i = 1  
Because the sample was selected over 
four quarters, 
n1 p1 = N1 
for the first quarter, where n1 is the 
number of telephone numbers selected 
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of telephone numbers available for 
selection. 
n1 n2 p2 = (1 – ) ,N1 N2 
for the second quarter, where n2 is the 
number of telephone numbers selected 
in the second quarter, and N2 is the 
number of telephone numbers available 
for selection. 
n1 n2 n3 p3 = (1 – ) (1 –  ) ,N1 N2 N3 
for the third quarter, where n3 is the 
number of telephone numbers selected 
in the third quarter, and N3 is the 
number of telephone numbers available 
for selection. 
n1 n2 n3 n4 p4 = (1 – ) (1 –  ) (1 –  ) ,N1 N2 N3 N4 
for the fourth quarter, where n4 is the 
number of telephone numbers selected 
in the third quarter, and N4 is the 
number of telephone numbers available 
for selection. 
The base sampling weight for a 
household in a particular IAP area is 
given by w = 1 /  p. Generally, this 
weight is the same for all households 
within an IAP area. 
Households with multiple telephone 
lines—The base sampling weight of 
eligible households that have multiple 
voice-use landline telephone lines was 
adjusted to compensate for the higher 
probability of selection of these 
households. The adjustment divides the 
base sampling weight by the number of 
telephone lines in that household. 
The number of telephone lines in 
the kth household in an IAP area is tk. 
The adjusted base sampling weight for 
that household is given by 
w 
wk = .tk 
If the household had only one telephone 
line, the adjusted weight is the same as 
the base sampling weight. 
Unit nonresponse adjustment 1 
(residential status unknown)—When a 
selected telephone number is called, 
three results are possible: 1) the number 
called is a household, 2) the number 
called is not a working residential number (i.e., a business number or 
nonworking number), or 3) the 
residential status of the telephone 
number is unknown. A minimum of 10 
call attempts were made before a 
number was assigned unresolved status. 
Adjustment of the base sampling 
weight to account for numbers of 
unknown residential status occurred in 
two steps. First, unresolved telephone 
numbers that had been finalized as 
‘‘ring-no-answer at all attempts’’ were 
redistributed as follows: 20.4% were 
grouped with known, unscreened 
households (category 1), and 79.6% 
were grouped with nonresidential 
numbers (category 2). This redistribution 
is based on research by Frankel et al. 
(17), who drew a national sample to 
estimate the percentage of residential 
telephone numbers among ‘‘ring-no­
answer at all attempt’’ numbers. Second, 
adjustment of the base sampling weight 
to account for nonresponse in the 
remaining category 3 numbers used the 
same method as NIS. This method, 
described in detail in the 1999 National 
Immunization Survey Methodology 
Report, uses information external to the 
survey to allocate these unknown 
numbers as either residential or 
nonresidential (26). 
Among the telephone numbers in 
the sample for an IAP area, let the count 
in each of the three categories 
mentioned above be n1, n2, and n3. The 
first nonresponse adjustment factor is 
^ n1 + n31A1 = ,n1 
^ 
households among the n3 in the ‘‘status 
unknown’’ category. The procedure to 
estimate the number of households in 
the unknown category is based on a 
study conducted in 1994 and 1995, 
which asked telephone company 
business offices to report the status of a 
sample of category 3 telephone numbers 
(27). The results showed the proportion 
of residential numbers varies according 
to regional groupings of IAP areas by 
whether the telephone number was 
directory listed and by type of 
noncontact (e.g., ring-no-answer 
compared with answering machine). 
where n31 is the estimated number of Therefore, the nonresponse adjustment 
factors for each IAP area were defined 
by IAP area grouping and calling 
disposition code and by whether the 
number was directory listed. To keep the 
notation simple, the adjustment factor is 
denoted by A1, although it could differ 
among households within an IAP area. 
The nonresponse-adjusted base sampling 
weight after nonresponse adjustment 1 
for the kth household in an IAP area is 
given by 
A1wk . 
Each known household has an adjusted 
weight. 
Unit nonresponse adjustment 2 
(households of unknown eligibility)—A 
second form of nonresponse may occur 
because a household respondent does 
not complete the screener questions that 
determine eligibility (i.e., asthma status). 
The adjustment for this form of 
nonresponse is completed separately 
within three urban setting categories 
based on the U.S. Census Bureau-
defined Metropolitan Statistical Areas 
(MSAs). An MSA is a geographic entity 
associated with at least one urbanized 
area with a population of at least 
50,000. The MSA comprises the central 
county or counties containing the core 
and adjacent outlying counties having a 
high degree of social and economic 
integration with the central county 
measured through commuting (18). The 
three categories used for the adjustment 
are (from most urban to most rural) 
within a central city of an MSA; outside 
a central city, but still within an MSA; 
and not within an MSA. 
The number of households (within 
each urban setting category) in which 
the selected person had asthma out of 
the n1 households contacted is q1. The 
number of households in which the 
selected person did not have asthma is 
q2, and q3 denotes the number of 
households that did not respond to 
screening questions: 
n1 = q1 + q2 + q3 . 
The nonresponse adjustment to the 
sampling weight to account for not 
being able to screen households is given 
by 
Series 1, No. 46 [ Page 37 ∑ 
n1 
A1wk 
k = 1  
A2 = . 
q1 + ∑ 
q2 
A1wk 
k = 1  
The nonresponse-adjusted base sampling 
weight after nonresponse adjustment 2 is 
given by 
wak = A2A1wk . 
This adjusted weight is defined for all 
households in which a screening 
interview was completed. 
Subsampling adjustment—A single 
household member was randomly 
selected from among all household 
members to be the focus of the 
interview. The interviewer first asked 
the number of people of all ages living 
in the household and then the number of 
females living in the household. The 
computer-assisted telephone 
interviewing (CATI) system created an 
internal household roster of oldest to 
youngest household members by sex 
based on this information and randomly 
selected a household member from that 
roster (e.g., the oldest male or the 
second oldest female). In households 
with more than one household member, 
the randomly selected person 
represented all of the people in the 
household. Therefore, the sampling 
weight for this completed interview 
must be increased to reflect the selection 
probability. This adjustment simply 
multiplies the weight by the total 
number of household members. The 
number of household members in the 
kth household in an IAP area is mk. 
The sampling weight for the 
selected person is 
wpk = wak mk . 
Unit nonresponse adjustment 3 
(sampled persons who do not complete 
the interview)—Data were not obtained 
for all persons selected for an interview. 
Therefore, the weights of the persons for 
whom data were available were adjusted 
to account for those for whom no data 
were collected. The nonresponse 
adjustment factor A3 within an IAP area 
was computed as follows. 
The number of households in which 
interviews were completed among the q1households in which the sampled 
respondent had asthma is q *1. The 
nonresponse adjustment factor for the 
interview nonresponse is given by 
q1 
p∑ wkmk 
k = 1  
A3 = . 
q* 1 
p∑ wkmk 
k = 1  
The numerator gives the estimated 
number of respondents who had asthma 
based on the sampled households in 
which the respondent had asthma. The 
denominator gives the estimated number 
of sampled respondents with asthma 
based on the households in which an 
interview was completed. The 
nonresponse-adjusted sampling weight 
for respondents is 
wpak = A3wpk . 
Poststratification weight 
adjustment—Despite the weighting and 
nonresponse adjustments, the estimated 
number of people is unlikely to match 
perfectly the number of people in the 
sampled population. Any discrepancies 
are likely due to random sampling error 
and nonrandom response biases. Among 
these biases may be greater nonresponse 
for some categories of age, sex, or race. 
Poststratification adjusts the weights to 
match population control totals for key 
demographic variables obtained from an 
independent source. Thus, the NAS 
sampling weight was further adjusted so 
that the sum of all person weights 
equaled external population control 
totals. 
The sample of interviewed 
households was divided into cells 
representing more detailed categories of 
selected variables. Poststratification 
adjustments were not made in each cell 
formed by cross-classification of 
categories of the stratification variables 
because control totals for each cell were 
not available. Only the marginal 
population control totals for those 
variables were determined. Therefore, 
raking was used to adjust the weights 
(28). Raking iteratively adjusts the 
weights so they match the marginal 
control totals. 
The independent source for NAS 
population control totals was the 2002 NHIS. The NAS weights were adjusted 
so that the sum of the weights equaled 
the 2002 NHIS population counts for 
the following groups: 
+	 Number of males and females in 
nine age groups. 
+	 Household size. 
+	 Number of persons of various racial 
and ethnic backgrounds. 
+	 Number of males and females by 
asthma status. 
The poststratification process also 
included an adjustment for potential bias 
that may exist because households that 
had no telephone at the time of the 
survey could not be contacted. This 
adjustment incorporated information 
about household interruptions in 
telephone service from NAS itself. 
Evidence suggests that households that 
had telephones at the time of the survey, 
but had interruptions in telephone 
service of 1 week or more during the 
year, were more similar to households 
with no telephone service at the time of 
the survey than were households with 
uninterrupted telephone service during 
the year (17,19–21). Therefore, 
noncoverage of households without 
telephones could be somewhat 
compensated for by proportionately 
increasing the weights for interviews 
completed in households with 
interrupted service. Completed 
interviews in households with 
interrupted service represent the 
households without telephone service at 
the time of the survey. 
To adjust for households without 
telephones, the numbers of telephone 
and nontelephone households were 
determined from the 2002 NHIS. Next, 
from NAS, the weighted proportion of 
telephone households having an 
interruption in telephone service for at 
least 1 week during the past 12 months 
was computed. This proportion was then 
applied to the number of telephone 
households to estimate the number of 
telephone households with interruption. 
These calculations produced two control 
totals: one for households with 
telephones and no interruption in service 
and the other for those without 
telephones or with an interruption in 
telephone service. These control totals 
are mutually exclusive and exhaustive. 
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persons in telephone and nontelephone 
households is denoted by M and the 
number of persons in telephone 
households is Mt. The number in 
nontelephone households is M – Mt. 
From NAS, the weighted proportion 
of persons in households with an 
interruption in telephone service is 
denoted as pIt. The number of persons in 
telephone households with interruptions 
in telephone service is given by 
M1t = Mt pit. The number of persons in 
telephone households without 
interruptions in telephone service is 
given by M t – MIt. 
The other control total combines 
persons in telephone households with 
interruptions and persons in 
nontelephone households: 
MIt + (M – Mt). 
The final sampling weight for the 
responding household member in 
household k in an IAP area is denoted 
by 
pwfk . 
The subscript f denotes the final weight. 
Production of sampling weights for 
the four-state study 
The process to produce four-state 
study sampling weights was identical to 
that for the national study to the point 
of the subsampling adjustment. For the 
four-state study, these adjustments were 
made separately for each specific state 
for adults with asthma and children with 
asthma because up to one such adult 
and one such child could be sampled 
within a single household. In households 
with multiple asthma-positive adults, the 
randomly selected adult represents all of 
the nonselected asthma-positive adults in 
the household. Therefore, the sampling 
weight for the completed adult interview 
must be increased to reflect the selection 
probability. The adjustment multiplied 
the weight by the number of eligible 
adults in the household. The same 
process occured for sampled children. 
Here, mak denotes the number of 
adults with asthma in the household, 
and mck denotes the number of children 
with asthma in the household. The 
sampling weight for the selected adult 
with asthma is a awk = wakmk . 
The sampling weight for the selected 
child with asthma is 
wc ck .k = wakm
Similarly, the nonresponse 
adjustment for the four-state study 
detailed interview was implemented 
separately for adults and children, with 
completed adult interviews representing 
sampled adults without a completed 
interview and completed child 
interviews representing sampled children 
without a completed interview. Again, 
the adjustment also varied by 
geographic area within the adult and 
child categories. 
Households in which the selected 
adult had asthma is denoted as q, and q* 
is the number of households in which 
the selected adult respondent completed 
a detailed interview. The nonresponse 
adjustment factor to account for selected 
adults with asthma who did not respond 
(in other households) is given by 
q 
a∑ wk 
k = 1Aa 3 = . 
q 
a∑ wk 
k = 1  
Similarly, the adjustment for 
nonresponse by selected children with 
asthma is given by 
u 
c∑ wk 
k = 1  
Ac = . 
3 
u 
c∑wk 
k = 1  
To compute the nonresponse-adjusted 
weights, wak is multiplied by Aa3 and wck 
by Ac3. 
The four-state study used two 
independent sources of population 
control totals for poststratification: the 
2003 BRFSS for adults and 2003 
SLAITS NSCH for children. Because 
the NAS four-state study was restricted 
to asthma-positive adults and children 
(i.e., those who had ever been diagnosed 
as having asthma), only totals for those 
groups were culled from the BRFSS and 
NSCH. In NAS, asthma-positive status 
was determined by a positive response 
to the following question: ‘‘Have you ever been told by a 
doctor or other health professional that 
you have asthma?’’ 
The questions that determined 
asthma-positive status in the BRFSS and 
NSCH were these: 
BRFSS—‘‘Have you ever been told 
by a doctor, nurse, or other health 
professional that you had asthma?’’ 
NSCH—‘‘Has a doctor or other 
health professional ever told you that 
[the sampled child] has asthma?’’ 
The NAS weights for sampled 
adults were adjusted so that the sum of 
the weights equaled the 2003 BRFSS 
counts of asthma-positive adults in the 
following groups by each state: 
+	 Six age groups. 
+	 Males and females. 
+	 Number of adults of various racial 
and ethnic backgrounds. 
The NAS weights for sampled children 
were adjusted so that the sum of the 
weights equaled the 2003 SLAITS 
NSCH counts of asthma-positive 
children in the following groups by each 
state: 
+	 Three age groups. 
+	 Males and females. 
+	 Number of children of various racial 
and ethnic backgrounds. 
Finally, the adjustment for 
nontelephone households was slightly 
different for the four-state study. The 
separate proportions of adults and 
children in telephone and nontelephone 
households were determined from the 
March 2004 ASEC. These proportions 
were applied to the state control totals 
of the numbers of adults and children to 
derive the estimated numbers of adults 
and children in each state in telephone 
and nontelephone households. The 
weighted proportions of adults and 
children in telephone households having 
an interruption in telephone service for 
at least 1 week during the past 12 
months were computed from NAS. 
These proportions were applied to the 
number of adults and children in 
telephone households to estimate the 
number of adults and children in 
telephone households with interruption. 
These calculations produced two control 
totals for adults and two control totals 
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Table I. Number of values imputed for 2003 NAS poststratification variables 
Number of missing values 
Variable National study Four-state study 
Age. . . . . . . . . . . . . . . . . . . . . .  . . .  10 
  
Sex . . . . . . . . . . . . . . . . . . . . . .  . . .  11 
  
Race . . . . . . . . . . . . . . . . . . . . .  310  122 
  
Hispanic ethnicity . . . . . . . . . . . . .  61  123 
  
Number of telephone lines. . . . . . . .  59  82 
  
Interrupted telephone service . . . . . .  124  106 
  
. . . Category not applicable. 
NOTE: NAS is National Asthma Survey. 
Table II. Summary statistics for poststratified weights, total screener and detailed 
interviews, national sample: NAS, 2003 
Unweighted 
sample size 
Minimum 
weight 
Maximum 
weight 
Mean 
weight 
Median 
weight 
Sum of 
weights 
United  States  . . . . . . . . . . .  8,621  9,108.50 
Weight = post_pr_int 
114,806.07 32,339.06 26,971.21 278,795,037 
United  States  . . . . . . . . . . .  7,521  9,102.80 
Weight = post_sr_int 
150,939.64 37,068.88 31,259.29 278,795,037 
NOTE: NAS is National Asthma Survey. 
Table III. Summary statistics for poststratified weights, total screening and detailed 
interviews, by state and the entire four-state sample: NAS, 2003 
Unweighted Minimum Maximum Mean Median Sum of 
Four-state sample sample size weight weight weight weight weights 
Weight = weight_int1 
Total  . . . . . . . . . . . . . . . . . . . . .  5,741  56.026  14,910.770 1,596.073 1,169.764 9,163,056 
Alabama. . . . . . . . . . . . . . . . . . .  1,488  56.026  1,698.840 353.095 302.576 525,405 
California  . . . . . . . . . . . . . . . . . .  1,433  408.729 14,910.770 3,228.165 2,883.732 4,625,961 
Illinois  . . . . . . . . . . . . . . . . . . . .  1,313  213.474 4,434.976 1,068.409 922.778 1,402,821 
Texas . . . . . . . . . . . . . . . . . . . .  1,507  342.057 6,772.682 1,731.167 1,414.565 2,608,869 
Weight = post_adult_int2 
Total  . . . . . . . . . . . . . . . . . . . . .  3,736  65.538  14,910.770 1,794.087 1,269.086 6,702,710 
Alabama. . . . . . . . . . . . . . . . . . .  987  65.538  1,698.840 396.830 324.731 391,671 
California  . . . . . . . . . . . . . . . . . .  931  817.640 14,910.770 3,730.567 3,314.775 3,473,158 
Illinois  . . . . . . . . . . . . . . . . . . . .  888  213.474 4,434.976 1,178.439 1,007.008 1,046,454 
Texas . . . . . . . . . . . . . . . . . . . .  930  503.346 6,772.682 1,926.266 1,662.099 1,791,427 
Weight = post_child_int3 
Total  . . . . . . . . . . . . . . . . . . . . .  2,005  56.026  10,119.622  1,227.105 949.506 2,460,346 
Alabama. . . . . . . . . . . . . . . . . . .  501  56.026  967.894 266.934 219.651 133,734 
California  . . . . . . . . . . . . . . . . . .  502  408.729 10,119.622 2,296.420 1,695.575 1,152,803 
Illinois  . . . . . . . . . . . . . . . . . . . .  425  247.825 3,113.136 838.511 640.074 356,367 
Texas . . . . . . . . . . . . . . . . . . . .  577  342.057 4,994.654 1,416.711 1,232.606 817,442 
1weight_int is a person-level interview weight that includes all sample adults and sample children in the sample and reduces the
 
analyst’s work by eliminating the need to aggregate the adult and child weights to examine the whole sample. It should be used if
 
the analyst wishes to examine characteristics of asthmatics in the entire sample across all ages.
 
2post_adult_int is a person-level interview weight that only includes sample adults 18 years of age and over; it should be used if
 
the analyst is only interested in examining characteristics of asthmatic adults.
 
3post_child_int is a person-level interview weight that only includes sample children under 18 years of age; it should be used if the
 
analyst is only interested in examining characteristics of asthmatic children.
 
NOTE: NAS is National Asthma Survey.
 for children: one for those in households 
with telephones and no interruption in 
service and the other for those in 
households without telephones or with 
an interruption in telephone service. 
These control totals are mutually 
exclusive and exhaustive. 
The final sampling weights for adult 
and child respondents after 
poststratification are denoted by 
wa = cfk  wfk . 
Imputation of missing values of 
poststratification variables 
Missing values of required 
poststratification variables were imputed 
either by Weighted Sequential Hot Deck 
(WSHD) (29) or the use of models. 
Table I shows the number of cases 
imputed for each of these variables. 
In the national study, only 6.1% of 
the 10,054 cases required imputation of 
any variable, and no single variable 
required imputation in more than 3.1% 
of cases. Similarly, in the four-state 
study, only 3.1% of the 5,741 cases 
required imputation of any variable, and 
no single variable required imputation in 
more than 2.1% of cases. 
Trimming weights 
The weighting process resulted in a 
small number of extremely large 
weights, which can increase the variance 
of estimates. Extremely large weights 
were trimmed to reduce their impact. 
Trimming introduces bias in the 
estimates, so trimming should be 
minimized. Therefore, only weights that 
were greater than the median plus five 
times the interquartile range were 
defined as extreme and were truncated 
to the median plus five times the 
interquartile range. 
Standard errors of estimates 
SUDAAN software can be used to 
compute standard errors of estimates 
using the with-replacement option (See 
Tables II and III). 
Imputation methods 
Age—For the national study, no 
cases were missing age. The 10 cases 
missing age data in the four-state study 
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category (for adults or children as 
applicable) used in the weighting 
process. 
Sex—For the national study, no 
cases were missing sex. For the 
four-state study, WSHD was used to 
impute sex. States were used as donor 
pools. 
Race and ethnicity—A combination 
race and ethnicity variable was used for 
weighting. If information on ethnicity 
was missing, the variable was imputed 
using WSHD. For cases imputed as 
non-Hispanic that were missing data on 
race, race was imputed using WSHD 
with the household base weight. The 
donor pools for both imputations were 
IAP areas for the national study and 
states for the four-state study. 
Number of telephone lines—WSHD 
was used to impute the number of 
household telephone lines. Donor pools 
were defined by household size (one 
person, two people, three or more 
people) for the national study and IAP 
area for both studies. 
Interrupted telephone service—For 
interruption in telephone service, WSHD 
was used with donor pools defined by 
IAP area for the national study, by state 
for the four-state study, and by income 
(those with an income below $30,000 or 
who did not know their income and 
those with income at or above $30,000 
or with refused income) for both studies. 
Weight trimming 
In sample surveys, very large or 
extreme sampling weights are often 
truncated, or ‘‘trimmed,’’ because large 
variation in weights can result in large 
sampling variances of survey estimates. 
This is especially true if the sampling 
weights are not correlated with values or 
characteristics of interest. In such 
situations, the few observations with 
very large weights may contribute 
unduly to the overall estimate. Large 
weights can also be a result of sample 
selection procedures and adjustments for 
unit nonresponse. 
Though a trimming procedure 
reduces estimate variance, it may result 
in increased estimate bias. The objective 
of trimming is to reduce variance, so 
this reduction more than compensates 
for the increase in bias, resulting in a smaller mean squared error than that 
before trimming. Therefore, trimming as 
little as possible is advisable. 
No strict rules or procedures exist 
to define or trim extreme weights, and 
various methods of weight trimming are 
practiced. In some surveys that employ 
weighting, the size of nonresponse and 
other adjustments to the base sampling 
weights are restricted to avoid large 
final weights altogether. Other surveys 
examine the distribution of final weights 
to identify extreme weights and propose 
trimming rules. This method is more 
common because identifying extreme 
weights by examining the entire weight 
distribution is easier. 
Some common procedures to trim 
weights are 1) to identify any sampling 
weight larger than four to five times the 
mean weight as an outlier weight and 
trim that weight by making it equal to 
the limit, 2) to identify any weight 
larger than the median weight plus five 
to six times the interquartile range of 
the final weights and trim the weight by 
making it equal to the limit, and 3) to 
truncate weights above a certain 
percentile (e.g., 95 or 99) in the 
distribution of weights. The standard 
deviation of weights is not used to guide 
trimming because it is affected by 
extreme weights. 
Typically, once trimming has been 
completed, the weights of observations 
with untrimmed weights are increased 
such that the sum of the new weights 
equals the sum of the weights before 
trimming. 
Trimming NAS weights—The 
distribution of final NAS weights was 
examined to identify extreme weights. A 
decision was made to define a final 
weight as extreme if it exceeded the 
median plus five times the interquartile 
range to avoid undue trimming. A 
formal description of the trimming 
process is given below. 
The final poststratified sampling 
weight for the responding person in a 
household in the sample is denoted by 
wpfk. The number of respondent persons 
in the sample with a final sampling 
weight is n. The median of these n 
weights is wm, and the interquartile 
range is qr. Any weight exceeding the 
value wm + 5qr is set equal to wm + 5qr.
Assuming that there are trimmed g weights, the sum of the original 
n 
weights is ∑
wp fk . 
i = 1  
The sum of the new 
n – g
weights is ∑
wp fk + g ( wm + 5qr).
k = 1  
For the two sums to be equal, the 
untrimmed weights are adjusted by a 
factor equal to 
This adjustment is done as part of 
raking the weights, such that the sum of 
the weights agrees with various control 
totals in the other margins. A second 
round of raking occurs after trimming is 
complete. 
Estimation of variance for national 
study estimates—The final weight 
attached to a responding person in the 
national study in household k in an IAP 
area is w
p
fk. For variance estimation, IAP 
areas should be distinguished, as these 
are strata for sample selection. 
Therefore, the final weight in IAP area 
h is denoted by wpfhk. 
Some characteristic of interest for 
the respondent in household k in stratum 
h is denoted by yhk, and yhk equals 1 if 
the person has the characteristic and 0 if 
the person does not have the 
characteristic. Assuming nh households 
are in the sample in IAP area h, the 
estimated proportion of persons having 
the characteristic in stratum h is given 
by 
∑

nh 
wpfhk yhk 
^ k = 1  R .h = 
∑

nh
wpfhk
k = 1  
The numerator is the sum of the 
weights of all responding persons over 
all households in IAP area h having the 
characteristic, and it is an estimate of 
the number of persons with the 
characteristic. The denominator is the 
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therefore gives an estimate of the 
number of persons in IAP area h. 
The estimated total number of 
persons in IAP area h is denoted 
by 
n h
^ pNh = ∑wfhk . 
k = 1  
For estimating the variance of the 
^ sample proportion Rh , define 
p ^ wfhk (yhk — Rh) 
zhk = ^ Nh 
and 
n h ∑ z hk 
k = 1  
z h = . nh 
An estimate of the variance of the 
proportion of persons having the 
characteristic in IAP area is given by 
^ n h 
n h 
v (R  h) = (z hk – z h)2 . nh – 1 ∑ k = 1  
The basic building block to 
compute variance is the IAP area 
because sample selection occurred at 
this level. For states consisting of a 
single IAP area, the estimate of the 
variance is computed using the formula 
given above. For states consisting of 
multiple IAP areas and for national-level 
estimates, zhk is defined slightly 
differently. The estimated proportion at 
the national level is given by L nh ∑ ∑ zhk 
^ h = 1  k = 1  R = , 
L 
^∑ Nh 
h = 1  
where L is the number of strata (IAP 
areas). 
^ For estimating the variance of R, define 
p ^)wfhk (yhk — R  
,z hk = ^ N 
where wpfhk and yhk are as defined 
– earlier. Also zhk and zh are defined as 
before and 
L
^ ^ N = ∑ Nh . 
h = 1  
The variance of R ^ is given by 
L n hn h
v (R  ^ ) =  ∑ – z h)2 .(nh – 1) ∑ (zhk h = 1  k = 1  
Estimation of variance for four-state 
study estimates—There are two sets of 
estimates for the four-state study: adults 
and children. Variance estimation is 
similar to the procedure described for 
the national study except for adult-level 
estimates; the final adult weight (wafk) is  
used. For child-level estimates the final 
child weight (wcfk) is used. Because each 
of the four states in the study (Alabama, 
California, Illinois, and Texas) contains 
multiple IAP areas, the variance is 
estimated at the IAP area level. The 
final weights at the IAP area level for adults and children are denoted by wafhk 
for adults and wcfhkfor children. 
Underestimation of variance—The 
formulas for variance estimation assume 
the weights are fixed. That is, in 
repeated samples of households and 
persons, weights attached to each person 
in an IAP area are assumed to be 
constant. However, the final weights are 
actually obtained after various 
adjustments to the base sampling 
weight, and these adjustments depend on 
the sample selected. Therefore, the 
variance estimates do not reflect the 
sampling variability of the weights. To a 
certain extent, the variance is 
underestimated. In addition, a slight 
overestimation of variance is due to the 
assumption of with-replacement 
sampling of households when 
households were actually selected 
without replacement. The extent of 
underestimation depends on variability 
in weights in repeated samples. 
This underestimation may not be 
severe, as the weights have been raked 
to multiple control totals, and may not 
be highly variable in repeated samples. 
An alternative method of variance 
estimation would use a jackknife 
technique or resampling procedure, such 
as bootstrap estimation. For NIS, 
jackknife variance estimates of 
vaccination coverage rates were 
computed but found to be very similar 
to estimates obtained using Taylor-series 
approximation (30). Using a resampling 
procedure may involve a substantial 
amount of work, in view of the large 
number of strata. 
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National Study Questionnaire 
SLAITS National Asthma Survey 
National Study Questionnaire 
Form Approved 
OMB No. 0920–0406 
Exp. Date 12/31/04 
Section Subject 
Section 1 NAS Eligibility Screening, Respondent Selection, 
and Initial Demographics 
Section 2 History of Asthma (Symptoms & Episodes) 
Section 3 Health Care Utilization 
Section 4 Knowledge of Asthma/Management Plan 
Section 5 Modifications to Environment 
Section 6 Medications 
Section 7 Family History of Asthma 
Section 8 Demographic Information 
Proxy Interview Variable Listing 
The following public burden estimate statement will be available as a CATI screen: 
Public reporting burden of this collection of information is estimated to average 10 minutes per response, including the time for 
reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing 
the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of 
information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other 
aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer, 
1600 Clifton Road NE, MS D-24, Atlanta, Georgia 30333; ATTN: PRA (0920–0406). 
NOTE: CATI variable names are provided with corresponding SAS data file variable names in parentheses (if different). 
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Section 1. NAS Eligibility Screening, Respondent Selection, and Initial Demographics 
CASEID	 UNIQUE HOUSEHOLD ID NUMBER 
SAMP_TYPE	 DERIVED. NIS/NAS OR NAS-ONLY SAMPLE GROUP 
(1) NIS/NAS SAMPLE 
(2) NAS-ONLY SAMPLE 
PROX_STAT DERIVED. DATA PROVIDED BY PROXY ONLY, SAMPLED RESPONDENT ONLY, OR BOTH PROXY 
AND SAMPLED RESPONDENT 
(0) NEITHER SAMPLED PERSON NOR PROXY DATA 
(1) ONLY PROXY DATA 
(2) ONLY SAMPLED PERSON DATA 
(3) BOTH PROXY AND SAMPLED PERSON DATA 
COMPLETE_STATUS DERIVED. SCREENER AND INTERVIEW COMPLETE STATUS 
(0) DID NOT COMPLETE SCREENER 
(1) SCREENER COMPLETE ONLY 
(2) SAMPLED R INTERVIEW COMPLETED 
(3) PROXY R INTERVIEW COMPLETED 
(4) BOTH SAMPLED & PROXY R INTERVIEWS COMPLETED 
IAPID	 IAP AREA LOCATION 
SPANISH	 CATI FLAG. CASE PLACED IN SPANISH QUEUE 
(0) NOT PLACED IN SPANISH QUEUE 
(1) PLACED IN SPANISH QUEUE 
LTR	 ADVANCE LETTER MAILED TO HOUSEHOLD 
(0) NO, LETTER WAS NOT MAILED 
(1) YES, LETTER MAILED 
CALLDATE	 CATI DATE. DATE THE INTERVIEW WAS COMPLETED OR THE LAST DATE THE HOUSEHOLD WAS 
CONTACTED, IF A COMPLETED INTERVIEW WAS NOT OBTAINED. 
INTRODUCTORY STATEMENT 
Now I have some important questions for both adults and children in your household that will allow us to 
compare people who do and do not have asthma. If nobody in your household has asthma, the interview will be 
very brief. 
ROSTER	 I need to ask questions about just one person in your household. Please tell me how many people of all ages live 
in your household. 
ENTER NUMBER ____ 
(96) DON’T KNOW [END INTERVIEW] 
(97) REFUSED	 [END INTERVIEW] 
FEMROSTER [IF ROSTER = 1, SKIP TO R_ASTHMX01.] 
Of these people, how many are female? 
ENTER NUMBER ____ 
(96) DON’T KNOW 
(97) REFUSED 
RANDOMLY SAMPLE ONE PERSON FROM HOUSEHOLD ROSTER CREATED FROM ROSTER AND 
FEMROSTER. 
R_ASTHMX01 [Have you/Has the (SELECTED PERSON) in your household] ever been told by a doctor or other health 
professional that [you have/(he or she has)] asthma? 
(0) NO	 [SKIP TO R_DOB (S3Q2)] 
(1) YES 
(6) DON’T KNOW [SKIP TO R_DOB (S3Q2)] 
(7) REFUSED	 [SKIP TO R_DOB (S3Q2)] 
CUR_AST (S3Q2) (Do you/Does he/Does she) still have asthma? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
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R_DOB (S2Q5)	 Please tell me [your age/the age of the (SELECTED PERSON)] in your household. 
ENTER NUMBER ____ [SKIP TO R_SEX] 
(996) DON’T KNOW 
(997) REFUSED 
AGECAT	 For the purposes of this survey, it is important to get at least an age range for the person selected for the 
interview. Would you please tell me if [you are/the (SELECTED PERSON) is] 18 years of age or older? 
(1)	 UNDER 18 [SKIP TO AGECAT_K] 
(2)	 18 OR OLDER [SKIP TO AGECAT_A] 
(6)	 DON’T KNOW [END INTERVIEW] 
(7)	 REFUSED [END INTERVIEW] 
AGECAT_K	 Would you say that [the (SELECTED PERSON) is]: 
(1)	 0 to 5 [SKIP TO R_SEX (S2Q6)] 
(2)	 6 to 11 or [SKIP TO R_SEX (S2Q6)] 
(3)	 12 to 17 years of age [SKIP TO R_SEX (S2Q6)] 
(6)	 DON’T KNOW [END INTERVIEW] 
(7)	 REFUSED [END INTERVIEW] 
AGECAT_A	 Would you say that [you are/the (SELECTED PERSON) is]: 
(1) 	  18 to 24  
(2) 	  25 to 34  
(3) 	  35 to 44  
(4) 	  45 to 54  
(5) 	  55 to 64 or  
(6) 	  65 or older  
(96) DON’T KNOW [END INTERVIEW] 
(97) REFUSED	 [END INTERVIEW] 
R_SEX (S2Q6)	 [READ IF NECESSARY]: 
Are you/Is the (AGE) year old] male or female? 
(1)	 MALE 
(2)	 FEMALE 
(7)	 REFUSED 
FLG_PROXY DERIVED. INTERVIEW DONE BY PROXY BECAUSE OF ILLNESS. 
(0)	 INTERVIEW NOT CONDUCTED BY PROXY FOR ILLNESS 
(1)	 INTERVIEW CONDUCTED BY PROXY FOR ILLNESS 
FLG_TYPE DERIVED. EXPECTED INTERVIEW TYPE 
(1) CURRENT ASTHMA-SAMPLED PERSON INTERVIEW: DATA IN ORIGINAL FIELDS 
(2)	 ASTHMA, NOT CURRENT-SAMPLED PERSON INT: DATA IN ORIGINAL FIELDS 
(3)	 NO ASTHMA-SAMPLED PERSON INTERVIEW: DATA IN ORIGINAL FIELDS 
(4)	 ASTHMA-PROXY INT B/C SAMPLED PERSON UNAVAILABLE: DATA IN PROXY FIELDS 
(5)	 NO ASTHMA-PROXY INT B/C SAMPLED PERSON UNAVAILABLE, SAMPLED NEVER 
INTERVIEWED: DATA IN PROXY FIELDS 
(6)	 NO ASTHMA-PROXY INT B/C SAMPLED PERSON UNAVAILABLE, SAMPLED PERSON 
INTERVIEWED AT CALLBACK: DATA IN BOTH FIELDS 
(7)	 CURRENT ASTHMA-SAMPLED PERSON & PROXY INTS: DATA IN BOTH FIELDS 
(8)	 ASTHMA, NOT CURRENT-SAMPLED PERSON & PROXY INTS: DATA IN BOTH FIELDS 
(9)	 CURRENT ASTHMA-PROXY INT B/C SAMPLED PERSON ILL: DATA IN ORIGINAL FIELDS 
(10) ASTHMA, NOT CURRENT-PROXY INT B/C SAMPLED PERSON ILL: DATA IN ORIGINAL FIELDS 
(11) NO ASTHMA-PROXY INTERVIEW B/C SAMPLED PERSON ILL: DATA IN ORIGINAL FIELDS 
(12) SAMPLED PERSON OR ASTHMA STATUS NOT DETERMINED 
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PROXYREL (S3Q6B) What is your relationship to [the (AGE) year old]? 
(1) SPOUSE 
(2) UNMARRIED PARTNER, BOYFRIEND/GIRLFRIEND 
(3) CHILD 
(4) GRANDCHILD 
(5) MOTHER (BIRTH/ADOPTIVE/STEP/FOSTER/OTHER) 
(6) FATHER (BIRTH/ADOPTIVE/STEP/FOSTER/OTHER) 
(7) BROTHER/SISTER 
(8) GRANDFATHER/GRANDMOTHER 
(9) OTHER RELATIVE 
(10) FOSTER CHILD 
(11) HOUSEMATE/ROOMMATE 
(12) ROOMER/BOARDER 
(13) OTHER NON-RELATIVE 
(90) UNRELATED LEGAL GUARDIAN 
(96) DON’T KNOW 
(97) REFUSED 
RELA_CHLD (S3Q6) [IF R_DOB (S2Q5) > 17, SKIP TO OTH_CHLD (S3Q7).] 
What is your relationship to [the (AGE) year old] who lives in this household? 
(1) MOTHER (STEP, FOSTER, ADOPTIVE) OR FEMALE GUARDIAN 
(2) FATHER (STEP, FOSTER, ADOPTIVE) OR MALE GUARDIAN 
(3) SISTER OR BROTHER (STEP/FOSTER/HALF/ADOPTIVE) 
(4) IN-LAW OF ANY TYPE 
(5) AUNT/UNCLE 
(6) GRANDPARENT 
(7) OTHER FAMILY MEMBER 
(8) FRIEND 
(96) DON’T KNOW 
(97) REFUSED 
OTH_CHLD (S3Q7) [IF SAMPLED RESPONDENT IS SAME PERSON WHO ANSWERED R_ASTHMX01, SKIP TO 
AGEDGNOS (S3Q8)] {Have you/Has [the (AGE) year old/NAME]} ever been told by a doctor or other 
health professional that {you have/he has/she has} asthma? 
(0) NO	 [SKIP TO INS1 (S5Q1_A)] 
(1) YES 
(6) DON’T KNOW [SKIP TO INS1 (S5Q1_A)] 
(7) REFUSED [SKIP TO INS1 (S5Q1_A)] 
AGEDGNOS (S3Q8) [IF OTH_CHLD (S3Q7) = 0, 6, 7 SKIP TO INS1_A).] 
How old {were you/was [the (AGE) year old]} when {you were/he or his parent or guardian was/she or her 
parent or guardian was} first told by a doctor or other health professional that {you/he/she} had 
asthma? 
[INTERVIEWER: ENTER 0 IF LESS THAN ONE YEARS OLD] 
__ __ __ (ENTER AGE IN YEARS) 
(996) DON’T KNOW 
(997) REFUSED 
CUR_AST2 (S3Q9)	 [IF SAMPLED RESPONDENT IS SAME PERSON WHO ANSWERED CUR_AST (S3Q2), SKIP TO 
LAST_MD (S3Q10)] {Do you/Does [the (AGE) year old]} still have asthma? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
Section 2. History of Asthma (Symptoms & Episodes) 
LAST_MD (S3Q10)	 How long has it been since {you/[the (AGE) year old]/[the (AGE) year old]’s parents or guardians} last 
talked to a doctor or other health professional about (your/his/her) asthma? 
[INTERVIEWER: READ RESPONSE OPTIONS IF NECESSARY.] 
(0) NEVER 
(1) WITHIN THE PAST YEAR 
(2) 1 YEAR TO LESS THAN 3 YEARS AGO 
(3) 3 YEARS TO 5 YEARS AGO 
(4) MORE THAN 5 YEARS AGO 
(6) DON’T KNOW 
(7) REFUSED 
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LAST_MED (S3Q11)	 How long has it been since {you/[the (AGE) year old]} last took asthma medication? 
[INTERVIEWER: READ RESPONSE OPTIONS IF NECESSARY.] 
(0) NEVER 
(1) LESS THAN ONE DAY AGO 
(2) 1–6 DAYS AGO 
(3) 1 WEEK TO LESS THAN 3 MONTHS AGO 
(4) 3 MONTHS TO LESS THAN 1 YEAR AGO 
(5) 1 YEAR TO LESS THAN 3 YEARS AGO 
(6) 3 YEARS TO 5 YEARS AGO 
(7) MORE THAN 5 YEARS AGO 
(96) DON’T KNOW 
(97) REFUSED 
LASTSYMP (S3Q12)	 Symptoms of asthma include coughing, wheezing, shortness of breath, chest tightness or phlegm 
production when {you do not/[the (AGE) year old/NAME] does not} have a cold or respiratory infection. 
How long has it been since {you/[the (AGE) year old]} last had any symptoms of asthma? 
[INTERVIEWER: READ RESPONSE OPTIONS IF NECESSARY] 
(0) NEVER 
(1) LESS THAN ONE DAY AGO 
(2) 1–6 DAYS AGO 
(3) 1 WEEK TO LESS THAN 3 MONTHS AGO 
(4) 3 MONTHS TO LESS THAN 1 YEAR AGO 
(5) 1 YEAR TO LESS THAN 3 YEARS AGO 
(6) 3 YEARS TO 5 YEARS AGO 
(7) MORE THAN 5 YEARS AGO 
(96) DON’T KNOW 
(97) REFUSED 
FLG_ASTHMA DERIVED. SOURCE OF ASTHMA STATUS REPORT 
ASTHSTAT	 DERIVED. ASTHMA STATUS OF HOUSEHOLD MEMBER 
(0) NO, PERSON DOES NOT HAVE ASTHMA 
(1) YES, PERSON HAS ASTHMA 
LTASTHM	 DERIVED. RISK FACTOR FOR LIFETIME ASTHMA PREVALENCE BASED ON BRFSS RULES 
(1) NOT AT RISK 
(2) AT RISK 
(9) DON’T KNOW/NOT SURE OR REFUSED 
ASTATUS1	 DERIVED. CURRENT ASTHMA STATUS OF HOUSEHOLD MEMBER BASED ON SELF­
IDENTIFICATION 
(1) PERSON SELF-IDENTIFIED ASTHMA 
(0) PERSON DID NOT SELF-IDENTIFY ASTHMA 
(6) DON’T KNOW 
CASTHMA	 DERIVED. RISK FACTOR FOR CURRENT ASTHMA PREVALENCE BASED ON BRFSS RULES 
(1) NOT AT RISK 
(2) AT RISK 
(9) DON’T KNOW/NOT SURE OR REFUSED 
ASTHMST	 DERIVED. COMPUTED ASTHMA STATUS BASED ON BRFSS RULES 
(1) CURRENT 
(2) FORMER 
(3) NEVER 
(9) DON’T KNOW/NOT SURE OR REFUSED 
ASTATUS2	 DERIVED. CURRENT ASTHMA STATUS OF HOUSEHOLD MEMBER BASED ON SELF-REPORTED 
BEHAVIORS 
(1) BEHAVIORS INDICATE ASTHMA 
(0) BEHAVIORS DO NOT INDICATE ASTHMA 
(6) DON’T KNOW 
IF {[CUR_AST (S3Q2) = 0, 6, 7 OR CUR_AST2 (S3Q9) = 0, 6, 7] AND
 
LAST_MD (S3Q10) = 0 OR > 2  AND 
  
LAST_MED (S3Q11) = 0 OR > 5  AND 
  
LASTSYMP (S3Q12) = 0 OR > 5}, 
  
SKIP TO SECTION 3. 
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ELSE IF CUR_AST (S3Q2) = 1 OR CUR_AST2  (S3Q9) = 1, 
CONTINUE. 
ELSE IF {[CUR_AST (S3Q2) = 0, 6, 7 OR CUR_AST2 (S3Q9) = 0, 6, 7] AND 
[LAST_MD (S3Q10) = 1, 2 OR 
LAST_MED (S3Q11) ≥ 1 AND ≤ 5 OR  
LASTSYMP (S3Q12) ≥ 1 AND ≤ 5]}, 
CONTINUE. 
SYMP_30D (S4Q1)	 IF LASTSYMP (S3Q12) = 0 OR  ≥ 5 AND ≤ 7, SKIP TO SECTION 3. 
IF LASTSYMP (S3Q12) = 4, SKIP TO EPIS_INT. 
During the past 30 days, how many days did {you/[the (AGE) year old/NAME]} have any symptoms of 
asthma? 
__ __DAYS (1–29) [SKIP TO ASLEEP30 (S4Q3)] 
(0) NO SYMPTOMS IN THE PAST 30 DAYS [SKIP TO EPIS_INT] 
(30) EVERY DAY 
(96) DON’T KNOW [SKIP TO ASLEEP30 (S4Q3)] 
(97) REFUSED [SKIP TO ASLEEP30 (S4Q3)] 
DUR_30D (S4Q2)	 {Do you/Does [the (AGE) year old/NAME]} have symptoms all the time? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HELP SCREEN: ‘‘ALL THE TIME’’ MEANS SYMPTOMS THAT CONTINUE THROUGHOUT THE DAY. IT 
DOES NOT MEAN SYMPTOMS FOR A LITTLE WHILE EACH DAY. 
ASLEEP30 (S4Q3)	 During the past 30 days, on how many days did symptoms of asthma make it difficult for {you/[the (AGE) 
year old/NAME]} to stay asleep? 
__ __ DAYS/NIGHTS 
(0) NONE 
(96) DON’T KNOW 
(97) REFUSED 
SYMPFREE (S4Q4)	 [IF SYMP_30D (S4Q1) = 30, SKIP TO EPIS_INT.] During the past two weeks, on how many days {were 
you/was [the (AGE) year old/NAME]} completely symptom-free, that is no coughing, wheezing, or other 
symptoms of asthma? 
__ __ NUMBER OF DAYS 
(96) DON’T KNOW 
(97) REFUSED 
INTRODUCTORY STATEMENT 
Asthma attacks, sometimes called episodes, refer to periods of worsening asthma symptoms that make {you limit 
your/limit [the (AGE) year old/NAME]’s} activity more than [you usually do/(he/she) usually does], or make 
(you/him/her) seek medical care. [CONTINUE] 
EPIS_12M (S4Q5)	 [IF R_DOB (S2Q5) = 0, FILL: ‘‘Since birth’’/ELSE FILL: ‘‘During the past 12 months’’], {have you/has 
[the (AGE) year old/NAME]} had an episode of asthma or an asthma attack? 
(0) NO	 [SKIP TO INS1 (S5Q1_A)] 
(1) YES 
(6) DON’T KNOW	 [SKIP TO INS1 (S5Q1_A)] 
(7) REFUSED	 [SKIP TO INS1 (S5Q1_A)] 
HELP SCREEN: (ADD TO ALL QUESTIONS THAT REFER TO ‘‘ASTHMA ATTACKS OR EPISODES’’) 
Asthma attacks, sometimes called episodes, refer to periods of worsening asthma symptoms that make {you limit 
your/limit [the (AGE) year old/NAME]’s} activity more than [you usually do/(he/she) usually does], or make 
(you/him/her) seek medical care. 
EPIS_TP (S4Q6)	 During the past 3 months, how many asthma episodes or attacks {have you/has [the (AGE) year 
old/NAME]} had? 
_ _ ATTACKS OR EPISODES DURING PAST 3 MONTHS 
(0) NONE 
(996) DON’T KNOW 
(997) REFUSED 
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DUR_ASTH (S4Q7)	 How long did {your/[the (AGE) year old/NAME]’s} most recent asthma episode or attack last? 
_ _ENTER AMOUNT 
(96) DON’T KNOW [SKIP TO COMPASTH (S4Q9)] 
(97) REFUSED [SKIP TO COMPASTH (S4Q9)] 
DUR2ASTH (S4Q8)	 ENTER PERIOD 
(1)	 MINUTES 
(2)	 HOURS 
(3)	 DAYS 
(4)	 WEEKS 
(6)	 DON’T KNOW 
(7)	 REFUSED 
COMPASTH (S4Q9)	 Compared with other episodes or attacks, was this most recent attack shorter, longer, or about the 
same? 
(1)	 SHORTER 
(2)	 LONGER 
(3)	 ABOUT THE SAME 
(4)	 THE MOST RECENT ATTACK WAS ACTUALLY THE FIRST ATTACK 
(6)	 DON’T KNOW 
(7)	 REFUSED 
Section 3. Health Care Utilization 
INS1 (S5Q1_A)	 {Do you/[Does the (AGE) year old/NAME]} have any kind of health care coverage, including health insurance, 
prepaid plans such as HMOs, or government plans such as Medicare? 
(0)	 NO 
(1)	 YES [SKIP TO INS2 (S5Q1_B)] 
(6)	 DON’T KNOW 
(7)	 REFUSED 
IF (A) INS1 (S5Q1_A) = 0, 6, 7 OR 
(B)	 R_ASTHMX01 = 0, 6, 7 OR S3Q7 = 0, 6, 7 
(C)	 {[CUR_AST (S3Q2) = 0, 6, 7 OR CUR_AST2 (S3Q9) = 0, 6, 7] AND 
LAST_MD (S3Q10) = 0 OR > 2  AND  
LAST_MED (S3Q11) = 0 OR > 5  AND  
LASTSYMP (S3Q12) = 0 OR > 5},  
SKIP TO SECTION 5. 
ELSE IF INS1 (S5Q1_A) = 1, CONTINUE TO INS2 (S5Q1_B). 
ELSE SKIP TO NER_TIME (S5Q1). 
INS2 (S5Q1_B) [IF R_DOB (S2Q5) = 0, FILL: ‘‘Since birth’’/ELSE FILL: ‘‘During the past 12 months’’], was there any time 
that {you/[the (AGE) year old/NAME]} did not have any health insurance or coverage? 
(0)	 NO 
(1)	 YES 
(6)	 DON’T KNOW 
(7)	 REFUSED 
IF (A) (R_ASTHMX01 = 0, 6, 7 OR S3Q7 = 0, 6, 7) OR 
(B) {[CUR_AST (S3Q2) = 0, 6, 7 OR CUR_AST2 (S3Q9) = 0, 6, 7] AND 
LAST_MD (S3Q10) = 0 OR > 2  AND  
LAST_MED (S3Q11) = 0 OR > 5  AND  
LASTSYMP (S3Q12) = 0 OR > 5},  
SKIP TO SECTION 5. 
ELSE SKIP TO NER_TIME (S5Q1). 
NER_TIME (S5Q1)	 [IF LAST_MD (S3Q10) = 0, 2, 3, 4, SKIP TO MISS_DAY (S5Q9).] [IF R_DOB (S2Q5) = 0, FILL: ‘‘Since 
birth’’/ELSE FILL: ‘‘During the past 12 months’’], how many times did {you/[the (AGE) year old/NAME]} 
see a doctor or other health professional for a routine checkup for (your/his/her) asthma? 
_ _ _ ENTER NUMBER 
(0)	 NONE 
(996) DON’T KNOW 
(997) REFUSED 
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ER_VISIT (S5Q2) [IF R_DOB (S2Q5) = 0, FILL: ‘‘Since birth’’/ELSE FILL: ‘‘During the past 12 months’’], {have you/has [the 
(AGE) year old/NAME]} had to visit an emergency room or urgent care center because of (your/his/her) 
asthma? 
(0) NO [SKIP TO URG_TIME (S5Q4)] 
(1) YES 
(6) DON’T KNOW [SKIP TO URG_TIME (S5Q4)] 
(7) REFUSED [SKIP TO URG_TIME (S5Q4)] 
ER_TIMES (S5Q3)	 [IF R_DOB (S2Q5) = 0, FILL: ‘‘Since birth’’/ELSE FILL: ‘‘During the past 12 months’’], how many times 
did {you/[the (AGE) year old/NAME]} visit an emergency room or urgent care center because of (your/his/ 
her) asthma? 
_ _ _ ENTER NUMBER 
(996) DON’T KNOW 
(997) REFUSED 
URG_TIME (S5Q4)	 [IF ER_TIMES (S5Q3) > 0, INSERT: ‘‘Besides those emergency room or urgent care center visits,’’] [IF 
R_DOB (S2Q5) = 0, FILL: ‘‘Since birth’’/ELSE FILL: ‘‘During the past 12 months’’], how many times did 
{you/[the (AGE) year old/NAME]} see a doctor or other health professional for urgent treatment of 
worsening asthma symptoms or an asthma episode or attack? 
_ _ _ ENTER NUMBER 
(0)	 NONE 
(996) DON’T KNOW 
(997) REFUSED 
HOSP_VST (S5Q5)	 [IF LASTSYMP (S3Q12) = 0 OR > 5 A ND < 7, SKIP T O MISS_DAY (S5Q9).] ‘‘Since birth’’/ELSE FILL: 
‘‘During the past 12 months,’’ that is since (1 YEAR AGO TODAY)], {have you/has [the 
(AGE) year old/NAME]} had to stay overnight in a hospital because of (your/his/her) asthma? Do not 
include an overnight stay in the emergency room. 
(0)	 NO [SKIP TO MISS_DAY (S5Q9)] 
(1)	 YES 
(6)	 DON’T KNOW [SKIP TO MISS_DAY (S5Q9)] 
(7)	 REFUSED [SKIP TO MISS_DAY (S5Q9)] 
HOSPTIME (S5Q6) [IF R_DOB (S2Q5) = 0, FILL: ‘‘Since birth’’/ELSE FILL: ‘‘During the past 12 months’’], how many 
different times did {you/[the (AGE) year old/NAME]} stay in any hospital overnight or longer because of 
(your/his/her) asthma? 
_ _ _ TIMES 
(996) DON’T KNOW 
(997) REFUSED 
HOSPPLAN (S5Q8)	 The last time {you/[the (AGE) year old/NAME]} left the hospital, did a health professional talk with 
{you/(AGE) year old/NAME] or [the (AGE) year old/NAME]’s parents or guardians} about how to better 
control (your/his/her) asthma to prevent serious episodes or attacks and hospitalizations in the future? 
(0)	 NO 
(1)	 YES 
(6)	 DON’T KNOW 
(7)	 REFUSED 
[SKIP THIS QUESTION IF INTERVIEW IS FOR SAMPLED CHILD (S2Q5 < 18).] 
MISS_DAY (S5Q9) During the past 12 months, how many days were you unable to work or carry out your usual activities 
because of your asthma? 
_ _ _ ENTER NUMBER DAYS 
(0)	 ZERO 
(996) DON’T KNOW 
(997) REFUSED 
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[SKIP THIS QUESTION IF INTERVIEW IS FOR SAMPLED ADULT (S2Q > 17).]
 
[FOR CHILDREN 0–4, INSERT ‘‘DAYCARE OR PRESCHOOL’’ IN FILL.
 
FOR CHILDREN 5–13, INSERT ‘‘SCHOOL’’ IN FILL.
 
FOR CHILDREN 14–17, INSERT ‘‘SCHOOL OR WORK’’ IN FILL.]
 
MISS_SCH (S5Q11)	 [IF R_DOB (S2Q5) = 0, FILL: ‘‘Since birth’’/ELSE FILL: ‘‘During the past 12 months,’’ that is since (1 
YEAR AGO TODAY)] about how many days of (daycare or preschool/school/school or work) did [the 
(AGE) year old/NAME] miss because of (his/her) asthma? 
_ _ _ ENTER NUMBER 
(0)	 ZERO 
(994) CHILD DID NOT GO TO SCHOOL IN PAST 12 MONTHS 
(995) HOME SCHOOLED 
(996) DON’T KNOW 
(997) REFUSED THIS QUESTION 
ACT_DAYS (S5Q12)	 [IF R_DOB (S2Q5) = 0, FILL: ‘‘Since birth’’/ELSE FILL: ‘‘During the past 12 months’’], would you say 
{you/[the (AGE) year old/NAME]} limited (your/his/her) usual activities due to asthma not at all, a little, a 
moderate amount, or a lot? 
(1)	 NOT AT ALL 
(2)	 A LITTLE 
(3)	 A MODERATE AMOUNT 
(4)	 A LOT 
(6)	 DON’T KNOW 
(7) REFUSED 
Section 4. Knowledge of Asthma/Management Plan 
TCH_SIGN (S6Q1) Has a doctor or other health professional ever taught {you/(AGE) year old/NAME] or [the (AGE) year 
old/NAME]’s parent or guardian} 
a. How to recognize early signs or symptoms of an asthma episode? 
(0)	 NO 
(1)	 YES 
(6)	 DON’T KNOW 
(7)	 REFUSED 
TCH_RESP (S6Q2)	 Has a doctor or other health professional ever taught {you/(AGE) year old/NAME] or [the (AGE) year 
old/NAME]’s parent or guardian} 
b.	 What to do during an asthma episode or attack? 
(0)	 NO 
(1)	 YES 
(6)	 DON’T KNOW 
(7)	 REFUSED
 
[SKIP IF R_DOB (S2Q5) < 5 YEARS OLD.]
 
TCH_MON (S6Q3)	 Has a doctor or other health professional ever taught {you/(AGE) year old/NAME] or [the (AGE) year 
old/NAME]’s parent or guardian} 
c.	 How to use a peak flow meter, a device that measures how much air you can blow out of your lungs, to 
adjust daily medications? 
(0)	 NO 
(1)	 YES 
(6)	 DON’T KNOW 
(7)	 REFUSED 
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MGT_PLAN (S6Q4) An asthma management plan is a printed form that tells when to change the amount or type of medicine, 
when to call the doctor for advice, and when to go to the emergency room. Has a doctor or other health 
professional EVER given {you/(AGE) year old/NAME] or [the (AGE) year old/NAME]’s parent or 
guardian} an asthma management plan? 
[READ IF NECESSARY: Include nurses and asthma educators] 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
MGT_CLAS (S6Q5)	 Have {you/(AGE) year old/NAME] or [the (AGE) year old/NAME]’s parent or guardian}, ever taken a 
course or class on how to manage (your/his/her) asthma? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
Section 5. Modifications to Environment 
IF R_ASTHMX01 = 0, 6, 7 OR S3Q7 = 0, 6, 7,
 
ASK HH_INT THROUGH S_INSIDE (S7Q10), CIGARETS (S7Q18) THROUGH EMP_STAT (S7Q20),
 
UNEMP_R (S7Q22). THEN SKIP TO SECTION 7.
 
ELSE, IF {[CUR_AST (S3Q2) = 0, 6, 7 OR CUR_AST2 (S3Q9) = 0, 6, 7] AND 
LAST_MD (S3Q10) = 0 OR > 2  AND  
LAST_MED (S3Q11) = 0 OR > 5  AND  
LASTSYMP (S3Q12) = 0 OR > 5},  
ASK HH_INT THROUGH S_INSIDE (S7Q10), CIGARETS (S7Q18) THROUGH UNEMP_R (S7Q22), THEN 
SKIP TO SECTION 6. 
ELSE, CONTINUE. 
INTRODUCTORY STATEMENT 
READ: The following questions are about {your/[the (AGE) year old/NAME]’s} household and living 
environment. (IF R_ASTHMX01 = 1 OR  S3Q7 = 1) I will be asking about various things that may be related to 
experiencing asthma symptoms. [CONTINUE] 
AIRCLEANER (S7Q1) Is an air cleaner or purifier regularly used inside your home? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DEHUMID (S7Q2) Is a dehumidifier regularly used to reduce moisture inside your home? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
KITC_FAN (S7Q3) Is an exhaust fan that vents to the outside used regularly when cooking in your kitchen? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
COOK_GAS (S7Q4) Is gas used for cooking? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
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ENV_MOLD (S7Q5)	 In the past 30 days, has anyone seen or smelled mold or a musty odor inside your home? Do not include 
mold on food. 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
ENV_PETS (S7Q6)	 Does your household have indoor pets such as dogs, cats, hamsters, birds, or other feathered or furry pets 
that arekept inside? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
C_ROACH (S7Q7) In the past 30 days, has anyone seen cockroaches inside your home? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HELP SCREEN: Studies have shown that cockroaches are a leading cause of asthma in children that live in 
urban areas. Cockroach droppings and carcasses can cause children to experience symptoms of asthma. 
WOOD_STOVE (S7Q8) Is a fireplace or wood burning stove used in your home? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HELP SCREEN: OCCASIONAL USE SHOULD BE CODED AS ‘‘YES.’’ 
GAS_STOVE (S7Q9) Are unvented gas logs, an unvented gas fireplace, or an unvented gas stove used in your home? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HELP SCREEN: ‘‘Unvented’’ means no chimney. 
S_INSIDE (S7Q10) In the past week, has anyone smoked inside your home? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HELP SCREEN: ‘‘Smoked’’ means ‘‘anything.’’ 
MOD_ENV (S7Q11)	 FOR ADULT INTERVIEW, READ: 
[FILL ONLY IF QUESTIONS HH_INT THROUGH S_INSIDE WERE ASKED OF THIS RESPONDENT]: 
Now, back to questions specifically about you. Has a health professional ever advised you to change 
things in your home, school, or work to improve your asthma? 
FOR CHILD INTERVIEW, READ:
 
[FILL ONLY IF QUESTIONS HH_INT THROUGH S_INSIDE WERE ASKED OF THIS RESPONDENT]: Now,
 
back to questions specifically about [the (AGE) year old/NAME]. Has a health professional ever advised you to
 
change things in [the (AGE) year old/NAME]’s home, school, or work to improve [the (AGE) year old/NAME]’s
 
asthma?
 
(0) NO
 
(1) YES
 
(6) DON’T KNOW
 
(7) REFUSED
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MATTRESS (S7Q12)	 {Do you/Does [the (AGE) year old/NAME]} use a mattress cover that is made especially for controlling 
dust mites? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
E_PILLOW (S7Q13)	 {Do you/Does [the (AGE) year old/NAME]} use a pillow cover that is made especially for controlling dust 
mites? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
CARPET (S7Q14) Do you have carpeting or rugs in {your/[the (AGE) year old/NAME]’s} bedroom? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HOTWATER (S7Q15) Are {your/[the (AGE) year old/NAME]’s} sheets and pillowcases washed in cold, warm, or hot water? 
(1) COLD 
(2) WARM 
(3) HOT 
(6) DON’T KNOW 
(7) REFUSED 
BATH_FAN (S7Q16)	 In {your/[the (AGE) year old/NAME]’s} bathroom, {do you/does [the (AGE) year old/NAME]} regularly 
use an exhaust fan that vents to the outside? 
(0)  NO OR ‘‘NO FAN’’  
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HELP SCREEN: IF RESPONDENT INDICATES THEY HAVE MORE THAN ONE BATHROOM, THIS 
QUESTION REFERS TO THE BATHROOM THEY USE MOST FREQUENTLY FOR SHOWERING AND 
BATHING. 
[SKIP THIS QUESTION IF ENV_PETS (S7Q6) = 0, 6, 7.] 
PETBEDRM (S7Q17) Is the pet allowed in {your/[the (AGE) year old/NAME]’s} bedroom? 
(0) NO 
(1) YES 
(2) SOME ARE/SOME AREN’T 
(6) DON’T KNOW 
(7) REFUSED 
SKIP TO SECTION 6 IF INTERVIEW IS FOR SAMPLED CHILD (R_DOB/S2Q5 <18). 
CIGARETS (S7Q18) Have you smoked at least 100 cigarettes in your entire life? 
(0) NO [SKIP TO EMP_STAT (S7Q20)] 
(1) YES 
(6) DON’T KNOW [SKIP TO EMP_STAT (S7Q20)] 
(7) REFUSED [SKIP TO EMP_STAT (S7Q20)] 
CIG_FREQ (S7Q19) Do you now smoke cigarettes every day, some days, or not at all? 
(1) EVERY DAY 
(2) SOME DAYS 
(3) NOT AT ALL 
(6) DON’T KNOW 
(7) REFUSED 
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EMP_STAT (S7Q20)	 [IF R_ASTHMX01 = 1 OR  S3Q7 = 1:] We are interested in things that affect asthma in the workplace. 
However, first I’d like to ask how you would describe {your/[the (AGE) year old/ NAME]’s} current 
employment status. Would you say {you/[the (AGE) year old/NAME]} is . . . 
(1) EMPLOYED FULL-TIME 
(2) EMPLOYED PART-TIME 
(3) NOT EMPLOYED 
(6) DON’T KNOW 
(7) REFUSED 
WORKENV2 (S7Q21)	 [IF R_ASTHMX01 = 0, 6, 7 OR S3Q7 = 0, 6, 7, SKIP TO UNEMP_R (S7Q22).] Was your asthma 
caused or made worse by chemicals, smoke, fumes, or dust in any job you ever had? 
(0) NO 
(1) YES 
(2) NEVER BEEN EMPLOYED 
(6) DON’T KNOW 
(7) REFUSED 
UNEMP_R (S7Q22)	 [IF EMP_STAT (S7Q20) = 1 OR 2, SKIP  TO OTC  (S8Q1).] What is the main reason you are not 
employed? 
(1) KEEPING HOUSE 
(2) GOING TO SCHOOL 
(3) RETIRED 
(4) DISABLED 
(5) UNABLE TO WORK FOR OTHER HEALTH REASONS 
(6) LOOKING FOR WORK 
(7) LAID OFF 
(8) OTHER 
(96) DON’T KNOW 
(97) REFUSED 
Section 6. Medications 
IF LAST_MED (S3Q11) = 0, SKIP TO SECTION 7. 
IF [CUR_AST (S3Q2) = 0, 6, 7 OR CUR_AST2 (S3Q9) = 0, 6, 7] AND
 
LAST_MD (S3Q10) = 0 OR > 2  AND 
  
LASTSYMP (S3Q12) = 0 OR > 5  AND 
  
LAST_MED (S3Q11) = 6 OR 7, 
  
ASK OTC (S8Q1), INHALERE (S8Q2), INHALERH (S8Q3), THEN SKIP TO SECTION 7. 
OTC (S8Q1)	 Over-the-counter medication can be bought without a doctor’s order. {Have you/Has [the (AGE) year old/ 
NAME]} ever used over-the-counter medication for (your/his/her) asthma? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
INHALERE (S8Q2) {Have you/Has [the (AGE) year old/NAME]} ever used a prescription inhaler? 
(0) NO	 [SKIP TO SCR_MED1 (S8Q4)] 
(1) YES 
(6) DON’T KNOW [SKIP TO SCR_MED1 (S8Q4)] 
(7) REFUSED	 [SKIP TO SCR_MED1 (S8Q4)] 
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INHALERH (S8Q3)	 Did a health professional show {you/the (AGE) year old/NAME] or [the (AGE) year old/NAME]’s parents 
or guardians} how to use the inhaler? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
SCR_MED1 (S8Q4) [IF LAST_MED (S3Q11) = 4, 5, 6, 7, 96, OR 97, SKIP TO SECTION 7.] Now I am going to ask 
questions about specific prescription medications {you /[the (AGE) year old/NAME]} may have taken for 
asthma in the past 3 months. I will be asking for the names, amount, and how often {you take/[the (AGE) 
year old/NAME] takes} each medicine. I will ask separately about medication taken in various forms: pill or 
syrup, inhaler, and Nebulizer. 
It may help to get {your/[the (AGE) year old/NAME]’s} medicines so you can read the labels. Are {your/[the 
(AGE) year old/NAME]’s} asthma medicines handy? 
(0) NO [SKIP TO INH_SCR (S8Q7)] 
(1) YES 
(2) RESPONDENT KNOWS THE MEDS [SKIP TO INH_SCR (S8Q7)] 
(6) DON’T KNOW 
(7) REFUSED [SKIP TO INH_SCR (S8Q7)] 
SCR_MED2 (S8Q5) Can you please go get the asthma medicines while I wait on the phone? 
(0) NO [SKIP TO INH_SCR (S8Q7)] 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED [SKIP TO INH_SCR (S8Q7)] 
SCR_MED3 (S8Q6) Am I correct that you have all the medications? 
(0) NO 
(1) YES I HAVE ALL THE MEDICATIONS 
(2) YES I HAVE SOME OF THE MEDICATIONS BUT NOT ALL 
(6) DON’T KNOW 
(7) REFUSED 
INH_SCR (S8Q7)	 In the past 3 months, {have you/has [the (AGE) year old/NAME]} taken prescription asthma 
medicine using an inhaler? 
(0) NO	 [SKIP TO PILLS (S8Q27)] 
(1) YES 
(6) DON’T KNOW [SKIP TO PILLS (S8Q27)] 
(7) REFUSED	 [SKIP TO PILLS (S8Q27)] 
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INH_MEDS (S8Q8_01 to S8Q8_34) 
In the past 3 months, what medications did {you/[the (AGE) year old/NAME]} take by inhaler? [MARK ALL 
THAT APPLY. PROBE: Any other medications?] 
Variable Name Brand Name Type (not shown in CATI) 
INH_MEDX01 (S8Q8_01) Advair 
INH_MEDX02 (S8Q8_02) Aerobid Corticosteroids 
INH_MEDX03 (S8Q8_03) Albuterol Beta 2 agonist 
INH_MEDX04 (S8Q8_04) Alupent Beta 2 agonist 
INH_MEDX05 (S8Q8_05) Atrovent Anti-inflammatories 
INH_MEDX06 (S8Q8_06) Azmacort Corticosteroids 
INH_MEDX07 (S8Q8_07) Beclomethasone dipropionate Corticosteroids 
INH_MEDX08 (S8Q8_08) Beclovent Corticosteroids 
INH_MEDX09 (S8Q8_09) Bitolterol Beta 2 agonist 
INH_MEDX10 (S8Q8_10) Brethaire Beta 2 agonist 
INH_MEDX11 (S8Q8_11) Budesonide Corticosteroids 
INH_MEDX12 (S8Q8_12) Combivent 
INH_MEDX13 (S8Q8_13) Cromolyn Anti-inflammatories 
INH_MEDX14 (S8Q8_14) Flovent Inhaled corticosteroid 
INH_MEDX15 (S8Q8_15) Flovent Rotadisk Inhaled corticosteroid 
INH_MEDX16 (S8Q8_16) Flunisolide Corticosteroids 
INH_MEDX17 (S8Q8_17) Fluticasone Inhaled corticosteroid 
INH_MEDX18 (S8Q8_18) Intal Anti-inflammatories 
INH_MEDX19 (S8Q8_19) Ipratropium Bromide Anti-inflammatories 
INH_MEDX20 (S8Q8_20) Maxair Beta 2 agonist 
INH_MEDX21 (S8Q8_21) Metaproteronol Beta 2 agonist 
INH_MEDX22 (S8Q8_22) Nedocromil Anti-inflammatories 
INH_MEDX23 (S8Q8_23) Pirbuterol Beta 2 agonist 
INH_MEDX24 (S8Q8_24) Proventil Beta 2 agonist 
INH_MEDX25 (S8Q8_25) Pulmicort Turbuhaler Corticosteroids 
INH_MEDX26 (S8Q8_26) Salmeterol Corticosteroids (long lasting) 
INH_MEDX27 (S8Q8_27) Serevent Beta 2 agonist (long lasting) 
INH_MEDX28 (S8Q8_28) Terbutaline Beta 2 agonist 
INH_MEDX29 (S8Q8_29) Tilade Anti-inflammatories 
INH_MEDX30 (S8Q8_30) Tornalate Beta 2 agonist 
INH_MEDX31 (S8Q8_31) Triamcinolone acetonide Corticosteroids 
INH_MEDX32 (S8Q8_32) Vanceril Corticosteroids 
INH_MEDX33 (S8Q8_33) Ventolin Beta 2 agonist 
INH_MEDX34 (S8Q8_34) Other, please specify [SKIP TO OTH_I1 (S8Q8_34A)] 
IF ANY ANSWER SELECTED FROM INH_MEDX01 (S8Q8_01)–INH_MEDX33 (S8Q8_33), SKIP TO ILP01 
(S8Q16_nn). 
(0) NO 
(1) YES 
(6) DON’T KNOW [SKIP TO REC_MED1] 
(7) REFUSED [SKIP TO PILLS (S8Q27)] 
OTH_I1 (S8Q8_34A) ENTER OTHER MEDICATION. 
IF MORE THAN ONE MEDICATION IS GIVEN, ENTER ALL MEDICATIONS ON ONE LINE. 
______________________ ENTER TEXT 
INTRODUCTORY STATEMENT 
READ: I’m going to read a list of medicines to see if you recognize the name of any of the medications {you 
have/[CHILD’S NAME] has} taken. Please let me know if you hear the name. [CONTINUE] 
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DK1INHLR (S8Q9)	 In the past 3 months, did {you/[the (AGE) year old/NAME]} take Flovent or Flovent Rotadisk using an 
inhaler? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK2INHLR (S8Q10)	 In the past 3 months, did {you/[the (AGE) year old/NAME]} take: 
Beclovent, Vanceril, Beclomethasone dipropionate, 
Pulmicort Turbuhaler, Budesonide, 
Aerobid, Flunisolide, 
Azmacort or Triamcinolone acetonide? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK3INHLR (S8Q11)	 In the past 3 months, did {you/[the (AGE) year old/NAME]} take: 
Ventolin, Proventil, Albuterol, 
Alupent, Metaproteronol, 
Tornalate, Bitolterol, 
Maxair, Pirbuterol 
Brethaire, Terbutaline 
Serevent? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK4INHLR (S8Q12)	 In the past 3 months, did {you/[the (AGE) year old/NAME]} take: 
Intal, Cromolyn, 
Tilade, or Nedocromil? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK5INHLR (S8Q13)	 In the past 3 months, did {you/[the (AGE) year old/NAME]} take: 
Atrovent or Ipratropium Bromide? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK6INHLR (S8Q14) Did {you/[the (AGE) year old/NAME]} take a medication by inhaler that we have not mentioned? 
(0) NO 
(1) YES [SKIP TO DK7INHLR (S8Q15)] 
(6) DON’T KNOW 
(7) REFUSED 
IF DK6INHLR (S8Q14) = 1, CONTINUE. ALL OTHERS, SKIP TO ILP01 (S8Q16_nn). 
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DK7INHLR (S8Q15) Will you please tell me what that medication was? 
SPELL OUT: _____________________________________ 
REPEAT ILP01 (S8Q16_nn)–ILP11 (S8Q26_nn) FOR EACH MEDICINE REPORTED IN INH_MEDS 
(S8Q8_nn), OR IF AN ANSWER OF (1) ‘‘YES’’ IS GIVEN FOR ANY ITEM IN DK1INHLR (S8Q9) 
THROUGH DK7INHLR (S8Q15). IF AN ANSWER OF (1) ‘‘YES’’ IS PROVIDED DURING QUESTIONS 
DK1INHLR (S8Q9) THROUGH DK6INHLR (S8Q14), USE THE PHRASE ‘‘THIS MEDICATION’’ FOR FILL 
‘‘[MEDICINE FROM INH_MEDS (S8Q8_nn) SERIES]’’ FOR QUESTIONS ILP01 (S8Q16_nn) THROUGH 
ILP11 (S8Q26_nn). 
ILP01 (S8Q16_01 to S8Q16_34) 
How long {have you/has [the (AGE) year old/NAME]} been taking [MEDICINE FROM INH_MEDS (S8Q8_nn) 
SERIES]? Would you say less than 6 months, 6 months to 1 year, or longer than 1 year? 
(1) Less than 6 months 
(2) 6 months to 1 year 
(3) Longer than 1 year 
(6) DON’T KNOW 
(7) REFUSED 
ILP02 (S8Q17_01 to S8Q17_34) 
A spacer is a small attachment for an inhaler that makes it easier to use. {Do you/Does [the (AGE) year 
old/NAME]} use a spacer with [MEDICINE FROM INH_MEDS (S8Q8_nn) SERIES]? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HELP SCREEN: A spacer is a device that attaches to a metered dose inhaler. It holds the medicine in its 
chamber long enough for you to inhale it in one or two slow, deep breaths. The spacer makes it easy to take the 
medicines the right way, especially for young children. 
ASK IF INH_MEDS (S8Q8_nn) = 03, 04, 09, 10, 20, 21, 23, 24, 28, 30, 33, OR DK3INHLR 
(S8Q11) = 1; ELSE, SKIP TO ILP06 (S8Q21_nn). 
ILP03 (S8Q18_03, _04, _09, _10, _20, _21, _23, _24, _28, _30, _33, _34) 
In the past 3 months, did {you/[the (AGE) year old/NAME]} take [MEDICINE FROM INH_MEDS (S8Q8_nn) 
SERIES] when {you/he/she had} an asthma episode or attack? 
(0) NO 
(1) YES 
(2) NO ATTACK IN PAST 3 MONTHS 
(6) DON’T KNOW 
(7) REFUSED 
ILP04 (S8Q19_03, _04, _09, _10, _20, _21, _23, _24, _28, _30, _33, _34) 
[IF THE AGE OF THE CHILD IS LESS THAN 6 YEARS OLD (S2Q5 < 6), SKIP TO ILP05 (S8Q20_nn).] In 
the past 3 months, did {you/[the (AGE) year old/NAME]} take [MEDICINE FROM INH_MEDS (S8Q8_nn) 
SERIES] before exercising? 
(0) NO 
(1) YES 
(2) DIDN’T EXERCISE IN PAST 3 MONTHS 
(6) DON’T KNOW 
(7) REFUSED 
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ILP05 (S8Q20_03, _04, _09, _10, _20, _21, _23, _24, _28, _30, _33, _34) 
In the past 3 months, did {you/[the (AGE) year old/NAME]} take [MEDICINE FROM INH_MEDS (S8Q8_nn) 
SERIES] on a regular schedule everyday? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
ASK IF INH_MEDS (S8Q8_nn) = 14, 15, 17, OR DK1_INHLR (S8Q9) = 1; 
ELSE SKIP TO ILP07 (S8Q22_nn). 
ILP06 (S8Q21_14, _15, _17, _34) 
Is the dosage 44, 50, 100, 110, 220, or 250 micrograms for the Flovent? 
(1) 44 MICROGRAMS 
(2) 50 MICROGRAMS 
(3) 100 MICROGRAMS 
(4) 110 MICROGRAMS 
(5) 220 MICROGRAMS 
(6) 250 MICROGRAMS 
(7) TOOK MORE THAN 1 IN PAST 3 MONTHS 
(96) DON’T KNOW 
(97) REFUSED 
ILP07 (S8Q22_01 to S8Q22_34) 
On average, how many puffs {Do you/does [the (AGE) year old/NAME]} take each time {you use/he uses/she 
uses} [MEDICINE FROM INH_MEDS (S8Q8_nn) SERIES]? 
__ __ PUFFS EACH TIME 
(96) DON’T KNOW 
(97) REFUSED
 
INTERVIEWER: PROBE FOR NUMBER OF PUFFS IF RANGE IS GIVEN.
 
ILP09 (S8Q24_01 to S8Q24_34) 
How many times per day or per week {do you/does [the (AGE) year old/NAME]} use [MEDICINE FROM 
INH_MEDS SERIES]? 
__ __ __ TIMES 
(994) LESS OFTEN THAN ONCE A WEEK [SKIP TO ILP11 (S8Q26_nn)] 
(996) DON’T KNOW [SKIP TO ILP11 (S8Q26_nn)] 
(997) REFUSED [SKIP TO ILP11 (S8Q26_nn)] 
ILP10 (S8Q25_01 to S8Q25_34) 
ENTER PERIOD 
(1) PER DAY 
(2) PER WEEK 
(6) DON’T KNOW 
(7) REFUSED 
ILP11 (S8Q26_01 to S8Q26_34) 
How many full canisters of this inhaler {have you /has [the (AGE) year old/NAME]} used in the past 3 months?
 
[INTERVIEWER: IF RESPONDENT USED LESS THAN ONE CANISTER IN THE PAST 3 MONTHS,
 
CODE IT AS ‘00’]
 
___ CANISTERS
 
(96) DON’T KNOW 
(97) REFUSED 
HELP SCREEN: IF RESPONDENT INDICATES HE/SHE HAS MULTIPLE CANISTERS, (I.E., ONE IN THE 
CAR, ONE IN PURSE, ETC.) ASK THE RESPONDENT TO ESTIMATE HOW MANY CANISTERS HE/SHE 
USED. 
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PILLS (S8Q27)	 In the past 3 months, {have you/has [the (AGE) year old/NAME]} taken any medicine in pill form for 
[your/his/her] asthma? 
(0) NO	 [SKIP TO SYRUP (S8Q38)] 
(1) YES 
(6) DON’T KNOW	 [SKIP TO SYRUP (S8Q38)] 
(7) REFUSED	 [SKIP TO SYRUP (S8Q38)] 
PILLS_MD (S8Q28_01 to S8Q28_48) 
What medications {Do you/does [the (AGE) year old/NAME]} take in pill form? 
[MARK ALL THAT APPLY. PROBE: Any other medications?] 
VARIABLE NAMES Medication Type (not shown in CATI) 
PILLS_MX01 (S8Q28_01) Accolate Leukotriene modifiers 
PILLS_MX02 (S8Q28_02) Aerolate Methylxanthines 
PILLS_MX03 (S8Q28_03) Albuterol Beta 2 agonist – Rescue bronchodilators 
PILLS_MX04 (S8Q28_04) Alupent Beta 2 agonist – Rescue bronchodilators 
PILLS_MX05 (S8Q28_05) Choledyl Methylxanthines 
PILLS_MX06 (S8Q28_06) Cromolyn Anti-Inflammatories 
PILLS_MX07 (S8Q28_07) Deltasone Corticosteriods 
PILLS_MX08 (S8Q28_08) Elixophyllin Methylxanthines 
PILLS_MX09 (S8Q28_09) Intal Anti-Inflammatories 
PILLS_MX10 (S8Q28_10) Marax Methylxanthines 
PILLS_MX11 (S8Q28_11) Medrol Corticosteriods 
PILLS_MX12 (S8Q28_12) Metaprel Beta 2 agonist – Rescue bronchodilators 
PILLS_MX13 (S8Q28_13) Metaproteronol Beta 2 agonist – Rescue bronchodilators 
PILLS_MX14 (S8Q28_14) Methylpredinisolone Corticosteriods 
PILLS_MX15 (S8Q28_15) Montelukast Leukotriene modifiers 
PILLS_MX16 (S8Q28_16) Nedocromil Corticosteriods 
PILLS_MX17 (S8Q28_17) Pediapred Corticosteriods 
PILLS_MX18 (S8Q28_18) Prednisolone Corticosteriods 
PILLS_MX19 (S8Q28_19) Prednisone Corticosteriods 
PILLS_MX20 (S8Q28_20) Prelone Corticosteriods 
PILLS_MX21 (S8Q28_21) Proventil Beta 2 agonist – Rescue bronchodilators 
PILLS_MX22 (S8Q28_22) Quibron Methylxanthines 
PILLS_MX23 (S8Q28_23) Respid Methylxanthines 
PILLS_MX24 (S8Q28_24) Singulair Leukotriene modifiers 
PILLS_MX25 (S8Q28_25) Slo-phyllin Methylxanthines 
PILLS_MX26 (S8Q28_26) Slo-bid Methylxanthines 
PILLS_MX27 (S8Q28_27) Sustaire Methylxanthines 
PILLS_MX28 (S8Q28_28) Theo-24 Methylxanthines 
PILLS_MX29 (S8Q28_29) Theobid Methylxanthines 
PILLS_MX30 (S8Q28_30) Theochron Methylxanthines 
PILLS_MX31 (S8Q28_31) Theoclear Methylxanthines 
PILLS_MX32 (S8Q28_32) Theodur Methylxanthines 
PILLS_MX33 (S8Q28_33) Theo-Dur Methylxanthines 
PILLS_MX34 (S8Q28_34) Theolair Methylxanthines 
PILLS_MX35 (S8Q28_35) Theophylline Methylxanthines 
PILLS_MX36 (S8Q28_36) Theo-Sav Methylxanthines 
PILLS_MX37 (S8Q28_37) Theospan Methylxanthines 
PILLS_MX38 (S8Q28_38) Theox Methylxanthines 
PILLS_MX39 (S8Q28_39) Tilade Corticosteriods 
PILLS_MX40 (S8Q28_40) T-Phyl Methylxanthines 
PILLS_MX41 (S8Q28_41) Unidur Methylxanthines 
PILLS_MX42 (S8Q28_42) Uniphyl Methylxanthines 
PILLS_MX43 (S8Q28_43) Ventolin Beta 2 agonist – Rescue bronchodilators 
PILLS_MX44 (S8Q28_44) Volmax Beta 2 agonist – Rescue bronchodilators 
PILLS_MX45 (S8Q28_45) Zafirlukast Leukotriene modifiers 
PILLS_MX46 (S8Q28_46) Zileuton Leukotriene modifiers 
PILLS_MX47 (S8Q28_47) Zyflo Filmtab Leukotriene modifiers 
PILLS_MX48 (S8Q28_48) Other, please specify: [SKIP TO OTH_P1 (S8Q29)] 
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IF ANY ANSWER SELECTED FROM PILLS_MX01 (S8Q28_01)–PILLS_MX47 (S8Q28_47), SKIP TO PILLX (S8Q37_nn). 
(0) NO 
(1) YES 
(6) DON’T KNOW [SKIP TO REC_MED2] 
(7) REFUSED [SKIP TO SYRUP (S8Q38)] 
OTH_P1 (S8Q29) ENTER OTHER MEDICATION. 
IF MORE THAN ONE MEDICATION IS GIVEN, ENTER ALL MEDICATIONS ON ONE LINE. 
________________________ ENTER TEXT 
INTRODUCTORY STATEMENT 
READ: I’m going to read a list of medicines to see if you recognize the name of the medications {you 
have/[CHILD’S NAME] has} taken within the past 3 months. If you recognize any that were taken, please let 
me know. [CONTINUE] 
DK1_PILL (S8Q30) Did {you/[the (AGE) year old/NAME]} take: 
Accolate or Zafirlukast 
Zyflo Filmtab or Zileuton 
Singulair or Montelukast? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK2_PILL (S8Q31)	 Did {you/[the (AGE) year old/NAME]} take: 
Intal or Cromolyn 
Tilade or Nedocromil? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK3_PILL (S8Q32)	 Did {you/[the (AGE) year old/NAME]} take: 
Medrol, Methylpredinisolone, 
Deltasone, Prednisone, 
Pediapred, 
Prelone, or Prednisolone? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK4_PILL (S8Q33)	 Did {you/[the (AGE) year old/NAME]} take: 
Proventil, Ventolin, Volmax, or Albuterol 
Alupent, Metaprel, or Metaproteronol? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK5_PILL (S8Q34)	 Did {you/[the (AGE) year old/NAME]} take: 
Theophylline, Elixophyllin, Theo-Dur, Choledyl, Theo-Sav, Theospan, Theoclear, T-Phyl, Theodur, Unidur, 
Uniphyl, Aerolate, Theox, Marax, Theobid, Quibron, Theo-24, Sustaire, Slo-phyllin, Slo-bid, Respid, 
Theochron, or Theolair? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
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DK6_PILL (S8Q35) Did {you/[the (AGE) year old/NAME]} take a medication in pill form that we have not mentioned? 
(0) NO [SKIP TO PILLX (S8Q37_nn)] 
(1) YES [SKIP TO DK7_PILL (S8Q36)] 
(6) DON’T KNOW [SKIP TO PILLX (S8Q37_nn)] 
(7) REFUSED [SKIP TO PILLX (S8Q37_nn)] 
DK7_PILL (S8Q36) Will you please tell me what that medication was? 
SPELL OUT: _____________________________________ 
REPEAT PILLX (S8Q37_nn) FOR EACH PILL REPORTED IN PILLS_MD (S8Q28_nn), OR IF AN ANSWER 
OF (1) ‘‘YES’’ IS GIVEN FOR QUESTIONS DK1_PILL (S8Q30) THROUGH DK6_PILL (S8Q35). IF AN 
ANSWER OF (1) ‘‘YES’’ IS PROVIDED DURING QUESTIONS DK1_PILL (S8Q30) THROUGH DK6_PILL 
(S8Q35), USE THE PHRASE ‘‘THIS MEDICATION’’ FOR FILL ‘‘[MEDICATION LISTED IN PILLS_MD 
(S8Q28_nn)]’’ FOR QUESTION PILLX (S8Q37_nn). 
PILLX (S8Q37_01 TO S8Q37_48) 
How long {have you/has [the (AGE) year old/NAME]} been taking [MEDICATION LISTED IN PILLS_MD 
(S8Q28_nn)]? 
(1) LESS THAN 6 MONTHS 
(2) 6 MONTHS TO 1 YEAR 
(3) LONGER THAN 1 YEAR 
(6) DON’T KNOW 
(7) REFUSED 
SYRUP (S8Q38) In the past 3 months, {have you/has [the (AGE) year old/NAME]} taken prescription medicine in syrup form? 
(0) NO [SKIP TO NEB_SCR (S8Q47)] 
(1) YES 
(6) DON’T KNOW [SKIP TO NEB_SCR (S8Q47)] 
(7) REFUSED [SKIP TO NEB_SCR (S8Q47)] 
SYRUP_ID (S8Q39_01 to S8Q39_11) 
What prescriptions medications {have you/has [the (AGE) year old/NAME]} taken as a syrup? 
[MARK ALL THAT APPLY. PROBE: Any other medications?] 
Variable Names Medication 
SYRUP_IX01 (S8Q39_01) Aerolate 
SYRUP_IX02 (S8Q39_02) Albuterol 
SYRUP_IX03 (S8Q39_03) Alupent 
SYRUP_IX04 (S8Q39_04) Metaproteronol 
SYRUP_IX05 (S8Q39_05) Prednisolone 
SYRUP_IX06 (S8Q39_06) Prelone 
SYRUP_IX07 (S8Q39_07) Proventil 
SYRUP_IX08 (S8Q39_08) Slo-Phyllin 
SYRUP_IX09 (S8Q39_09) Theophylline 
SYRUP_IX10 (S8Q39_10) Ventolin 
SYRUP_IX11 (S8Q39_11) Other, please specify: [SKIP TO OTH_S1 (S8Q40)] 
IF ANY ANSWER SELECTED FROM SYRUP_IX01 (S8Q39_01)–SYRUP_IX10 (S8Q39_10), SKIP TO 
NEB_SCR (S8Q47). 
(0) NO 
(1) YES 
(6) DON’T KNOW [SKIP TO REC_MED3] 
(7) REFUSED [SKIP TO NEB_SCR (S8Q47)] 
OTH_S1 (S8Q40) ENTER OTHER MEDICATION. 
IF MORE THAN ONE MEDICATION IS GIVEN, ENTER ALL MEDICATIONS ON ONE LINE. 
________________________ ENTER TEXT 
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INTRODUCTORY STATEMENT 
READ: I’m going to read a list of medicines to see if you recognize the name of the medications {you 
have/[CHILD’S NAME] has} taken within the past 3 months. [CONTINUE] 
DK1_SYRP (S8Q41)	 Which of these prescriptions medications {have you/has [the (AGE) year old/NAME]} taken as a syrup? 
Alupent or Metaproteronol? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK2_SYRP (S8Q42)	 Which of these prescriptions medications {have you/has [the (AGE) year old/NAME]} taken as a syrup? 
Ventolin or Proventil or Albuterol? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK3_SYRP (S8Q43)	 Which of these prescriptions medications {have you/has [the (AGE) year old/NAME]} taken as a syrup? 
Aerolate, Slo-Phyllin, or Theophylline? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK4_SYRP (S8Q44)	 Which of these prescriptions medications {have you/has [the (AGE) year old/NAME]} taken as a syrup? 
Prelone or Prednisolone? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK5_SYRP (S8Q45) Did {you/[the (AGE) year old/NAME]} take a medication in syrup form that we have not mentioned? 
(0) NO [SKIP TO NEB_SCR (S8Q47)] 
(1) YES 
(6) DON’T KNOW [SKIP TO NEB_SCR (S8Q47)] 
(7) REFUSED [SKIP TO NEB_SCR (S8Q47)] 
DK6_SYRP (S8Q46)	 Will you please tell me what that medication was? 
SPELL OUT: _____________________________________ 
NEB_SCR (S8Q47)	 A nebulizer is a small machine with a tube and facemask or mouthpiece that you breathe through 
continuously. In the past 3 months, were any of {your/[the (AGE) year old/NAME]’s} asthma medicines 
used with a nebulizer? 
(0) NO	 [SKIP TO SECTION 7] 
(1) YES 
(6) DON’T KNOW	 [SKIP TO SECTION 7] 
(7) REFUSED	 [SKIP TO SECTION 7] 
NEB_ID (S8Q48_01 to S8Q48_08) 
In the past 3 months, what prescriptions medications {have you/has [the (AGE) year old/NAME]} taken using a 
nebulizer? 
[MARK ALL THAT APPLY, PROBE: Any other medications?] 
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Variable Names Medication 
NEB_IDX01 (S8Q48_01) Albuterol 
NEB_IDX02 (S8Q48_02) Alupent 
NEB_IDX03 (S8Q48_03) Cromolyn 
NEB_IDX04 (S8Q48_04) Intal 
NEB_IDX05 (S8Q48_05) Metaproteronol 
NEB_IDX06 (S8Q48_06) Proventil 
NEB_IDX07 (S8Q48_07) Ventolin 
NEB_IDX08 (S8Q48_08) Other, please specify: [SKIP TO OTH_N1 (S8Q49)] 
IF AN ANSWER SELECTED FROM NEB_IDX01 (S8Q48_01)–NEB_IDX07 (S8Q48_07), SKIP TO 
SECTION 9. 
(0) NO 
(1) YES 
(6) DON’T KNOW	 [SKIP TO DK1_NEB (S8Q50)] 
(7) REFUSED	 [SKIP TO SECTION 7] 
OTH_N1 (S8Q49)	 ENTER OTHER MEDICATION. 
IF MORE THAN ONE MEDICATION IS GIVEN, ENTER ALL MEDICATIONS ON ONE LINE. 
________________________ ENTER TEXT 
DK1_NEB (S8Q50)	 In the past 3 months, which of these prescriptions medications {have you/has [the (AGE) year old/NAME]} 
taken using a nebulizer? 
Alupent or Metaproteronol? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK2_NEB (S8Q51)	 In the past 3 months, which of these prescriptions medications {have you/has [the (AGE) year old/NAME]} 
taken using a nebulizer? 
Ventolin, Proventil or Albuterol? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK3_NEB (S8Q52)	 In the past 3 months, which of these prescriptions medications {have you/has [the (AGE) year old/NAME]} 
taken using a nebulizer? 
Intal or Cromolyn 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK4_NEB (S8Q53) Did {you/[the (AGE) year old/NAME]} take a medication using a nebulizer that we have not mentioned? 
(0) NO	 [SKIP TO SECTION 7] 
(1) YES 
(6) DON’T KNOW	 [SKIP TO SECTION 7] 
(7) REFUSED	 [SKIP TO SECTION 7] 
DK5_NEB (S8Q54)	 Will you please tell me what that medication was? 
SPELL OUT: _____________________________________ 
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Section 7. Family History of Asthma 
OTHRASTH	 [IF ROSTER = 1, SKIP TO BRO_N (S9Q1).] Besides {you/[the (AGE) year old}, has anyone else in your 
household ever been told by a doctor or health professional that they have asthma? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
BRO_N (S9Q1)	 How many biological brothers [have you/ has the (AGE) year old] ever had? 
__ __NUMBER 
(0) NONE 
(96) DON’T KNOW 
(97) REFUSED 
HELP SCREEN: RESPONDENTS WHO ARE ADOPTED AND DO NOT HAVE ANY HEALTH
 
INFORMATION REGARDING THEIR BIOLOGICAL PARENTS/SIBLINGS SHOULD BE CODED AS
 
‘‘DON’T KNOW.’’
 
PARENTS/SIBLINGS WHO ARE DECEASED SHOULD BE INCLUDED.
 
HALF-BROTHERS SHOULD BE INCLUDED.
 
SIS_N (S9Q2)	 How many biological sisters [have you/has the (AGE) year old] ever had? 
__ __ NUMBER 
(0) NONE
 
(96) DON’T KNOW
 
(97) REFUSED
 
HELP SCREEN: RESPONDENTS WHO ARE ADOPTED AND DO NOT HAVE ANY HEALTH
 
INFORMATION REGARDING THEIR BIOLOGICAL PARENTS/SIBLINGS SHOULD BE CODED AS
 
‘‘DON’T KNOW.’’
 
PARENTS/SIBLINGS WHO ARE DECEASED SHOULD BE INCLUDED.
 
HALF-SISTERS SHOULD BE INCLUDED.
 
PARENTS1 (S9Q3) Were either of [your/the (AGE) year old’s] biological parents ever told they have asthma? 
(0) NO [SKIP TO BROASTH1 (S9Q5)] 
(1) YES 
(6) DON’T KNOW [SKIP TO BROASTH1 (S9Q5)] 
(7) REFUSED [SKIP TO BROASTH1 (S9Q5)] 
HELP SCREEN: RESPONDENTS WHO ARE ADOPTED AND DO NOT HAVE ANY HEALTH 
INFORMATION REGARDING THEIR BIOLOGICAL PARENTS/SIBLINGS SHOULD BE CODED AS 
‘‘DON’T KNOW.’’ 
PARENTS/SIBLINGS WHO ARE DECEASED SHOULD BE INCLUDED. 
PARENTS2 (S9Q4)	 Who? 
(1) FATHER 
(2) MOTHER 
(3) BOTH 
(6) DON’T KNOW 
(7) REFUSED 
BROASTH1 (S9Q5)	 [IF BRO_N (S9Q1) = 0, 96, 97, SKIP TO SISASTH1 (S9Q7). ELSE IF BRO_N (S9Q1) > 1, SKIP TO 
BROASTH2 (S9Q6).] Was [your/the (AGE) year old’s] biological brother ever told that he had asthma? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED
 
ALL SKIP TO SISASTH1 (S9Q7).
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BROASTH2 (S9Q6) How many of [your/the (AGE) year old’s] biological brothers were ever told they had asthma? 
__ __NUMBER 
(0) ZERO 
(96) DON’T KNOW 
(97) REFUSED 
HELP SCREEN: RESPONDENTS WHO ARE ADOPTED AND DO NOT HAVE ANY HEALTH
 
INFORMATION REGARDING THEIR BIOLOGICAL PARENTS/SIBLINGS SHOULD BE CODED AS
 
‘‘DON’T KNOW.’’
 
PARENTS/SIBLINGS WHO ARE DECEASED SHOULD BE INCLUDED.
 
SISASTH1 (S9Q7)	 [IF SIS_N (S9Q2) = 0, 96, 97, SKIP TO GRANDSCR (S9Q9). ELSE IF SIS_N (S9Q2) > 1, SKIP TO 
SISASTH2 (S9Q8).] [IF SIS_N (S9Q2) = 1, ASK:] Was [your/the (AGE) year old’s] biological sister ever 
told that she had asthma? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED
 
ALL SKIP TO GRANDSCR (S9Q9).
 
SISASTH2 (S9Q8)	 How many of [your/the (AGE) year old’s] biological sisters were ever told they had asthma? 
__ __ NUMBER 
(0) ZERO 
(96) DON’T KNOW 
(97) REFUSED 
HELP SCREEN: RESPONDENTS WHO ARE ADOPTED AND DO NOT HAVE ANY HEALTH
 
INFORMATION REGARDING THEIR BIOLOGICAL PARENTS/SIBLINGS SHOULD BE CODED AS
 
‘‘DON’T KNOW.’’
 
PARENTS/SIBLINGS WHO ARE DECEASED SHOULD BE INCLUDED.
 
GRANDSCR (S9Q9) Were any of [your/the (AGE) year old’s] biological grandparents ever told they had asthma? 
(0) NO [SKIP TO OTHER_T (S11Q1)] 
(1) YES 
(6) DON’T KNOW [SKIP TO OTHER_T (S11Q1)] 
(7) REFUSED [SKIP TO OTHER_T (S11Q1)] 
HELP SCREEN: RESPONDENTS WHO ARE ADOPTED AND DO NOT HAVE ANY HEALTH
 
INFORMATION REGARDING THEIR BIOLOGICAL GRANDPARENTS SHOULD BE CODED AS ‘‘DON’T
 
KNOW.’’
 
GRANDPARENTS WHO ARE DECEASED SHOULD BE INCLUDED.
 
GRNDASTH	 Which of {your/the (AGE) year old’s} biological grandparents were told they had asthma? 
[MARK ALL THAT APPLY] 
(S9Q10_01) MOTHER’S MOTHER 
(S9Q10_02) MOTHER’S FATHER 
(S9Q10_03) FATHER’S MOTHER 
(S9Q10_04) FATHER’S FATHER 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HELP SCREEN: RESPONDENTS WHO ARE ADOPTED AND DO NOT HAVE ANY HEALTH
 
INFORMATION REGARDING THEIR BIOLOGICAL GRANDPARENTS SHOULD BE CODED AS ‘‘DON’T
 
KNOW.’’
 
GRANDPARENTS THAT ARE DECEASED SHOULD BE INCLUDED.
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Section 8. Demographic Information 
OTHER_T (S11Q1) Now, I just have a few more general questions about you and your household. Do you have any other home 
phone numbers in addition to (AREA CODE AND TELEPHONE NUMBER CALLED)? Please do not 
include cellular phones in your answer. 
(0) NO [SKIP TO WO_SERVICE (S11Q7)] 
(1) YES 
(6) DON’T KNOW [SKIP TO WO_SERVICE (S11Q7)] 
(7) REFUSED [SKIP TO WO_SERVICE (S11Q7)] 
SEC_USE (S11Q2) Is this second number for home use only, for business use only, or for both home and business use? 
(1) HOME ONLY 
(2) BUSINESS ONLY	 [SKIP TO THIRD_TN (S11Q4)] 
(3) BOTH HOME AND BUSINESS 
(6) DON’T KNOW	 [SKIP TO WO_SERVICE (S11Q7)] 
(7) REFUSED [SKIP TO WO_SERVICE (S11Q7)] 
SEC_FAX (S11Q3) Is this second number used only for computer or fax communications? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED	 [SKIP TO WO_SERVICE (S11Q7)] 
THIRD_TN (S11Q4)	 Do you have a third home phone number in addition to the two you have already told me 
about? Please do not include cellular phones in your answer. 
(0) NO	 [SKIP TO WO_SERVICE (S11Q7)] 
(1) YES 
(6) DON’T KNOW	 [SKIP TO WO_SERVICE (S11Q7)] 
(7) REFUSED	 [SKIP TO WO_SERVICE (S11Q7)] 
THIRD_USE (S11Q5) Is this third number for home use only, for business use only, or for both home and 
business use? 
(1) HOME ONLY 
(2) BUSINESS ONLY	 [SKIP TO WO_SERVICE (S11Q7)] 
(3) BOTH HOME AND BUSINESS 
(6) DON’T KNOW	 [SKIP TO WO_SERVICE (S11Q7)] 
(7) REFUSED [SKIP TO WO_SERVICE (S11Q7)] 
THIRD_FAX (S11Q6) Is this third number used only for computer or fax communications? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
NUM_PHON DERIVED. NUMBER OF TELEPHONES FOR HOME USE 
WO_SERVICE (S11Q7) During the past 12 months, has your household been without telephone service for 1 week or more? 
Please do not include cellular phones in your answer. 
(0) NO	 [SKIP TO R_ETH_2 (HISPANIC)] 
(1) YES 
(6) DON’T KNOW	 [SKIP TO R_ETH_2 (HISPANIC)] 
(7) REFUSED [SKIP TO R_ETH_2 (HISPANIC)] 
C11Q21_A (S11Q8) For how long was your household without telephone service in the past 12 months? 
(ENTER THE NUMBER, THEN CONTINUE TO THE NEXT SCREEN TO ENTER TIME PERIOD.) 
ENTER NUMBER __ __ __ 
(996) DON’T KNOW	 [SKIP TO R_ETH_2 (HISPANIC)] 
(997) REFUSED	 [SKIP TO R_ETH_2 (HISPANIC)] 
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C11Q21 (S11Q9) ENTER PERIOD 
(1) DAYS 
(2) WEEK(S) 
(3) MONTH(S) 
(6) DON’T KNOW 
(7) REFUSED 
NOPHONE DERIVED. NUMBER OF DAYS WITHOUT TELEPHONE SERVICE 
R_ETH_2 (HISPANIC) [Are you/Is the (AGE) year old] of Hispanic or Latino origin? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HISPANIC_DERIVED DERIVED. HISPANIC ORIGIN OF HOUSEHOLD MEMBER. 
R_RACE2	 Now, I’m going to read a list of categories. Please choose one or more of the following categories to describe 
[yourself/the (AGE) year old]. [Are you/Is the (AGE) year old] white, black or African-American, American Indian, 
Alaska Native, Asian, or Native Hawaiian or Other Pacific Islander? 
[MARK ALL THAT APPLY] 
(S2Q11_01) WHITE 
(S2Q11_02) BLACK/AFRICAN-AMERICAN 
(S2Q11_03) AMERICAN INDIAN 
(S2Q11_04) ALASKA NATIVE 
(S2Q11_05) ASIAN 
(S2Q11_06) NATIVE HAWAIIAN 
(S2Q11_07) PACIFIC ISLANDER 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HELP SCREEN: BE SURE TO READ THE ENTIRE QUESTION AS WRITTEN (INCLUDING ALL 
RESPONSE CATEGORIES). 
RACE INFORMATION IS COLLECTED BY SELF-IDENTIFICATION. IT IS ‘‘WHATEVER RACE YOU 
CONSIDER YOURSELF TO BE.’’ DO NOT TRY TO EXPLAIN OR DEFINE ANY OF THE GROUPS. 
MULTIPLE RACES MAY BE SELECTED. 
RACE DERIVED. RACE OF HOUSEHOLD MEMBER 
RACEARRAY DERIVED. ARRAY OF RESPONSES TO RACE VARIABLE 
R_EDUC 
HEIGHT1 (S2Q18)	 [IF THE SAMPLED PERSON IS UNDER 5, I.E. R_DOB (S2Q5) < 05, SKIP TO (S2Q14_1).] The next 
questions are about [your/the (AGE) year old’s] education level. What is the highest level of school that [you 
have/the (AGE) year old has] completed? 
_ _ENTER HIGHEST GRADE COMPLETED (1–12) 
(13) GRADUATED HIGH SCHOOL 
(14) SOME POST-HIGH SCHOOL, BUT NOT BACHELOR’S DEGREE (B.A.) 
(15) COLLEGE GRADUATE—BACHELOR’S DEGREE OR B.A. 
(16) SOME GRADUATE OR PROFESSIONAL SCHOOL (WITH OR WITHOUT DEGREE) 
(17) PRESCHOOL/HEADSTART 
(18) KINDERGARTEN 
(19) NO FORMAL SCHOOLING 
(96) DON’T KNOW 
(97) REFUSED 
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HEIGHT1—FEET 
(S2Q14_1) 
HEIGHT2—INCHES 
(S2Q14_2) 
HEIGHT3—CENTIMETERS 
(S2Q14_3)
 
How tall [are you/is the (AGE) year old]?
 
__ __ feet/__ __inches OR __ __ __centimeters
 
(96) DON’T KNOW (996) DON’T KNOW 
(97) REFUSED (997) REFUSED 
HELP SCREEN: WE ARE INTERESTED IN LOOKING AT HOW HEIGHT AND WEIGHT MAY BE 
RELATED TO ASTHMA FOR PEOPLE WHO DO AND DO NOT HAVE ASTHMA. 
HEIGHT DERIVED. RESPONDENT HEIGHT IN INCHES. 
WEIGHT1—POUNDS 
(S2Q15_1) 
WEIGHT2—KILOGRAMS 
(S2Q15_2)
 
How much [do you/does the (AGE) year old] weigh?
 
__ __ __ pounds OR __ __ __kilograms
 
(996) DON’T KNOW (996) DON’T KNOW 
(997) REFUSED (997) REFUSED 
HELP SCREEN: WE ARE INTERESTED IN LOOKING AT HOW HEIGHT AND WEIGHT MAY BE 
RELATED TO ASTHMA FOR PEOPLE WHO DO AND DO NOT HAVE ASTHMA. 
WEIGHT DERIVED. RESPONDENT WEIGHT IN POUNDS. 
BIRTHW1—POUNDS 
(S2Q16_1) BIRTHW2—OUNCES 
(S2Q16_2) 
BIRTHW3—GRAMS 
(S2Q16_3) 
[ASK BIRTHWT ONLY FOR SAMPLED PERSON’S AGE (S2Q5) < 18.] How much did [the (AGE) year old] 
weigh at birth? 
__ __ pounds /__ __ ounces OR __ __ __ __ grams [SKIP TO INC_TOT (S10Q1)] 
(96) DON’T KNOW (9996) DON’T KNOW [SKIP TO BIRTHRF (S2Q17)] 
(97) REFUSED (9997) REFUSED [SKIP TO BIRTHRF (S2Q17)] 
BIRTHWEIGHT DERIVED. CHILD’S BIRTHWEIGHT IN GRAMS 
BIRTHRF (S2Q17) At birth, did [the (AGE) year old/NAME] weigh less than 5 1/2 pounds? 
[INTERVIEWER NOTE: 5 1/2 pounds = 2500 GRAMS] 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
INC_TOT (S10Q1)	 What was the total combined income of your household in (FILL LAST CALENDAR YEAR), including 
income from all sources including wages, salaries, unemployment payments, public assistance, Social 
Security or retirement benefits, help from relatives, and so forth? Can you tell me that amount before taxes? 
{___________________ RECORD INCOME
 
(999999996) DON’T KNOW [SKIP TO RANGE_20 (S10Q3)]
 
(999999997) REFUSED [SKIP TO RANGE_20 (S10Q3)]
 
HELP SCREEN: RESPONDENT MAY GIVE A RANGE AS AN ANSWER TO THIS QUESTION. BE 
PREPARED TO PROBE FOR A MORE ACCURATE ANSWER. 
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RANGE_20 (S10Q3)	 For the purposes of this survey, it is important to get at least a range for the total income received by all 
members of your household in [FILL YEAR]. Would you say that the total combined income, before taxes, 
was above or below $20,000? 
(1) MORE THAN $20,000 [SKIP TO RANGE_40 (S10Q9)] 
(2) $20,000	 [SKIP TO C11Q22 (S11Q11)] 
(3) LESS THAN $20,000	 [SKIP TO RANGE_10 (S10Q4)] 
(6) DON’T KNOW	 [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED [SKIP TO C11Q22 (S11Q11)] 
RANGE_10 (S10Q4) Was the total combined household income more or less than $10,000? 
(1) MORE THAN $10,000 [SKIP TO RANGE_15 (S10Q6)] 
(2) $10,000	 [SKIP TO C11Q22 (S11Q11)] 
(3) LESS THAN $10,000	 [SKIP TO RANGE_7 (S10Q5)] 
(6) DON’T KNOW	 [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED [SKIP TO C11Q22 (S11Q11)] 
RANGE_7 (S10Q5) Was it more than $7,500? 
(0) NO	 [SKIP TO C11Q22 (S11Q11)] 
(1) YES	 [SKIP TO C11Q22 (S11Q11)] 
(6) DON’T KNOW	 [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED [SKIP TO C11Q22 (S11Q11)] 
RANGE_15 (S10Q6) Was it more than $15,000? 
(0) NO	 [SKIP TO RANGE_12 (S10Q8)] 
(1) YES	 [SKIP TO RANGE_17 (S10Q7)] 
(6) DON’T KNOW	 [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED [SKIP TO C11Q22 (S11Q11)] 
RANGE_17 (S10Q7) Was it more than $17,500? 
(0) NO	 [SKIP TO C11Q22 (S11Q11)] 
(1) YES	 [SKIP TO C11Q22 (S11Q11)] 
(6) DON’T KNOW	 [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED [SKIP TO C11Q22 (S11Q11)] 
RANGE_12 (S10Q8) Was it more than $12,500? 
(0) NO	 [SKIP TO C11Q22 (S11Q11)] 
(1) YES	 [SKIP TO C11Q22 (S11Q11)] 
(6) DON’T KNOW	 [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED [SKIP TO C11Q22 (S11Q11)] 
RANGE_40 (S10Q9) Was the total combined household income more or less than $40,000? 
(1) MORE THAN $40,000 [SKIP TO RANGE_60 (S10Q10)] 
(2) $40,000	 [SKIP TO C11Q22 (S11Q11)] 
(3) LESS THAN $40,000	 [SKIP TO RANGE_30 (S10Q13)] 
(6) DON’T KNOW	 [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED [SKIP TO C11Q22 (S11Q11)] 
RANGE_60 (S10Q10) Was the total combined household income more or less than $60,000? 
(1) MORE THAN $60,000 [SKIP TO RANGE_75 (S10Q16)] 
(2) $60,000	 [SKIP TO C11Q22 (S11Q11)] 
(3) LESS THAN $60,000	 [SKIP TO RANGE_50 (S10Q11)] 
(6) DON’T KNOW	 [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED	 [SKIP TO C11Q22 (S11Q11)] 
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RANGE_50 (S10Q11) Was the total combined household income more or less than $50,000? 
(1) MORE THAN $50,000 [SKIP TO C11Q22 (S11Q11)] 
(2) $50,000 [SKIP TO C11Q22 (S11Q11)] 
(3) LESS THAN $50,000 [SKIP TO RANGE_45 (S10Q12)] 
(6) DON’T KNOW [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED [SKIP TO C11Q22 (S11Q11)] 
RANGE_45 (S10Q12) Was the total combined household income more or less than $45,000? 
(1) MORE THAN $45,000 [SKIP TO C11Q22 (S11Q11)] 
(2) LESS THAN $45,000 [SKIP TO C11Q22 (S11Q11)] 
(6) DON’T KNOW [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED [SKIP TO C11Q22 (S11Q11)] 
RANGE_30 (S10Q13) Was the total combined household income more or less than $30,000? 
(1) MORE THAN $30,000 [SKIP TO RANGE_35 (S10Q14)] 
(2) $30,000 [SKIP TO C11Q22 (S11Q11)] 
(3) LESS THAN $30,000 [SKIP TO RANGE_25 (S10Q15)] 
(6) DON’T KNOW [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED [SKIP TO C11Q22 (S11Q11)] 
RANGE_35 (S10Q14) Was the total combined household income more or less than $35,000? 
(1) MORE THAN $35,000 [SKIP TO C11Q22 (S11Q11)] 
(2) LESS THAN $35,000 [SKIP TO C11Q22 (S11Q11)] 
(6) DON’T KNOW [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED [SKIP TO C11Q22 (S11Q11)] 
RANGE_25 (S10Q15) Was the total combined household income more or less than $25,000? 
(1) MORE THAN $25,000 [SKIP TO C11Q22 (S11Q11)] 
(2) LESS THAN $25,000 [SKIP TO C11Q22 (S11Q11)] 
(6) DON’T KNOW [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED [SKIP TO C11Q22 (S11Q11)] 
RANGE_75 (S10Q16) Was the total combined household income more or less than $75,000? 
(1) MORE THAN $75,000 [SKIP TO C11Q22 (S11Q11)] 
(2) $75,000 [SKIP TO C11Q22 (S11Q11)] 
(3) LESS THAN $75,000 [SKIP TO C11Q22 (S11Q11)] 
(6) DON’T KNOW [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED [SKIP TO C11Q22 (S11Q11)] 
BESTINCOME DERIVED. BEST INCOME VALUE 
C11Q22 (S11Q11) Please tell me your Zip Code. 
___ ___ ___ ___ ___ (00001–99995) 
(99996) DON’T KNOW 
(99997) REFUSED 
CLOSING STATEMENT 
Those are all the questions I have for you. I’d like to thank you on behalf of the Centers for Disease Control and 
Prevention for the time and effort you’ve spent answering these questions. If you have any questions about this 
survey, you may call my supervisor toll-free at 1–866–775–6858. If you have questions about your rights as a 
survey participant, you may call the chairman of the Institutional Review Board at 1–800–223–8118. Thanks 
again. 
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Proxy Variable Listing 
[THE FOLLOWING QUESTIONS ARE ASKED IF SAMPLED ADULT NOT AVAILABLE AT THE INITIAL 
CALL.] 
INS1P (S5Q1_AP)	 Does [the (AGE) year old/NAME] have any kind of health care coverage, including 
health insurance, prepaid plans such as HMOs, or government plans such as Medicare? 
(0) NO 
(1) YES [SKIP TO INS2P (S5Q1_BP)] 
(6) DON’T KNOW 
(7) REFUSED 
INS2P (S5Q1_BP) [IF INS1P (S5Q1_AP) = 0, 6, 7, SKIP TO AIRCLEANEP (S7Q1P).] [IF R_DOB (S2Q5) = 0, FILL: ‘‘Since 
birth’’/ELSE FILL: ‘‘During the past 12 months’’], was there any time that [the (AGE) year old/NAME] did 
not have any health insurance or coverage? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
AIRCLEANEP (S7Q1P) Is an air cleaner or purifier regularly used inside your home? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DEHUMIDP (S7Q2P) Is a dehumidifier regularly used to reduce moisture inside your home? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
KITC_FANP (S7Q3P) Is an exhaust fan that vents to the outside used regularly when cooking in your kitchen? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
COOK_GASP (S7Q4P) Is gas used for cooking? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
ENV_MOLDP (S7Q5P)	 In the past 30 days, has anyone seen or smelled mold or a musty odor inside your home? Do not 
include mold on food. 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
ENV_PETSP (S7Q6P)	 Does your household have indoor pets such as dogs, cats, hamsters, birds, or other feathered or furry pets 
that are kept inside? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
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C_ROACHP (S7Q7P) In the past 30 days, has anyone seen cockroaches inside your home? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HELP SCREEN: Studies have shown that cockroaches are a leading cause of asthma in children that live in 
urban areas. Cockroach droppings and carcasses can cause children to experience symptoms of asthma. 
WOOD_STOVP (S7Q8P) Is a fireplace or wood burning stove used in your home? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HELP SCREEN: OCCASIONAL USE SHOULD BE CODED AS ‘‘YES.’’ 
GAS_STOVEP (S7Q9P) Are unvented gas logs, an unvented gas fireplace, or an unvented gas stove used in your home? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HELP SCREEN: ‘‘Unvented’’ means no chimney. 
S_INSIDE (S7Q10P) In the past week, has anyone smoked inside your home? 
(0) NO
 
(1) YES
 
(6) DON’T KNOW
 
(7) REFUSED
 
HELP SCREEN: ‘‘Smoked’’ means ‘‘anything.’’
 
SKIP TO OTHRASTHP IF INTERVIEW IS FOR SAMPLED CHILD (R_DOB/S2Q5 < 18). 
CIGARETSP (S7Q18P) {Has (the (AGE) year old) smoked at least 100 cigarettes in [his or her]} entire life? 
(0) NO [SKIP TO EMP_STATP (S7Q20P)] 
(1) YES 
(6) DON’T KNOW [SKIP TO EMP_STATP (S7Q20P)] 
(7) REFUSED [SKIP TO EMP_STATP (S7Q20P)] 
CIG_FREQP (S7Q19P) Does [the (AGE) year old] now smoke cigarettes every day, some days, or not at all? 
(1) EVERY DAY 
(2) SOME DAYS 
(3) NOT AT ALL 
(6) DON’T KNOW 
(7) REFUSED 
EMP_STATP (S7Q20P)	 [IF R_ASTHMX01 = 1 OR  S3Q7 = 1:] We are interested in things that affect 
asthma in the workplace. However, first I’d like to ask how you would describe [the 
(AGE) year old/NAME]’s current employment status. Would you say [the (AGE) year old/NAME] is . . . 
(1) EMPLOYED FULL-TIME 
(2) EMPLOYED PART-TIME 
(3) NOT EMPLOYED 
(6) DON’T KNOW 
(7) REFUSED 
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UNEMP_RP (S7Q22P)	 [IF EMP_STATP (S7Q20P) = 1 OR 2, SKIP  TO  OTHRASTHP] What is the main reason [the (AGE) 
year old is] not employed? 
(1) KEEPING HOUSE 
(2) GOING TO SCHOOL 
(3) RETIRED 
(4) DISABLED 
(5) UNABLE TO WORK FOR OTHER HEALTH REASONS 
(6) LOOKING FOR WORK 
(7) LAID OFF 
(8) OTHER 
(96) DON’T KNOW 
(97) REFUSED 
OTHRASTHP	 Besides [the (AGE) year old/NAME], has anyone else in your household ever been told by a doctor or health 
professional that they have asthma? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
OTHER_TP (S11Q1P)	 Now, I just have a few more general questions about you and your household. Do you have any other 
home phone numbers in addition to (AREA CODE AND TELEPHONE NUMBER CALLED)? Please do 
not include cellular phones in your answer. 
(0) NO	 [SKIP TO WO_SERVICP (S11Q7P)] 
(1) YES 
(6) DON’T KNOW	 [SKIP TO WO_SERVICP (S11Q7P)] 
(7) REFUSED [SKIP TO WO_SERVICP (S11Q7P)] 
SEC_USEP (S11Q2P) Is this second number for home use only, for business use only, or for both home and business use? 
(1) HOME ONLY 
(2) BUSINESS ONLY	 [SKIP TO THIRD_TNP (S11Q4P)] 
(3) BOTH HOME AND BUSINESS 
(6) DON’T KNOW	 [SKIP TO WO_SERVICP (S11Q7P)] 
(7) REFUSED [SKIP TO WO_SERVICP (S11Q7P)] 
SEC_FAXP (S11Q3P) Is this second number used only for computer or fax communications? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED	 [SKIP TO WO_SERVICP (S11Q7P)] 
THIRD_TNP (S11Q4P)	 Do you have a third home phone number in addition to the two you have already told me about? Please 
do not include cellular phones in your answer. 
(0) NO	 [SKIP TO WO_SERVICP (S11Q7P)] 
(1) YES 
(6) DON’T KNOW	 [SKIP TO WO_SERVICP (S11Q7P)] 
(7) REFUSED [SKIP TO WO_SERVICP (S11Q7P)] 
THIRD_USEP (S11Q5P) Is this third number for home use only, for business use only, or for both home and business use? 
(1) HOME ONLY 
(2) BUSINESS ONLY	 [SKIP TO WO_SERVICP (S11Q7P)] 
(3) BOTH HOME AND BUSINESS 
(6) DON’T KNOW	 [SKIP TO WO_SERVICP (S11Q7P)] 
(7) REFUSED	 [SKIP TO WO_SERVICP (S11Q7P)] 
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THIRD_FAXP (S11Q6P) Is this third number used only for computer or fax communications? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
WO_SERVICP (S11Q7P) During the past 12 months, has your household been without telephone service for 1 week or more? 
Please do not include cellular phones in your answer. 
(0) NO [SKIP TO R_ETH_2P (HISPANICP)] 
(1) YES 
(6) DON’T KNOW [SKIP TO R_ETH_2P (HISPANICP)] 
(7) REFUSED [SKIP TO R_ETH_2P (HISPANICP)] 
C11Q21_AP (S11Q8P) For how long was your household without telephone service in the past 12 months? 
(ENTER THE DAYS, WEEKS, OR MONTHS, THEN CONTINUE TO THE NEXT SCREEN TO ENTER
 
TIME PERIOD.)
 
ENTER NUMBER __ __ __
 
(996) DON’T KNOW [SKIP TO R_ETH_2P (HISPANICP)] 
(997) REFUSED [SKIP TO R_ETH_2P (HISPANICP)] 
C11Q21P (S11Q9P) ENTER PERIOD 
(1) DAYS 
(2) WEEK(S) 
(3) MONTH(S) 
(6) DON’T KNOW 
(7) REFUSED 
[NOTE: DEMOGRAPHICS (R_ETH_2P to BIRTHRFP) ARE ONLY ASKED FOR THE SAMPLED 
RESPONDENT.] 
R_ETH_2P (HISPANICP) (Is the (AGE) year old) of Hispanic or Latino origin? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
R_RAC2P	 Now, I’m going to read a list of categories. Please choose one or more of the following categories to describe (the 
(AGE) year old/NAME). (Is the (AGE) year old/NAME) White, Black or African-American, American Indian, Alaska 
Native, Asian, or Native Hawaiian or Other Pacific Islander? 
[MARK ALL THAT APPLY] 
(S2Q11_01P) WHITE 
(S2Q11_02P) BLACK/AFRICAN-AMERICAN 
(S2Q11_03P) AMERICAN INDIAN 
(S2Q11_04P) ALASKA NATIVE 
(S2Q11_05P) ASIAN 
(S2Q11_06P) NATIVE HAWAIIAN 
(S2Q11_07P) PACIFIC ISLANDER 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HELP SCREEN: BE SURE TO READ THE ENTIRE QUESTION AS WRITTEN (INCLUDING ALL 
RESPONSE CATEGORIES). 
RACE INFORMATION IS COLLECTED BY SELF-IDENTIFICATION. IT IS ‘‘WHATEVER RACE YOU 
CONSIDER YOURSELF TO BE.’’ DO NOT TRY TO EXPLAIN OR DEFINE ANY OF THE GROUPS. 
MULTIPLE RACES MAY BE SELECTED.] 
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R_EDUCP (S2Q18P)	 [SKIP IF A PERSON’S AGE IS UNDER 5, I.E. R_DOB < 05.] The next questions are about [the (AGE) 
year old/NAME]’s education level. What is the highest level of school that [the (AGE) year old/NAME] 
has completed? 
_ _ ENTER HIGHEST GRADE COMPLETED (1–12) 
(13) GRADUATED HIGH SCHOOL 
(14) SOME POST-HIGH SCHOOL, BUT NOT BACHELOR’S DEGREE (B.A.) 
(15) COLLEGE GRADUATE—BACHELOR’S DEGREE OR B.A. 
(16) SOME GRADUATE OR PROFESSIONAL SCHOOL (WITH OR WITHOUT DEGREE) 
(17) PRESCHOOL/HEADSTART 
(18) KINDERGARTEN 
(19) NO FORMAL SCHOOLING 
(96) DON’T KNOW 
(97) REFUSED 
HEIGHT1P—FEET 
(S2Q14_1P) 
HEIGHT2P—INCHES 
(S2Q14_2P) 
HEIGHT3P—CENTIMETERS 
(S2Q14_3P) 
How tall is {the (AGE) year old/NAME}? 
__ __ feet/__ __inches OR __ __ __centimeters 
(96) DON’TKNOW	 (996) DON’TKNOW 
(97) REFUSED	 (997) REFUSED 
HELP SCREEN: WE ARE INTERESTED IN LOOKING AT HOW HEIGHT AND WEIGHT MAY BE 
RELATED TO ASTHMA FOR PEOPLE WHO DO AND DO NOT HAVE ASTHMA. 
WEIGHT1P—POUNDS 
(S2Q15_1P) 
WEIGHT2P—KILOGRAMS 
(S2Q15_2P) 
How much does {the (AGE) year old/NAME} weigh? 
__ __ __ pounds OR __ __ __kilograms 
(996) DON’T KNOW (996) DON’T KNOW 
(997) REFUSED (997) REFUSED 
HELP SCREEN: WE ARE INTERESTED IN LOOKING AT HOW HEIGHT AND WEIGHT MAY BE 
RELATED TO ASTHMA FOR PEOPLE WHO DO AND DO NOT HAVE ASTHMA. 
BIRTHW1P—POUNDS 
(S2Q16_1P) 
BIRTHW2P—OUNCES 
(S2Q16_2P) 
BIRTHW3P—GRAMS 
(S2Q16_3P) 
[ASK BIRTHWTP ONLY FOR SAMPLED PERSONS WITH AGE < 18 (R_DOB/S2Q5).] How much did [the 
(AGE) year old/NAME] weigh at birth? 
__ __ pounds /__ __ ounces OR __ __ __ __ grams [SKIP TO INC_TOTP (S10Q1P)] 
(96) DON’T KNOW (9996) DON’T KNOW [SKIP TO BIRTHRFP (S2Q17P)] 
(97) REFUSED (9997) REFUSED [SKIP TO BIRTHRFP (S2Q17P)] 
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BIRTHRFP (S2Q17P)	 At birth, did [the (AGE) year old/NAME] weigh less than 5 1/2 pounds? 
[INTERVIEWER NOTE: 5 1/2 pounds = 2500 GRAMS] 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
INC_TOTP (S10Q1P) What was the total combined income of your household in [CATI: FILL LAST CALENDAR YEAR], 
including income from all sources including wages, salaries, unemployment payments, public assistance, 
Social Security or retirement benefits, help from relatives, and so forth? Can you tell me that amount 
before taxes? 
$___________________ RECORD INCOME
 
(999999996) DON’T KNOW [SKIP TO RANGE_20P (S10Q3P)]
 
(999999997) REFUSED [SKIP TO RANGE_20P (S10Q3P)]
 
HELP SCREEN: RESPONDENT MAY GIVE A RANGE AS AN ANSWER TO THIS QUESTION. BE
 
PREPARED TO PROBE FOR A MORE ACCURATE ANSWER.
 
RANGE_20P (S10Q3P)	 For the purposes of this survey, it is important to get at least a range for the total income received by all 
members of your household in [FILL YEAR]. Would you say that the total combined income, before 
taxes, was above or below $20,000? 
(1) MORE THAN $20,000	 [SKIP TO RANGE_40P (S10Q9P)] 
(2) $20,000	 [SKIP TO C11Q22P (S11Q11P)] 
(3) LESS THAN $20,000	 [SKIP TO RANGE_10P (S10Q4P)] 
(6) DON’T KNOW	 [SKIP TO C11Q22P (S11Q11P)] 
(7) REFUSED [SKIP TO C11Q22P (S11Q11P)] 
RANGE_10P (S10Q4P) Was the total combined household income more or less than $10,000? 
(1) MORE THAN $10,000	 [SKIP TO RANGE_15P (S10Q6P)] 
(2) $10,000	 [SKIP TO C11Q22P (S11Q11P)] 
(3) LESS THAN $10,000	 [SKIP TO RANGE_7P (S10Q5P)] 
(6) DON’T KNOW	 [SKIP TO C11Q22P (S11Q11P)] 
(7) REFUSED [SKIP TO C11Q22P (S11Q11P)] 
RANGE_7P (S10Q5P) Was it more than $7,500? 
(0) NO	 [SKIP TO C11Q22P (S11Q11P)] 
(1) YES	 [SKIP TO C11Q22P (S11Q11P)] 
(6) DON’T KNOW	 [SKIP TO C11Q22P (S11Q11P)] 
(7) REFUSED [SKIP TO C11Q22P (S11Q11P)] 
RANGE_15P (S10Q6P) Was it more than $15,000? 
(0) NO	 [SKIP TO RANGE_12P (S10Q8P)] 
(1) YES	 [SKIP TO RANGE_17P (S10Q7P)] 
(6) DON’T KNOW	 [SKIP TO C11Q22P (S11Q11P)] 
(7) REFUSED [SKIP TO C11Q22P (S11Q11P)] 
RANGE_17P (S10Q7P) Was it more than $17,500? 
(0) NO	 [SKIP TO C11Q22P (S11Q11P)] 
(1) YES	 [SKIP TO C11Q22P (S11Q11P)] 
(6) DON’T KNOW	 [SKIP TO C11Q22P (S11Q11P)] 
(7) REFUSED [SKIP TO C11Q22P (S11Q11P)] 
RANGE_12P (S10Q8P) Was it more than $12,500? 
(0) NO	 [SKIP TO C11Q22P (S11Q11P)] 
(1) YES	 [SKIP TO C11Q22P (S11Q11P)] 
(6) DON’T KNOW	 [SKIP TO C11Q22P (S11Q11P)] 
(7) REFUSED	 [SKIP TO C11Q22P (S11Q11P)] 
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RANGE_40P (S10Q9P) Was the total combined household income more or less than $40,000? 
(1) MORE THAN $40,000 [SKIP TO RANGE_60P (S10Q10P)] 
(2) $40,000 [SKIP TO C11Q22P (S11Q11P)] 
(3) LESS THAN $40,000 [SKIP TO RANGE_30P (S10Q13P)] 
(6) DON’T KNOW [SKIP TO C11Q22P (S11Q11P)] 
(7) REFUSED [SKIP TO C11Q22P (S11Q11P)] 
RANGE_60P (S10Q10P) Was the total combined household income more or less than $60,000? 
(1) MORE THAN $60,000	 [SKIP TO RANGE_75P (S10Q16P)] 
(2) $60,000	 [SKIP TO C11Q22P (S11Q11P)] 
(3) LESS THAN $60,000	 [SKIP TO RANGE_50P (S10Q11P)] 
(6) DON’T KNOW	 [SKIP TO C11Q22P (S11Q11P)] 
(7) REFUSED [SKIP TO C11Q22P (S11Q11P)] 
RANGE_50P (S10Q11P) Was the total combined household income more or less than $50,000? 
(1) MORE THAN $50,000	 [SKIP TO C11Q22P (S11Q11P)] 
(2) $50,000	 [SKIP TO C11Q22P (S11Q11P)] 
(3) LESS THAN $50,000	 [SKIP TO RANGE_45P (S10Q12P)] 
(6) DON’T KNOW	 [SKIP TO C11Q22P (S11Q11P)] 
(7) REFUSED [SKIP TO C11Q22P (S11Q11P)] 
RANGE_45P (S10Q12P) Was the total combined household income more or less than $45,000? 
(1) MORE THAN $45,000	 [SKIP TO C11Q22P (S11Q11P)] 
(2) LESS THAN $45,000	 [SKIP TO C11Q22P (S11Q11P)] 
(6) DON’T KNOW	 [SKIP TO C11Q22P (S11Q11P)] 
(7) REFUSED [SKIP TO C11Q22P (S11Q11P)] 
RANGE_30P (S10Q13P) Was the total combined household income more or less than $30,000? 
(1) MORE THAN $30,000	 [SKIP TO RANGE_35P (S10Q14P)] 
(2) $30,000	 [SKIP TO C11Q22P (S11Q11P)] 
(3) LESS THAN $30,000	 [SKIP TO RANGE_25P (S10Q15P)] 
(6) DON’T KNOW	 [SKIP TO C11Q22P (S11Q11P)] 
(7) REFUSED [SKIP TO C11Q22P (S11Q11P)] 
RANGE_35P (S10Q14P) Was the total combined household income more or less than $35,000? 
(1) MORE THAN $35,000	 [SKIP TO C11Q22P (S11Q11P)] 
(2) LESS THAN $35,000	 [SKIP TO C11Q22P (S11Q11P)] 
(6) DON’T KNOW	 [SKIP TO C11Q22P (S11Q11P)] 
(7) REFUSED [SKIP TO C11Q22P (S11Q11P)] 
RANGE_25P (S10Q15P) Was the total combined household income more or less than $25,000? 
(1) MORE THAN $25,000	 [SKIP TO C11Q22P (S11Q11P)] 
(2) LESS THAN $25,000	 [SKIP TO C11Q22P (S11Q11P)] 
(6) DON’T KNOW	 [SKIP TO C11Q22P (S11Q11P)] 
(7) REFUSED [SKIP TO C11Q22P (S11Q11P)] 
RANGE_75P (S10Q16P) Was the total combined household income more or less than $75,000? 
(1) MORE THAN $75,000 
(2) $75,000 
(3) LESS THAN $75,000 
(6) DON’T KNOW 
(7) REFUSED 
C11Q22P (S11Q11P)	 Please tell me your Zip Code. 
___ ___ ___ ___ ___ (00001–99995) (99996) 
DON’T KNOW 
(99997) REFUSED 
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CLOSING STATEMENT 
Those are all the questions I have for you. I’d like to thank you on behalf of the Centers for Disease Control and 
Prevention for the time and effort you’ve spent answering these questions. [the (AGE) year old/NAME] about 
(his/her) asthma.] If you have any questions about this survey, you may call my supervisor toll-free at 
1–866–775–6858. If you have questions about your rights as a survey participant, you may call the chairman of 
the Institutional Review Board at 1–800–223–8118. Thanks again. 
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Four-State Study Questionnaire 
Form Approved 
OMB No. 0920–0406 
Exp. Date 12/31/04 
SLAITS National Asthma Survey 
National Study Questionnaire 
Section Subject 
Section 1 NAS Eligibility Screening, Respondent Selection, 
and Initial Demographics 
Section 2 History of Asthma (Symptoms & Episodes) 
Section 3 Health Care Utilization 
Section 4 Knowledge of Asthma/Management Plan 
Section 5 Modifications to Environment 
Section 6 Medications 
Section 7 Family History of Asthma 
Section 8 Demographic Information 
The following public burden estimate statement will be available as a CATI screen: 
Public reporting burden of this collection of information is estimated to average 18 minutes per response, including the time for 
reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing 
the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of 
information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other 
aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer, 
1600 Clifton Road NE, MS D-24, Atlanta, Georgia 30333; ATTN: PRA (0920–0406). 
NOTE: CATI variable names are provided with corresponding SAS data file variable names, if different, in parentheses. 
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Section 1. NAS Eligibility Screening, Respondent Selection, and Initial Demographics 
CASEID HOUSEHOLD ID NUMBER 
CASEIDX UNIQUE ASTHMA INTERVIEW ID NUMBER 
CALLDATE CATI DATE. DATE THE INTERVIEW WAS COMPLETED OR THE LAST DATE THE HOUSEHOLD WAS 
CONTACTED, IF A COMPLETED INTERVIEW WAS NOT OBTAINED. 
SAMP_TYPE DERIVED. NIS/NAS OR NAS-ONLY SAMPLE GROUP 
(1) NIS/NAS SAMPLE 
(2) NAS-ONLY SAMPLE 
IAPID IAP AREA LOCATION 
SPANISH CATI FLAG. CASE PLACED IN SPANISH QUEUE 
(0) NOT PLACED IN SPANISH QUEUE 
(1) PLACED IN SPANISH QUEUE 
LTR Advance letter mailed to household 
(0) NO, LETTER WAS NOT MAILED 
(1) YES, LETTER MAILED 
INTRODUCTORY STATEMENT 
Now I have some questions regarding asthma for both adults and children in your household. 
SCR_OTHRS (S2Q2)	 Including yourself, has anyone living in your household ever been told by a doctor or other health 
professional that they have asthma? 
[INCLUDE EXERCISE-INDUCED ASTHMA] 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED
 
IF SCR_OTHRS (S2Q2) = 0, 6, 7, END INTERVIEW.
 
ROST	 I need to randomly select household members for the interview. How many people 18 years of age or older who live 
in your household have been diagnosed with asthma? 
_ _ _ ENTER NUMBER OF PEOPLE (RANGE 00–30) [SKIP TO ROSTKID] 
(96) DON’T KNOW	 [END INTERVIEW] 
(97) REFUSED	 [END INTERVIEW] 
ROSTKID	 How many people under 18 years of age who live in your household have been diagnosed with asthma? 
_ _ _ ENTER NUMBER OF PEOPLE (RANGE 00–30) 
(96) DON’T KNOW	 [END INTERVIEW]
 
(97) REFUSED [END INTERIVEW]
 
RANDOMLY SAMPLE ONE ADULT FROM ROST IF > 0 AND ONE CHILD FROM ROSTKID IF > 0.
 
R_DOB (S2Q5) Please tell me [your age/the age of the (SELECTED PERSON) in your household]. 
ENTER NUMBER ____ 
(996) DON’T KNOW	 [END INTERVIEW] 
(997) REFUSED [END INTERVIEW] 
R_SEX (S2Q6) [READ IF NECESSARY] [Are you/Is the (AGE) year old] male or female? 
(1) MALE 
(2) FEMALE 
(7) REFUSED 
HH_TOTAL DERIVED. NUMBER OF PEOPLE WITH ASTHMA IN THE HOUSEHOLD 
COMPLETE DERIVED. TOTAL NUMBER OF HOUSEHOLD MEMBERS WHO WERE SAMPLED AND COMPLETED AN 
INTERVIEW 
FLG_PROXY DERIVED. INTERVIEW DONE BY PROXY BECAUSE OF ILLNESS 
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PROXYREL (S3Q6B)	 [ASK IF ADULT INTERVIEW IS TO BE DONE BY PROXY BECAUSE OF ILLNESS.] What is your 
relationship to [the (AGE) year old]? 
(1) SPOUSE 
(2) UNMARRIED PARTNER, BOYFRIEND/GIRLFRIEND 
(3) CHILD 
(4) GRANDCHILD 
(5) MOTHER (BIRTH/ADOPTIVE/STEP/FOSTER/OTHER) 
(6) FATHER (BIRTH/ADOPTIVE/STEP/FOSTER/OTHER) 
(7) BROTHER/SISTER 
(8) GRANDFATHER/GRANDMOTHER 
(9) OTHER RELATIVE 
(10) FOSTER CHILD 
(11) HOUSEMATE/ROOMMATE 
(12) ROOMER/BOARDER 
(13) OTHER NON-RELATIVE 
(90) UNRELATED LEGAL GUARDIAN 
(96) DON’T KNOW 
(97) REFUSED 
RELA_CHLD (S3Q6)	 [RELA_CHLD IS ONLY ASKED FOR AGE (R_DOB/S2Q5) < 18] What is your relationship to [the 
(AGE) year old/NAME] who lives in this household? 
(1) MOTHER (STEP, FOSTER, ADOPTIVE) OR FEMALE GUARDIAN 
(2) FATHER (STEP, FOSTER, ADOPTIVE) OR MALE GUARDIAN 
(3) SISTER OR BROTHER (STEP/FOSTER/HALF/ADOPTIVE) 
(4) IN-LAW OF ANY TYPE 
(5) AUNT/UNCLE 
(6) GRANDPARENT 
(7) OTHER FAMILY MEMBER 
(8) FRIEND 
(96) DON’T KNOW 
(97) REFUSED 
OTH_CHLD (S3Q7)	 {Have you/Has [the (AGE) year old/NAME]} ever been told by a doctor or other health professional that {you 
have/he has/she has} asthma? 
(0) NO	 [END INTERVIEW] 
(1) YES 
(6) DON’T KNOW [END INTERVIEW] 
(7) REFUSED	 [END INTERVIEW] 
AGEDGNOS (S3Q8)	 How old {were you/was [the (AGE) year old/NAME]} when (you were/he or his parent or guardian was/she 
or her parent or guardian was) first told by a doctor or other health professional that (you/he/she) had asthma? 
[INTERVIEWER: ENTER 0 IF LESS THAN ONE YEARS OLD] 
__ __ __ (ENTER AGE IN YEARS) 
(996) DON’T KNOW 
(997) REFUSED 
CUR_AST2 (S3Q9) {Do you/Does [the (AGE) year old/NAME]} still have asthma? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
Section 2. History of Asthma (Symptoms & Episodes) 
LAST_MD (S3Q10) How long has it been since {you/[the (AGE) year old/NAME] or [the (AGE) year old/NAME]’s parents or 
guardians} last talked to a doctor or other health professional about (your/his/her) asthma? 
(0) NEVER 
(1) WITHIN THE PAST YEAR 
(2) 1 YEAR TO LESS THAN 3 YEARS AGO 
(3) 3 YEARS TO 5 YEARS AGO 
(4) MORE THAN 5 YEARS AGO 
(6) DON’T KNOW 
(7) REFUSED 
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LAST_MED (S3Q11)	 How long has it been since {you/[the (AGE) year old/NAME]} last took asthma medication? 
(0) NEVER 
(1) LESS THAN ONE DAY AGO 
(2) 1–6 DAYS AGO 
(3) 1 WEEK TO LESS THAN 3 MONTHS AGO 
(4) 3 MONTHS TO LESS THAN 1 YEAR AGO 
(5) 1 YEAR TO LESS THAN 3 YEARS AGO 
(6) 3 YEARS TO 5 YEARS AGO 
(7) MORE THAN 5 YEARS AGO 
(96) DON’T KNOW 
(97) REFUSED 
INTRODUCTORY STATEMENT 
READ: Symptoms of asthma include coughing, wheezing, shortness of breath, chest tightness, or phlegm production 
when {you do not/[the (AGE) year old/NAME] does not} have a cold or respiratory infection. [CONTINUE] 
LASTSYMP (S3Q12)	 How long has it been since {you/[the (AGE) year old/NAME] last had any symptoms of asthma? 
[INTERVIEWER: READ RESPONSE OPTIONS IF NECESSARY] 
(0) NEVER 
(1) LESS THAN ONE DAY AGO 
(2) 1–6 DAYS AGO 
(3) 1 WEEK TO LESS THAN 3 MONTHS AGO 
(4) 3 MONTHS TO LESS THAN 1 YEAR AGO 
(5) 1 YEAR TO LESS THAN 3 YEARS AGO 
(6) 3 YEAR TO 5 YEARS AGO 
(7) MORE THAN 5 YEARS AGO 
(96) DON’T KNOW 
(97) REFUSED 
ASTHSTAT	 DERIVED. ASTHMA STATUS OF HOUSEHOLD MEMBER 
(0) NO, PERSON DOES NOT HAVE ASTHMA 
(1) YES, PERSON HAS ASTHMA 
LTASTHM DERIVED. RISK FACTOR FOR LIFETIME ASTHMA PREVALENCE BASED ON BRFSS RULES 
(1) NOT AT RISK 
(2) AT RISK 
(9) DON’T KNOW/NOT SURE OR REFUSED 
ASTATUS1	 DERIVED. CURRENT ASTHMA STATUS OF HOUSEHOLD MEMBER BASED ON SELF-IDENTIFICATION 
(1) PERSON SELF-IDENTIFIED ASTHMA 
(0) PERSON DID NOT SELF-IDENTIFY ASTHMA 
(6) DON’T KNOW 
CASTHMA	 DERIVED. RISK FACTOR FOR CURRENT ASTHMA PREVALENCE BASED ON BRFSS RULES 
(1) NOT AT RISK 
(2) AT RISK 
(9) DON’T KNOW/NOT SURE OR REFUSED 
ASTHMST	 DERIVED. COMPUTED ASTHMA STATUS BASED ON BRFSS RULES 
(1) CURRENT 
(2) FORMER 
(3) NEVER 
(9) DON’T KNOW/NOT SURE OR REFUSED 
ASTATUS2	 DERIVED. CURRENT ASTHMA STATUS OF HOUSEHOLD MEMBER BASED ON SELF-REPORTED 
BEHAVIORS 
(1) BEHAVIORS INDICATE ASTHMA 
(0) BEHAVIORS DO NOT INDICATE ASTHMA 
(6) DON’T KNOW 
FLG_TYPE	 DERIVED. EXPECTED INTERVIEW TYPE 
(1) SAMPLED PERSON INT: SYMPTOMS, MEDS, DR VISITS IN PAST 3 YRS 
(2) SAMPLED PERSON INT: NO SYMPTOMS, MEDS, DR VISITS IN PAST 3 YRS 
(3) SAMPLED PERSON ILL, PROXY INT: SYMPTOMS, MEDS, DR VISITS IN PAST 3 YRS 
(4) SAMPLED PERSON ILL, PROXY INT: NO SYMPTOMS, MEDS, DR VISITS IN PAST 3 YRS 
(5) SAMPLED PERSON OR ASTHMA STATUS NOT DETERMINED 
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IF THIS IS AN ADULT INTERVIEW (R_DOB/S2Q5 > 17) AND
 
CUR_AST2 (S3Q9) = 0, 6, 7 AND
 
LAST_MD (S3Q10) = 0 OR > 2 A ND 
  
LAST_MED (S3Q11) = 0 OR > 5 A ND 
  
LASTSYMP (S3Q12) = 0 OR > 5, 
  
SKIP TO INS1 (S5Q1_A). COMPLETE INS1 (S5Q1_A), INS2 (S5Q1_B), HH_INT through S_INSIDE (S7Q10), 
CIGARETS (S7Q18) through UNEMP_R (S7Q22), SECTION 6 [OTC (S8Q1) through INHALERH (S8Q3), if 
applicable], SECTION 7 [START AT BRO_N (S9Q1)], AND DEMOGRAPHICS [OTHER_T (S11Q1) THROUGH 
C11Q22 (S11Q11)]. 
IF THIS IS A CHILD INTERVIEW (R_DOB/S2Q5 < 18) AND
 
CUR_AST2 (S3Q9) = 0, 6, 7 AND
 
LAST_MD (S3Q10) = 0 OR > 2 A ND 
  
LAST_MED (S3Q11) = 0 OR > 5 A ND 
  
LASTSYMP (S3Q12) = 0 OR > 5, 
  
SKIP TO INS1 (S5Q1_A). COMPLETE INS1 (S5Q1_A), INS2 (S5Q1_B), HH_INT through S_INSIDE (S7Q10), 
SECTION 6 [OTC (S8Q1) through INHALERH (S8Q3), if applicable], SECTION 7 [START AT BRO_N (S9Q1)] 
and DEMOGRAPHICS [OTHER_T (S11Q1) through C11Q22 (S11Q11)]. 
IF CUR_AST2 (S3Q9) = 1, CONTINUE. 
IF CUR_AST2 (S3Q9) = 0, 6, 7 AND
 
[LAST_MD (S9Q10) = 1, 2 OR
 
LAST_MED (S3Q11) ≥ 1 AND ≤ 5 OR 
  
LASTSYMP (S3Q12) ≥ 1 AND ≤ 5],
 
CONTINUE. 
IF BOTH AN ADULT AND CHILD WERE SAMPLED, COMPLETE DETAILED INTERVIEWS FOR BOTH, 
BUT ASK HOUSEHOLD-LEVEL QUESTIONS ONLY FOR THE FIRST INTERVIEW COMPLETED. 
SYMP_30D (S4Q1)	 IF LASTSYMP (S3Q12) = 0 OR  ≥ 5 AND ≤ 7, SKIP TO SECTION 3. 
IF LASTSYMP (S3Q12) = 4, SKIP TO EPIS_INT. 
During the past 30 days, how many days did {you/[the (AGE) year old/NAME]} have any symptoms of asthma? 
__ __ DAYS (1–29)	 [SKIP TO ASLEEP30 (S4Q3)] 
(0) NO SYMPTOMS IN THE PAST 30 DAYS [SKIP TO EPIS_INT] 
(30) EVERY DAY 
(96) DON’T KNOW	 [SKIP TO ASLEEP30 (S4Q3)] 
(97) REFUSED	 [SKIP TO ASLEEP30 (S4Q3)] 
DUR_30D (S4Q2) {Do you/Does [the (AGE) year old/NAME]} have symptoms all the time? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HELP SCREEN: ‘‘ALL THE TIME’’ MEANS SYMPTOMS THAT CONTINUE THROUGHOUT THE DAY. IT 
DOES NOT MEAN SYMPTOMS FOR A LITTLE WHILE EACH DAY. 
ASLEEP30 (S4Q3)	 During the past 30 days, on how many days did symptoms of asthma make it difficult for {you/[the (AGE) year 
old/NAME]} to stay asleep? 
__ __ DAYS/NIGHTS 
(0) NONE 
(96) DON’T KNOW 
(97) REFUSED 
SYMPFREE (S4Q4)	 [IF SYMP_30D = 30, SKIP TO EPIS_INT.] During the past two weeks, on how many days {were you/was [the 
(AGE) year old/NAME]} completely symptom-free, that is no coughing, wheezing, or other symptoms of 
asthma? 
__ __ NUMBER OF DAYS 
(96) DON’T KNOW 
(97) REFUSED 
INTRODUCTORY STATEMENT 
READ: Asthma attacks, sometimes called episodes, refer to periods of worsening asthma symptoms that make {you 
limit your/limit [the (AGE) year old/NAME]’s} activity more than {you usually do/[he/she] usually does}, or make 
{you/him/her} seek medical care. [CONTINUE] 
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EPIS_12M (S4Q5) During the past 12 months, {have you/has [the (AGE) year old/NAME]} had an episode of asthma or an asthma 
attack? 
(0) NO [SKIP TO INS1 (S5Q1_A)] 
(1) YES 
(6) DON’T KNOW [SKIP TO INS1 (S5Q1_A)] 
(7) REFUSED [SKIP TO INS1 (S5Q1_A)] 
HELP SCREEN: (ADD TO ALL QUESTIONS THAT REFER TO ‘‘ASTHMA ATTACKS OR EPISODES’’) 
Asthma attacks, sometimes called episodes, refer to periods of worsening asthma symptoms that make {you limit 
your/limit [the (AGE) year old/NAME]’s} activity more than [you usually do/(he/she) usually does], or make 
(you/him/her) seek medical care. 
EPIS_TP (S4Q6)	 During the past 3 months, how many asthma episodes or attacks {have you/has [the (AGE) year old/NAME]} 
had? 
__ __ ATTACKS OR EPISODES DURING PAST 3 MONTHS 
(0) NONE 
(996) DON’T KNOW 
(997) REFUSED 
DUR_ASTH (S4Q7)	 How long did {your/[the (AGE) year old/NAME]’s} most recent asthma episode or attack last? 
ENTER AMOUNT 
__ __ 
(96) DON’T KNOW	 [SKIP TO COMPASTH (S4Q9)] 
(97) REFUSED	 [SKIP TO COMPASTH (S4Q9)] 
DUR2ASTH (S4Q8)	 ENTER PERIOD 
(1) MINUTES 
(2) HOURS 
(3) DAYS 
(4) WEEKS 
(6) DON’T KNOW 
(7) REFUSED 
COMPASTH (S4Q9)	 Compared with other episodes or attacks, was this most recent attack shorter, longer, or about the same? 
(1) SHORTER 
(2) LONGER 
(3) ABOUT THE SAME 
(4) THE MOST RECENT ATTACK WAS ACTUALLY THE FIRST ATTACK 
(6) DON’T KNOW 
(7) REFUSED 
Section 3. Health Care Utilization 
INS1 (S5Q1_A)	 {Do you/[Does the (AGE) year old/NAME]} have any kind of health care coverage, including health insurance, 
prepaid plans such as HMOs, or government plans such as Medicare or Medicaid? 
(0) NO	 [SKIP TO NER_TIME (S5Q1)] 
(1) YES 
(6) DON’T KNOW [SKIP TO NER_TIME (S5Q1)] 
(7) REFUSED	 [SKIP TO NER_TIME (S5Q1)] 
INS2 (S5Q1_B)	 [IF R_DOB (S2Q5) = 0, FILL: ‘‘Since birth,’’/ELSE FILL: ‘‘During the past 12 months], was there any time that 
{you/[the (AGE) year old/NAME]} did not have any health insurance or coverage? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
NER_TIME (S5Q1) [IF LAST_MD (S3Q10) = 0, 2, 3, OR 4, SKIP TO MISS_DAY (S5Q9).] [IF 
R_DOB (S2Q5) = 0, FILL: ‘‘Since birth,’’/ELSE FILL: ‘‘During the past 12 months], how many times did 
{you/[the (AGE) year old/NAME]} see a doctor or other health professional for a routine checkup for 
(your/his/her) asthma? 
__ __ __ ENTER NUMBER 
(0) NONE 
(996) DON’T KNOW 
(997) REFUSED 
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ER_VISIT (S5Q2) [IF R_DOB (S2Q5) = 0, FILL: ‘‘Since birth,’’/ELSE FILL: ‘‘During the past 12 months], {have you/has [the 
(AGE) year old/NAME]} had to visit an emergency room or urgent care center because of (your/his/her) asthma? 
(0) NO [SKIP TO URG_TIME (S5Q4)] 
(1) YES 
(6) DON’T KNOW [SKIP TO URG_TIME (S5Q4)] 
(7) REFUSED [SKIP TO URG_TIME (S5Q4)] 
HELP SCREEN: An urgent care center treats people with illnesses or injuries that must be addressed immediately 
and cannot wait for a regular medical appointment. 
ER_TIMES (S5Q3)	 [IF R_DOB (S2Q5) = 0, FILL: ‘‘Since birth,’’/ELSE FILL: ‘‘During the past 12 months’’], how many times did 
{you/[the (AGE) year old/NAME]} visit an emergency room or urgent care center because of (your/his/her) 
asthma? 
__ __ __ ENTER NUMBER 
(996) DON’T KNOW 
(997) REFUSED 
HELP SCREEN: An urgent care center treats people with illnesses or injuries that must be addressed immediately 
and cannot wait for a regular medical appointment. 
URG_TIME (S5Q4)	 [IF ER_TIMES (S5Q3) > 0, INSERT: ‘‘Besides those emergency room or urgent care 
center visits,’’] [IF R_DOB (S2Q5) = 0, FILL: ‘‘Since birth,’’/ELSE FILL: ‘‘During the past 12 months], how 
many times did {you/[the (AGE) year old/NAME]} see a doctor or other health professional for urgent 
treatment of worsening asthma symptoms or an asthma episode or attack? 
__ __ __ ENTER NUMBER 
(0) NONE 
(996) DON’T KNOW 
(997) REFUSED 
HELP SCREEN: An urgent care center treats people with illnesses or injuries that must be addressed immediately 
and cannot wait for a regular medical appointment. 
HOSP_VST (S5Q5)	 [IF LASTSYMP (S3Q12) = 0 OR > 5 AND < 7, SKIP TO MISS_DAY (S5Q9).] [IF R_DOB (S2Q5) = 0, FILL: 
‘‘Since birth,’’/ELSE FILL: ‘‘During the past 12 months, that is since (1 YEAR AGO TODAY)], {have you/has 
[the (AGE) year old/NAME]} had to stay overnight in a hospital because of (your/his/her) asthma? Do not 
include an overnight stay in the emergency room. 
(0) NO	 [SKIP TO MISS_DAY (S5Q9)] 
(1) YES 
(6) DON’T KNOW	 [SKIP TO MISS_DAY (S5Q9)] 
(7) REFUSED	 [SKIP TO MISS_DAY (S5Q9)] 
HOSPTIME (S5Q6)	 [IF R_DOB (S2Q5) = 0, FILL: ‘‘Since birth,’’/ELSE FILL: ‘‘During the past 12 months’’], how many different 
times did {you/[the (AGE) year old/NAME]} stay in any hospital overnight or longer because of (your/his/her) 
asthma? 
__ __ __ TIMES 
(996) DON’T KNOW 
(997) REFUSED 
HOSPPLAN (S5Q8)	 The last time {you/[the (AGE) year old/NAME]} left the hospital, did a health professional talk with 
{you/(AGE) year old/NAME] or [the (AGE) year old/NAME] parents or guardians} about how to better 
control (your/his/her) asthma to prevent serious episodes or attacks and hospitalizations in the future? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
[SKIP THIS QUESTION IF INTERVIEW IS FOR SAMPLED CHILD (S2Q5< 18).] 
MISS_DAY (S5Q9) During the past 12 months, how many days were you unable to work or carry out your usual activities because 
of your asthma? 
__ __ __ENTER NUMBER DAYS 
(0) ZERO 
(996) DON’T KNOW 
(997) REFUSED 
[SKIP THIS QUESTION IF INTERVIEW IS FOR SAMPLED ADULT (S2Q5 > 17).]
 
[FOR CHILDREN 0–4, INSERT ‘‘DAYCARE OR PRESCHOOL’’ IN FILL.
 
FOR CHILDREN 5–13, INSERT ‘‘SCHOOL’’ IN FILL.
 
FOR CHILDREN 14–17, INSERT ‘‘SCHOOL OR WORK’’ IN FILL.]
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MISS_SCH (S5Q11)	 [IF R_DOB (S2Q5) = 0, FILL: ‘‘Since birth,’’/ELSE FILL: ‘‘During the past 12 months, that is since (1 YEAR 
AGO TODAY)’’] about how many days of [daycare or preschool/school/ school or work] did [the (AGE) year 
old/NAME] miss because of (his/her) asthma? 
__ __ __ ENTER NUMBER 
(0) ZERO 
(994) CHILD DID NOT GO TO SCHOOL IN PAST 12 MONTHS 
(995) HOME SCHOOLED 
(996) DON’T KNOW 
(997) REFUSED 
ACT_DAYS (S5Q12)	 [IF R_DOB (S2Q5) = 0, FILL: ‘‘Since birth,’’/ELSE FILL: ‘‘During the past 12 months,’’ would you say 
{you/[the (AGE) year old/NAME]} limited (your/his/her) usual activities due to asthma not at all, a little, a 
moderate amount, or a lot? 
(1) NOT AT ALL 
(2) A LITTLE 
(3) A MODERATE AMOUNT 
(4) A LOT 
(6) DON’T KNOW 
(7) REFUSED 
Section 4. Knowledge of Asthma/Management Plan 
TCH_SIGN (S6Q1)	 Has a doctor or other health professional ever taught {you/the (AGE) year old/NAME] or [the (AGE) year 
old/NAME]’s parent or guardian} . . . 
a. How to recognize early signs or symptoms of an asthma episode? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
TCH_RESP (S6Q2) Has a doctor or other health professional ever taught {you/the (AGE) year old/NAME] or [the (AGE) year 
old/NAME]’s parent or guardian} . . . 
b. What to do during an asthma episode or attack? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
[SKIP IF SAMPLED CHILD (R_DOB/S2Q5) < 5 YEARS OLD.] 
TCH_MON (S6Q3) Has a doctor or other health professional ever taught {you/the (AGE) year old/NAME] or [the (AGE) year 
old/NAME]’s parent or guardian} . . . 
c. How to use a peak flow meter, a device that measures how much air you can blow out of your lungs, to adjust 
daily medications? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
MGT_PLAN (S6Q4)	 An asthma management plan is a printed form that tells when to change the amount or type of medicine, when 
to call the doctor for advice, and when to go to the emergency room. Has a doctor or other health professional 
EVER given {you/the (AGE) year old/NAME] or [the (AGE) year old/NAME]’s parent or guardian} an 
asthma management plan? 
[READ IF NECESSARY: Include nurses and asthma educators] 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
MGT_CLAS (S6Q5)	 Have {you/the (AGE) year old/NAME] or [the (AGE)year old/NAME]’s parent or guardian} ever taken a 
course or class on how to manage (your/his/her) asthma? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
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Section 5. Modifications to Environment 
IF CUR_AST2 = 0, 6, 7 AND
 
LAST_MD (S3Q10) = 0 > 2  AND 
  
LAST_MED (S3Q11) = 0 OR > 5  AND 
  
LASTSYMP (S3Q12) = 0 OR > 5, 
  
ASK HH_INT THROUGH S_INSIDE (S7Q10), CIGARETS (S7Q18) THROUGH UNEMP_R (S7Q22). THEN,
 
SKIP TO SECTION 6 [OTC (S8Q1) THROUGH INHALERH (S8Q3), IF APPLICABLE.
 
QUESTIONS HH_INT THROUGH S_INSIDE (S7Q10) ARE HOUSEHOLD-LEVEL
 
QUESTIONS AND SHOULD BE ASKED ONLY ONCE IN A HOUSEHOLD.
 
QUESTIONS MOD_ENV (S7Q11) THROUGH UNEMP_R (S7Q22) ARE INDIVIDUAL-LEVEL
 
QUESTIONS AND SHOULD BE ASKED OF (OR ABOUT) EACH PERSON WITH ASTHMA.
 
INTRODUCTORY STATEMENT 
READ: The following questions are about {your/[the (AGE) year old/NAME]’s} household and living environment. 
I will be asking about various things that may be related to experiencing asthma symptoms. [CONTINUE] 
AIRCLEANER (S7Q1) Is an air cleaner or purifier regularly used inside your home? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DEHUMID (S7Q2)	 Is a dehumidifier regularly used to reduce moisture inside your home? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
KITC_FAN (S7Q3)	 Is an exhaust fan that vents to the outside used regularly when cooking in your kitchen? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
COOK_GAS (S7Q4) Is gas used for cooking? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
ENV_MOLD (S7Q5)	 In the past 30 days, has anyone seen or smelled mold or a musty odor inside your home? Do not include mold 
on food. 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
ENV_PETS (S7Q6)	 Does your household have indoor pets such as dogs, cats, hamsters, birds, or other feathered or furry pets that 
are kept inside? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
C_ROACH (S7Q7) In the past 30 days, has anyone seen cockroaches inside your home? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HELP SCREEN: Studies have shown that cockroaches are a leading cause of asthma in children that live in urban 
areas. Cockroach droppings and carcasses can cause children to experience symptoms of asthma. 
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WOOD_STOVE (S7Q8) Is a fireplace or wood burning stove used in your home? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HELP SCREEN: OCCASIONAL USE SHOULD BE CODED AS ‘‘YES.’’ 
GAS_STOVE (S7Q9)	 Are unvented gas logs, an unvented gas fireplace, or an unvented gas stove used in your home? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HELP SCREEN: ‘‘Unvented’’ means no chimney. 
S_INSIDE (S7Q10) In the past week, has anyone smoked inside your home? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HELP SCREEN: ‘‘Smoked’’ means ‘‘anything.’’ 
MOD_ENV (S7Q11) FOR ADULT INTERVIEW, READ: [FILL ONLY IF QUESTIONS HH_INT THROUGH S_INSIDE WERE 
ASKED OF THIS RESPONDENT]: Now, back to questions specifically about you. Has a health professional 
ever advised you to change things in your home, school, or work to improve your asthma? 
FOR CHILD INTERVIEW, READ: [FILL ONLY IF QUESTIONS HH_INT THROUGH S_INSIDE WERE 
ASKED OF THIS RESPONDENT]: Now, back to questions specifically about [the (AGE) year old/NAME]. 
Has a health professional ever advised you to change things in [the (AGE) year old/NAME]’s home, school, or 
work to improve [the (AGE) year old/NAME]’s asthma? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
MATTRESS (S7Q12)	 {Do you/Does [the (AGE) year old/NAME]} use a mattress cover that is made especially for controlling dust 
mites? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
E_PILLOW (S7Q13) {Do you/Does [the (AGE) year old/NAME]} use a pillow cover that is made especially for controlling dust 
mites? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
CARPET (S7Q14) Do you have carpeting or rugs in {your/[the (AGE) year old/NAME]’s} bedroom? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HOTWATER (S7Q15) Are {your/[the (AGE) year old/NAME]’s} sheets and pillowcases washed in cold, warm, or hot water? 
(1) COLD 
(2) WARM 
(3) HOT 
(6) DON’T KNOW 
(7) REFUSED 
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BATH_FAN (S7Q16)	 In {your/[the (AGE) year old/NAME]’s} bathroom, {Do you/does [the (AGE) year old/NAME]} regularly 
use an exhaust fan that vents to the outside? 
(0)  NO OR ‘‘NO FAN’’  
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HELP SCREEN: IF RESPONDENT INDICATES THEY HAVE MORE THAN ONE BATHROOM, THIS 
QUESTION REFERS TO THE BATHROOM THEY USE MOST FREQUENTLY FOR SHOWERING AND 
BATHING. 
[SKIP THIS QUESTION IF ENV_PETS = 0, 6, 7. 
PETBEDRM (S7Q17) Is the pet allowed in {your/[the (AGE) year old/NAME]’s} bedroom? 
(0) NO 
(1) YES 
(2) SOME ARE/SOME AREN’T 
(6) DON’T KNOW 
(7) REFUSED 
SKIP TO SECTION 6 IF INTERVIEW IS FOR SAMPLED CHILD (R_DOB/S2Q5 < 18). 
CIGARETS (S7Q18)	 Have you smoked at least 100 cigarettes in your entire life? 
(0) NO	 [SKIP TO EMP_STAT (S7Q20)] 
(1) YES 
(6) DON’T KNOW [SKIP TO EMP_STAT (S7Q20)] 
(7) REFUSED	 [SKIP TO EMP_STAT (S7Q20)] 
CIG_FREQ (S7Q19)	 Do you now smoke cigarettes every day, some days or not at all? 
(1) EVERY DAY 
(2) SOME DAYS 
(3) NOT AT ALL 
(6) DON’T KNOW 
(7) REFUSED 
EMP_STAT (S7Q20)	 We are interested in things that affect asthma in the workplace. However, first I’d like to ask how you would 
describe your current employment status. Would you say . . . 
(1) EMPLOYED FULL-TIME 
(2) EMPLOYED PART-TIME 
(3) NOT EMPLOYED 
(6) DON’T KNOW 
(7) REFUSED 
WORKENV2 (S7Q21) Was your asthma caused or made worse by chemicals, smoke, fumes, or dust in any job you ever had? 
(0) NO 
(1) YES 
(2) NEVER BEEN EMPLOYED 
(6) DON’T KNOW 
(7) REFUSED 
UNEMP_R (S7Q22)	 [IF EMP_STAT (S7Q20) = 1 OR 2, SKIP  TO OTC  (S8Q1).] What is the main reason you are not employed? 
(1) KEEPING HOUSE 
(2) GOING TO SCHOOL 
(3) RETIRED 
(4) DISABLED 
(5) UNABLE TO WORK FOR OTHER HEALTH REASONS 
(6) LOOKING FOR WORK 
(7) LAID OFF 
(8) OTHER 
(96) DON’T KNOW 
(97) REFUSED 
Section 6. Medications 
IF LAST_MED (S3Q11) = 0, SKIP TO SECTION 7. 
IF CUR_AST2 (S3Q9) = 0, 6, 7, AND
 
LAST_MD (S3Q10) = 0 OR > 2  AND 
  
LASTSYMP (S3Q12) = 0 OR > 5  AND 
  
LAST_MED (S3Q11) = 6 OR 7, 
  
Series 1, No. 46 [ Page 91 
ASK OTC (S8Q1), INHALERE (S8Q2), INHALERH (S8Q3), THEN SKIP TO SECTION 7. 
OTC (S8Q1) Over-the-counter medication can be bought without a doctor’s order. {Have you/Has [the (AGE) year old/NAME]} 
ever used over-the-counter medication for (your/his/her) asthma? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
INHALERE (S8Q2)	 {Have you/Has [the (AGE) year old/NAME]} ever used a prescription inhaler? 
(0) NO	 [SKIP TO SCR_MED1 (S8Q4)] 
(1) YES 
(6) DON’T KNOW [SKIP TO SCR_MED1 (S8Q4)] 
(7) REFUSED	 [SKIP TO SCR_MED1 (S8Q4)] 
INHALERH (S8Q3)	 Did a health professional show {you/the (AGE) year old/NAME] or [the (AGE) year old/NAME’s] parents or 
guardians} how to use the inhaler? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
SCR_MED1 (S8Q4)	 [IF LAST_MED (S3Q11) = 4, 5, 6, 7, 96, or 97, SKIP TO SECTION 7.] Now I am going to ask questions 
about specific prescription medications {you/[the (AGE) year old/NAME]} may have taken for asthma in the 
past 3 months. I will be asking for the names, amount, and how often {you take/[the (AGE) year old/NAME] 
takes} each medicine. I will ask separately about medication taken in various forms: pill or syrup, inhaler, and 
Nebulizer. 
It may help to get {your/[the (AGE) year old/NAME]’s} medicines so you can read the labels. Are {your/[the 
(AGE) year old/NAME]’s} asthma medicines handy? 
(0) NO	 [SKIP TO INH_SCR (S8Q7)] 
(1) YES 
(2) RESPONDENT KNOWS THE MEDS [SKIP TO INH_SCR (S8Q7)] 
(6) DON’T KNOW 
(7) REFUSED	 [SKIP TO INH_SCR (S8Q7)] 
SCR_MED2 (S8Q5)	 Can you please go get the asthma medicines while I wait on the phone? 
(0) NO	 [SKIP TO INH_SCR (S8Q7)] 
(1) YES 
(8) DON’T KNOW 
(9) REFUSED [SKIP TO INH_SCR (S8Q7)] 
SCR_MED3 (S8Q6)	 Am I correct that you have all the medications? 
(0) NO 
(1) YES, I HAVE ALL THE MEDICATIONS 
(2) YES, I HAVE SOME OF THE MEDICATIONS BUT NOT ALL 
(6) DON’T KNOW 
(7) REFUSED 
INH_SCR (S8Q7)	 In the past 3 months, {have you/has [the (AGE) year old/NAME]} taken prescription asthma medicine using an 
inhaler? 
(0) NO	 [SKIP TO PILLS (S8Q27)] 
(1) YES 
(6) DON’T KNOW [SKIP TO PILLS (S8Q27)] 
(7) REFUSED [SKIP TO PILLS (S8Q27)] 
INH_MEDS (S8Q8_01 to S8Q8_34) 
In the past 3 months, what medications did {you/[the (AGE) year old/NAME]} take by inhaler? [MARK ALL 
THAT APPLY. PROBE: Any other medications?] 
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INH_MEDS (S8Q8_01 to S8Q8_34) 
In the past 3 months, what medications did {you/[the (AGE) year old/NAME]} take by inhaler? [MARK ALL 
THAT APPLY. PROBE: Any other medications?] 
Variable Name Brand Name Type (not shown in CATI) 
INH_MEDX01 (S8Q8_01) Advair 
INH_MEDX02 (S8Q8_02) Aerobid Corticosteroids 
INH_MEDX03 (S8Q8_03) Albuterol Beta 2 agonist 
INH_MEDX04 (S8Q8_04) Alupent Beta 2 agonist 
INH_MEDX05 (S8Q8_05) Atrovent Anti-inflammatories 
INH_MEDX06 (S8Q8_06) Azmacort Corticosteroids 
INH_MEDX07 (S8Q8_07) Beclomethasone dipropionate Corticosteroids 
INH_MEDX08 (S8Q8_08) Beclovent Corticosteroids 
INH_MEDX09 (S8Q8_09) Bitolterol Beta 2 agonist 
INH_MEDX10 (S8Q8_10) Brethaire Beta 2 agonist 
INH_MEDX11 (S8Q8_11) Budesonide Corticosteroids 
INH_MEDX12 (S8Q8_12) Combivent 
INH_MEDX13 (S8Q8_13) Cromolyn Anti-inflammatories 
INH_MEDX14 (S8Q8_14) Flovent Inhaled corticosteroid 
INH_MEDX15 (S8Q8_15) Flovent Rotadisk Inhaled corticosteroid 
INH_MEDX16 (S8Q8_16) Flunisolide Corticosteroids 
INH_MEDX17 (S8Q8_17) Fluticasone Inhaled corticosteroid 
INH_MEDX18 (S8Q8_18) Intal Anti-inflammatories 
INH_MEDX19 (S8Q8_19) Ipratropium Bromide Anti-inflammatories 
INH_MEDX20 (S8Q8_20) Maxair Beta 2 agonist 
INH_MEDX21 (S8Q8_21) Metaproteronol Beta 2 agonist 
INH_MEDX22 (S8Q8_22) Nedocromil Anti-inflammatories 
INH_MEDX23 (S8Q8_23) Pirbuterol Beta 2 agonist 
INH_MEDX24 (S8Q8_24) Proventil Beta 2 agonist 
INH_MEDX25 (S8Q8_25) Pulmicort Turbuhaler Corticosteroids 
INH_MEDX26 (S8Q8_26) Salmeterol Corticosteroids (long lasting) 
INH_MEDX27 (S8Q8_27) Serevent Beta 2 agonist (long lasting) 
INH_MEDX28 (S8Q8_28) Terbutaline Beta 2 agonist 
INH_MEDX29 (S8Q8_29) Tilade Anti-inflammatories 
INH_MEDX30 (S8Q8_30) Tornalate Beta 2 agonist 
INH_MEDX31 (S8Q8_31) Triamcinolone acetonide Corticosteroids 
INH_MEDX32 (S8Q8_32) Vanceril Corticosteroids 
INH_MEDX33 (S8Q8_33) Ventolin Beta 2 agonist 
INH_MEDX34 (S8Q8_34) Other, please specify [SKIP TO OTH_I1 (S8Q8_34A)] 
IF ANY ANSWER SELECTED FROM INH_MEDX01 (S8Q8_01)–INH_MEDX33 (S8Q8_33), SKIP TO ILP01 
(S8Q16_nn). 
(0) NO 
(1) YES 
(6) DON’T KNOW	 [SKIP TO REC_MED1] 
(7) REFUSED	 [SKIP TO PILLS (S8Q27)] 
OTH_I1 (S8Q8_34A) ENTER OTHER MEDICATION. 
IF MORE THAN ONE MEDICATION IS GIVEN, ENTER ALL MEDICATIONS ON ONE LINE. 
_____________________ ENTER TEXT 
INTRODUCTORY STATEMENT 
READ: I’m going to read a list of medicines to see if you recognize the name of any of the medications {you 
have/[CHILD’S NAME] has} taken. Please let me know if you hear the name. [CONTINUE] 
DK1INHLR (S8Q9)	 In the past 3 months, did {you/[the (AGE) year old/NAME]} take Flovent or Flovent Rotadisk using an 
inhaler? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
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DK2INHLR (S8Q10)	 In the past 3 months, did {you/[the (AGE) year old/NAME]} take: 
Beclovent, Vanceril, Beclomethasone dipropionate,
 
Pulmicort Turbuhaler, Budesonide,
 
Aerobid, Flunisolide,
 
Azmacort, or Triamcinolone acetonide?
 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK3INHLR (S8Q11)	 In the past 3 months, did {you/[the (AGE) year old/NAME]} take: 
Ventolin, Proventil, Albuterol, 
Alupent, Metaproteronol, 
Tornalate, Bitolterol, 
Maxair, Pirbuterol, 
Brethaire, Terbutaline, or 
Serevent? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK4INHLR (S8Q12)	 In the past 3 months, did {you/[the (AGE) year old/NAME]} take: 
Intal, Cromolyn, 
Tilade, or Nedocromil? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK5INHLR (S8Q13) In the past 3 months, did {you/[the (AGE) year old/NAME]} take: 
Atrovent or Ipratropium Bromide? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK6INHLR (S8Q14)	 Did {you/[the (AGE) year old/NAME]} take a medication by inhaler that we have not mentioned? 
(0) NO 
(1) YES [SKIP TO DK7INHLR (S8Q15)] 
(6) DON’T KNOW 
(7) REFUSED 
IF DK6INHLR (S8Q14) = 1, CONTINUE. ALL OTHERS, SKIP TO ILP01 (S8Q16_nn). 
DK7INHLR (S8Q15)	 Will you please tell me what that medication was? 
SPELL OUT: _____________________________________ 
REPEAT ILP01 (S8Q16_nn)–ILP11 (S8Q26_nn) FOR EACH MEDICINE REPORTED IN INH_MEDS 
(S8Q8_nn), OR IF AN ANSWER OF (1) ‘‘YES’’ IS GIVEN FOR ANY ITEM IN DK1INHLR (S8Q9) THROUGH 
DK7INHLR (S8Q15). IF AN ANSWER OF (1) ‘‘YES’’ IS PROVIDED DURING QUESTIONS DK1INHLR 
(S8Q9) THROUGH DK6INHLR (S8Q15), USE THE PHRASE ‘‘THIS MEDICATION’’ FOR FILL ‘‘[MEDICINE 
FROM INH_MEDS (S8Q8_nn) SERIES]’’ FOR QUESTIONS ILP01 (S8Q16_nn) THROUGH ILP11 (S8Q26_nn). 
ILP01 (S8Q16_01 to S8Q16_34) 
How long {have you/has [the (AGE) year old/NAME]} been taking [MEDICINE FROM INH_MEDS (S8Q8_nn) 
SERIES]? Would you say less than 6 months, 6 months to 1 year, or longer than 1 year? 
(1) LESS THAN 6 MONTHS 
(2) 6 MONTHS TO 1 YEAR 
(3) LONGER THAN 1 YEAR 
(6) DON’T KNOW 
(7) REFUSED 
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ILP02 (S8Q17_01 to S8Q17_34) 
A spacer is a small attachment for an inhaler that makes it easier to use. {Do you/Does [the (AGE) year 
old/NAME]} use a spacer with [MEDICINE FROM INH_MEDS (S8Q8_nn) SERIES]? 
0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HELP SCREEN: A spacer is a device that attaches to a metered dose inhaler. It holds the medicine in its 
chamber long enough for you to inhale it in one or two slow, deep breaths. The spacer makes it easy to take the 
medicines the right way, especially for young children. 
ASK IF INH_MEDS (S8Q8_nn) = 03, 04, 09, 10, 20, 21, 23, 24, 28, 30, 33, OR DK3INHLR (S8Q11) = 1; 
ELSE, SKIP TO ILP06 (S8Q21_nn). 
ILP03 (S8Q18_03, _04, _09, _10, _20, _21, _23, _24, _28, _30, _33, _34) 
In the past 3 months, did {you/[the (AGE) year old/NAME]} take [MEDICINE FROM INH_MEDS (S8Q8_nn) 
SERIES] when {you/he/she had} an asthma episode or attack? 
(0) NO 
(1) YES 
(2) NO ATTACK IN PAST 3 MONTHS 
(6) DON’T KNOW 
(7) REFUSED 
ILP04 (S8Q19_03, _04, _09, _10, _20, _21, _23, _24, _28, _30, _33, _34) 
[IF THE AGE OF THE CHILD IS LESS THAN 6 YEARS (S2Q5 < 6), SKIP TO ILP05 (S8Q20_nn).] In the past 
3 months, did {you/[the (AGE) year old/NAME]} take [MEDICINE FROM INH_MEDS (S8Q8_nn) SERIES] 
before exercising? 
(0) NO 
(1) YES 
(2) DIDN’T EXERCISE IN PAST 3 MONTHS 
(6) DON’T KNOW 
(7) REFUSED 
ILP05 (S8Q20_03, _04, _09, _10, _20, _21, _23, _24, _28, _30, _33, _34) 
In the past 3 months, did {you/[the (AGE) year old/NAME]} take [MEDICINE FROM INH_MEDS (S8Q8_nn) 
SERIES] on a regular schedule everyday? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
ASK IF INH_MEDS (S8Q8_nn) = 14, 15, 17, OR DK1_INHLR (S8Q9) = 1;
 
ELSE SKIP TO ILP07 (S8Q22_nn).
 
ILP06 (S8Q21_14, _15, _17, _34) 
Is the dosage 44, 50, 100, 110, 220, or 250 micrograms for the Flovent? 
(1) 44 MICROGRAMS 
(2) 50 MICROGRAMS 
(3) 100 MICROGRAMS 
(4) 110 MICROGRAMS 
(5) 220 MICROGRAMS 
(6) 250 MICROGRAMS 
(7) TOOK MORE THAN 1 IN PAST 3 MONTHS 
(96) DON’T KNOW 
(97) REFUSED 
ILP07 (S8Q22_01 to S8Q22_34) 
On average, how many puffs {Do you/does [the (AGE) year old/NAME]} take each time {you use/he uses/she uses} 
[MEDICINE FROM INH_MEDS (S8Q8_nn) SERIES]? 
__ __ PUFFS EACH TIME 
(96) DON’T KNOW 
(97) REFUSED 
INTERVIEWER: PROBE FOR NUMBER OF PUFFS IF RANGE IS GIVEN. 
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ILP09 (S8Q24_01 to S8Q24_34) 
How many times per day or per week {Do you/does [the (AGE) year old/NAME]} use [MEDICINE FROM 
INH_MEDS (S8Q8_nn) SERIES]? 
__ __ __ TIMES 
(994) LESS OFTEN THAN ONCE A WEEK [SKIP TO ILP11 (S8Q26_nn)] 
(996) DON’T KNOW [SKIP TO ILP11 (S8Q26_nn)] 
(997) REFUSED [SKIP TO ILP11 (S8Q26_nn)] 
ILP10 (S8Q25_01 to S8Q25_34) 
ENTER PERIOD 
(1) PER DAY 
(2) PER WEEK 
(6) DON’T KNOW 
(7) REFUSED 
ILP11 (S8Q26_01 to S8Q26_34) 
How many full canisters of this inhaler {have you /has [the (AGE) year old/NAME]} used in the past 3 months? 
[INTERVIEWER: IF RESPONDENT USED LESS THAN ONE CANISTER IN THE PAST 3 MONTHS, 
CODE IT AS ‘00’] 
___ CANISTERS 
(96) DON’T KNOW 
(97) REFUSED 
HELP SCREEN: IF RESPONDENT INDICATES HE/SHE HAS MULTIPLE CANISTERS, (I.E., ONE IN THE 
CAR, ONE IN PURSE, ETC.) ASK THE RESPONDENT TO ESTIMATE HOW MANY CANISTERS HE/SHE 
USED. 
PILLS (S8Q27) In the past 3 months, {have you/has [the (AGE) year old/NAME]} taken any medicine in pill form for your/his/her 
asthma? 
(0) NO [SKIP TO SYRUP (S8Q38)] 
(1) YES 
(6) DON’T KNOW [SKIP TO SYRUP (S8Q38)] 
(7) REFUSED [SKIP TO SYRUP (S8Q38)] 
PILLS_MD (S8Q28_01 to S8Q28_48) 
What medications {Do you/does [the (AGE) year old/NAME]} take in pill form? 
[MARK ALL THAT APPLY. PROBE: Any other medications?] 
Variable names Medication Type (not shown in CATI) 
PILLS_MX01 (S8Q28_01) Accolate Leukotriene modifiers 
PILLS_MX02 (S8Q28_02) Aerolate Methylxanthines 
PILLS_MX03 (S8Q28_03) Albuterol Beta 2 agonist – Rescue bronchodilators 
PILLS_MX04 (S8Q28_04) Alupent Beta 2 agonist – Rescue bronchodilators 
PILLS_MX05 (S8Q28_05) Choledyl Methylxanthines 
PILLS_MX06 (S8Q28_06) Cromolyn Anti-inflammatories 
PILLS_MX07 (S8Q28_07) Deltasone Corticosteriods 
PILLS_MX08 (S8Q28_08) Elixophyllin Methylxanthines 
PILLS_MX09 (S8Q28_09) Intal Anti-inflammatories 
PILLS_MX10 (S8Q28_10) Marax Methylxanthines 
PILLS_MX11 (S8Q28_11) Medrol Corticosteriods 
PILLS_MX12 (S8Q28_12) Metaprel Beta 2 agonist – Rescue bronchodilators 
PILLS_MX13 (S8Q28_13) Metaproteronol Beta 2 agonist – Rescue bronchodilators 
PILLS_MX14 (S8Q28_14) Methylpredinisolone Corticosteriods 
PILLS_MX15 (S8Q28_15) Montelukast Leukotriene modifiers 
PILLS_MX16 (S8Q28_16) Nedocromil Corticosteriods 
PILLS_MX17 (S8Q28_17) Pediapred Corticosteriods 
PILLS_MX18 (S8Q28_18) Prednisolone Corticosteriods 
PILLS_MX19 (S8Q28_19) Prednisone Corticosteriods 
PILLS_MX20 (S8Q28_20) Prelone Corticosteriods 
PILLS_MX21 (S8Q28_21) Proventil Beta 2 agonist – Rescue bronchodilators 
PILLS_MX22 (S8Q28_22) Quibron Methylxanthines 
PILLS_MX23 (S8Q28_23) Respid Methylxanthines 
PILLS_MX24 (S8Q28_24) Singulair Leukotriene modifiers 
PILLS_MX25 (S8Q28_25) Slo-phyllin Methylxanthines 
PILLS_MX26 (S8Q28_26) Slo-bid Methylxanthines 
PILLS_MX27 (S8Q28_27) Sustaire Methylxanthines 
PILLS_MX28 (S8Q28_28) Theo-24 Methylxanthines 
PILLS_MX29 (S8Q28_29) Theobid Methylxanthines 
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PILLS_MX30 (S8Q28_30) Theochron Methylxanthines 
PILLS_MX31 (S8Q28_31) Theoclear Methylxanthines 
PILLS_MX32 (S8Q28_32) Theodur Methylxanthines 
PILLS_MX33 (S8Q28_33) Theo-Dur Methylxanthines 
PILLS_MX34 (S8Q28_34) Theolair Methylxanthines 
PILLS_MX35 (S8Q28_35) Theophylline Methylxanthines 
PILLS_MX36 (S8Q28_36) Theo-Sav Methylxanthines 
PILLS_MX37 (S8Q28_37) Theospan Methylxanthines 
PILLS_MX38 (S8Q28_38) Theox Methylxanthines 
PILLS_MX39 (S8Q28_39) Tilade Corticosteriods 
PILLS_MX40 (S8Q28_40) T-Phyl Methylxanthines 
PILLS_MX41 (S8Q28_41) Unidur Methylxanthines 
PILLS_MX42 (S8Q28_42) Uniphyl Methylxanthines 
PILLS_MX43 (S8Q28_43) Ventolin Beta 2 agonist – Rescue bronchodilators 
PILLS_MX44 (S8Q28_44) Volmax Beta 2 agonist – Rescue bronchodilators 
PILLS_MX45 (S8Q28_45) Zafirlukast Leukotriene modifiers 
PILLS_MX46 (S8Q28_46) Zileuton Leukotriene modifiers 
PILLS_MX47 (S8Q28_47) Zyflo Filmtab Leukotriene modifiers 
PILLS_MX47 (S8Q28_48) Other, please specify: [SKIP TO OTH_P1 (S8Q29)] 
IF ANY ANSER SELECTED FROM PILLS_MX01 (S8Q28_01)–PILLS_MX47 (S8Q28_47), SKIP TO PILLX 
(S8Q37_nn). 
(0) NO 
(1) YES 
(6) DON’T KNOW	 [SKIP TO REC_MED2] 
(7) REFUSED	 [SKIP TO SYRUP (S8Q38)] 
OTH_P1 (S8Q29)	 ENTER OTHER MEDICATION. 
IF MORE THAN ONE MEDICATION IS GIVEN, ENTER ALL MEDICATIONS ON ONE LINE. 
________________________ ENTER TEXT 
REC_MED2	 READ: I’m going to read a list of medicines to see if you recognize the name of the medications {you have/[CHILD’S 
NAME] has} taken within the past 3 months. If you recognize any that were taken, please let me know. 
[CONTINUE] 
DK1_PILL (S8Q30)	 Did {you/[the (AGE) year old/NAME]} take: 
Accolate or Zafirlukast 
Zyflo Filmtab or Zileuton 
Singulair or Montelukast? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK2_PILL (S8Q31)	 Did {you/[the (AGE) year old/NAME]} take: 
Intal or Cromolyn 
Tilade or Nedocromil? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK3_PILL (S8Q32)	 Did {you/[the (AGE) year old/NAME]} take: 
Medrol, Methylpredinisolone, 
Deltasone, Prednisone, 
Pediapred, 
Prelone, or Prednisolone? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
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DK4_PILL (S8Q33)	 Did {you/[the (AGE) year old/NAME]} take: 
Proventil, Ventolin, Volmax, or Albuterol 
Alupent, Metaprel, or Metaproteronol? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK5_PILL (S8Q34)	 Did {you/[the (AGE) year old/NAME]} take: 
Theophylline, Elixophyllin, Theo-Dur, choledyl, Theo-Sav, Theospan, Theoclear, T-Phyl, Theodur, Unidur, 
Uniphyl, Aerolate, Theox, Marax, Theobid, Quibron, Theo-24, Sustaire, Slo-phyllin, Slo-bid, Respid, 
Theochron, or Theolair? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK6_PILL (S8Q35)	 Did {you/[the (AGE) year old/NAME]} take a medication in pill form that we have not mentioned? 
(0) NO	 [SKIP TO PILLX (S8Q37_nn)] 
(1) YES	 [SKIP TO DK7_PILL (S8Q36)] 
(6) DON’T KNOW	 [SKIP TO PILLX (S8Q37_nn)] 
(7) REFUSED	 [SKIP TO PILLX (S8Q37_nn)] 
DK7_PILL (S8Q36)	 Will you please tell me what that medication was? 
SPELL OUT: _____________________________________ 
REPEAT PILLX (S8Q37_nn) FOR EACH PILL REPORTED IN PILLS_MD (S8Q28_nn), OR IF AN ANSWER 
OF (1) ‘‘YES’’ IS GIVEN FOR QUESTIONS DK1_PILL (S8Q30) THROUGH DK6_PILL (S8Q35). IF AN 
ANSWER OF (1) ‘‘YES’’ IS PROVIDED DURING QUESTIONS DK1_PILL (S8Q30) THROUGH DK6_PILL 
(S8Q35), USE THE PHRASE ‘‘THIS MEDICATION’’ FOR FILL ‘‘[MEDICATION LISTED IN PILLS_MD 
(S8Q28_nn)]’’ FOR QUESTION PILLX (S8Q37_nn). 
PILLX (S8Q37_01 TO S8Q37_48) 
How long {have you/has [the (AGE) year old/NAME]} been taking [MEDICATION LISTED IN PILLS_MD 
(S8Q28_nn)]? 
(1) LESS THAN 6 MONTHS 
(2) 6 MONTHS TO 1 YEAR 
(3) LONGER THAN 1 YEAR 
(6) DON’T KNOW 
(7) REFUSED 
SYRUP (S8Q38) In the past 3 months, {have you/has [the (AGE) year old/NAME]} taken prescription medicine in syrup form? 
(0) NO	 [SKIP TO NEB_SCR (S8Q47)] 
(1) YES 
(6) DON’T KNOW	 [SKIP TO NEB_SCR (S8Q47)] 
(7) REFUSED	 [SKIP TO NEB_SCR (S8Q47)] 
SYRUP_ID (S8Q39_01 to S8Q39_11) 
What prescriptions medications {have you/has [the (AGE) year old/NAME]} taken as a syrup? 
[MARK ALL THAT APPLY. PROBE: Any other medications?] 
Variable names Medication 
SYRUP_IX01 (S8Q39_01) Aerolate 
SYRUP_IX02 (S8Q39_02) Albuterol 
SYRUP_IX03 (S8Q39_03) Alupent 
SYRUP_IX04 (S8Q39_04) Metaproteronol 
SYRUP_IX05 (S8Q39_05) Prednisolone 
SYRUP_IX06 (S8Q39_06) Prelone 
SYRUP_IX07 (S8Q39_07) Proventil 
SYRUP_IX08 (S8Q39_08) Slo-Phyllin 
SYRUP_IX09 (S8Q39_09) Theophylline 
SYRUP_IX10 (S8Q39_10) Ventolin 
SYRUP_IX11 (S8Q39_11) Other, please specify: [SKIP TO OTH_S1 (S8Q40)] 
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IF ANY ANSWER SELECTED FROM SYRUP_IX01 (S8Q39_01)–SYRUP_IX10 (S8Q39_10), SKIP TO 
NEB_SCR (S8Q47). 
(0) NO 
(1) YES 
(6) DON’T KNOW	 [SKIP TO REC_MED3] 
(7) REFUSED	 [SKIP TO NEB_SCR (S8Q47)] 
OTH_S1 (S8Q40)	 ENTER OTHER MEDICATION. 
IF MORE THAN ONE MEDICATION IS GIVEN, ENTER ALL MEDICATIONS ON ONE LINE. 
________________________ ENTER TEXT 
REC_MED3	 READ: I’m going to read a list of medicines to see if you recognize the name of the medications {you have/[CHILD’S 
NAME] has} taken within the past 3 months. [CONTINUE] 
DK1_SYRP (S8Q41)	 Which of these prescriptions medications {have you/has [the (AGE) year old/NAME]} taken as a syrup? 
Alupent or Metaproteronol? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK2_SYRP (S8Q42)	 Which of these prescriptions medications {have you/has [the (AGE) year old/NAME]} taken as a syrup? 
Ventolin or Proventil or Albuterol? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK3_SYRP (S8Q43)	 Which of these prescriptions medications {have you/has [the (AGE) year old/NAME]} taken as a syrup? 
Aerolate, Slo-Phyllin, or Theophylline? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK4_SYRP (S8Q44) Which of these prescriptions medications {have you/has [the (AGE) year old/NAME]} taken as a syrup? 
Prelone or Prednisolone? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK5_SYRP (S8Q45)	 Did {you/[the (AGE) year old/NAME]} take a medication in syrup form that we have not mentioned? 
(0) NO	 [SKIP TO NEB_SCR (S8Q47)] 
(1) YES 
(6) DON’T KNOW	 [SKIP TO NEB_SCR (S8Q47)] 
(7) REFUSED	 [SKIP TO NEB_SCR (S8Q47)] 
DK6_SYRP (S8Q46)	 Will you please tell me what that medication was? 
SPELL OUT: _____________________________________ 
NEB_SCR (S8Q47)	 A nebulizer is a small machine with a tube and facemask or mouthpiece that you breathe through continuously. 
In the past 3 months, were any of {your/[the (AGE) year old/NAME]’s} asthma medicines used with a 
nebulizer? 
(0) NO	 [SKIP TO SECTION 7] 
(1) YES 
(6) DON’T KNOW	 [SKIP TO SECTION 7] 
(7) REFUSED	 [SKIP TO SECTION 7] 
NEB_ID (S8Q48_01 to S8Q48_08) 
In the past 3 months, what prescriptions medications {have you/has [the (AGE) year old/NAME]} taken using a 
nebulizer? 
[MARK ALL THAT APPLY. PROBE: Any other medications?] 
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Variable names Medication 
NEB_IDX01 (S8Q48_01) Albuterol 
NEB_IDX02 (S8Q48_02) Alupent 
NEB_IDX03 (S8Q48_03) Cromolyn 
NEB_IDX04 (S8Q48_04) Intal 
NEB_IDX05 (S8Q48_05) Metaproteronol 
NEB_IDX06 (S8Q48_06) Proventil 
NEB_IDX07 (S8Q48_07) Ventolin 
NEB_IDX08 (S8Q48_08) Other, please specify: [SKIP TO OTH_N1 (S8Q49)] 
IF AN ANSWER SELECTED FROM NEB_IDX01 (S8Q48_01)–NEB_IDX07 (S8Q48_07), SKIP TO SECTION 9. 
(0) NO 
(1) YES 
(6) DON’T KNOW	 [SKIP TO DK1_NEB (S8Q50)] 
(7) REFUSED	 [SKIP TO SECTION 7] 
OTH_N1 (S8Q49)	 ENTER OTHER MEDICATION. 
IF MORE THAN ONE MEDICATION IS GIVEN, ENTER ALL MEDICATIONS ON ONE LINE. 
________________________ ENTER TEXT 
DK1_NEB (S8Q50)	 In the past 3 months, which of these prescriptions medications {have you/has [the (AGE) year old/NAME]} 
taken using a nebulizer? 
Alupent or Metaproteronol? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK2_NEB (S8Q51)	 In the past 3 months, which of these prescriptions medications {have you/has [the (AGE) year old/NAME]} 
taken using a nebulizer? 
Ventolin, Proventil or Albuterol? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK3_NEB (S8Q52)	 In the past 3 months, which of these prescriptions medications {have you/has [the (AGE) year old/NAME]} 
taken using a nebulizer? 
Intal or Cromolyn? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
DK4_NEB (S8Q53)	 Did {you/[the (AGE) year old/NAME]} take a medication using a nebulizer that we have not mentioned? 
(0) NO	 [SKIP TO SECTION 7] 
(1) YES 
(6) DON’T KNOW	 [SKIP TO SECTION 7] 
(7) REFUSED	 [SKIP TO SECTION 7] 
DK5_NEB (S8Q54)	 Will you please tell me what that medication was? 
SPELL OUT: _____________________________________ 
Section 7. Family History of Asthma 
BRO_N (S9Q1) How many biological brothers [have you/has the (AGE) year old] ever had? 
__ __NUMBER 
(0) NONE 
(96) DON’T KNOW 
(97) REFUSED 
HELP SCREEN: RESPONDENTS WHO ARE ADOPTED AND DO NOT HAVE ANY HEALTH INFORMATION
 
REGARDING THEIR BIOLOGICAL PARENTS/SIBLINGS SHOULD BE CODED AS ‘‘DON’T KNOW.’’
 
PARENTS/SIBLINGS WHO ARE DECEASED SHOULD BE INCLUDED.
 
HALF-BROTHERS SHOULD BE INCLUDED.
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SIS_N (S9Q2) How many biological sisters [have you/has the (AGE) year old] ever had? 
__ __NUMBER 
(0) NONE 
(96) DON’T KNOW 
(97) REFUSED 
HELP SCREEN: RESPONDENTS WHO ARE ADOPTED AND DO NOT HAVE ANY HEALTH INFORMATION
 
REGARDING THEIR BIOLOGICAL PARENTS/SIBLINGS SHOULD BE CODED AS ‘‘DON’T KNOW.’’
 
PARENTS/SIBLINGS WHO ARE DECEASED SHOULD BE INCLUDED.
 
HALF-SISTERS SHOULD BE INCLUDED.
 
PARENTS1 (S9Q3) Were either of [your/the (AGE) year old’s] biological parents ever told they have asthma? 
(0) NO [SKIP TO BROASTH1 (S9Q5)] 
(1) YES 
(6) DON’T KNOW [SKIP TO BROASTH1 (S9Q5)] 
(7) REFUSED [SKIP TO BROASTH1 (S9Q5)] 
HELP SCREEN: RESPONDENTS WHO ARE ADOPTED AND DO NOT HAVE ANY HEALTH INFORMATION 
REGARDING THEIR BIOLOGICAL PARENTS/SIBLINGS SHOULD BE CODED AS ‘‘DON’T KNOW.’’ 
PARENTS/SIBLINGS WHO ARE DECEASED SHOULD BE INCLUDED. 
PARENTS2 (S9Q4)	 Who? 
(1) FATHER 
(2) MOTHER 
(3) BOTH 
(6) DON’T KNOW 
(7) REFUSED 
BROASTH1 (S9Q5)	 [IF BRO_N (S9Q1) = 0, 96, 97, SKIP TO SISASTH1 (S9Q7). ELSE IF BRO_N (S9Q1) > 1, SKIP TO 
BROASTH2 (S9Q6).] IF BRO_N (S9Q1) = 1, ASK: Was {your/the (AGE) year old’s} biological brother ever 
told that he had asthma? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
ALL SKIP TO SISASTH1 (S9Q7). 
BROASTH2 (S9Q6)	 How many of {your/the (AGE) year old’s} biological brothers were ever told they had asthma? 
__ _ _NUMBER 
(0) ZERO 
(96) DON’T KNOW 
(97) REFUSED 
HELP SCREEN: RESPONDENTS WHO ARE ADOPTED AND DO NOT HAVE ANY HEALTH INFORMATION 
REGARDING THEIR BIOLOGICAL PARENTS/SIBLINGS SHOULD BE CODED AS ‘‘DON’T KNOW.’’ 
PARENTS/SIBLINGS WHO ARE DECEASED SHOULD BE INCLUDED. 
SISASTH1 (S9Q7)	 [IF SIS_N (S9Q2) = 0, 96, 97, SKIP TO GRANDSCR (S9Q9). ELSE IF SIS_N (S9Q2) > 1, SKIP TO 
SISASTH2 (S9Q8).] [IF SIS_N = 1, ASK:] Was {your/the (AGE) year old’s} biological sister ever told that she 
had asthma? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
ALL SKIP TO GRANDSCR (S9Q9). 
SISASTH2 (S9Q8)	 How many of {your/the (AGE) year old’s} biological sisters were ever told they had asthma? 
__ __ NUMBER 
(0) ZERO 
(96) DON’T KNOW 
(97) REFUSED 
HELP SCREEN: RESPONDENTS WHO ARE ADOPTED AND DO NOT HAVE ANY HEALTH INFORMATION 
REGARDING THEIR BIOLOGICAL PARENTS/SIBLINGS SHOULD BE CODED AS ‘‘DON’T KNOW.’’ 
PARENTS/SIBLINGS WHO ARE DECEASED SHOULD BE INCLUDED. 
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GRANDSCR (S9Q9) Were any of {your/the (AGE) year old’s} biological grandparents ever told they had asthma? 
(0) NO [SKIP TO OTHER_T (S11Q1)] 
(1) YES 
(6) DON’T KNOW [SKIP TO OTHER_T (S11Q1)] 
(7) REFUSED [SKIP TO OTHER_T (S11Q1)] 
HELP SCREEN: RESPONDENTS WHO ARE ADOPTED AND DO NOT HAVE ANY HEALTH INFORMATION 
REGARDING THEIR BIOLOGICAL GRANDPARENTS SHOULD BE CODED AS ‘‘DON’T KNOW.’’ 
GRANDPARENTS WHO ARE DECEASED SHOULD BE INCLUDED. 
GRNDASTH Which of {your/the (AGE) year old’s} biological grandparents were told they had asthma?] 
(S9Q10_01) MOTHER’S MOTHER 
(S9Q10_02) MOTHER’S FATHER 
(S9Q10_03) FATHER’S MOTHER 
(S9Q10_04) FATHER’S FATHER 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HELP SCREEN: RESPONDENTS WHO ARE ADOPTED AND DO NOT HAVE ANY HEALTH INFORMATION 
REGARDING THEIR BIOLOGICAL GRANDPARENTS SHOULD BE CODED AS ‘‘DON’T KNOW.’’ 
GRANDPARENTS THAT ARE DECEASED SHOULD BE INCLUDED. 
Section 8. Demographic Information 
OTHER_T (S11Q1)	 [IF THE FIRST ASTHMA DETAILED INTERVIEW HAS BEEN DONE, SKIP TO R_ETH_2 (HISPANIC), 
ELSE ASK:] Now, I just have a few more general questions about you and your household. Do you have any 
other home phone numbers in addition to (AREA CODE AND TELEPHONE NUMBER CALLED)? Please do 
not include cellular phones in your answer. 
(0) NO	 [SKIP TO WO_SERVICE (S11Q7)] 
(1) YES 
(6) DON’T KNOW	 [SKIP TO WO_SERVICE (S11Q7)] 
(7) REFUSED	 [SKIP TO WO_SERVICE (S11Q7)] 
SEC_USE (S11Q2) Is this second number for home use only, for business use only, or for both home and business use? 
(1) HOME ONLY 
(2) BUSINESS ONLY	 [SKIP TO THIRD_TN (S11Q4)] 
(3) BOTH HOME AND BUSINESS 
(6) DON’T KNOW	 [SKIP TO WO_SERVICE (S11Q7)] 
(7) REFUSED	 [SKIP TO WO_SERVICE (S11Q7)] 
SEC_FAX (S11Q3)	 Is this second number used only for computer or fax communications? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED	 [SKIP TO WO_SERVICE (S11Q7)] 
THIRD_TN (S11Q4)	 Do you have a third home phone number in addition to the two you have already told me about? Please do not 
include cellular phones in your answer. 
(0) NO	 [SKIP TO WO_SERVICE (S11Q7)] 
(1) YES 
(6) DON’T KNOW	 [SKIP TO WO_SERVICE (S11Q7)] 
(7) REFUSED	 [SKIP TO WO_SERVICE (S11Q7)] 
THIRD_USE (S11Q5) Is this third number for home use only, for business use only, or for both home and business use? 
(1) HOME ONLY 
(2) BUSINESS ONLY	 [SKIP TO WO_SERVICE (S11Q7)] 
(3) BOTH HOME AND BUSINESS 
(6) DON’T KNOW	 [SKIP TO WO_SERVICE (S11Q7)] 
(7) REFUSED	 [SKIP TO WO_SERVICE (S11Q7)] 
THIRD_FAX (S11Q6) Is this third number used only for computer or fax communications? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
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NUM_PHON DERIVED. NUMBER OF TELEPHONES FOR HOME USE 
WO_SERVICE (S11Q7)	 During the past 12 months, has your household been without telephone service for 1 week or more? Please 
do not include cellular phones in your answer. 
(0) NO	 [SKIP TO R_ETH_2 (HISPANIC)] 
(1) YES 
(6) DON’T KNOW	 [SKIP TO R_ETH_2 (HISPANIC)] 
(7) REFUSED	 [SKIP TO R_ETH_2 (HISPANIC)] 
C11Q21_A (S11Q8)	 For how long was your household without telephone service in the past 12 months? 
(ENTER THE NUMBER, THEN CONTINUE TO THE NEXT SCREEN TO ENTER TIME PERIOD.) 
ENTER NUMBER __ __ __ 
(996) DON’T KNOW	 [SKIP TO R_ETH_2 (HISPANIC)] 
(997) REFUSED	 [SKIP TO R_ETH_2 (HISPANIC)] 
C11Q21 (S11Q9) ENTER PERIOD 
(1) DAYS 
(2) WEEK(S) 
(3) MONTH(S) 
(6) DON’T KNOW 
(7) REFUSED 
NOPHONE DERIVED. NUMBER OF DAYS WITHOUT TELEPHONE SERVICE 
R_ETH_2 (HISPANIC) (Are you/Is [the (AGE) year old]) of Hispanic or Latino origin? 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
R_RACE2	 Now, I’m going to read a list of categories. Please choose one or more of the following categories to describe 
(yourself/the (AGE) year old). (Are you/Is the (AGE) year old) White, Black or African-American, American Indian 
or Alaska Native, Asian, or Native Hawaiian or Other Pacific Islander? 
[MARK ALL THAT APPLY] 
(S2Q11_01) WHITE
 
(S2Q11_02) BLACK/AFRICAN-AMERICAN
 
(S2Q11_03) AMERICAN INDIAN
 
(S2Q11_04) ALASKA NATIVE
 
(S2Q11_05) ASIAN
 
(S2Q11_06) NATIVE HAWAIIAN
 
(S2Q11_07) PACIFIC ISLANDER
 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
HELP SCREEN: BE SURE TO READ THE ENTIRE QUESTION AS WRITTEN (INCLUDING ALL RESPONSE 
CATEGORIES). 
RACE INFORMATION IS COLLECTED BY SELF-IDENTIFICATION. IT IS ‘‘WHATEVER RACE YOU 
CONSIDER YOURSELF TO BE.’’ DO NOT TRY TO EXPLAIN OR DEFINE ANY OF THE GROUPS. 
MULTIPLE RACES MAY BE SELECTED. 
RACE DERIVED. RACE OF HOUSEHOLD MEMBER 
RACEARRAY DERIVED. ARRAY OF RESPONSES TO RACE VARIABLE 
R_EDUC (S2Q18)	 [IF THE SAMPLED PERSON IS UNDER 5, I.E. R_DOB (S2Q5) < 05, SKIP TO HEIGHT1 (S2Q14_1).] The 
next questions are about [your/the (AGE) year old’s] education level. What is the highest level of school that 
[you have/the (AGE) year old has] completed? 
_ _ ENTER HIGHEST GRADE COMPLETED (1–12) 
(13) GRADUATED HIGH SCHOOL 
(14) SOME POST-HIGH SCHOOL, BUT NOT BACHELOR’S DEGREE (B.A.) 
(15) COLLEGE GRADUATE—BACHELOR’S DEGREE OR B.A. 
(16) SOME GRADUATE OR PROFESSIONAL SCHOOL (WITH OR WITHOUT DEGREE) 
(17) PRESCHOOL/HEADSTART 
(18) KINDERGARTEN 
(19) NO FORMAL SCHOOLING 
(96) DON’T KNOW 
(97) REFUSED 
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HEIGHT1—FEET 
(S2Q14_1) 
HEIGHT2—INCHES 
(S2Q14_2) 
HEIGHT3—CENTIMETERS 
(S2Q14_3) 
How tall {are you/is [the (AGE) year old]}? 
__ __ feet / __ __inches OR __ __ __centimeters 
(96) DON’T KNOW (996) DON’T KNOW 
(97) REFUSED (997) REFUSED 
HELP SCREEN: WE ARE INTERESTED IN LOOKING AT HOW HEIGHT AND WEIGHT MAY BE RELATED 
TO ASTHMA FOR PEOPLE WHO DO AND DO NOT HAVE ASTHMA. 
HEIGHT DERIVED. RESPONDENT HEIGHT IN INCHES. 
WEIGHT1—POUNDS 
(S2Q15_1) 
WEIGHT2—KILOGRAMS 
(S2Q15_2) 
How much {do you/ does the (AGE) year old} weigh? 
__ __ __ pounds OR __ __ __kilograms 
(996) DON’T KNOW (996) DON’T KNOW 
(997) REFUSED (997) REFUSED 
HELP SCREEN: WE ARE INTERESTED IN LOOKING AT HOW HEIGHT AND WEIGHT MAY BE RELATED 
TO ASTHMA FOR PEOPLE WHO DO AND DO NOT HAVE ASTHMA. 
WEIGHT DERIVED. RESPONDENT WEIGHT IN POUNDS. 
BIRTHW1—POUNDS 
(S2Q16_1) 
BIRTHW2—OUNCES 
(S2Q16_2) 
BIRTHW3—GRAMS 
(S2Q16_3) 
[ASK BIRTHWT ONLY FOR SAMPLED PERSONS AGE (S2Q5) < 18.] How much did [the (AGE) year old] 
weigh at birth? 
__ __ pounds /__ __ ounces OR __ __ __ __ grams [SKIP TO INC_TOT (S10Q1)] 
(96) DON’T KNOW (9996) DON’T KNOW [SKIP TO BIRTHRF S2Q17] 
(97) REFUSED (9997) REFUSED [SKIP TO BIRTHRF (S2Q17)] 
BIRTHWEIGHT DERIVED. CHILD’S BIRTHWEIGHT IN GRAMS 
BIRTHRF At birth, did [the (AGE) year old/NAME] weigh less than 5 1/2 pounds? 
(S2Q17) [INTERVIEW NOTE: 5 1/2 pounds = 2500 GRAMS] 
(0) NO 
(1) YES 
(6) DON’T KNOW 
(7) REFUSED 
INC_TOT (S10Q1) What was the total combined income of your household in (FILL LAST CALENDAR YEAR), including 
income from all sources including wages, salaries, unemployment payments, public assistance, Social Security 
or retirement benefits, help from relatives, and so forth? Can you tell me that amount before taxes? 
$___________________ RECORD INCOME
 
(999999996) DON’T KNOW [SKIP TO RANGE_20 (S10Q3)]
 
(999999997) REFUSED [SKIP TO RANGE_20 (S10Q3)]
 
HELP SCREEN: RESPONDENT MAY GIVE A RANGE AS AN ANSWER TO THIS QUESTION. BE
 
PREPARED TO PROBE FOR A MORE ACCURATE ANSWER.
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RANGE_20 (S10Q3)	 For the purposes of this survey, it is important to get at least a range for the total income received by all 
members of your household in [FILL YEAR]. Would you say that the total combined income, before taxes, 
was above or below $20,000? 
(1) MORE THAN $20,000	 [SKIP TO RANGE_40 (S10Q9)] 
(2) $20,000	 [SKIP TO C11Q22 (S11Q11)] 
(3) LESS THAN $20,000	 [SKIP TO RANGE_10 (S10Q4)] 
(6) DON’T KNOW	 [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED	 [SKIP TO C11Q22 (S11Q11)] 
RANGE_10 (S10Q4)	 Was the total combined household income more or less than $10,000? 
(1) MORE THAN $10,000	 [SKIP TO RANGE_15 (S10Q6)] 
(2) $10,000	 [SKIP TO C11Q22 (S11Q11)] 
(3) LESS THAN $10,000	 [SKIP TO RANGE_7 (S10Q5)] 
(6) DON’T KNOW	 [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED	 [SKIP TO C11Q22 (S11Q11)] 
RANGE_7 (S10Q5) Was it more than $7,500? 
(0) NO	 [SKIP TO C11Q22 (S11Q11)] 
(1) YES	 [SKIP TO C11Q22 (S11Q11)] 
(6) DON’T KNOW	 [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED	 [SKIP TO C11Q22 (S11Q11)] 
RANGE_15 (S10Q6) Was it more than $15,000? 
(0) NO	 [SKIP TO RANGE_12 (S10Q8)] 
(1) YES	 [SKIP TO RANGE_17 (S10Q7)] 
(6) DON’T KNOW	 [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED	 [SKIP TO C11Q22 (S11Q11)] 
RANGE_17 (S10Q7) Was it more than $17,500? 
(0) NO	 [SKIP TO C11Q22 (S11Q11)] 
(1) YES	 [SKIP TO C11Q22 (S11Q11)] 
(6) DON’T KNOW	 [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED	 [SKIP TO C11Q22 (S11Q11)] 
RANGE_12 (S10Q8)	 Was it more than $12,500? 
(0) NO	 [SKIP TO C11Q22 (S11Q11)] 
(1) YES	 [SKIP TO C11Q22 (S11Q11)] 
(6) DON’T KNOW	 [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED	 [SKIP TO C11Q22 (S11Q11)] 
RANGE_40 (S10Q9) Was the total combined household income more or less than $40,000? 
(1) MORE THAN $40,000	 [SKIP TO RANGE_60 (S10Q10)] 
(2) $40,000	 [SKIP TO C11Q22 (S11Q11)] 
(3) LESS THAN $40,000	 [SKIP TO RANGE_30 (S10Q13)] 
(6) DON’T KNOW	 [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED	 [SKIP TO C11Q22 (S11Q11)] 
RANGE_60 S10Q10) Was the total combined household income more or less than $60,000? 
(1) MORE THAN $60,000	 [SKIP TO RANGE_75 (S10Q16)] 
(2) $60,000	 [SKIP TO C11Q22 (S11Q11)] 
(3) LESS THAN $60,000	 [SKIP TO RANGE_50 (S10Q11)] 
(6) DON’T KNOW	 [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED	 [SKIP TO C11Q22 (S11Q11)] 
RANGE_50 (S10Q11) Was the total combined household income more or less than $50,000? 
(1) MORE THAN $50,000	 [SKIP TO C11Q22 (S11Q11)] 
(2) $50,000	 [SKIP TO C11Q22 (S11Q11)] 
(3) LESS THAN $50,000	 [SKIP TO RANGE_45 (S10Q12)] 
(6) DON’T KNOW	 [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED	 [SKIP TO C11Q22 (S11Q11)] 
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RANGE_45 (S10Q12) Was the total combined household income more or less than $45,000? 
(1) MORE THAN $45,000 [SKIP TO C11Q22 (S11Q11)] 
(2) LESS THAN $45,000 [SKIP TO C11Q22 (S11Q11)] 
(6) DON’T KNOW [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED [SKIP TO C11Q22 (S11Q11)] 
RANGE_30 (S10Q13) Was the total combined household income more or less than $30,000? 
(1) MORE THAN $30,000 [SKIP TO RANGE_35 (S10Q14)] 
(2) $30,000 [SKIP TO C11Q22 (S11Q11)] 
(3) LESS THAN $30,000 [SKIP TO RANGE_25 (S10Q15)] 
(6) DON’T KNOW [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED [SKIP TO C11Q22 (S11Q11)] 
RANGE_35 (S10Q14) Was the total combined household income more or less than $35,000? 
(1) MORE THAN $35,000 [SKIP TO C11Q22 (S11Q11)] 
(2) LESS THAN $35,000 [SKIP TO C11Q22 (S11Q11)] 
(6) DON’T KNOW [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED [SKIP TO C11Q22 (S11Q11)] 
RANGE_25 (S10Q15) Was the total combined household income more or less than $25,000? 
(1) MORE THAN $25,000 [SKIP TO C11Q22 (S11Q11)] 
(2) LESS THAN $25,000 [SKIP TO C11Q22 (S11Q11)] 
(6) DON’T KNOW [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED [SKIP TO C11Q22 (S11Q11)] 
RANGE_75 (S10Q16) Was the total combined household income more or less than $75,000? 
(1) MORE THAN $75,000 [SKIP TO C11Q22 (S11Q11)] 
(2) $75,000 [SKIP TO C11Q22 (S11Q11)] 
(3) LESS THAN $75,000 [SKIP TO C11Q22 (S11Q11)] 
(6) DON’T KNOW [SKIP TO C11Q22 (S11Q11)] 
(7) REFUSED [SKIP TO C11Q22 (S11Q11)] 
BESTINCOME DERIVED. BEST INCOME VALUE 
C11Q22 (S11Q11) Please tell me your Zip Code. 
___ ___ ___ ___ ___ (00001–99995) 
(99996) DON’T KNOW 
(99997) REFUSED 
CLOSING STATEMENT 
Those are all the questions I have. I’d like to thank you on behalf of the Centers for Disease Control and Prevention 
for the time and effort you’ve spent answering these questions. If you have any questions about this survey, you may 
call my supervisor toll-free at 1–866–775–6858. If you have questions about your rights as a survey participant, you 
may call the chairman of the Institutional Review Board at 1–800–223–8118. Thanks again. 
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Summary of NAS Pretests 
The SLAITS 2003 NAS fielded a 
series of four pretests to determine the 
most effective data collection 
methodology for the main study—one 
that would obtain the highest possible 
response rates, produce asthma 
prevalence estimates, and gather 
high-quality analytic data on people 
with asthma. Although the basic 
questionnaire remained the same 
(particularly for the detailed asthma 
interview), the sampling and screening 
procedures varied substantially among 
the pretests. This appendix briefly 
summarizes each of the four pretests. 
Table VI provides detail on how specific 
elements differed by pretest. 
Pretest I 
Sample design—The Pretest I 
screening methodology collected 
demographic information (i.e., age, sex, 
race, and ethnicity) and asthma status 
for all household members to allow 
calculation of asthma prevalence rates. 
These items were administered at the 
beginning of the interview. The 
screening interview respondent was the 
household member who was determined 
to be most knowledgeable about the 
health of all members. Detailed 
interviews were conducted with up to 
one asthma-positive adult and one 
asthma-positive child. 
Data collection—The NIS advance 
letter in use at the time was mailed to 
address-matched cases. No mention of 
asthma was made in the letter. The 
pretest was conducted between 
September 17, 2001, and November 15, 
2001, in eight urban areas within the 
four pilot states initially chosen for the 
study (Jefferson County, Alabama; 
Chicago, Illinois; Dallas, El Paso, 
Houston, and Bexar Counties and 
Houston, Texas; and Santa Clara and 
San Diego Counties, California). 
Results—A total of 461 household 
screening interviews and 73 detailed 
asthma interviews were completed. The 
Pretest I interview completion rate was 
82.8%, the screener completion rate was 54.4%, and the resolution rate was 
82.6%. The unweighted CASRO 
response rate, equal to the product of 
these three components, was 37.2%. 
Because the screener completion rate 
was lower than anticipated, a second 
pretest was planned to examine ways to 
increase screener-level response. 
Pretest II 
Sample design—For Pretest II, the 
study design was modified in several 
ways. First, three new general 
recruitment questions related to 
‘‘breathing problems’’ were added at the 
beginning of the screening interview in 
an attempt to increase salience and 
respondent interest. The request for the 
most knowledgeable household 
respondent to come to the telephone to 
answer the household screening 
questions was eliminated. Instead, 
anyone over the age of 17 years who 
answered the telephone was asked to 
complete the screening interview. In 
households where no one had asthma, 
the person who answered the telephone 
provided the demographic information 
needed to develop prevalence rates. 
Finally, the screening interview time 
was reduced by shortening the informed 
consent script, revising the ethnicity 
question to yes or no format, and 
dropping a question that asked for the 
total number of people in the household 
(which was now derived from the 
household roster). No changes were 
made in the procedures for detailed 
interviews. 
Data collection—As in the first 
pretest, the NIS advance letter in use at 
the time was mailed to address-matched 
cases. However, for Pretest II, the letter 
was revised to note that some 
households might be asked questions 
about asthma. The second pretest was 
conducted from November 13, 2001, 
through January 7, 2002, in three urban 
areas (Jefferson County, Alabama; 
Chicago, Illinois; and Houston, Texas). 
Pretest II was designed and 
implemented prior to the actual 
completion of Pretest I. 
Results—A total of 313 household 
screening interviews and 47 detailed 
asthma interviews were completed in the 
second pretest. The interview completion rate was 95.5%. The 
screener completion rate was 68.0%, 
and the resolution rate was 84.7%. The 
unweighted CASRO response rate was 
55.0%. Though response rates in Pretest 
II were substantially higher than those 
of Pretest I, there was interest in testing 
other approaches to improve response 
rates. Therefore, a third pretest was 
fielded. 
Pretest III 
Sample design—The goal of Pretest 
III was to investigate additional methods 
to increase response. The data collection 
approach was changed to uncouple the 
NIS screener and interview and the 
NAS interview. Rather than proceeding 
directly to the NAS interview, 
households that completed the NIS 
screener and interview were mailed a 
separate NAS-specific advance letter 
and recontacted for NAS after 
approximately 3 weeks using an 
introduction that mentioned only NAS. 
In addition, known households that did 
not complete the NIS screener or 
interview during NIS data collection 
were contacted for the NAS after the 
NIS data collection period closed. 
The recontacted sample was divided 
into two groups to test differing content 
of advance letters and introductory 
scripts. The NAS-specific advance letter 
and introductory script for the first 
group had an asthma-specific focus. 
These items for the second group 
focused more generally on air quality 
and health. The second group also 
received two additional questions at the 
beginning of the survey asking about air 
quality in their neighborhood. This 
experiment was designed to determine 
whether the more general air quality 
focus might increase response in 
asthma-negative households. 
The final change implemented for 
the third pretest moved the initial 
demographic questions to the end of the 
survey for respondents eligible for the 
detailed interview. This change was 
intended to minimize the number of 
breakoffs occurring before a household 
member was sampled. 
Data collection—As noted above, 
separate NAS-specific advance letters 
were mailed to households identified 
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Table IV. NAS Pretest III unweighted response rates by group 
Interview  completion  rate  . . . . . . . .  76.2  79.5  77.9  
Screener completion rate . . . . . . . .  54.2  52.8  53.5  
Resolution rate. . . . . . . . . . . . . . .  77.9  77.9  77.9  
CASRO response rate . . . . . . . . . .  32.2  32.7  32.5  
Percent of Percent of Percent of 
Percentage rate asthma group air quality group total sample 
NOTES: NAS is National Asthma Survey. CASRO is the Council of American Survey Research Organizations. during earlier NIS administration. The 
third pretest was conducted from March 
6, 2002, through July 10, 2002, in four 
states (Alabama, California, Illinois, and 
Texas). Full-state samples were used for 
this pretest, as opposed to the urban 
samples used in the first two pretests. 
Results—A total of 5,529 household 
screening interviews and 981 detailed 
asthma interviews were completed in the 
third pretest. The overall interview 
completion rate was 77.9%. The 
screener completion rate was 53.5%, 
and the resolution rate was 77.9%. The 
unweighted CASRO response rate was 
32.5%. No significant differences were 
observed in the CASRO response rate 
between the asthma-focused and air 
quality-focused groups (Table IV). 
The changes implemented as part of 
the third pretest were unsuccessful in 
raising response rates. In fact, the 
response rates were lower than those 
observed in either of the previous 
pretests, so a fourth pretest was 
designed and implemented. 
Pretest IV 
Sample design—In Pretest IV, the 
NIS and NAS interviews were rejoined, 
and two separate screening approaches 
were tested. In the first screening 
approach (Approach A), all household 
members were rostered, one adult was 
sampled in all households, and one child 
was sampled in households with 
children. Once selected, the sampled 
persons were screened for asthma. If the Table V. NAS Pretest IV unweighted response ra
Percentage rate 
Per
App
Interview  completion  rate  . . . . . . . .  
Screener completion rate . . . . . . . .  
Resolution rate. . . . . . . . . . . . . . .  
8
5
8
CASRO response rate . . . . . . . . . .  3
NOTE: NAS is National Asthma Survey. CASRO is the Council of Amsampled adult or child had asthma, the 
adult (or, for a child, a parent or 
guardian) completed a detailed 
interview. A shorter screening interview, 
which included household environment 
questions and demographics, was 
administered to sampled respondents 
who screened negative for lifetime 
asthma. In the second screening 
approach (Approach B), households 
were immediately screened for the 
presence of asthma. In asthma-negative 
households, the interview was 
terminated. In asthma-positive 
households, a maximum of one adult 
and one child with asthma were 
randomly sampled for a detailed 
interview. 
Data collection—The NIS advance 
letter in use at the time was mailed to 
address-matched cases. As in Pretest I, 
no mention of asthma was made in the 
letter. The data collection for the fourth 
pretest took place between July 17, 
2002, and November 4, 2002. Full-state 
samples in Alabama, California, Illinois, 
and Texas were used for Pretest IV. 
Results—Among the 4,268 persons 
screened using Approach A, 250 detailed 
asthma interviews were completed. As 
Table V shows, the interview completion 
rate was 88.1%. The screener 
completion rate was 50.5%, and the 
resolution rate was 82.9%. The 
unweighted CASRO response rate was 
36.9%. Among the 2,800 households 
that were screened using Approach B, a 
total of 266 detailed asthma interviews tes 
cent of 
roach A 
Percent of 
Approach B 
8.1  
0.5  
2.9  
76.8  
84.5  
83.4  
6.9  54.1  
erican Survey Research Organizations. were completed. The interview 
completion rate was 76.8%. The 
screener completion rate was 84.5%, 
and the resolution rate was 83.4%. The 
unweighted CASRO response rate was 
54.1%. 
Conclusion 
A plan for main study data 
collection in 2003 was developed by 
incorporating selected design elements 
from the four pretests. A national study, 
with an estimated 10,000 completed 
screening interviews, would be fielded. 
In addition, a separate state-specific 
study would be fielded in four states 
used for the pretests—Alabama, 
California, Illinois, and Texas—with an 
estimated 12,000 screening interviews 
completed per state. The national study 
questionnaire synthesized and refined 
the previous pretest methodologies in 
that it retained the most successful 
elements of previous questionnaires, 
sampled only one person, and allowed 
proxy interviews for sampled 
respondents not immediately available. 
The questionnaire, which was most 
similar to the questionnaire used in 
Pretest IV, Approach A, was designed to 
produce prevalence rates and detailed 
analytical data on persons with asthma. 
The questionnaire chosen for the 
state-specific study was used in Pretest 
IV, Approach B, which gathered detailed 
analytical data for persons with asthma 
without allowing production of 
prevalence rates. 
Although Pretest II generated the 
highest response rates of the four 
pretests and could be used to calculate 
prevalence rates, it was not chosen for 
the main study because of the 
burdensome screening household roster 
process. This protocol collected 
demographic information (i.e., age, sex, 
race, and ethnicity) and asthma status 
for all household members at the 
beginning of the interview, which can be 
burdensome, especially to respondents 
who reside in large or transient 
households (See Table VI). 
Table VI. SLAITS 2003 National Asthma Survey: Summary of pretests 
Data  collection  period  
Pretest  I  
September  17,  2001–  
November  15,  2001  
Pretest  II  
November  13,  2001–  
January  7,  2002  
Pretest  III  
March  6,  2002–  
July  10,  2002  
Pretest  IV  
July  17,  2002–  
November  4,  2002  
Asthma  prevalence  . . . . . . . . . .  All  household  All  household  All  household  Approach  A:  One  adult  
members  screened  members  screened  members  screened  and  one  child  screened  
Approach  B:  Household  is  
immediately  screened  (any  household  
member)  
Number  of  household  Randomly  select  up  Randomly  select  up  to  Randomly  select  up  to  Approach  A:  Randomly  select  one  
members  sampled  for  detailed  to  two  with  asthma:  two  with  asthma:  one  two  with  asthma:  one  adult  and  one  child;  asthma  
interview  .  . . . . . . . . . . . . . . .  one  adult  and  one  adult  and  one  child  adult  and  one  child  status  unknown  
child  Approach  B:  Randomly  select  up  to  
two  with  asthma:  one  adult  and  
one  child  
Respondent  to  provide  
household  screening  
information  necessary  for  Any  household  member  Any  household  member  Any  household  member  
sampling . . . . . . . . . . . . . . . .  Most  knowledgeable  person  over  age  17  over  age  17  over  age  17  
Advance  letter  . . . . . . . . . . . . .  NIS  advance  letter;  no  NIS  advance  letter  that  Separate  NAS  advance  letter  NIS  advance  letter;  no  
mention  of  asthma  mentions  asthma  mailed  approximately  3  weeks  mention  of  asthma  
after  NIS  is  complete.  
Two  experimental  groups:  
asthma  and  air  quality  
Informed  consent  script  for  Standard  script  with  most  Shortened  and  moved  to  Shortened  and  moved  Approach  A:  Standard  script  
screening. . . . . . . . . . . . . . . .  knowledgeable  person  follow  initial  ‘‘breathing’’  to  follow  initial  with  most  knowledgeable  person  
providing  informed  consent  questions  ‘‘breathing’’  questions  providing  informed  consent  before  
before  screening  questions  screening  questions  
Approach  B:  After-asthma  screening,  
rostering,  and  sampling  of  respondents  
Total  number  of  persons  in  Separate  question  asking  Question  removed;  Question  removed;  Approach  A:  Derived  from  household  roster  
household  . . . . . . . . . . . . . . .  total  persons  in  household  information  derived  from  information  derived  Approach  B:  Not  determined  
household  roster  from  household  roster  
Hispanic  ethnicity  question  . . . . .  Detailed  Hispanic  categories  General  yes  or  no  question  General  yes  or  no  question  General  yes  or  no  question  
Breathing  and  air  quality  None  Addition  of  general  Addition  of  general  ‘‘breathing’’  None  
questions  . . . . . . . . . . . . . . . .  ‘‘breathing’’  questions  questions  plus  general  ‘‘air  
quality’’  questions  in  one-half  
of  the  sample  
Placement  of  demographic  Household  with  asthma:  Household  with  asthma:  Household  with  asthma:  Approach  A:  Household  
measures.  .  .  .  . . . . . . . . . . . .  telephone  information  and  telephone  information  and  age  and  sex  of  household  with  asthma:  asked  at  the  end  
income  at  end  of  survey;  income  at  end  of  survey;  all  members  after  initial  informed  of  the  detailed  asthma  interview  
all  others  after  initial  others  after  initial  informed  consent  script;  all  others  Household  without  asthma:  
informed  consent  script  consent  script  asked  at  the  end  of  detailed  Asked  after  informed  consent  
Household  without  asthma:  Household  without  asthma:  asthma  interview  Approach  B:  All  demographics  
All  demographics  asked  after  All  demographics  asked  after  Household  without  asthma:  asked  at  the  end  of  the  
informed  consent  informed  consent  All  demographics  asked  after  detailed  asthma  interview  
informed  consent  
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Table VI. SLAITS 2003 National Asthma Survey: Summary of pretests—Con. 
Pretest  I  Pretest  II  Pretest  III  Pretest  IV  
Data  collection  period  
September  17,  2001–  
November  15,  2001  
November  13,  2001–  
January  7,  2002  
March  6,  2002–  
July  10,  2002  
July  17,  2002–  
November  4,  2002  
Location  . . . . . . . . . . . . . . . .  Jefferson  County,  Alabama;  
Chicago,  Illinois;  Dallas,  
El  Paso,  and  Bexar  
Counties  and  Houston,  
Texas;  Santa  
Clara  and  San  Diego  
Counties,  California  
Jefferson  County,  Alabama;  
Chicago,  Illinois;  
Houston,  Texas  
California,  Illinois,  Alabama,  
and  Texas  state  samples  
California,  Illinois,  Alabama,  
and  Texas  state  samples  
Connection  to  NIS  . . . . . . . . . .  Occurs  immediately  after  
NIS  screener  or  interview  
Occurs  immediately  after  
NIS  screener  or  interview  
Minimum  of  3-week  delay  
after  NIS  screener  or  interview  
Occurs  immediately  after  
NIS  screener  or  interview  
NIS  unresolved  cases  . . . . . . . .  Finalized  with  NIS-level 
disposition  
Finalized  with  NIS-level  
disposition  
Dialed  for  NAS  after  the  
close  of  the  NIS  quarter  
Finalized  with  NIS-level  disposition  
NOTES: SLAITS is State and Local Area Integrated Telephone Survey. NIS is National Immunization Survey. NAS is National Asthma Survey. 
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 Advance letter for Pretest I 
FROM THE DIRECTOR 
NATIONAL CENTER FOR HEALTH STATISTICS 
Within the next few weeks, your household may be called to take part in an important national study about the health of children 
and teenagers. The survey is being conducted by the U.S. Department of Health and Human Services. 
We are relying on your help to make this study a success. Local, State, and federal health authorities depend on the results of this 
study to measure the progress of health care for the country. Although participation is completely voluntary and there is no penalty
for not answering any question, we hope you will agree to participate. The information we are gathering will help shape health 
care policy in the years ahead. 
Your telephone number was selected at random using scientific methods, and your address was obtained through commercial 
listings. This study is authorized by the Public Health Service Act [Secs. 306 & 2102 (a)(7)], and by law, information you provide
during the interview will be kept strictly confidential. The information reported in this survey will be summarized for research 
purposes only. 
You may call our toll-free telephone number (1–800–290–1296) to participate immediately or visit the study’s web site at 
http://www.cdc.gov/nis to learn more about the study. This study has been approved by the NCHS Institutional Review Board. If 
you have questions about your rights as a study participant, you may call Margot Palmer, Institutional Review Board chairman, 
toll-free at 1–800–223–8118. 
We appreciate your taking the time to talk to us. Thank you for your assistance. 
Sincerely, 
Edward J. Sondik, Ph.D. 
Director, National Center for Health Statistics 
Centers for Disease Control and Prevention 
If you prefer to contact us using a TTY, please call the AT&T Relay Service at 1–800–682–8786 and request that 1–800–290– 
1296 be called. 
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FROM THE DIRECTOR 
NATIONAL CENTER FOR HEALTH STATISTICS 
Within the next few weeks, your household will be called to take part in an important national study being conducted by the U.S. 
Department of Health and Human Services. This study, designed to help local, State, and federal health authorities understand 
how to improve health care services, is about health-related topics including asthma in adults and children and vaccinations for 
young children. 
Childhood immunization rates are at an all-time high of 78%, but many children have not received all of their immunizations. 
Asthma is one of the nation’s most common and costly chronic conditions, affecting more than 14.5 million Americans, including 
about 4.5 million children. The Department of Health and Human Services is committed to improving immunization and other 
health care services. 
You may call the study’s toll-free telephone number (1–866–775–6858) to participate immediately or to obtain more information 
about the study’s background and content. You may also visit the study’s web site at http://www.cdc.gov/nis for more information. 
If you have a child between 18 and 35 months of age, please take a moment to locate the child’s immunization records. They will 
help you during the interview. 
We are relying on your help to make this study a success. Although participation is completely voluntary and there is no penalty 
for not answering any question, we hope you will agree to participate. The information we are gathering will help shape health 
care policy in the years ahead. If you would like to learn more about your rights as a respondent, please contact the Chair of the 
Institutional Review Board at 1–800–223–8118. 
Your telephone number was selected at random using scientific methods, and your address was obtained through commercial 
listings. When the interviewer calls, you will be asked a few questions to determine whether or not your household is eligible for 
participation in this study. 
We appreciate your taking the time to talk to us. Thank you for your assistance. 
Sincerely, 
Edward J. Sondik, Ph.D. 
Director, National Center for Health Statistics 
Centers for Disease Control and Prevention 
If you prefer to contact us using a TTY, please call the AT&T Relay Service at 1–800–682–8786 and request that 1–866–775– 
6858 be called. 
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NIS advance letter 
FROM THE DIRECTOR 
NATIONAL CENTER FOR HEALTH STATISTICS 
Within the next few weeks, your household will be called to take part in an important national study being conducted by the U.S. 
Department of Health and Human Services. This study provides important information for measuring the progress of 
vaccination for young children for the country. 
Childhood immunization rates are at an all-time high of 78%, but many children have not received all of their immunizations. The 
Department of Health and Human Services is committed to improving immunization services and reducing the costs of vaccines. 
Local, State, and federal health authorities depend on the results of this study to measure the progress of immunization for the 
country. 
The results of this study also help local, State, and federal health authorities understand how to improve health care services for all 
children. Therefore, some households may be asked questions about the types of health and related services their children need or 
use. 
You may call Jim Murphy at the study’s toll-free telephone number (1–866–775–6858) to participate immediately or to obtain 
more information about the study’s background and content. You may also visit the study’s web site at http://www.cdc.gov/nis for 
more information. If you have a child between 18 and 35 months of age, please take a moment to locate the child’s immunization 
records. They will help you during the interview. 
We are relying on your help to make this study a success. Although participation is completely voluntary and there is no penalty 
for not answering any question, we hope you will agree to participate. The information we are gathering will help shape health 
care policy in the years ahead. If you would like to learn more about your rights as a respondent, please contact the Chair of the 
Institutional Review Board at 1–800–223–8118. 
Your telephone number was selected at random using scientific methods, and your address was obtained through commercial 
listings. When the interviewer calls, you will be asked a few questions to determine whether or not your household is eligible for 
participation in this study. 
We appreciate your taking the time to talk to us. Thank you for your assistance. 
Sincerely, 
Edward J. Sondik, Ph.D. 
Director, National Center for Health Statistics 
Centers for Disease Control and Prevention 
If you prefer to contact us using a TTY, please call the AT&T Relay Service at 1–800–682–8786 and request that 1–866–775– 
6858 be called. 
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Dear Resident, 
The National Center for Environmental Health and the National Center for Health Statistics, Centers for Disease Control and 
Prevention, are requesting your help for an important study about asthma comparing characteristics of people who do and do not 
have asthma. A professional interviewer will be contacting you soon to conduct an interview at your convenience. 
Asthma is one of the nation’s most common and costly chronic conditions, affecting more than 14.5 million Americans. Untreated 
or improperly treated asthma results in higher health care costs for everyone. This study will provide important information to help 
the National Center for Environmental Health improve health care for people with asthma and reduce health care costs overall. 
Your help in this study is voluntary, but we urge you to participate. Because we are talking to only a sample of households in your 
area, everyone’s participation is extremely important to the completeness and accuracy of the study’s results. The information you 
provide will be kept completely confidential, as required by law. No individual person or household will be identified in reports 
resulting from the study. 
We hope that you will take a few minutes to help with this important research, and thank you in advance for your time. You may 
call our toll-free telephone number (1–866–775–6858) to participate immediately. 
If you have any questions about the study, please call our toll-free number, 1–866–775–6858. This study has been approved by the 
National Center for Health Statistics Institutional Review Board. If you have questions about your rights as a study participant, 
you may call the Institutional Review Board chairman, toll-free at 1–800–223–8118. 
Sincerely, 
Richard Joseph Jackson, MD, MPH 
Director 
National Center for Environmental Health 
If you prefer to contact us using a TTY, please call the AT&T Relay Service at 1–800–682–8786 and request that 1–866–775– 
6858 be called. 
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Dear Resident, 
The National Center for Environmental Health and the National Center for Health Statistics, Centers for Disease Control and 
Prevention, are requesting your help for an important study about air quality and health. A professional interviewer will be 
contacting you soon to conduct an interview at your convenience. 
Your help in this study is voluntary, but we urge you to participate. Because we are talking to only a sample of households in your 
area, everyone’s participation is extremely important to the completeness and accuracy of the study’s results. The information you 
provide will be kept completely confidential, as required by law. No individual person or household will be identified in reports 
resulting from the study. 
Your telephone number was randomly selected from all possible telephone numbers in your area. We obtained your address from 
commercial listings in order to mail you this letter. 
We hope that you will take a few minutes to help with this important research, and thank you in advance for your time. You may 
call our toll-free telephone number (1–866–775–6858) to participate immediately. 
If you have any questions about the study, please call our toll-free number, 1–866–775–6858. This study has been approved by the 
National Center for Health Statistics Institutional Review Board. If you have questions about your rights as a study participant, 
you may call the Institutional Review Board chairman, toll-free at 1–800–223–8118. 
Sincerely, 
Richard Joseph Jackson, MD, MPH 
Director 
National Center for Environmental Health 
If you prefer to contact us using a TTY, please call the AT&T Relay Service at 1–800–682–8786 and request that 1–866–775– 
6858 be called. 
Series 1, No. 46 [ Page 115 Asthma-focused introductory script 
Hello, my name is [INTERVIEWER NAME]. I’m calling on behalf of the Centers for Disease Control and Prevention. We’re 
conducting a study regarding asthma, comparing characteristics of people who do and do not have asthma. Your telephone number 
has been selected at random. Your participation is voluntary and your answers will be kept private. 
Air quality-focused introductory script 
Hello, my name is [INTERVIEWER NAME]. I’m calling on behalf of the Centers for Disease Control and Prevention. We’re 
conducting a study regarding air quality and health. Your telephone number has been selected at random. Your participation is 
voluntary and your answers will be kept private. 
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FROM THE DIRECTOR 
NATIONAL CENTER FOR HEALTH STATISTICS 
Within the next few weeks, your household will be called to take part in an important national study being conducted by the U.S. 
Department of Health and Human Services. This study provides important information for measuring the progress of 
vaccination for young children for the country. 
Childhood immunization rates are at an all-time high of 78%, but many children have not received all of their immunizations. The 
Department of Health and Human Services is committed to improving immunization services and reducing the costs of vaccines. 
Local, State, and federal health authorities depend on the results of this study to measure the progress of immunization for the 
country. 
The results of this study also help local, State, and federal health authorities understand how to improve health care services for all 
children. Therefore, some households may be asked questions about the types of health and related services their children need or 
use. 
You may call Jim Murphy at the study’s toll-free telephone number (1–866–775–6858) to participate immediately or to obtain 
more information about the study’s background and content. You may also visit the study’s web site at http://www.cdc.gov/nis for 
more information. If you have a child between 18 and 35 months of age, please take a moment to locate the child’s immunization 
records. They will help you during the interview. 
We are relying on your help to make this study a success. Although participation is completely voluntary and there is no penalty 
for not answering any question, we hope you will agree to participate. The information we are gathering will help shape health 
care policy in the years ahead. If you would like to learn more about your rights as a respondent, please contact the Chair of the 
Institutional Review Board at 1–800–223–8118. 
Your telephone number was selected at random using scientific methods, and your address was obtained through commercial 
listings. When the interviewer calls, you will be asked a few questions to determine whether or not your household is eligible for 
participation in this study. 
We appreciate your taking the time to talk to us. Thank you for your assistance. 
Sincerely, 
Edward J. Sondik, Ph.D. 
Director, National Center for Health Statistics 
Centers for Disease Control and Prevention 
If you prefer to contact us using a TTY, please call the AT&T Relay Service at 1–800–682–8786 and request that 1–866–775– 
6858 be called. 
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Advance Letters 
Advance letter for cases in the NIS and NAS sample 
FROM THE DIRECTOR 
NATIONAL CENTER FOR HEALTH STATISTICS 
Within the next few weeks, your household will be called to take part in an important national study being conducted by the U.S. 
Department of Health and Human Services. This study provides important information for measuring the progress of 
vaccination for young children for the country. 
Childhood immunization rates are at an all-time high of 78%, but many children have not received all of their immunizations. The 
Department of Health and Human Services is committed to improving immunization services and reducing the costs of vaccines. 
Local, State, and federal health authorities depend on the results of this study to measure the progress of immunization for the 
country. 
The results of this study also help local, State, and federal health authorities understand how to improve health care services. 
Therefore, some households may be asked questions about asthma and other health-related topics or services. 
You may call Jim Murphy at the study’s toll-free telephone number (1–866–775–6858) to participate immediately or to obtain 
more information about the study’s background and content. You may also visit the study’s web site at http://www.cdc.gov/nis for 
more information. If you have a child between 18 and 35 months of age, please take a moment to locate the child’s immunization 
records. They will help you during the interview. 
We are relying on your help to make this study a success. Although participation is completely voluntary and there is no penalty 
for not answering any question, we hope you will agree to participate. The information we are gathering will help shape health 
care policy in the years ahead. 
Your telephone number was selected at random using scientific methods, and your address was obtained through commercial 
listings. When the interviewer calls, you will be asked a few questions to determine whether or not your household is eligible for 
participation in this study. 
This study is authorized by the Public Health Service Act, and by law, information you provide during the interview will be kept 
strictly confidential. The information reported in this survey will be summarized for research purposes only. 
We appreciate your taking the time to talk to us. Thank you for your assistance. 
Sincerely, 
Edward J. Sondik, Ph.D. 
Director, National Center for Health Statistics 
Centers for Disease Control and Prevention 
If you prefer to contact us using a TTY, please call the AT&T Relay Service at 1–800–682–8786 and request that 1–866–775– 
6858 be called. 
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FROM THE DIRECTOR 
NATIONAL CENTER FOR ENVIRONMENTAL HEALTH 
Dear Resident, 
The National Center for Environmental Health and the National Center for Health Statistics, Centers for Disease Control and 
Prevention, are requesting your help in an important health study about asthma. A professional interviewer will be contacting you 
soon to conduct a telephone interview at your convenience. If no one in your household has asthma, we have only a few questions 
about your household so that people with and without asthma can be compared. For most households, this interview will be very 
brief. 
Asthma is one of the nation’s most common and costly chronic conditions, affecting more than 14.5 million Americans. Untreated 
or improperly treated asthma results in higher health care costs for everyone. Your participation in this study will provide 
important information to assist the National Center for Environmental Health in improving the health of people with asthma and in 
reducing the cost of health care. 
Your telephone number was selected at random using scientific methods, and your address was obtained through commercial 
listings. Your participation in this study is completely voluntary and there is no penalty for not answering any question. All 
information you provide will be kept confidential as required by law. No individual person or household will be identified in any 
reports resulting from the study. 
We hope that you will take a few minutes to help with this important research, and thank you in advance for your time. You may 
call our toll-free telephone number (1–866–775–6858) to participate immediately if you want. 
We appreciate your taking the time to talk to us. Thank you for your assistance. 
Sincerely, 
Henry Falk, M.D., M.P.H., Director 
National Center for Environmental Health 
You may have questions about your rights as a participant in this research study. If so, please call the office of the Institutional 
Review Board at the National Center for Health Statistics, toll-free, at 1–800–223–8118. Please leave a brief message with your 
name and phone number. Say that you are calling about Protocol #2001–06. Your call will be returned as soon as possible. 
If you prefer to contact us using a TTY, please call the AT&T Relay Service at 1–800–682–8786 and request that 1–866–775– 
6858 be called. 
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Disposition Code Frequencies and Unweighted Response Rate Calculations Table VII. SLAITS 2003 National Asthma Survey: National study case disposition frequencies 
Disposition 
Sample 
category code Number 
Percent of 
total sample 
Total number of phone lines in the sample . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
No contact . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
3 + fax or modem prior to any contact . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
2 + temporarily not in service  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Nonworking number  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Number changed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Answering machine—known household . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Answering machine—nonresidential . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Answering machine—residential status unknown . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Answering service—nonresidential . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Spanish case—residential status unknown . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other language case—residential status unknown . . . . . . . . . . . . . . . . . . . . . . . . . .  
Physical or mental impairment case—residential status unknown . . . . . . . . . . . . . . . . .  
Appointment at introduction—residential status unknown . . . . . . . . . . . . . . . . . . . . . .  
Callback at introduction—residential status unknown . . . . . . . . . . . . . . . . . . . . . . . . .  
Hangup during introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Refusal at introduction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Callback—known household . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Appointment—known household . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Refusal—known household. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
NIS-level callback . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
NIS-level appointment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
NIS-level refusal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Not residential . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Refusal prior to NAS screening . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Callback prior to NAS screening . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Appointment prior to NAS screening . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
 Refusal at or prior to NAS item BATH_FAN (S7Q16)1 . . . . . . . . . . . . . . . . . . . . . . . .  
Callback at or prior to NAS item BATH_FAN (S7Q16)1 . . . . . . . . . . . . . . . . . . . . . . . .  
Refusal—partial interview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Callback—partial interivew . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Emancipated minor household—known household, unknown eligibility; interviews were not 
conducted in households in which no one over the age of 17 years resided.. . . . . . . . . .  
Other language case—known household, unknown eligibility . . . . . . . . . . . . . . . . . . . .  
Other language case—known eligible household . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Screened—asthma-negative household . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Completed household interview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Converted household interview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
GENESYS IDplus—resolved numbers (nonworking, business, and modem numbers) . . . . .  
. . .  
UH 
Z 
Z 
Z 
Z 
UO  
Z 
UH 
Z 
UH 
UH 
UH 
UH 
UH 
UH 
UH 
UO 
UO 
UO 
UO 
UO 
UO 
Z 
UO 
UO 
UO 
R 
R 
P 
P 
UO 
UO 
Y 
X  
I 
I 
Z 
55,204  
4,692 
913 
799 
3,227 
288 
91 
262 
1,705 
5
2
4
6
502 
88 
1,337 
3,290 
222 
73 
295 
3
2
22 
1,967 
2,469 
370 
154 
10 
218 
11 
23 
24 
430 
19 
8,852  
870 
51 
21,908 
100.00
 
8.50
 
1.65
 
1.45
 
5.85
 
0.52
 
0.16
 
0.47
 
3.09
 
0.91
 
0.16
 
2.42
 
5.96
 
0.40
 
0.13
 
0.53
 
0.04
 
3.56
 
4.47
 
0.67
 
0.28
 
0.02
 
0.39
 
0.02
 
0.04
 
0.04
 
0.78
 
0.03
 
16.04 
  
1.58
 
0.09
 
39.69
 
. . . Category not applicable.
 
1The variable BATH_FAN (S7Q16) denotes the point at which a sampled respondent interview is considered a ‘‘partially complete’’ interview (also known as ‘‘partial complete’’). That is, sampled-

respondent cases need to complete at least through the variable BATH_FAN (S7Q16) and proxy-respondent cases need to complete at least through the variable S_INSIDEP (S7Q10P) for these
 
cases to be considered partially completed interviews (in contrast to full interviews, where all questions are asked).
 
NOTES: SLAITS is State and Local Area Integrated Telephone Survey. NIS is National Immunization Survey. NAS is National Asthma Survey.
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Table VIII. Unweighted response rate calculations for the National Asthma Survey, national sample: 2003 
Calculation of response rates 
Calculated 
rate (percent) Formula 
Interview  completion  rate  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  79.50  (I+P)/(I+P+R+Y) 
Screener completion rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  70.80  (I+P+R+X+Y)/(I+P+R+X+Y+UO) 
Resolution rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  78.90  (I+P+R+X+Y+UO+Z)/(I+P+R+X+Y+UO+Z+UH) 
CASRO response rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  44.40  .  .  .  
. . . Category not applicable. 
NOTES: Formulas based on letter codes identified in Table VII, ‘‘Design and Operation of the National Asthma Survey,’’ Vital and Health Statistics series report, vol 1, no 46. CASRO is the Council of 
American Survey Research Organizations. 
Table IX. SLAITS 2003 National Asthma Survey: Four-state study case disposition frequencies 
Sample Percent of 
Disposition category code Number total sample 
Total  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  .  .  .  210,109 100.00 
No contact . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  UH 18,962 9.02 
3 + fax or modem prior to any contact . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Z 3,063 1.46 
2  +  temporarily  not  in  service  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Z 3,131 1.49 
Nonworking  number  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Z 14,768 7.03 
Number changed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Z 1,359 0.65 
Answering machine—known household . . . . . . . . . . . . . . . . . . . . . . . . . . . .  UO 379 0.18 
Answering machine—nonresidential. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Z 1,020 0.49 
Answering machine—residential status unknown . . . . . . . . . . . . . . . . . . . . . .  UH 6,514 3.10 
Answering service—nonresidential . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Z 28 0.01 
Answering service—residential status unknown . . . . . . . . . . . . . . . . . . . . . . .  UH 4  0.00  
Spanish case—residential status unknown . . . . . . . . . . . . . . . . . . . . . . . . . .  UH 33 0.02 
Other language case—residential status unknown . . . . . . . . . . . . . . . . . . . . .  UH 58 0.03 
Physical or mental impairment case—residential status unknown . . . . . . . . . . . .  UH 28 0.01 
Appointment at introduction—residential status unknown . . . . . . . . . . . . . . . . .  UH 1,961 0.93 
Callback at introduction—residential status unknown . . . . . . . . . . . . . . . . . . . .  UH 281 0.13 
Hangup during introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  UH 5,140 2.45 
Refusal at introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  UH 7,843 3.73 
Callback—known household . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  UO 1,323 0.63 
Appointment—known household . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  UO 334 0.16 
Refusal—known household . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  UO 1,199 0.57 
NIS-level callback . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  UO 37 0.02 
NIS-level appointment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  UO 7  0.00  
NIS-level refusal. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  UO 216 0.10 
Not residential . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Z 6,302 3.00 
Refusal prior to NAS screening . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  UO 4,572 2.18 
Callback prior to NAS screening . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  UO 645 0.31 
Appointment prior to NAS screening . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1 UO 84 0.04 
Refusal at or prior to NAS item BATH_FAN (S7Q16) . . . . . . . . . . . . . . . . . . .  R 1,673 0.80 
Callback at or prior to NAS item BATH_FAN (S7Q16)1 . . . . . . . . . . . . . . . . . . .  R 334 0.16 
Appointment at or prior to NAS item BATH_FAN (S7Q16)1 . . . . . . . . . . . . . . . .  R 183 0.09 
Refusal—partial interview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  P 84 0.04 
Callback—partial interivew . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  P 20 0.01 
Appointment—partial interview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  P 9  0.00  
Emancipated minor household—known household, unknown eligibility; interviews 
were not conducted in households in which no one over the age of 17 years 
resided. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  UO 88 0.04 
Other language case—known household, unknown eligibility . . . . . . . . . . . . . . .  UO 1,260 0.60 
Other language case—known eligible household. . . . . . . . . . . . . . . . . . . . . . .  Y 10 0.00 
Physical or mental impairment case—known eligible household . . . . . . . . . . . . .  R 8  0.00  
Screened—asthma-negative household . . . . . . . . . . . . . . . . . . . . . . . . . . . .  X 40,852 19.44 
Completed household interview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  I 4,664 2.22 
Converted household interview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  I 348 0.17 
GENESYS IDplus—resolved numbers (nonworking, business, and modem 
numbers)  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Z 81,285 38.69 
. . . Category not applicable.
 
1The variable BATH_FAN (S7Q16) denotes the point at which a sampled respondent interview is considered a ‘‘partially complete’’ interview (also known as ‘‘partial complete’’). That is, sampled-

respondent cases need to complete at least through the variable BATH_FAN (S7Q16) and proxy-respondent cases need to complete at least through the variable S_INSIDEP (S7Q10P) for these
 
cases to be considered partially completed interviews (in contrast to full interviews, where all questions are asked).
 
NOTES: SLAITS is State and Local Area Integrated Telephone Survey. NIS is National Immunization Survey. NAS is National Asthma Survey.
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Table X. Unweighted response rate calculations for the National Asthma Survey, four-state sample: 2003 
Calculated 
rate 
Calculation of response rates (percent) Formula 
Interview completion rate . . . . . . . . . . . . . . . . . .  69.90  (I+P)/(I+P+R+Y)
 
Screener completion rate . . . . . . . . . . . . . . . . . .  82.60  (I+P+R+X+Y)/(I+P+R+X+Y+UO)
 
Resolution rate . . . . . . . . . . . . . . . . . . . . . . . .  80.60  (I+P+R+X+Y+UO+Z)/(I+P+R+X+Y+UO+Z+UH)
 
CASRO response rate. . . . . . . . . . . . . . . . . . . .  46.50  . . . 
  
. . . Category not applicable. 
NOTES: Formulas based on letter codes identified in Table IX, ‘‘Design and Operation of the National Asthma Survey,’’ Vital and Health Statistics series report, vol 1, no 46. CASRO is the Council of 
American Survey Research Organizations. 
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Weighted Frequencies and Percentages for Selected Variables Table XI. Unweighted and weighted estimates of the frequency and percentage of persons diagnosed with asthma during their lifetime 
(ASTHSTAT), national sample, all ages: NAS, 2003 
Standard error 
Weighted estimate of weighted 
of number of estimate of Standard error 
Unweighted number persons of all number of Percent of of percent of 
of persons of all ages with persons of all persons with persons with 
Reporting status of adult data ages with asthma asthma ages with asthma asthma asthma 
Self-reported responses only; excludes proxy 
responses . . . . . . . . . . . . . . . . . . . . . .  919  30,877,453 1,143,131.27 11.08 0.40 
Self-reported and proxy-reported responses . 976 30,877,453 1,099,091.58 11.08 0.39 
NOTE: NAS is National Asthma Survey. 
Table XII. Unweighted and weighted estimates of the frequency and percentage of persons of all ages who had an asthma episode or attack 
in the 12 months prior to the date of interview (S4Q5), four-state sample (weight_int): NAS, 2003 
Weighted estimate
 Standard error of
 Standard error
 
Unweighted number
 of number of
 weighted estimate
 of percent of
 
of asthmatic
 asthmatic persons
 of asthmatic
 Percent of asthmatic
 asthmatic persons
 
persons who
 who had
 persons who had
 persons who had
 who had an
 
had an asthma
 an asthma attack
 an asthma attack
 an asthma attack
 asthma attack
 
attack in the
 in the past
 in the past
 in the past
 in the past
 
Four-state sample past 12 months
 12 months
 12 months
 12 months
 12 months
 
Total  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2,896  4,418,991.02 97,708.02 64.33 1.05
 
Alabama . . . . . . . . . . . . . . . . . . . . . . . . . . . .  790  270,955.64 9,291.01 66.36 1.71
 
California . . . . . . . . . . . . . . . . . . . . . . . . . . . .  676  2,155,905.86 81,894.68 62.68 1.79
 
Illinois . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  641  671,753.18 27,828.96 63.34 1.82
 
Texas . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  789  1,320,376.34 44,489.82 67.35 1.64
 
NOTE: NAS is National Asthma Survey. 
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